measure_id,measure_name,location_id,location_name,sex_id,sex_name,age_id,age_name,cause_id,cause_name,metric_id,metric_name,year,val,upper,lower
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,136146.38760340962,141429.00855706827,131772.48465450486
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.00047137461893135565,0.0005144794004191785,0.00043044505873619386
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,14.04777200929892,14.592840123663532,13.596466671723633
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,823706.5526085399,847026.4084272243,788768.942537437
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.002852931518818761,0.00315296911852475,0.0025594156711760832
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,84.9911779320731,87.39735281190063,81.38626714840744
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,660739.9888210925,689970.6078639188,617897.0707018614
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.002287886486433565,0.002522381933197625,0.002043858936744609
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,68.17606316095149,71.19211874077654,63.75547179201125
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,1450299.8216364728,1486545.99913974,1406697.364919538
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.005024364150340105,0.005573856362343165,0.004481618812734596
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,149.64393545881964,153.3838660345592,145.1449738500176
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,162759.04492272678,171326.21501723063,154273.03083487487
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.0005633469773794446,0.0006119959658891635,0.0005155422229109704
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,16.793702688505622,17.67767511238696,15.918104053299107
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,113671.23998803034,116660.18273170045,108885.09471126401
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,0.0003938236634792882,0.0004412901554230982,0.0003476491334951557
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,11.728755286682034,12.037158520517648,11.234914217264556
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,142095.80525240913,147963.91815499432,136079.03395993102
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.0004921107819946167,0.0005443263540764272,0.0004431302245218109
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,14.66164112615498,15.267121107162389,14.04082236748883
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,484178.6908174572,567332.0621101046,439558.856749351
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.000444773959587961,0.0005278424411442914,0.0003958595495159262
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,19.21655276420862,22.516824290551813,17.445637579460694
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,1498805.00648345,2005175.5601574508,1156510.953797114
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.0013765812818077908,0.0018108041830989423,0.001071914057929614
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,59.4860245537076,79.58334946176835,45.90072671002017
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,315847.0233262299,367844.4190503234,266088.3691885895
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.00029006785819287345,0.000337088916634827,0.00024334578337014285
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,12.535642530899825,14.599365527148342,10.560772878752196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,84140.8620590801,102551.67163771854,63977.63915864221
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,7.728128237249491e-05,9.566293909419491e-05,5.896224021503897e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,3.339464016176429,4.070170055928779,2.5392064994555086
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,640843.5146826447,882494.5282753607,403387.49310662097
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0005888534139805111,0.0008159759831300785,0.0003752933713016541
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,25.43441800940973,35.02529745391554,16.01003347053068
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,2007504.7296822951,2323868.2074428946,1790834.775855028
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.0018436599438944109,0.002128414062772272,0.0016225659056089174
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,79.67579179745927,92.23193187208958,71.07638484480992
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,321191.66108375543,421377.0086875728,242468.64377019447
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.0002951095256171076,0.00038930160972308397,0.00022337327615205388
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,12.747765690016287,16.724018786117906,9.623330342790139
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2013,2937127.7622349765,3555041.5860158615,2375097.059390338
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.002697013653308919,0.003195173535469745,0.0021886899480127327
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2013,116.57157096880513,141.09593320038465,94.26515215866561
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,1972969.1518427366,2218127.860603219,1633364.345724372
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0018123990146460712,0.0020936786003369493,0.001494050750701024
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,78.30511033959543,88.03520658680348,64.82654591798851
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,64753.75990193678,101723.4821211072,44402.007502696346
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,5.931554470285182e-05,9.252533078800875e-05,4.100324829841186e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,2.570009931117772,4.037300068367252,1.7622698730746915
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,1248492.2683979534,1287711.924462263,1190446.739797152
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.004323992821369921,0.004759141940139121,0.0038695469270063243
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,128.8211538371192,132.86789203100685,122.83193615535042
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,569180.9358949187,586532.3030501732,540149.5529944226
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.0019719082958497003,0.0022083812534842906,0.0017332593271888667
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,58.728873826476566,60.51921181588159,55.733375706549765
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2014,1851644.4620940606,1919038.8782518362,1773862.5793619547
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.006414249432498175,0.007135578393171992,0.005739685253417233
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2014,191.05522888751892,198.00907767888089,183.02958697142552
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,770707.9581258614,794193.4814776897,740308.7199976764
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.0026696283905534883,0.0029450217922398617,0.0023767770168956082
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,79.52270987198251,81.94597855632384,76.38607456348575
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,284980.72965252964,304318.19723391184,264479.5706746511
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,0.000986336569032491,0.0010816574336256594,0.0008884277946765648
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,29.4047046541111,31.39997122417809,27.289366801104283
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,1618907.3570238473,1762520.2834132127,1496124.9709218217
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.0011693203750533978,0.0012988669638591868,0.0010549843921749953
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,37.523838063285844,40.85256973545261,34.67792699053232
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,23851250.20151535,26033225.221177574,21736184.67528873
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.017228530338151683,0.019196957316759168,0.015103336047383745
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,552.8361127556425,603.4110125117712,503.81207444052285
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2014,8450661.3033131,9046595.154514404,7917995.806655368
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.006103831148080314,0.00669413252185567,0.005516672786181996
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,195.87362111698974,209.68647163736622,183.5272359135591
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,4812784.232115738,5206869.64056542,4466091.753211716
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.0034771315957528603,0.0038599450995537065,0.003086417827703863
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,111.55310115548872,120.68740830753909,103.51729084200093
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,899642.7134840393,1034356.782176638,746401.4165574134
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.0006498486485129949,0.000756657005186415,0.0005369132644280333
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,20.85236523827401,23.97483477091013,17.300462415957103
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,1891528.4158392565,2287112.4555119295,1557828.6345295655
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.0013660292500008717,0.001641691703118794,0.001104692481825054
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,43.84278424587476,53.01182741606963,36.108125124528655
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,10933274.179508785,11713972.264713429,10148685.971640423
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.007896315475945076,0.008681319324325781,0.007076871066081256
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,253.41685429584996,271.51226191657435,235.23127948164978
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,3483078.8999828547,3711052.7617041613,3198343.6933185793
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.0025160735331382295,0.0027853551597886196,0.002240929417055785
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,80.73253113437983,86.01662242766943,74.13279722160775
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,1815385.3173803934,1966583.1971940137,1674573.108368123
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.0013112303401077226,0.0014471966846228614,0.001173265160422058
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,42.077901725691625,45.58244121216877,38.81408647067689
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,1536264.9162315067,1651555.7526016315,1419534.791316356
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.0011099400842143723,0.0012444808390056155,0.0009855642961223061
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,35.608310561361705,38.280578776935435,32.90268180168046
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,2103062.4015590297,2482872.409253008,1590268.275654382
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0015193242255811376,0.001775470145455107,0.0012000125667989223
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,48.7458239353245,57.54924876484934,36.860027223878234
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,4233626.772432398,4554919.884533151,3886408.47893788
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.00305823666701838,0.0033836692740983245,0.002710192149991803
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,98.12910216257956,105.57619334850224,90.0811042575908
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,379489.1980307329,456308.16960980353,276122.7560254792
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.0002741216809019509,0.00032928540486600803,0.00020070423858134398
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,8.795988943956383,10.576537186704748,6.400110258153352
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,546875.7272976758,624107.1654640352,431935.6052717068
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.00039512829739427155,0.0004600384914203413,0.00031570412915639856
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,12.675756980674066,14.465865578658807,10.011617796202353
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,2020930.553135749,2266349.196881704,1811674.729782047
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0014601665055891024,0.0016685998114057677,0.0012832725496920475
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,46.84213119669904,52.530566304291746,41.99189588505107
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,220690.97789922796,238545.52793200559,205253.59379499752
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.00015937629418686947,0.00017528091692055477,0.00014343292857265587
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,5.115284998112979,5.529126618645506,4.757469648930305
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,1281532.3054263252,1370677.3489231295,1206178.0257869926
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.0009255775860881214,0.001012713687826658,0.0008423414725925376
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,29.703991703447702,31.770239757609414,27.95739281729521
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,1577670.9622888963,1823663.2759940047,1439456.029273696
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.0011393166420292416,0.0013373583185744627,0.0010070147458160236
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,36.56804044359212,42.26977235816731,33.36442614047056
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,4288422.652567909,5336378.61855823,3382524.0918804035
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.0030975751049265236,0.003930762617756928,0.0024737160534146377
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,99.399188263442,123.68923166503971,78.40182189437877
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,650781.2826695506,723028.0453961727,549616.9519691607
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.0004698127792702413,0.0005255659119344526,0.0003950406789017672
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,15.08413150361014,16.758702820732434,12.73929444637376
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,232102.35029420163,251575.54528621485,207139.61113678926
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,0.00016767120711440474,0.00018601004828283218,0.00014628930107778686
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,5.379783450091123,5.831142826700796,4.801184694767175
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,572769.6347306361,855246.1164348358,412715.5607080782
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.00041391995609086187,0.000621640211553625,0.00029654950552928484
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,13.275938816357566,19.823318881169385,9.566126065841335
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,38020.62718643722,41132.66891147013,35309.41715114885
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.0001316424333989769,0.00014597676520847945,0.00011820619817446871
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,3.923020740891449,4.244125497368977,3.64327435088073
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,324629.59291728836,334347.82938677067,313577.62605941243
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.0011244653789949136,0.0012358258144070547,0.0010071331020446626
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,33.49572903878782,34.49847007847974,32.355371858500206
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,289645.08896557486,298787.8637546564,280493.0703016054
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0010033072310065014,0.0011104328202055458,0.0008939633366657863
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,29.88597967985746,30.82934378984411,28.941661774113275
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,53539.31980834324,57471.64607354639,49381.376240600395
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,0.00018543366731381544,0.00020877050334298315,0.0001645184489251071
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,5.524260844815188,5.930003691262688,5.095238493981111
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,1023918.0387451383,1043741.7158737216,987346.6514989843
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.0035474984353787596,0.00395273285447446,0.0031426690276880227
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,105.64927514933183,107.69470949092818,101.87578898387974
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,2146016.447515648,2216518.6591544882,2059705.2541355575
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.007434628131870349,0.008278707488798855,0.00657566160934129
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,221.42893626176894,228.70345167630012,212.5232283116912
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2014,857639.3584125135,878180.7383072474,822181.5218166215
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.002971324543880437,0.003311870183053232,0.0026317299985623125
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,88.49241162590104,90.61189952857087,84.83382315205169
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2013,17769510.22005902,19682371.563308,15784038.172314811
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.027906585434541317,0.030539917454963532,0.025258676812802913
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,1555.3318607729682,1722.7610220470735,1381.5472208876909
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,936240.4384004964,1041133.9963718394,808170.1527836991
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.001470425618451223,0.0016261248565083949,0.0012842739331063188
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,81.94736743754264,91.12850359055264,70.73761583655343
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,708059.397405004,832010.3772236421,507993.51880013244
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0006477285842246001,0.0007721975197877309,0.00046658931147624844
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,28.627724799018402,33.639217552057886,20.538811728498093
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,599152.5512301014,652582.0292079439,548378.5528822809
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.0005480242430877209,0.0006047092379447201,0.0004967623091258434
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,24.22448513798074,26.384705590262953,22.17162904006811
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,161313.00478693162,204917.46630705663,107237.83241276834
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.000147544227091373,0.00018255398119031895,0.0001001724672516534
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,6.522086034685517,8.28506881407163,4.335759352403583
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,115102.66270063931,137825.1869856907,85473.02929742681
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.00010530439605078747,0.0001310343910768135,7.719788770194084e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,4.653744252960412,5.572444258010107,3.455781209080641
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,869812.6710213468,992974.4586907402,757267.5213680137
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0007956557906391076,0.0009174881454313227,0.0006787700965892021
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,35.16761145174837,40.147196181612195,30.617270641996996
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,145757.49042664553,159393.16178339548,131889.54289913236
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00013331874967749706,0.0001487282295288995,0.00012001776102341479
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,5.893157182324379,6.444464386891592,5.332458762389718
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,428092.32505416137,471883.3089865692,383371.7500610268
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.0003914340632060389,0.00042994377835182647,0.0003528794115830563
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,17.308306782082767,19.078830895299426,15.500198142540171
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2014,126226903.25326167,134087847.61929965,118596744.5341314
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.09117302294850015,0.09957910403235246,0.08243105993973113
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,2925.7498005401085,3107.954669852691,2748.894195473144
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,8264207.8721163105,9200286.362473514,7371735.046759492
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.005968544971403238,0.006715102531673599,0.005218069857119668
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,191.55191096587012,213.24880272085116,170.86573295248616
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,15631926.797595263,17952064.470503934,13128511.190074988
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.011289800876756427,0.012994522635528524,0.009536750782490496
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,362.3245562664163,416.1018585592439,304.2991470580813
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2014,8297657.164437651,8997542.600655818,7575100.263967954
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.0059933855619992505,0.006733178191205343,0.00532152452028552
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,192.3272152616671,208.54950720293192,175.57943287183414
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,270216.91018050094,338349.79482850665,190790.76572113103
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.0002481092902383909,0.00031365778190226386,0.00017540612323159856
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,10.7246304117558,13.428754318170672,7.5722886734520545
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,572258.516337981,835215.1221286379,463008.03692749597
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0005252630220781213,0.0007684082641990276,0.0004209856048745421
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,22.712350176770844,33.14882659695773,18.376311350770152
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,822157.4083360885,1037935.9212249813,706608.8242726044
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0007550162485101717,0.0009495697369852171,0.0006388826212028173
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,32.63057940675029,41.19460598815798,28.0445753041396
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,139835.23617091688,176308.72737642593,89991.07532533308
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.00010098802000141052,0.0001265532057852335,6.505749657711776e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,3.241170493699544,4.0865711719163915,2.0858577997054657
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,633240.6816647912,854924.7222053588,502639.1880117636
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.0004571873033637566,0.0006193124267943706,0.0003620717056926386
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,14.677566749438377,19.815869446234736,11.650420521831661
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,1052245.3153472084,1192257.205020254,805939.9393694829
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.001652577415154195,0.0018225662267164378,0.0012955311735670819
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,92.10105647487997,104.35603425416025,70.54240944445276
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2013,1387397.9176137876,1686547.8565411712,1197066.2206717446
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.002178906637141618,0.002609224282180779,0.0019064206623487514
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,121.43633437903664,147.62036676935088,104.77695836344022
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,208245.15920319306,232134.62334803317,184376.97636481174
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.0003270696476911729,0.00036244869293170585,0.0002919428818047397
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,18.22730772820309,20.318307663548502,16.138170505648507
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,1216833.2800069512,1337841.7498533437,1114997.4077753709
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.0019115434539291485,0.0021013403453728485,0.0017642029500210944
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,106.50713194712898,117.09877607489028,97.5936292849913
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2013,1807136.502633749,2008743.2818987954,1615334.1765286962
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.002838224869206454,0.003116361846218693,0.0025639623731424166
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,158.1752645123142,175.82152731053023,141.38716708772648
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,1942376.427070837,2260207.311511032,1683884.2208892857
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0030494793330908833,0.003546349630419725,0.002700824085316668
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,170.01256113561035,197.83170160631727,147.38722374269662
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,128328.04761560765,157448.66647434913,101042.69612002066
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.00020150125626548223,0.00024403231654260374,0.00016243995317402748
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,11.232313024702048,13.781186108738938,8.844077446572827
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,834194.5408340946,1023417.714632351,509128.02424278035
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.001310444856812954,0.0016194688472617427,0.0007931917442724344
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,73.01548165224752,89.57783071872795,44.563019886912706
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,1043438.1010129161,1128264.5416983196,953713.3527600744
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.001639116650831057,0.0017595208552645002,0.001511541874047018
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,91.33017754298241,98.75487660334508,83.47673881961539
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,383512.8091764923,394623.5388371977,369636.63111467997
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.0013283190153484642,0.0014697458828503694,0.0011883666239524227
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,39.57138048826358,40.71780089557693,38.13961730156338
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,6381239.059588827,6556327.7554829735,6077915.30757257
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.022108346128094293,0.02471235579080346,0.01947756411064551
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,658.4250454522677,676.4909385297332,627.1276824569172
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2014,3112546.32266303,3241900.343442666,2946084.530529972
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.010776089832198469,0.011808513260872299,0.00975305830005252
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,321.1568215568065,334.50374779102805,303.9810643053086
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,1307502.9597145114,1347785.5580031145,1262910.7195109231
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.004528820487007316,0.005020179990903501,0.004069645035508471
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,134.90995833879202,139.06637237710544,130.3088695049946
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,456491.4089424489,482354.8087709254,427558.15829084296
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.0015802106424403991,0.0017340385054962384,0.0014245877550861572
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,47.10141304451747,49.770034302645335,44.11604034534873
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,1875762.4513269383,1975170.109973949,1756391.9163508285
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.0064925559127242734,0.007055324003392909,0.0058688316349244695
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,193.54375627359343,203.8007755690247,181.22693987111094
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,3410901.7316343673,3526049.26541974,3231862.7902050912
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.011813971388390705,0.01305707827041918,0.010517995230705488
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,351.9415440657827,363.82262538218083,333.46805920688877
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,448310.8061376638,461794.1224979254,429422.6185317913
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.001552751789810136,0.0017237150363660567,0.001390187583191913
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,46.25732716663866,47.648554341243894,44.3084179239705
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,76088.8868880736,78600.2969649345,73798.88464706429
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.00026357160196740435,0.00029257734698957344,0.0002348315666623276
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,7.850956270383068,8.11008702517303,7.614670681402251
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,222372.67242241759,228780.11676055272,214487.78600552812
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.0007702329475896194,0.0008511750801856184,0.0006885983462235608
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,22.944718976960974,23.60584791918891,22.13114552375753
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,477224.99443125474,494235.38886890304,455331.4884683571
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0016533377378437708,0.0018415837860213443,0.0014570505810512033
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,49.2407329854217,50.99588893964655,46.98173085055116
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,1921113.6886922698,1970300.3280913192,1830288.2709645354
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.006656024406089131,0.007454263415435602,0.005843856644171934
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,198.22315948114385,203.2983047592852,188.85166763807567
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,465052.09940280335,484984.4835628822,443613.99939006486
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.0016098686560750946,0.0017456668518500123,0.0014712767230017063
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,47.98471689081228,50.041367773817676,45.77270416985225
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,277193.41518189665,307086.392566495,254504.8699484095
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.000959151231956546,0.0010589589807061305,0.0008649636715721695
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,28.60119880886724,31.685597435742437,26.260163425753603
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,857148.5412467999,882552.7561197297,817765.4799734314
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0029693398872979045,0.0033094228391071425,0.002627714613293439
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,88.44176843394,91.06301035517065,84.37816986525742
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,1010939.0789990721,1030474.9846659177,975420.4144734542
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.0035439935230720805,0.003954422602300456,0.0031378224887277377
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,105.40260534594559,107.43945939368585,101.6993557068917
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,2136891.055472044,2205724.6014733096,2049061.1205198662
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.007490704772838138,0.008369528636074014,0.006637091862517206
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,222.7966939513352,229.97342223739244,213.63936274944874
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2013,836903.8718828629,857279.5163852153,803321.793384655
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.0029338115993993367,0.003270155842949718,0.0025998366038186924
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,87.25733365446852,89.38174061505127,83.7559964916518
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,471586.5602914947,554401.3615226464,424931.9385093566
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.0004313477789621324,0.0005066508593916655,0.00038563082240035
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,19.06683297533934,22.41513870734383,17.18052841123596
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,1460217.8866814217,1901668.2084145497,1120570.2927154184
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.0013355839968935473,0.0017487043166394879,0.0010400352729027403
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,59.038430899617346,76.88681815262272,45.306054937455194
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,302344.66277588205,351638.97464166634,257562.9660304775
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.00027650399919773317,0.0003220743617068903,0.0002295569097465439
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,12.224171915691898,14.217202443106085,10.413592047450642
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,80521.41696854604,98962.40770282887,60985.05840574584
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,7.363656220722446e-05,9.173481911155464e-05,5.5870926361657215e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,3.25558134508315,4.00117360711245,2.4657019951860604
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,631964.308248321,867992.2312205571,399122.04290093604
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0005781149259730493,0.0007955315688918385,0.00035986431162049264
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,25.551105409574355,35.094008799455096,16.13700213183454
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,1960787.6405522297,2262688.278365162,1733736.6853047311
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.0017931092953397871,0.00205229446583426,0.001582240691062962
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,79.27709055026969,91.48330998275216,70.09713716500065
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,306209.2383399874,403078.93388337595,231990.6723416038
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0002801442652646249,0.0003615156526207389,0.00021288882410547058
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,12.380421527122362,16.29698417079929,9.379672310084297
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2012,2910135.1244820408,3518908.258245455,2343472.544429616
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.002661044779785327,0.0031705927803793205,0.0021607493334068395
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2012,117.66039371408291,142.27385100634814,94.74951864470859
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,1914749.4601638364,2183038.63534568,1599857.929461617
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0017515265812741135,0.0020305670804768605,0.0014484189331149407
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,77.41570948077641,88.26297554603887,64.68425204158012
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,62063.153823054374,96336.74825231126,42387.88089736344
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,5.66040230801392e-05,8.672605948211533e-05,3.90369953295573e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,2.509290737919937,3.8950149198033883,1.7137949070241594
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,383704.2649431098,394768.53961446194,370143.0290247068
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.0013447292203034953,0.0014886204107575774,0.001207649069540291
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,40.00580257259183,41.15938680021745,38.59187998595497
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,6346390.445044753,6523626.487288872,6044942.972182011
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.022248005385027723,0.024846065284262725,0.019601111686510124
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,661.6878319835394,680.1668293848762,630.2582931767665
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2013,3062010.8840595977,3189664.121770131,2904674.881856367
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.010726773530822076,0.011750796521461982,0.009708881958122929
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,319.2516062363238,332.56099758842896,302.8474282878807
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,1290390.4430310181,1330508.4562754617,1246663.4343182617
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.004522490214823716,0.0050035496269903255,0.004065640760130614
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,134.5387842199569,138.72157149676713,129.97971558955774
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,436315.16995309904,459893.8455833177,409407.8363846426
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.001528259444158841,0.001677659372873329,0.0013802385680981427
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,45.49112465861839,47.94948628857203,42.685710247459454
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,1844984.7039510047,1943269.618979069,1724826.58076193
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.006461684700762429,0.0070004848013220135,0.005851283005428565
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,192.3619322465944,202.60932135773604,179.83399708145342
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,3347746.0344931902,3461994.853094318,3182960.802073173
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.011732557306889298,0.012982718777028345,0.01044199663532501
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,349.04294571489635,360.95476452615196,331.8620955722702
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,435753.7374167545,449035.5522890693,418066.3038901624
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0015271269202361741,0.0016964158253031034,0.0013676553821425513
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,45.43258853781155,46.81737810658608,43.58846002966056
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,76032.34193852928,78572.09439744131,73690.65902296844
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0002664935045000108,0.00029563915064237313,0.00023747127096193486
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,7.9272896827862604,8.192089542307114,7.683140964706649
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,214974.48037805938,221081.01174674073,207803.79438217502
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.0007534257596590144,0.0008319879838613905,0.0006733713180897465
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,22.413685241224222,23.05036486837151,21.66605464529135
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,466642.9745715416,482393.7518367474,444668.915142503
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.0016358152896208751,0.001824212790963978,0.0014386322249140843
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,48.6531644764594,50.295373185633224,46.36210346006221
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,1868497.843039248,1915594.8933532457,1778754.620657872
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.006550375404135697,0.007322966359814486,0.005743734944293681
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,194.81346090074035,199.72389705889103,185.45664638279433
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,465723.8530081095,486185.65160567383,444902.4717901251
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.0016312758781872564,0.0017702444053887944,0.001492356035675046
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,48.557334955741666,50.6907245209988,46.38645456060489
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,266956.3855200698,295703.847092016,244675.17187170818
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.0009346589974351419,0.0010336139314521472,0.0008430756448143863
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,27.83342649629416,30.83069647003545,25.510340943866826
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,842765.6178776374,867620.3444912359,803991.4226624513
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.002954112575138579,0.0032964172403709482,0.0026125899396701093
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,87.86849145077916,90.45989680314551,83.82581342915266
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,257332.97596567022,290225.32228022144,222424.6062634237
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.00040616008912831576,0.00045415575286576976,0.00035802591701779686
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,21.959529351613266,24.766400261286993,18.980620930658617
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,210689.36209487257,250904.10231753322,174482.4688769123
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.0003326051479455904,0.0003956916952543052,0.000275784705745564
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,17.979192964419155,21.41092092300318,14.889474939098562
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,71412.87250238638,84292.41492774097,59983.92528534841
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.00011271525423320549,0.00013209857804939156,9.49999905714094e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,6.0940229829245665,7.193099729165793,5.1187328906665615
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,103484.8319075535,122377.35250058121,75550.40244675515
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0001633796985186499,0.0001980890660986069,0.0001203055609699876
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,8.830886112411203,10.44308081435992,6.44709941984676
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,361659.7899914327,400372.7198310013,328730.8689866896
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.0005709565325625517,0.0006312591819887621,0.0005231401580407369
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,30.862266073022194,34.16583692673342,28.052274059340004
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,98581.03615487927,124912.94541583907,75634.6692138349
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,9.048980023553241e-05,0.00011434651635912467,6.890997138341994e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,3.9125796296863586,4.957665944495617,3.001861997059863
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2012,17287796.173860613,19165053.936516233,15337997.741509726
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.02685817498861979,0.02936511224112181,0.02444033517844486
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,1552.4095905545478,1720.9835906978374,1377.3215830613517
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,915206.161007767,1018611.9133245825,784787.1826775214
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.0014218929559813283,0.0015655671622205585,0.001238065638130515
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,82.18368653786527,91.46931670152094,70.47232259569157
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,1035107.6071705945,1170715.7811951167,800192.0166514961
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.0016081748561842244,0.0017755803638610803,0.0012637481712416557
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,92.95059708404428,105.12794044210433,71.8556459390254
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2012,1376947.8328862682,1696580.294648319,1193258.1709556992
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.0021392734701116455,0.002579197023703873,0.001868806687010141
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,123.6471670517497,152.34952414236773,107.15220204875493
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,203413.74299137323,228195.19253708608,177875.3009361492
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.0003160259515788965,0.0003462998243477707,0.0002815223064525711
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,18.266148113654374,20.491472819921853,15.972846990964333
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,1181282.895553979,1295842.843759899,1079453.3340385193
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.001835723032015277,0.002015342847367077,0.0016968797167815216
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,106.07684621992618,116.36410091102476,96.9327548442086
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2012,1722644.1862882865,1925544.6662029098,1556707.639459677
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.0026764068203992027,0.002968068490608337,0.00244062803351259
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,154.69000958898826,172.9100677028061,139.78923888753025
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,1893579.6846175375,2195350.472999505,1639599.1627868977
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.002940969199665512,0.0033802440352460354,0.0026226650341844918
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,170.0396761574648,197.13809062984907,147.23273223362958
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,123470.36632938175,149919.2869810737,99483.7108478143
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.00019179926349284355,0.00023107175199261259,0.00015312568499682662
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,11.087392453691303,13.462452737059596,8.933438668001939
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,805009.8727319156,981434.9252743977,491968.16846891644
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.0012508083238585777,0.0015314622341258506,0.0007560878236689223
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,72.28827979876868,88.13089737862872,44.17775957663594
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,1008794.8054176847,1092622.7097800768,927915.3567535293
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.0015676057413407404,0.0016799789895296496,0.0014492020181919554
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,90.58776000609788,98.11533850017061,83.32494694870857
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2013,3928992.050104759,4483415.657497758,3312641.3410247625
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.020890320989250092,0.022990659387448403,0.0184212699051346
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,1471.3942133851324,1679.0239762553376,1240.5729607099206
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,220944.39514671778,265272.83583619026,166457.13442153687
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.0011745333722824984,0.001367671884067933,0.000925528080816112
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,82.74292753788875,99.34377841442249,62.3376329707743
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,376916.3903279576,447563.87218994333,277553.3613295755
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.0020046303674128916,0.002283619968693043,0.001492536844465891
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,141.15391138136357,167.6111540217973,103.94279361166976
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,248632.9032303918,279827.5915791111,215880.1294707501
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0003905332758962955,0.0004346114460766948,0.0003448296164670182
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,21.762371120064913,24.492783611731507,18.895582338258496
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,204429.56243339262,243332.151880058,170608.25547719095
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0003211512095945815,0.00038111525345323606,0.00026764546136289304
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,17.893335708128312,21.298406308479795,14.93302022219091
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,68951.3306752042,80436.12124594221,57903.597819149276
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.00010829908974391116,0.000127309614183806,9.123235365961515e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,6.035180492525778,7.0404226442655355,5.068193181815674
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,99874.4705128587,119241.75393057027,72670.8939429885
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.00015690502751943878,0.00019074739935859378,0.00011497032783774604
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,8.741824852951046,10.4370068013079,6.36074688050732
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,343935.4558852868,379492.4245543918,312445.56195941014
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.0005403420615346429,0.0005956551416468774,0.0004911965485338658
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,30.104024588365164,33.216259284689905,27.347773306886964
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2014,77625749.63273603,79955612.87438178,73702598.29966412
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.16394246732756598,0.18141139072813645,0.1454911540798508
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,5205.150629263332,5361.378287942661,4942.085940978213
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,2108757.7207811293,2154200.1276489436,2024215.5891690166
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.004454796289559941,0.004957667815833264,0.003929293600964727
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,141.40155334047662,144.44866816799637,135.7326286390465
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,4925186.316217963,5098359.149448264,4645741.022887632
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.010404005946464191,0.01161978052035282,0.00911391419947596
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,330.255575944736,341.8675820912102,311.5175302407669
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2014,2878062.177309537,2975871.426087361,2735867.3562122583
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.006080143620118825,0.00678417066480308,0.005333739688867678
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,192.98682749163584,199.54537121240347,183.4520343847831
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,112534.37125910034,138685.78285677364,67446.4245918829
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.00017758901338480086,0.00022117157854214734,0.00010769544705411255
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,9.603129250948495,11.834761976642534,5.755545844557474
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,34073.49940260705,45029.01918676013,15518.672362571251
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,5.3796557557775975e-05,7.152232487366353e-05,2.5252065174469528e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,2.907664699543,3.842554825301243,1.3242871029844814
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,310134.5678643226,361832.63941004453,244042.5557045365
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0004894629360177447,0.000557555491970288,0.0003901255078643792
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,26.465357268766926,30.877016191490995,20.825390313565602
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,41705.74983856663,48022.14084786243,34900.283098670174
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,6.580659177514931e-05,7.48568554624391e-05,5.6036869860995215e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,3.558963379155967,4.097973093104954,2.9782183500147323
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,263202.5127754796,304853.4647330091,216915.59494355734
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.00041520064157677197,0.0004706389473233836,0.00034934124479221073
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,22.460406727984083,26.014693925735283,18.51050902477869
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,270285.7975424843,320103.655059844,239605.8429124205
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.0004266866927689943,0.0005008318537144359,0.0003812832834718861
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,23.06485937989614,27.316070093492723,20.44678308525551
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,665647.9838164967,819285.359651769,489634.505222938
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.0010505319012050274,0.0012617960674428975,0.0007614518592929793
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,56.80312203909136,69.91377935574087,41.78299826773905
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,89040.12140817381,113806.59888663172,72702.3775727477
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.00014053214479533798,0.0001761103681955204,0.00011496684610839867
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,7.598245627854724,9.711694893668291,6.204062997560816
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,43174.88008649904,55608.96839485169,31508.151097418282
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,6.814851380354528e-05,8.868031551861297e-05,4.9592000417199406e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,3.6843317221743854,4.745395606984265,2.6887505040594792
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,329357.32074698753,434944.5538213089,175532.17490923847
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.0005199655596230983,0.0006811197390238764,0.0002834310939463672
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,28.10573236862205,37.116027046753395,14.979051684328862
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,1120117.3105341396,1301345.899311177,926335.696603765
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.0017672428714111783,0.0020317038543023044,0.0014669929494807317
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,95.58529708686041,111.0504526879511,79.04892811611991
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,115016.82180408543,143862.55751021314,75423.58044190411
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.0001815771845344017,0.00022813191686315163,0.00012232063033740319
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,9.814969359671295,12.27652244096817,6.436277054281265
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2014,1274176.1441253582,1501990.0971186548,901998.6592053025
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.0020104913349116007,0.002316873195040466,0.0014776931818711618
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2014,108.73191953361975,128.1724407831418,76.9721251526546
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,722414.9642986881,839058.0740544319,588083.856225014
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.0011399063515299662,0.0012955167898878565,0.0009415284217583506
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,61.64733669686394,71.6010854643224,50.184181228704674
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,12451.163458912682,20773.99546506849,8781.214504688294
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,1.9640829829764618e-05,3.301897425711051e-05,1.3862502841302754e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,1.0625209940998908,1.7727505052687456,0.7493456170352586
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,265174.0039685297,334079.5975825617,186671.680887029
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.00024245340434282165,0.00030828850233434587,0.0001727621099616254
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,10.721315806677618,13.507254921849317,7.547368946432247
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,567112.5419668012,821914.802982671,452757.9425156339
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.0005183324896365073,0.0007511116334092592,0.0004148625117129811
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,22.929067590936885,33.23104089044194,18.305568468422635
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,800607.0913449426,990965.9512352471,681177.3780861801
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.0007321148128652706,0.0009156022654610507,0.0006217773070704179
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,32.369543525817846,40.06598971940951,27.5408512204435
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,1572972.4020029202,1698360.3165252353,1455111.8314188502
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.0011383501936774018,0.0012587284630062087,0.0010232783854654502
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,37.299392496378935,40.27267609125633,34.50460240567886
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,23089444.08565192,25022421.01365434,21294201.487860456
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.016709729123999786,0.018399817711824414,0.01479784818472674
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,547.5126177530516,593.3486826656984,504.9426030496929
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2012,7941860.976234695,8433132.778851278,7479811.7019703295
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.005747080812721296,0.006220975944845527,0.0051735300455090245
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,188.32281439080396,199.97218583868602,177.36638743028703
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,4605565.238274099,4999340.690318392,4252447.05508686
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.0033336615013774256,0.0037110133925036355,0.0029332649239266198
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,109.21029845871728,118.54777006504486,100.83691969152609
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,910450.9336819401,1029336.5119615878,726507.9348637355
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.0006588851816586332,0.0007443457241505529,0.000530469342011558
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,21.58923238631254,24.40832815732872,17.227450767547428
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,1796442.916477743,2107582.3712700196,1471288.6000307614
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.0012998725620526873,0.0015401138429997816,0.0010667576877970155
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,42.59847747724098,49.976428057066094,34.88819695635913
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,10470164.615611983,11240092.059594892,9817476.438991904
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.0075763133229407005,0.008234745341446362,0.006861151140775269
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,248.27567158974534,266.53271531809327,232.79868518712343
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,3288539.478772585,3508162.9034428094,3053749.987223181
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.0023799912564361515,0.002615088448426173,0.0021422019021068214
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,77.98008700113756,83.18794716940404,72.41259872977606
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,1780420.8084267017,1910756.9166494356,1646787.423180914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.0012883764694896892,0.0014121005026042947,0.00117098134136375
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,42.21855034307492,45.30916887577136,39.04974453277869
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,131491.50397147326,136269.96956223546,127574.27907153551
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.0004606517479716986,0.0005029995883284581,0.00042081347602382043
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,13.709576954105216,14.207789688467962,13.301158960621123
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,810447.3243970496,833517.2913871438,775820.7407744266
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.0028402251910283768,0.003132902337970981,0.0025532756948456366
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,84.49891913534208,86.90424174727272,80.8886797016589
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,648649.8759363993,677231.4364130293,608009.6435157289
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.0022725995732602363,0.0025050883722148847,0.002030638062533804
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,67.62958154581698,70.60955432723543,63.3923466144652
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,1427270.0886129607,1463213.3336986213,1383996.8864670233
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.005003100922750523,0.005545245424849009,0.004466204450349892
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,148.81013999487772,152.55765728382,144.29838617845627
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,158887.74208152003,167371.65411783772,150475.63247068698
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.000556465341797179,0.0006041812636677218,0.000509658681242372
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,16.565965566894675,17.45051583380005,15.688901569808564
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,112937.49487606622,116006.82762266595,108240.98686043103
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,0.00039591279108964957,0.0004438906073462741,0.00034958190456451787
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,11.77509747963029,12.095112478442644,11.285429812053152
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,142888.03726451113,148932.59600443213,137089.45626022294
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0005007133821689293,0.000553466537156564,0.0004513486528195026
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,14.897803154824768,15.528021387148994,14.29323107144402
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,1241133.538564039,1280440.1787582706,1182131.9123891427
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.00434940169921637,0.004792908749988994,0.0038987871958247704
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,129.4031571876771,133.50134902725802,123.25152525685974
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,555983.3422036909,572641.0997941426,527869.516502569
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.0019489863232401605,0.0021818375785201405,0.001716468825422388
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,57.96797652261813,59.704748881832096,55.03677073910645
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2013,1848858.4232125385,1914773.63008217,1770789.6913424344
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.00648037744812749,0.007215250738925438,0.005804550726965419
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2013,192.7658142519754,199.63827044671964,184.62620633088278
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,750251.4532186451,772795.0410758618,720363.1888518764
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.002629541678495022,0.0028966931098612396,0.00233964060751934
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,78.22277274326188,80.5732139749418,75.10656030378942
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,276856.1463402812,295500.5733685518,257146.03986926793
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,0.0009695824094249478,0.001065211573490734,0.0008716033242491949
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,28.865596094273464,30.809502729980704,26.81057950934954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,770735.7468763684,794272.936972277,745817.945796522
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.001627606295139222,0.0017889311422494456,0.0014669810668753362
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,51.681248513926604,53.259521450657644,50.01039949044836
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,16929843.47786774,17356079.030810826,16124999.458703812
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.03576503149349511,0.04005274579319405,0.03144710167502709
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,1135.2210555012844,1163.8020388362327,1081.2526961278732
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,1448434.9460415319,1565347.5762600293,1330124.9935125504
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.00104849521874628,0.0011870059331015289,0.0009325673450893196
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,34.346275553901414,37.11858743728285,31.540829412578557
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,2031788.1639443527,2366619.4352947827,1534375.3699207846
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0014706241546506716,0.00169828081200602,0.001151443456759319
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,48.179144211277006,56.118891275026186,36.38415339428546
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,4024132.2824181532,4302786.913894594,3742684.9533297583
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.0029123528508435076,0.0031939569493665363,0.0025819370921548197
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,95.42296436233664,102.03061269560617,88.74909368198756
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,369686.31458177214,436796.4396048995,279420.1197653165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.00026757847985434775,0.0003173536271293133,0.0001999999601843716
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,8.766253578617919,10.357614552612958,6.625800112729752
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,521773.9899230604,587735.6072686055,409626.62945075263
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.0003776981511326192,0.0004359580609985072,0.0002943937237412776
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,12.372660079579541,13.936786857604774,9.713345516677421
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,1909302.7156294743,2166701.226146774,1729304.6218053778
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0013820985342574306,0.00161732988464349,0.0011988674026159442
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,45.27468587114706,51.37829459278961,41.00644852534488
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,210373.63570097953,224812.9003708868,195852.56383770306
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00015222260515297665,0.00016725238928010636,0.00013756320669521265
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,4.9885228748511095,5.330916549143284,4.644189332694361
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,1237258.767018696,1310535.4332340304,1159101.830059623
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.0008953063936907241,0.0009758931195497996,0.0008132025960913823
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,29.338722225420547,31.076308422426663,27.485411725986967
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,1513551.4714670496,1716266.8357477884,1393441.2820721148
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.0010951176238520085,0.0012501519759959261,0.0009762347093607638
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,35.890362936969346,40.69728766605287,33.042228353456345
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,4143515.955216032,5204295.745591383,3283078.4860669393
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.0029988236120562684,0.003806363315930848,0.0024012981219717544
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,98.25387128967826,123.40780387174743,77.85059222418629
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,620523.6497556997,681714.9867181678,519496.8135715012
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.0004488235491815834,0.0004992000406199397,0.00037541688606899465
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,14.714279243584874,16.165289885497593,12.318662123600069
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,224697.2076091381,241157.7800677567,200521.4348877514
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,0.00016263238559379665,0.00018050845238092063,0.00014272986925725257
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,5.328173163611563,5.718497464322311,4.7549007816612905
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,575241.1194966726,852357.9914373135,413670.9793819214
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0004164003185753181,0.0006265542027410625,0.0002958247452388603
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,13.640509057146783,20.21169298937674,9.809247895691371
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,92422.90533837517,118581.50328165229,71195.4141620775
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,8.4472105196976e-05,0.00010815225815790952,6.473659131578111e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,3.736773367954224,4.794398117788546,2.8785194166673596
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,108342.62816334561,133467.73837674144,65015.63677610655
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.00017014327681942596,0.00020758702881308583,0.00010486667407285145
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,9.483026790018664,11.682180505364965,5.690696596250101
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,32520.679968540942,43108.97815763732,14921.364265070497
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,5.1095500889588125e-05,6.792348682800732e-05,2.408192025467045e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,2.8464740481127904,3.773247905181521,1.3060389937740384
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,294495.90248739655,345855.6740993802,229156.4638482604
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.00046251255392980577,0.0005305565044402103,0.00035349123872541573
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,25.77667332038686,30.27209768272902,20.05763495512284
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,39717.93361240014,45916.402309755824,33080.46099277296
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,6.236802548746824e-05,7.099640104688743e-05,5.24139700789825e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,3.4764361440698384,4.018976469245395,2.8954706299691293
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,252902.68998265947,291265.0753733999,210331.8738531733
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.00039703936383524277,0.000446026837320698,0.000337787705094695
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,22.13609753639639,25.49388509016454,18.409953942941865
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,261906.91808663376,306779.2588980254,232065.91062406887
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.00041145346368773024,0.000479683121528297,0.00036716082045353817
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,22.924220713588376,26.851812440491294,20.312293367853307
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,642578.805135855,789059.3406934114,470295.46210823266
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.001009257325924915,0.0012191543667807595,0.0007308870492500875
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,56.243716135576214,69.06488234186675,41.164078645688804
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,85671.65339904363,109600.90168967564,70548.62683446094
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.0001345523671877008,0.00017036832258915017,0.00011144060138038207
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,7.498678941989929,9.593161108907154,6.174988825834698
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,41780.055913379016,53856.88888842489,30722.999165415524
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,6.562753108906975e-05,8.558023539749685e-05,4.8001115125709506e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,3.65692983668171,4.713992348293248,2.6891264232218868
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,320775.997637696,418559.16833915794,173713.06785398093
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0005039249271988657,0.0006566603201289702,0.00027567481551855547
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,28.076920698351476,36.635698005995266,15.204778619104546
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,1087127.769252773,1257367.7298091555,896373.4378520044
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.001706956651199233,0.0019475377661794758,0.0014067691322094647
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,95.15425216060146,110.05503621998318,78.45788374448456
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,109429.00093653658,137094.90171369573,72273.51937399161
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.00017190645493511786,0.00021371244569959378,0.00011663755366037303
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,9.578114958791748,11.9996593009158,6.3259654306998785
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2013,1242021.0389665684,1460958.5919234096,882203.5990751944
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.0019502332944500763,0.0022481092020588582,0.0014373462827924678
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2013,108.71176918958632,127.87496206414545,77.21762436543256
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,701489.8209035316,817479.0621652973,574836.2612879988
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0011015486141294697,0.0012599500686310207,0.0009110901484561743
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,61.40008671862896,71.55240719382473,50.3143384841065
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,12088.616604615538,20078.4618105562,8381.494367995305
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,1.8976922580394556e-05,3.149489407660604e-05,1.3399068253379158e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,1.0580939105796698,1.7574300575836375,0.7336164626933085
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,37904.539297728894,41007.88008784435,35161.27873963275
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.000132795137621608,0.000147457074607628,0.00011897370775164362
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,3.9520058917636045,4.275566639735057,3.6659878556892718
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,318799.84270384494,327912.52984828246,308217.8112783658
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0011173421883222479,0.0012280910801594496,0.0010007985264836065
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,33.23873288005882,34.18884054399169,32.13542833355493
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,278734.716070939,288016.70562345354,270216.99533776264
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0009769426776182945,0.0010792810790464986,0.0008714952607838799
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,29.061459671069155,30.029219155248526,28.17338443930066
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,54354.236127451884,58204.97710611592,50476.90948103291
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,0.00019048252233304876,0.0002147744433932591,0.00016829740643026122
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,5.667085404487961,6.0685716464338615,5.262827285675848
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,241114.37355973077,267693.4508632387,210563.7702168374
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.0003746489813951225,0.00041341254805869244,0.00033354326526577284
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,21.651589489505714,24.038337580418812,18.90820628728786
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,198680.69667755897,236355.96626571275,166878.63215511292
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.00030874856677921483,0.0003645677280620196,0.0002580090744151984
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,17.841130001674692,21.224294012123384,14.985368083407302
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,66803.1926634372,77051.03320074723,56439.13015526334
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.0001037935677472418,0.0001199814757143853,8.691886339131524e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,5.998793364257024,6.91902899016336,5.068121237342254
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,97335.7807585158,116534.02032375224,70863.42754059407
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0001512729745516635,0.0001821455402202917,0.00010908873585559337
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,8.740558833178957,10.464522427098467,6.363394352133829
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,330926.5250953489,365657.0146553877,300491.71074206056
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.0005143137895838246,0.0005643996189393218,0.00046674889121197294
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,29.71654143537869,32.83527007698426,26.98355585331641
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,774202.6649625249,797955.4747797104,750123.9925410612
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.001646386961789748,0.0018095195752038302,0.001486052955396448
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,52.18292292199265,53.78391333440745,50.559968669963666
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,16835496.30457493,17250476.63787606,16046769.635118525
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.03581505100768942,0.040028388575006124,0.03150258224849138
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,1134.7486204502436,1162.719186461978,1081.5867484218693
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2013,124460258.2585907,131633849.39749584,117300749.85379285
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.08995196793743458,0.0984471022907491,0.08180972044982962
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,2917.4485372249924,3085.603282102391,2749.623902959571
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,8336381.091754539,9327306.21881159,7529506.608525435
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.00602435740661126,0.00678305918667107,0.005302707700736244
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,195.41147641970758,218.63955824182256,176.4976896916585
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,15805017.876782747,18108143.51270431,13397054.673685942
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.011421784086099493,0.012928070031620147,0.009653409293066663
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,370.4823285006474,424.46944544527224,314.03773467720924
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2013,7987022.795028055,8593841.503878124,7429384.8610164765
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.005772782443680357,0.006408030036085222,0.005211952062243343
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,187.22223701097678,201.44655551445527,174.15075541800843
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,735982.9461997458,755299.1687618287,712351.1905705152
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.00256144326103341,0.0028174383886432827,0.00230996361456862
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,87.7810403120828,90.08489547632895,84.96246944132277
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,124659.08227769194,131010.93605079416,119656.42251564495
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0004338930619602889,0.0004816891452080552,0.0003913213252463598
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,14.868148756962475,15.625737414406464,14.271479118749546
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,475464.86585579667,496108.55437039986,457644.02683529106
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.0016548217182554932,0.001836213709314994,0.0014873082055463782
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,56.70892345016297,59.17110611763826,54.58342340083217
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,516552.410926071,537023.6755101318,487290.3608390245
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.00179805731604397,0.0019971034201167106,0.0015874425777461358
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,61.60945473116829,64.05107231343895,58.119355929873265
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,2808691.2901470955,2896937.3213464897,2661687.9574359795
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.009777281920297372,0.010842632504686252,0.008689691690856347
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,334.99396234336683,345.51910896815457,317.4608040801827
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,678181.8208839245,705825.8655791485,648805.6720987062
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.002359369492055531,0.0025591658074376198,0.002163158860631137
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,80.88707226889545,84.18419078816339,77.38336486094003
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,188764.02143886473,196172.89823626517,177098.61047878297
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.0006570742489481066,0.0007320724533939832,0.0005800661477294187
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,22.513975712283393,23.39763601471023,21.122636531081714
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,2148494.976101948,2354613.500396189,1857719.459534294
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.002518144015836336,0.002880443299341178,0.0021626100856592676
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,72.39060564754696,79.33548798369756,62.59332150867451
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,294649.3023669648,417692.70162609837,232401.2773314814
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,0.0003447446514567747,0.0004927464780917987,0.0002774237004024838
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,9.927806063885185,14.07358545475073,7.830443825292505
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2014,42927590.01360403,45647948.69712943,40128524.842170626
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.039701640594467014,0.042900324412661124,0.036851113324981796
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,1673.162520317097,1779.1922832190276,1564.0650625915807
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,1909458.6808061076,2170058.2155140266,1762332.544886998
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.0017660065069913364,0.001989568056470612,0.0015928806920980669
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,74.42380757471912,84.58103685656756,68.68936181848353
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,3218765.6283362852,3801522.231978168,2767228.5039879186
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.002976834350464685,0.003514536853126241,0.0025918881369674483
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,125.45586671207194,148.16961578048875,107.8565793364697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2014,1762657.7020148851,2015444.3062906037,1576283.4367924894
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.0016298916412128305,0.001890916969728772,0.0014453089934642858
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,68.70203526973995,78.55474472252607,61.43783909140975
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,1594740.0920477798,1717280.1503150598,1475424.8508476932
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.0011526800268315926,0.0012763464302128775,0.0010380088686396541
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,37.38199015409564,40.254427659412045,34.5851449540431
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,23484073.006370615,25550718.930508077,21533014.64753538
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.01697329694897016,0.018982668107437144,0.01513967208118848
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,550.4855557841639,598.9293981214474,504.75117892630755
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2013,8206682.99056014,8768470.840541879,7657440.010996085
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.005930837910659611,0.006472250338149941,0.005371117379765731
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,192.3712486321011,205.54000759252915,179.4965515221131
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,4713225.276155111,5094459.772473345,4330198.715313682
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0034070516166016976,0.0037767165818708877,0.0030318551583015958
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,110.48179057254579,119.41823373267846,101.50333997891607
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,904815.6713716049,1032016.104530897,727676.0189917814
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.0006538971126132328,0.0007527180296534662,0.0005279621753437225
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,21.209606936671545,24.191287377056977,17.057311039564244
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,1839497.5347592328,2204211.485756221,1529556.4962132608
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.0013293693294514836,0.0015974949225715986,0.0010866359496107844
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,43.1193014308395,51.66848972378809,35.85403425090792
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,10694783.727604657,11371663.803263964,9972420.166748434
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.007728838044715077,0.008447455123533044,0.007013994184794739
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,250.69433069318092,266.56094397391195,233.7615479442814
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,3395211.4457943174,3600013.588410126,3159875.0975887077
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0024543025582898646,0.002715448779544379,0.002209796702938545
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,79.58648651943055,84.38721343222232,74.07001327379562
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,1803355.7982078088,1930779.99340295,1684527.6932036974
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0013033935592152621,0.0014309287617765144,0.0011903690464764058
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,42.2721100630083,45.25903566545029,39.48668372711572
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,1494871.9085758599,1611686.1205664333,1380440.568395889
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.001080843484499477,0.0012226025746736972,0.0009620704782801887
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,35.040999625375136,37.77921868957562,32.358636992581005
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,2070130.9733783822,2451088.389814862,1601325.135964661
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.001496396593138512,0.0017425650034283216,0.0011761844161760075
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,48.52553469396355,57.45548287885656,37.536348878813634
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,4128503.18664951,4426179.672142573,3853228.1269866796
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.0029841143448644117,0.0032858495962777563,0.0026662702857561155
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,96.7754345953073,103.75321078924418,90.32276583674482
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,375782.9371751134,449374.13053558767,276673.9344310379
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.0002716238997589894,0.00032619785136014543,0.00020043582047642687
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,8.80865422999372,10.533690980086888,6.485459508022509
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,537349.8086520344,609752.595482248,423844.11015255516
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.0003884619609371641,0.0004489012909790617,0.0003090002518224862
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,12.595911620019471,14.293091165396463,9.935246772562826
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,1958606.1828733913,2229955.1701776017,1780265.475419866
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.0014158658371903547,0.0016356568718091666,0.0012371506881275968
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,45.91130392282774,52.27194238818713,41.730854328974836
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,213711.04537160395,231821.89039287256,199062.86687349368
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.00015445068160451026,0.00016976075646653254,0.00013981109323492683
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,5.009558757404982,5.434091528383399,4.666193674202833
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,1258852.9285827256,1334350.2986126351,1180286.868118229
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.000909797620054303,0.000993674405244482,0.0008326590067676536
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,29.5085249417082,31.278244005768457,27.66687330620024
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,1541702.7016507036,1764996.5925718045,1415657.7685384008
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.001114078220424848,0.001292026397115408,0.0009987178403470444
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,36.13875107362801,41.37293943667579,33.18415648352934
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,4202315.727414773,5266284.83823571,3338173.170071747
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.003037400902285298,0.003873192606169436,0.002434934806594242
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,98.50565990656354,123.44595144579353,78.24946346965582
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,639353.1411348662,710182.2261918267,539814.0225019455
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.00046187164888816096,0.0005121140541832783,0.00038288403644904344
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,14.98695175851743,16.64724246885065,12.653674774237698
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,229485.57353640592,246861.08339473826,206126.94769231838
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,0.0001658928817035589,0.00018503221594523615,0.00014463584196079912
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,5.379326382538756,5.786622305984521,4.83178140911577
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,574847.7835319416,860337.3685984538,413633.12087677483
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0004156800590330555,0.0006245671464842114,0.00029667343186223554
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,13.474894304877694,20.166999752825166,9.695892972859545
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2012,3793573.8008899163,4368591.449810697,3196582.6943692868
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.01987985009956042,0.02183629976118568,0.017472786011979928
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,1464.826016458478,1686.8596070174276,1234.3077373042383
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,214515.4598217038,257436.12530467927,161451.9097678
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.0011239402136216292,0.0013115753974962255,0.0008845803845025175
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,82.8316102366776,99.40471800867485,62.34199471203145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,368616.0412712219,435829.9751864387,270377.1269836101
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.0019321855148565145,0.0021928649272450755,0.0014402671729061706
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,142.33501064651816,168.28856374318744,104.4016725779741
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,1255833.8733105455,1298561.3225675016,1193680.083177729
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.00437125199204002,0.004846579440750621,0.0038924343682979713
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,149.78391065658366,154.88003409942166,142.37079818520232
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,99491.9286340978,106904.28843358578,93389.51908889384
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.00034587346964358803,0.0003683661787326771,0.0003235000771156644
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,11.866450225853908,12.750525947616536,11.138612901559442
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,1246860.5344714622,1285813.624463385,1197228.311271503
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.004339545048033469,0.004770998864065941,0.0038802122945942553
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,148.71365621327823,153.35961000951343,142.79399705814404
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,1292500.008903818,1348240.736648437,1218570.336263583
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.004497289473250982,0.004930235854030496,0.004064129999800034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,154.15709830070065,160.80532173364858,145.33947065348298
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,1781522.481665673,1835344.7327980094,1708778.0783622884
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.006201450241782081,0.006851134121529318,0.005568469785131102
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,212.48304405348796,218.90244985729072,203.80678405069173
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,179550.84528804105,191326.69838897203,168525.519322536
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.0006243788563373995,0.000671971848473585,0.0005701157348179859
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,21.415115757343244,22.819627425853344,20.100119821596127
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,263977.97951459273,272267.89120079204,252751.00263461636
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,0.0009189049552502303,0.001016889902041112,0.0008201395126374299
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,31.484780701676293,32.47352245944033,30.145733764280905
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,174783.75605564733,184124.0864284379,167310.88561849948
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0006081450808976622,0.0006732653144548466,0.0005523514756121028
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,20.84654272961106,21.96056842982011,19.95524987496355
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,1194631.36860379,1240682.2399352265,1132008.4971789035
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.004156745866097259,0.004529780045573686,0.0037600759520038467
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,142.48425845593894,147.97676804957052,135.0151984330258
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,678590.1424636429,703883.2006146018,635294.7747160872
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.002361857071216145,0.002616310658010557,0.0020904846754702692
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,80.93577298028369,83.95248820259906,75.7719136256634
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2013,1636962.3406117503,1699148.7051688288,1551826.7388263433
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.005697286354519899,0.006297444860835036,0.005126993356891244
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2013,195.24128643546425,202.65828407410973,185.08712222431427
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,1033641.3815464957,1068407.0808068172,989359.6046822234
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0035976741682440454,0.003963388809466443,0.003217032063591712
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,123.28290519539387,127.42942688316649,118.001396350543
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,349252.2637854725,383915.49734885537,317322.9482915122
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,0.0012139429886262806,0.0013229965394274679,0.00109300805577637
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,41.65548563963368,45.78978619440304,37.8472608091742
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2013,76986541.8092431,79257659.820436,73194875.71928388
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.16373263045225175,0.1811874308177104,0.14546904681608466
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,5189.058316477074,5342.136549720515,4933.491875966495
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,2078370.4830293183,2122099.48852973,1999367.8009214685
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.004421366847556841,0.0049158998252785795,0.003903123108752236
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,140.08663574480653,143.03406466329753,134.76168524071053
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,4994250.138771771,5165424.342917373,4723450.061760427
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.010623858524770444,0.011844393627884822,0.009325655799017039
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,336.62318904223093,348.1606981537444,318.3706820625024
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2013,2856872.8004173106,2948251.0859964923,2718009.4493772816
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.006077656238363378,0.00677405813331624,0.005333232203894428
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,192.55936447768522,198.7184572435995,183.1996762823956
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,1022832.8069965239,1123157.3483566553,933295.892578871
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.0009461367108989355,0.0010590098166846987,0.0008507395640539614
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,39.86633110954905,43.776619630721115,36.37650535084752
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,3183924.343901872,3419861.6444450878,2961311.519632147
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.0029447391781620546,0.0032180702366566756,0.0026740114677075875
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,124.09787919735466,133.2938636047859,115.4212347830748
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2014,4325528.220422687,4659732.712034642,4000180.945092144
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.004000557882524929,0.004375850961568571,0.003661134482937273
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,168.59347791691997,181.61956275675226,155.91261539941434
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,3546175.907631476,3924045.0185121265,3198819.1944068363
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.0032797620366143017,0.003662016803228906,0.0029604715697313863
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,138.21713767812534,152.9451117784813,124.67842671010204
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,323369.82041367237,398962.8194055542,276341.1118814745
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.000299070867615296,0.00037940174392724193,0.0002546528818085415
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,12.603788462067484,15.550130725201816,10.770779144049547
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,1179573.690607023,1393638.1038126606,847489.5253637709
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.001090958176572341,0.0012949431231350562,0.0007816490296520967
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,45.975525028316966,54.31898323307154,33.03208285744938
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,2410759.82739375,2568719.7514324943,2252787.3545038113
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.0022296532577863785,0.00241405091280836,0.0020534635317875486
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,93.96271692408219,100.11942463886425,87.80552010037289
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,2541309.8864777377,2731494.76570855,2300219.3367891414
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.0023509325245418588,0.0025973457317010834,0.00209445636152293
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,99.05108703326565,106.46380719200707,89.65424757375327
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,675522.8823237602,754562.2234786116,602943.238901335
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.0006248178871884087,0.0007209714260252586,0.0005534438373092198
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,26.32944379040386,29.410112032179025,23.500551251272366
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,1218962.6644782564,1334354.3562047696,1108185.11218443
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.001127767564183059,0.0012703430828603468,0.0009952017472477032
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,47.51076506332039,52.00831672395638,43.193055903971846
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2014,6364783.317440825,6690942.1026639,5973032.510092236
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.013435097191816897,0.014707204697427721,0.012182962818088776
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,426.7869366369446,448.6573290540988,400.51830836562493
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,1305887.8817880603,1345312.7883065925,1255862.3634069362
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.002757978320506819,0.0030435615457133874,0.0024626216836694075
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,87.56557149909872,90.20918625250842,84.21113872759322
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,998634.7719066396,1054309.969859232,930113.1207515051
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.0021077414465615106,0.002308839016991398,0.0018996558170232445
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,66.9628884228126,70.69615725471947,62.36820795510996
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,3461224.705467303,3646582.066276401,3226584.175119266
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.007304434100463823,0.007959253749856714,0.006637027872996105
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,232.09046017492147,244.51949290979087,216.35677244926086
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,9216190.024213064,9573360.791118048,8668912.551690375
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.019462910831363353,0.02151774399584948,0.017300307735994773
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,617.9863966648593,641.9362799304755,581.2890160410236
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,1132521.9834704762,1162673.7551897424,1090955.5098000925
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.002391819698577328,0.0026440538681185978,0.002139928247906637
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,75.94061948266084,77.96242943980114,73.15340315811264
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,227747.49840591542,236523.6846334141,219905.73592631935
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.00048104870226298543,0.0005354879741816633,0.00042883305602101
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,15.271479377002684,15.859961568552835,14.745654440067188
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,689680.2735932755,715921.5030813557,666925.3398650894
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.0014566328894884799,0.0016209053736719271,0.0013052983902588616
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,46.246119709878194,48.005710474911204,44.72030053035996
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,1122869.6746260393,1178648.8126284017,1039899.9322996615
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0023720130859221423,0.002678209692641412,0.0020597146237851414
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,75.29338938577723,79.03362785878927,69.7299003563864
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,4938862.385251068,5101682.996177085,4652533.927963505
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.01043374374290185,0.011686029731003113,0.009150549887576992
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,331.1726169996729,342.0904607490518,311.9730246391784
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,1123307.0728351541,1176978.1827447398,1069100.5919575642
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.0023710813792531637,0.002582713625459467,0.002168208084838285
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,75.32271887469271,78.92160471915648,71.68793403351485
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,389886.78128569137,424142.3729295671,361348.07712795434
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.0008228778930752896,0.0009161882945818323,0.000734056259522485
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,26.14363706054098,28.44062633593618,24.229990434159667
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,1939784.2800726148,2006452.1964963772,1836109.3529635968
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.004097495829485124,0.004575437578737325,0.003609463957769345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,130.07113507857284,134.5415144148967,123.11927162303787
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,147902.19292444692,158886.71813504276,138861.80769909825
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.0003119503362918462,0.0003319732068049216,0.0002911943727642143
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,9.917497688749583,10.654058798724083,9.3112997831945
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,1942779.448511997,2003419.3158240952,1848990.6144440565
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.004103151074800772,0.004541043477633861,0.0036533584914912034
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,130.27197440007077,134.3381463210039,123.98301730817383
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,1954310.5571416463,2047774.464455089,1824096.499758614
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.0041263205078583545,0.004560151991589829,0.003684228427477732
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,131.04518635130728,137.3123556639089,122.31375656244265
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,254148.6486098554,322387.90347580053,186840.61337689863
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.0004009112733116201,0.0005090587987979286,0.0002957928109809766
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,21.68779453110393,27.510996608247922,15.944058153164104
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,341147.2770317169,532678.5039559044,263582.18064174254
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.0005379944730720061,0.0008321237053295314,0.0004219022934217174
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,29.111829197515412,45.4561612195151,22.492805714634653
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,391835.77573881653,535461.0960193638,312003.66058310727
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.000618278077305824,0.0008499842992448873,0.0005020941136227758
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,33.43733614418929,45.69361392786623,26.624856440083853
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,51529.1502699849,72072.70656838448,35062.07844936472
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,8.126311555345921e-05,0.0001124960102940783,5.775907134439867e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,4.39724401263046,6.150329973838203,2.9920251687452066
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2013,6353602.3865266275,6675575.161003435,5981094.945148731
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.013505671520074316,0.01478371357740562,0.01225392426015057
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,428.24645098471245,449.948107713467,403.1386491377217
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,1293713.7553687685,1332617.141332366,1244376.3709920724
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0027514230737672877,0.003036710178279268,0.002455617241117827
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,87.19908653737072,89.82125833167879,83.87364083352968
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,981583.498766696,1037278.8459807968,915993.3780290657
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.0020863113280000564,0.002288042541611402,0.0018803883093720189
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,66.16083665912181,69.91482271770472,61.73992160703836
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,3377906.8510217182,3559005.8048721077,3155305.903763908
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.00717857508679274,0.007813367639240107,0.00652964471259756
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,227.6781788823598,239.88463744639205,212.67439679943564
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,9162864.452190354,9516426.248107817,8631726.816002399
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.01948602840111362,0.021537234527794193,0.017339182205061233
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,617.5967496527032,641.4275742926771,581.7969318730692
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,1112412.9912686748,1142820.4454209344,1072495.0705935683
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0023658223972253846,0.002613346858531203,0.002117057263398633
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,74.97902552893763,77.02855326643012,72.28847191543873
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,228814.96665457654,238236.47473476885,221621.2507444368
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0004866902175866962,0.0005423361513672887,0.00043508315886068075
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,15.422620340517794,16.057650226369947,14.937748433134571
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,657984.5764964045,681581.1786361804,636330.4307997343
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.0013994337710180416,0.0015550544238124887,0.0012520376675653059
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,44.349574075457284,45.94003575481667,42.89003813355286
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,1113710.5602566528,1168315.2560762751,1032867.8642532986
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.002369161829239668,0.002673543606223282,0.002059614171282921
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,75.06648446643531,78.74695827786577,69.61751307268109
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,4834252.715222485,4992741.183699653,4554188.238672805
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.010284329450790199,0.011506590700170374,0.009018726205404726
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,325.839018955198,336.5214822285179,306.962071542872
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,1108873.0703271965,1160949.8163693678,1056850.9359356423
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.0023570476728775216,0.0025669607809966737,0.002155628335184523
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,74.74042725228588,78.25051181764758,71.23402362950401
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,377502.7838788902,410393.5073602231,350435.23089393287
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.0008023211873687242,0.0008927876047454875,0.0007153215935415498
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,25.44449866359394,27.66140408894276,23.62008744024923
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,1935812.1686430455,2002609.9662750047,1832960.899316087
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.004117767112425283,0.004603915711666263,0.0036304795144280143
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,130.47789908168954,134.98021415103418,123.5455025625205
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,145101.61544931046,155672.39971625444,136191.74162653743
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.00030819443950466245,0.0003289333896177716,0.00028752707247139855
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,9.780160618814838,10.492654188768723,9.179615981112073
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,1924842.3372090447,1983248.6264235221,1833894.7372618993
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.0040937680031151525,0.004525292207561246,0.003645451428802313
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,129.7385088753599,133.67521824897887,123.60844524633356
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,1933675.970352335,2023078.922354538,1809760.7126843703
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.004111367040437732,0.004541432672219001,0.0036773439045345233
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,130.3339147274695,136.35986576647218,121.98176014006664
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,3541615.59446109,3815885.1891127573,3271753.6771676918
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.004152143253599441,0.004686172652584355,0.003647741524498186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,119.3299033535511,128.5710429830995,110.23727439636313
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,774760.8375646806,871566.875140212,633889.8450296387
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.0009081541390372627,0.001044579147222021,0.0007510642228937373
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,26.10450891770983,29.36625621913769,21.35805310505312
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,2044297.8184916505,2253788.282427068,1746111.4785108748
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.002396018464919619,0.0027203673052033552,0.0020104109363561105
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,68.87982464500179,75.93831988485802,58.83284292657245
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,9250373.829564434,9963196.70011923,8533164.639018856
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.010840706210264254,0.012010426811579385,0.009668638182265928
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,311.678719958344,335.69631361942226,287.51333523225105
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,1213753.4414807549,1307185.7923013298,1120927.731947939
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.0014224902146992733,0.001562330121836646,0.001272145455412404
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,40.89576550697832,44.04384103808658,37.768129926030646
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,1300557.6462061235,1436828.718643479,1188390.0279754675
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.0015241513473888781,0.0016966485638269654,0.0013458635568719447
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,43.82051470244723,48.41198248603902,40.041179908519965
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,411238.58974426804,440962.8779627369,383894.5851440075
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.00048205634181804855,0.0005371427984689925,0.0004305403187103868
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,13.856122964384397,14.857642283959969,12.934804052373925
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,1311863.7745790556,1531480.1349618044,1030592.7409533423
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0015378617159960244,0.001821418947768882,0.0011852130290507924
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,44.20145926575742,51.601132765139575,34.724415706540555
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,264731.71589905093,300414.9463973902,227976.31722248447
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.00042086407587081914,0.0004722604714282539,0.00036966478945242164
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,22.035252294681268,25.00538749004264,18.975873933916315
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,215735.56927852117,262006.00932467094,177752.22791869
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.00034301424432756447,0.00040874583818155516,0.00028284329760334395
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,17.957001041014834,21.80837493756614,14.795413442730858
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,73793.88927075232,87576.5172157452,61477.38655220253
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.00011731746654911695,0.00013755048770798363,9.716276804524793e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,6.142320206570428,7.289533274790227,5.117141776892346
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,107195.60016449649,127619.71494024404,77219.23144554446
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.00017047376073758356,0.0002054071351645305,0.0001244279700165645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,8.922550463901267,10.622575413502489,6.427432546664722
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,380640.80149062356,420839.97675260477,344388.51666389883
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.0006053106694383673,0.0006666035193632384,0.0005556125059380479
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,31.683079853167154,35.0291049636365,28.665578758888962
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,104572.16746513285,127978.26908535161,63603.88521112637
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.0001624606714455517,0.00019875665039720237,0.00010116977432758897
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,9.390371915849357,11.492193123555518,5.711501940749292
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,31077.16647316735,40932.42502987386,14469.854143385228
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,4.8303466391867816e-05,6.384160525294417e-05,2.292522531994364e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,2.790667520314221,3.6756500679427493,1.2993640207351156
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,280804.16877479805,330804.0503194571,220074.76442495064
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0004362904994196597,0.0005067607886386058,0.0003364089374534614
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,25.215653880326037,29.705543444959094,19.762274583552745
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,37959.33354132442,43858.89220547483,31510.31880418634
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,5.896565739128318e-05,6.753543420591989e-05,4.9165264243896635e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,3.4086723864613533,3.938440979181929,2.829563735082278
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,243605.8233267378,279056.40940399957,206644.3888111033
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.000378360018373048,0.00042396340504535627,0.0003272497888012023
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,21.87531670573327,25.0587085772971,18.55625366000604
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,254938.9313844356,297641.9162383914,226381.93843469193
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.0003961760492146963,0.0004599082264816081,0.00035309262925652476
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,22.89300718881303,26.72764999498064,20.328646220720895
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,623362.6729563781,769073.5947577811,454773.1405704955
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.0009685678253342953,0.001190699988405445,0.0007029383973541498
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,55.976723820610324,69.06127376429043,40.83772031137903
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,83106.77885471389,105068.82970444855,68678.0989588305
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.0001291315767842893,0.00016122728278579826,0.00010693964110707009
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,7.462822862825478,9.43497119361881,6.167156207333609
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,40772.07103768441,52633.98385184326,30386.826044441354
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,6.335701698029054e-05,8.27041936930159e-05,4.715396932735443e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,3.6612505995052973,4.7264266942388256,2.728676327710837
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,312985.07487343566,408341.0166558323,167890.64225874134
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0004863706477728755,0.000637405955249626,0.0002673902015847074
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,28.10543501598044,36.668208260795694,15.076244570775096
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,1058225.1411764352,1220344.4122796026,873660.832553412
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.0016437931591721214,0.0018749194131171725,0.001359529257536394
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,95.02650549595046,109.58449245641722,78.45299896573862
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,104391.64771897586,129644.80207499408,69409.40792037881
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.00016223403160331245,0.00020238463943980027,0.0001099632303097251
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,9.37416160295577,11.641844459681769,6.232826292412624
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2012,1223250.0579462247,1441490.3511784896,882293.6516734204
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.0019002449094223403,0.0021961960330868745,0.0013930688779092205
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2012,109.84541363770914,129.44295636970134,79.22820889189956
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,683806.3200664815,798442.3189351578,568575.7615983572
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0010623357329460409,0.001219472911840252,0.0008800192298021683
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,61.404442687616324,71.69852657643585,51.056968533487414
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,11787.72682875799,19728.037847634994,8266.806404670657
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,1.8304791425005327e-05,3.0357770091434158e-05,1.2795474168028862e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,1.0585143413172549,1.7715384222194022,0.7423427148726373
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,2643540.547914125,2709657.355733239,2553020.5859845374
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.00558435938551582,0.0062117717672740234,0.004978495399465949
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,177.2611126019391,181.69453766324642,171.19134787788943
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,313138.0043593474,334529.0470279851,291073.490130062
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.0006606522222432862,0.0007123706564941909,0.000604904228082587
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,20.997291338877524,22.431655576698702,19.51776784740296
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,384919.94107561937,397849.72733719146,367341.65781234123
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,0.0008131521625897697,0.000908689400658977,0.000713952588302156
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,25.810588406360868,26.677587893181645,24.631886588702194
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,236717.774590499,246671.32007506053,225936.26231183758
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.0004997906308705752,0.0005504887725960451,0.0004521740204741191
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,15.872976160579766,16.54040550957142,15.150027967651543
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,2329996.9485018305,2425264.1993874596,2192752.0855075773
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.0049197762715388485,0.005419158025524407,0.00438649492809879
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,156.236624316751,162.6247158101232,147.03374784396226
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,1213311.4562306565,1259568.5581252165,1136867.0334753576
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.0025629073925634064,0.0028693825779205874,0.002242896061549424
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,81.35791177246261,84.45965551308389,76.23197434717547
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,250689.26747307868,318046.4796481526,185423.6151048001
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.00039357928933946083,0.0004965419820355091,0.0002918339808133028
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,21.942360820647348,27.838011114400324,16.229780829110634
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,334265.5553669222,516579.6533597752,259836.04119291547
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0005246120665117561,0.0008111146891271344,0.0004143928334347708
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,29.2576363547863,45.21524699034983,22.742960747913997
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,380806.46920265374,513800.2219456956,303810.21110306564
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0005979364591828583,0.0008147068473888719,0.0004889886178270715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,33.33127514515023,44.971968578079846,26.59193726247734
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,48639.964489416634,68609.95115197205,33882.59157403721
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,7.63409433000922e-05,0.00010749263184324135,5.493140280041163e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,4.257364752341733,6.005300183922837,2.965679613452101
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2014,2753582.350914792,2849535.6354319286,2608832.3878305582
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.005815963044948317,0.006475494381246023,0.0051680284734907
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2014,184.63990331048817,191.07399640005275,174.93377660641823
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,1571837.6506436758,1626098.6308456243,1490383.3661515284
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.003319896033790073,0.0036900352962291223,0.0029433058107965794
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,105.39868246112749,109.03712172360017,99.93681159757458
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,663687.7144958759,725778.9878492965,603106.1319051483
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,0.0014000607114690387,0.0015433527856961705,0.0012441406368540354
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,44.50320339690078,48.66669852701452,40.44093972491291
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,273523.43261789304,311507.8854511171,235021.10481610015
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.00043835735987235105,0.0004906155017300832,0.0003827675759667022
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,22.2178348067256,25.303246137649456,19.0903573888414
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,222152.07808187933,267372.6567558139,182305.26516701689
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.0003560781065407784,0.0004229761061979182,0.00029165069203731885
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,18.04502863083446,21.718217933944636,14.808341015285006
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,76171.1969608447,91371.96634386951,62324.475632542635
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.00012206847382311057,0.00014571922960422853,0.0001005643603831271
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,6.1872544334100965,7.421986609204987,5.0625092364720645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,109912.38789713255,130816.94998635577,79269.69372771654
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.00017621711939167615,0.0002172231852572921,0.00012910667109167768
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,8.927992947948583,10.626034328754642,6.438939960520687
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,396293.0828704139,436589.43505395064,355867.60963844554
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.0006353066368017752,0.000703056293461928,0.0005797144542376246
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,32.19020091255944,35.463403824494804,28.90650972144195
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,747099.2542797419,766685.0445286189,722379.2257665973
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.0025959334289490247,0.0028618551891322185,0.0023418100547973296
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,88.87017348993307,91.1999744733824,85.92963619177029
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,123545.66631213007,129827.98022356941,118567.20850111134
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.00042932104638510233,0.0004758018806095453,0.00038713298381291557
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,14.696206342319853,15.443510430805526,14.104000679092318
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,500011.63502412615,521949.49069707457,481316.5745234117
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,0.0017374402175376084,0.0019258722589446144,0.0015606308754181862
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,59.47820252399913,62.087790244082775,57.25435708367003
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,524214.32755585935,545605.2719350306,494959.17652467603
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0018217767603571045,0.0020252791359538533,0.0016063829389099174
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,62.35720082562673,64.90173145820407,58.87719420974284
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,2860772.480967886,2951580.7815520633,2717126.014927649
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.009942492464885981,0.011050513932144387,0.008831430984346671
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,340.29929121525595,351.1012688387273,323.21202163884766
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,698653.4243420705,728459.2323117249,668501.2151033304
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.002426609196013953,0.0026318810063379163,0.0022254649219109607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,83.10736582179348,86.65287508324306,79.52065086952803
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,193193.76175874053,200866.88184476976,181033.24758607592
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.0006714029160118464,0.0007479911439747805,0.0005920744347009101
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,22.981100605199238,23.893846146502085,21.534563216678666
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,3742105.359280511,4051599.8311980264,3429090.461199615
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.004386177011033135,0.00485975524776306,0.003878695852503375
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,126.08513232213082,136.51312611121833,115.53852257864781
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,338055.3236224622,394950.4590196047,254287.24151000913
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.00039633689624627414,0.0004682111015573575,0.0003003794869706455
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,11.390312703363888,13.307316631979505,8.567861515204275
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,529828.7336780445,590556.4817841589,428270.45393614064
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.0006211985382076183,0.0007207785708550454,0.0004978047798127375
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,17.851855995499683,19.897994578047943,14.429988380813407
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,1497410.8354624968,1672810.5855519243,1332918.4950827174
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0017556979116223016,0.002025224718216687,0.001509818235234234
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,50.4532142211469,56.363069389828254,44.910869334644524
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,186667.5444301846,196056.07031847592,178035.11012593887
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.00021878468872570518,0.00023711753840225278,0.00019923491757945836
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,6.289508119101252,6.605841684108773,5.998650027996569
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,1177693.7420902867,1259101.200546523,1111183.651426967
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.0013802787248939471,0.0015100881801610373,0.0012455211069393817
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,39.680783155434554,42.42369635161357,37.4398164329866
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,1293745.7907840114,1489938.5945797337,1177308.1757987482
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.001515933280263787,0.0017571938553847533,0.0013439144864120594
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,43.590998531790504,50.20144726378171,39.66779202551695
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,3907879.5364093906,4734520.899783236,3180526.2598342556
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.004580792982304929,0.005612531438362746,0.0037393370505652093
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,131.6706669482606,159.52321936917318,107.1634910894965
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,429211.60552367626,470946.1789088369,365402.87468371645
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.000502777972040775,0.0005541275574716741,0.00042677715412106946
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,14.46169919893756,15.867888683855602,12.311751108536821
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,175239.39139701892,189346.51571598725,162618.83931047685
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,0.000205431826425126,0.00022737348323046975,0.00018358311993032792
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,5.90445210142106,6.379772399934476,5.479219825193552
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,278719.6799919131,364068.55525106296,223512.22447471402
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.00032682171991315446,0.00043674676191737225,0.00026038259037586926
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,9.391079180977172,12.266793036522927,7.530939322330189
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,2516053.6492142426,2726909.124221963,2226546.780408766
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.0029489100301302116,0.003305780239812796,0.0025949488272614726
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,84.77499344159376,91.87948086636943,75.02045465743652
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,583694.909694772,674947.0529665486,466687.3419499519
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.0006843892808521926,0.0008193004600345584,0.0005426304608928049
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,19.66680327214774,22.741419685757265,15.724392985593747
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2014,5045368.5155043,5559624.421559059,4114361.4203918194
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.005914182801207659,0.006754783750510807,0.0047884602843536695
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2014,169.9968054917578,187.32395631650573,138.62779219313967
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,1252810.5288350864,1295186.5225841415,1189945.9135353777
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0043537051787761235,0.0048207191619618695,0.0038691925315031675
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,149.02636886570906,154.06714744327243,141.54839423776082
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,100853.62505146385,108180.91961913099,94957.00776449183
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.00035003249895998413,0.00037173370146857784,0.00032742590748516536
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,11.99690550361093,12.868513841740262,11.29548143138087
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,1257033.9950746526,1297656.283703994,1204450.237884666
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.004367850785481209,0.004806230178164098,0.003900817168728373
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,149.52876553561478,154.36093451097818,143.2737363712076
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,1300314.3199568123,1356742.4007127923,1223366.0011297702
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.004517153263299828,0.004955471296257202,0.004068234344567817
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,154.67711759050528,161.38944302485797,145.5238352056758
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,1794249.8460000062,1847075.7885304254,1719269.8729669135
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.006235687300815095,0.00688281813481291,0.005597611941662825
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,213.43254485246834,219.71638284394552,204.51340435868508
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,178825.05013481775,190382.4793372638,168052.01079889294
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.0006208391787852638,0.0006684609526466281,0.000568054755279018
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,21.27189009865697,22.646688336555375,19.990397888200256
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,265560.3307223858,274607.2356361374,253800.60286345985
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,0.0009229161193546627,0.001022408312685029,0.0008211198597912033
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,31.58936717999397,32.66552942299762,30.190504781148874
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,173909.9824500786,183264.75664735786,166382.26793630648
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.0006041214118074484,0.0006666018511170201,0.0005484504554725863
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,20.687224921499737,21.800009335496807,19.791775901855623
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,1228825.3629073214,1276222.371246768,1162951.5488091188
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.0042687699417859135,0.0046513503713764455,0.00385355471284289
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,146.17324614476578,151.81129266924177,138.33731637530738
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,691092.1216718149,717925.258212762,648399.3868304286
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.002401505212089893,0.002662077404138665,0.0021236157643761263
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,82.20792136877594,85.3998205522011,77.12946528629531
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2014,1625259.95558071,1686513.9697079184,1540418.4128613584
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.005647402685385074,0.006248820860865867,0.00507369555161827
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2014,193.33058277236054,200.61697053309814,183.2383726979561
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,1050240.273231679,1085930.3322999263,1003128.4727145825
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.0036495246844931595,0.004021808171480852,0.003253495526644016
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,124.9299002154618,129.17536254605798,119.32578019875281
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,357798.0974227182,393689.9286248217,325085.8060055574
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,0.001241671877183778,0.0013562862096181975,0.001117338963183844
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,42.56138499693745,46.83084885669925,38.670138958552606
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,79038.15768888351,91888.39809944491,57371.32039941554
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,9.262262955101146e-05,0.00010901173314155788,6.693435067439978e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,2.6630828407825433,3.0960541515765145,1.9330483323020289
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,407287.4073184188,506646.2608318791,341049.18407878355
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.00047728573630635,0.0005986251072758346,0.00039723199678074145
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,13.722993265682392,17.07075421569171,11.491186744992126
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,1086576.247626429,1252902.476595094,799228.7026434931
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0012736501015107938,0.0015170754746125664,0.0009404891873974352
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,36.61070354961998,42.21483880897224,26.928920234310258
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,100174.9404120682,109837.1558727623,86169.03773312717
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,0.00011741482872304074,0.0001329666655468342,9.955197214498923e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,3.375257884146176,3.700813045725267,2.903348110631754
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,998548.0553299153,1018299.4932810202,964759.6925434702
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.0035445860304301542,0.003948546469957245,0.0031430345765139094
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,105.22439570171503,107.30575083685491,101.66386595357045
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,2115397.510213983,2181296.7093647877,2028273.6238580593
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.007508695871115622,0.008359597433962107,0.006665635375512918
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,222.91508505079952,229.85937117789993,213.7341966157829
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2012,805942.0240949391,825158.9144179444,774785.1446935489
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.002860802973313079,0.0031851326935390186,0.002536266594402685
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,84.92807331940357,86.95309921646601,81.64484244286929
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,48949.254938277256,52245.72016210525,45464.74476446054
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.0001702736722308705,0.0001872210970228264,0.00015412904759184857
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,5.838201201766943,6.231372196005842,5.422601995813808
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,66605.51661745789,71078.41713033718,61805.16798173879
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.00014059047486257941,0.00015541952128132134,0.00012698419956017656
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,4.466195152691505,4.766122960531031,4.144310496631978
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,496412.688220936,514489.35918769904,473491.5754582425
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.0010484317341901538,0.0011650676385724836,0.0009400316179991879
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,33.28667135187108,34.4987922744103,31.749709131414292
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,314742.00082588324,324905.0371511233,300867.5353818211
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0006647389404332284,0.0007350793407193872,0.0005980606194861673
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,21.104846412504816,21.786323051040767,20.174501998717727
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,68298.75035836267,71369.77269330813,63943.926658302764
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,0.00014426764714377624,0.00016174292890659356,0.0001288057503712741
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,4.579733981155763,4.785659642612849,4.287723747052487
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,2609416.121879163,2673565.5095994575,2520795.638881962
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.005550889533102091,0.006172004144496127,0.00495548916187426
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,175.88025270620392,180.20405925763617,169.90704175920143
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,312327.75856282806,334631.6897250189,290304.3828440714
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.0006635738007166468,0.0007167705979934044,0.0006083350930980674
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,21.05156193471859,22.554894813003635,19.567139096068757
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,383490.3192419876,395332.5948673759,365932.3832007623
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,0.0008158093482073426,0.0009089948328592889,0.0007184987579297599
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,25.848071410738026,26.64626622993376,24.664628799941923
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,237443.05153485286,247266.87631831598,226839.6350565244
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0005048374084908224,0.000555436847610782,0.0004575058041102283
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,16.004171798098536,16.666318694091757,15.289478746990032
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,2286363.6176867574,2378215.4369137036,2154446.4267825168
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.004861494331696811,0.005353539450882262,0.004349261246919501
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,154.1058198749183,160.29682982603546,145.2143177959696
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,1191026.5146650376,1235386.189301028,1116228.6501858076
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.0025334456132886565,0.0028327428734390226,0.00221675264950972
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,80.27774589980731,83.2676832729713,75.23620913754596
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,137599.2835316798,171155.3502393571,89704.86180500235
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,9.95551691605479e-05,0.000124982126424321,6.376684823146425e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,3.262847890486458,4.058552189665896,2.1271427553577626
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,627981.0709940615,858970.1294233409,493196.41458068206
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.00045420317680252805,0.0006120836953609449,0.0003602972212531433
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,14.891114693098372,20.36848450693103,11.695009157075797
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,382811.4111607098,393699.04777453456,368741.55303504074
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.001358491574022172,0.0014992815925918518,0.0012181054229449479
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,40.33967037650257,41.4869811916351,38.857025339060435
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,6334079.50666681,6506041.3804609915,6035678.872012979
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.022484228409950804,0.025068462947461102,0.019838089960329163
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,667.4688162057691,685.5897109961048,636.0241338083025
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2012,3033139.521216206,3166742.6427170383,2872334.9776609503
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.010759391310330395,0.011810776582590141,0.009750887295067009
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,319.62435007047833,333.7030993592576,302.6791857077063
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,1272450.0566690806,1314049.3220036856,1226985.5583558725
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.004515792479155594,0.005009021664900068,0.004059273100412212
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,134.08747586953072,138.47109820308282,129.29654534259853
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,418303.52106403286,441114.2617055424,392549.414973564
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.0014835994168772417,0.0016274067636877377,0.001343051805104134
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,44.079736562422966,46.48347305432209,41.36583587858251
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,1817551.3299418252,1916177.8894707602,1700056.813949452
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.006445772919691704,0.006988265009253364,0.005856416091476309
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,191.52882961330144,201.92183981564233,179.14756325604222
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,3277142.500007352,3387734.999586202,3112001.7877150974
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.011629657996434683,0.012888541003887866,0.010354367558627455
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,345.33674904384003,356.990698871504,327.93465050291155
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,424972.0043208074,437674.67632278847,407027.41227087873
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.0015080860090535822,0.0016726522826155396,0.0013470671947473098
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,44.78244397564729,46.1210184969947,42.89148955989449
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,76010.75819369171,78554.02903042847,73523.76026617583
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.00026976824029182174,0.00029956788510527216,0.00024011518184538833
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,8.009815907275312,8.27781917008574,7.7477425372082
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,212929.02309675395,219085.17247024793,205499.1050122733
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.0007556491913179825,0.0008348637783267294,0.0006754751879300651
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,22.43790638129059,23.086625383063012,21.65496094728803
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,458554.25085217867,473702.9914441011,437703.770828433
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0016276911798906062,0.0018152261496967824,0.0014329793732909169
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,48.32125372917702,49.917588593502,46.12408440029133
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,1827829.248159938,1873211.9933474804,1741567.9008529969
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.006488429684318339,0.007258871888024939,0.005691817781936842
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,192.61188989047088,197.39420548575416,183.52189357598232
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,463458.04026945046,483661.31622228044,442363.42731347226
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.0016437561299927385,0.001782433605362098,0.0015065398293893884
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,48.838002297587536,50.96697094560035,46.61510687557304
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,257534.13207251488,285574.59723993234,235315.8692871537
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.0009130167389444393,0.0010102055027693148,0.0008240638399162243
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,27.138276696100178,30.09310795002684,24.796973978967483
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,830336.4840776913,855125.4883011589,790093.2664123203
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0029471789062320893,0.003296527736754017,0.002611558113476612
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,87.4986980344122,90.11089879484507,83.2579724756085
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,781875.7283196534,805374.918455914,757655.0113818806
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.0016654142077261104,0.0018318917450734261,0.001503242744400661
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,52.969151119123765,54.56113320581636,51.32828829499233
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,16790663.91338492,17199443.122786112,16017962.415884713
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.03577791363709415,0.03990491473874197,0.03153114124010871
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,1137.5045701059232,1165.1978299589473,1085.1569387514842
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2014,101829489.15850614,109582815.50107712,94660717.88034707
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.11934603262788662,0.13173592533861955,0.10706923024785538
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,3431.005645793416,3692.24339406133,3189.463682536786
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,7159553.489229895,8101802.172676172,6285004.616081009
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.008389452575935223,0.00962956747634348,0.007201965847148831
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,241.23138244041527,272.9791657138185,211.7646518686315
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,13370077.333851317,15380979.770423863,11144438.253552508
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.015668205329606968,0.018060645328610975,0.013066096933802115
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,450.4865063766905,518.2411192107055,375.49663543550014
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2014,6748981.535001773,7426690.44973279,6101767.563988816
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.007909382836822474,0.008920271712580665,0.00698268397418154
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,227.39772084982854,250.23219769795685,205.5907295064339
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,992032.250480291,1075532.3077538903,917145.3771755398
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.0011626592099648982,0.001286812632085736,0.0010387812998508216
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,33.42517261290522,36.23859306995818,30.90196163318133
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,21371631.93856952,23592984.867717944,19281925.621383373
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.02504804974337717,0.028032621859602036,0.021982341854819076
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,720.0879671203359,794.9334220488637,649.6781650918148
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2014,6520855.430683212,7022560.818532933,6067227.042083159
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.007643125617205972,0.008422829990485594,0.00680229590440138
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,219.71132314384036,236.61560138840645,204.42693376665076
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,49734.24918143288,53079.81128479709,46149.29211084758
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.0001727223888899643,0.00018998917168193454,0.0001559150783761278
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,5.916069823154355,6.314036603129213,5.489626141151186
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2013,2763663.347240953,2861785.05709906,2619471.790815861
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.005878158260546522,0.006540240410345754,0.00523182481950954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2013,186.27684708162533,192.89046113156863,176.5580263962212
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,1539458.1405414275,1591231.046476731,1459594.8466296191
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0032743143703399175,0.003635430318779544,0.0029046891876555953
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,103.76278605731244,107.25239114669844,98.37982846868395
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,646638.333870696,707208.1038812767,588802.7348577613
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,0.0013736350770861957,0.0015109152832014153,0.0012212411593763206
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,43.58481294612134,47.667345573437956,39.6865693181621
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,3475074.7981986417,3748091.6693239296,3216848.409698806
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.00410240773873154,0.004571747367475873,0.003612508907736403
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,118.1997971777361,127.48608327719994,109.41658860840067
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,783387.7701590341,886426.8922094719,624597.008087847
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.0009245597435075454,0.0010620114152653764,0.0007447560497376364
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,26.645836685965854,30.1505679608285,21.24479154004794
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,1999493.0869462825,2242005.0476892153,1712042.4012554567
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.002360013291768847,0.002675141059455924,0.0019914963153840758
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,68.00995404698808,76.25865838792737,58.23272198140232
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,9042082.276544813,9677194.888018392,8411650.352579799
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.010670437403901117,0.011759554249041937,0.00962160318977813
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,307.55375156414334,329.1562166103956,286.1104935411324
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,1190655.091939139,1281384.80818772,1105844.021716787
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.001405234103995168,0.0015428701877924246,0.0012705304800197056
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,40.49846364423504,43.58450773863403,37.61373399642853
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,1294018.9736898714,1401743.4000419797,1194108.7058292176
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.0015271124975589883,0.001703715078043503,0.0013751483270626394
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,44.014241164987396,47.67833649683684,40.615933478711405
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,401613.69562431984,430811.73999098747,375665.86178383284
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.00047409174826339867,0.0005212370975608625,0.0004263495862453162
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,13.660326791009716,14.653457334247433,12.777747601998607
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,1290111.1542366736,1536411.89453658,1008691.9181176142
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.0015228245246586443,0.0017796801034998169,0.0011783587862229075
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,43.88132216508133,52.25889653075153,34.309241400538156
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,111751.02551548512,152525.84341550653,73590.64295048153
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.0005948303354105409,0.0008084999327748171,0.00040315572514799925
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,40.603068813660855,55.4179909087574,26.738062813982
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,16407.833429064274,21584.638037456916,12896.41896018324
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,8.731688241986202e-05,0.00011426260492646971,7.094510692640124e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,5.9615416210302845,7.842456384719111,4.685721532081703
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,7163.642018581516,11462.30327407465,3876.6307892076275
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,3.809907589937182e-05,6.108180442560927e-05,2.103020318056046e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,2.602802511164362,4.1646569814772105,1.4085159932384028
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,57023.07623754125,80697.7104326851,35714.97600612407
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.00030349777911420155,0.0004282662426063334,0.00019894020884738303
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,20.718484486021,29.320309810930205,12.976503989701273
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,204862.28391113604,246191.89221016254,157982.0198268221
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.001089839295132857,0.0012729693562722987,0.00088158509044031
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,74.43365617987074,89.45015309402646,57.4004112513557
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,11181.273803439013,16894.50432713466,6417.832736364408
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,5.9495112732007274e-05,9.02371966599938e-05,3.482747051979425e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,4.062549113721634,6.138366235147311,2.3318238291518925
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2014,301286.94790240633,373733.9382897462,205690.34483405133
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.001602766521954551,0.00195980775141653,0.0011126644044126338
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2014,109.46812006341821,135.79065377146185,74.73451976908562
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,174732.65956499113,219122.77669652633,133868.1343384151
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.0009298088275412384,0.0011363091071720994,0.0007399581422756749
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,63.48650643325175,79.61499359678494,48.63899051866761
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,120466.53739909496,152832.68353009626,69843.11608892243
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.00019300851052696393,0.00024098364006981552,0.0001141300102067681
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,9.785288236749903,12.41433424274057,5.673235381695507
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,37179.15859335317,49237.74575607923,16894.960902917843
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,5.95946462474741e-05,7.865347467563767e-05,2.776136429280448e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,3.019998674242056,3.9994968291888866,1.3723484193454831
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,340318.9854538569,394100.5233831374,270709.42495078826
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0005453537694641814,0.0006253260334335986,0.0004280633847808197
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,27.6435219024508,32.012103101977004,21.989257836576463
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,44962.470613424135,52180.75823495482,37636.10666069398
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,7.202887115076796e-05,8.247207144640125e-05,6.207424841656281e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,3.652223632286937,4.238552636817386,3.0571157745148274
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,279947.2049393966,328901.5893251712,223385.92415794963
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.00044830562689983296,0.0005119272747409647,0.0003699329544758019
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,22.73962670919328,26.716106584932234,18.145251811103464
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,286375.14456267643,339230.06943416886,253527.30359237967
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.00045906316772914465,0.0005341786691176449,0.00041122511012429714
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,23.261757114368294,27.555071139705266,20.59358387066974
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,703330.0609907369,872056.9081163713,512198.3393810155
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.0011269485215708523,0.0013443258362320788,0.0008170863626321982
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,57.130282989415065,70.83567261917274,41.60498420091173
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,95372.91984145435,123314.6164085309,76320.88889495429
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.00015282102962912368,0.00019559890949609666,0.0001243884463372097
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,7.746977133884862,10.016632763039722,6.199413650015837
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,45365.94957354419,60200.63438491842,32684.106860097716
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,7.270152886058989e-05,9.552003878793362e-05,5.193414505860073e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,3.6849975295656354,4.889993289506217,2.6548734054440737
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,337708.5209698673,441623.63392950036,177687.23307063695
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0005412195339091853,0.0007147459735826491,0.00029168392790197373
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,27.43147839261692,35.87232308209062,14.433226264539464
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,1175424.9695163423,1374295.8551226999,963920.9082407481
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.0018826800148164455,0.0021651631853370924,0.0015681596492766936
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,95.47773494381833,111.63167262286848,78.29762628037768
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,126072.98804443145,158341.8718739556,81120.89959766236
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.00020208235329727367,0.00025039819263049357,0.00013455789389760523
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,10.24069051471179,12.861836072369911,6.589310207844815
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2016,1310311.7597694274,1548916.9872127324,922600.9784313564
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.002099097292222465,0.0024452262949167395,0.0015209815532443763
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2016,106.43435535022823,125.81584481392028,74.94127993028984
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,754139.9502938908,886218.9594844729,597183.1896272298
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.0012080094060313682,0.0013836034436204413,0.0009797210586391652
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,61.257482316657075,71.98603152922783,48.508156429239435
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,13249.807647882011,22474.202798702732,9268.707540908512
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,2.1224526747688557e-05,3.659040730852468e-05,1.489089967742869e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,1.0762589322750207,1.8255405776951457,0.7528810641369741
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,3650477.1557556996,3939989.315355627,3371213.270441673
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.004308613694907841,0.004774544179095063,0.0038172861828213445
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,124.16586245451477,134.0132126649154,114.66709292578528
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,330736.04971426976,381724.9488387553,251085.74510509128
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.00039048695737987893,0.00046293609914581715,0.00029537318973089737
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,11.249523036412558,12.983838953282707,8.540329595503017
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,522069.018826146,580741.8439525185,420487.86026316986
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.0006163162612085612,0.0007148024565097254,0.0004999242801546821
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,17.757445730381882,19.753119617279783,14.302305039468646
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,1460136.1701680261,1632468.7300051032,1317969.9202865316
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.0017237834499592738,0.001969069106072459,0.0015128322846893211
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,49.66448470553804,55.52613511675263,44.82889903405186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,180176.96701226855,189250.3559240956,171964.79357159435
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.0002126674206044361,0.00023140040273764194,0.00019508192291136663
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,6.128466923356405,6.437085526227513,5.849141357305491
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,1157756.4536952234,1227365.4831387838,1092777.6646849436
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.0013664338758304165,0.001496364164845485,0.0012454862906357874
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,39.379462588525314,41.74711613262536,37.169300181128676
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,1270137.8855383939,1458881.6774894116,1163381.747645497
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.0014987013808096775,0.0017342560323574214,0.0013376074394236374
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,43.20195943299377,49.621814895883844,39.570799075536186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,3843094.9242745303,4634657.023575582,3120159.166500856
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.004536664517302779,0.005538426916166166,0.0037081860361618275
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,130.71748579901245,157.64136083026827,106.12783956012387
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,420304.79962681734,457419.33352190035,354128.1230822272
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,0.000495799015373127,0.000544116675037854,0.00041626535425467364
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,14.2960784885756,15.558477324139968,12.045171616147455
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,173990.05655207924,186773.72612697605,161711.0053811876
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,0.00020539316454400668,0.0002271270677401141,0.0001851691419774752
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,5.918027838151596,6.352846435933508,5.500373127902831
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,280591.11008882476,368316.83437278506,223233.79531665548
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.00033129458672887446,0.0004413279205455938,0.00026574871322863544
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,9.543913218664203,12.527780738007724,7.5929845721083815
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,2480955.45298199,2699154.0787465395,2229146.358843525
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.002928169190668993,0.003287252025794757,0.002580153656085858
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,84.38622141355913,91.80794175270104,75.82128811482703
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,561218.4582712883,643692.5048042238,453167.2528485594
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.000662649012800441,0.0007910656122336678,0.0005299585781923767
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,19.08905902527745,21.894298088814562,15.41384876148779
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2013,5059338.629460189,5591788.892654931,4161091.4802169884
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.005971800205347771,0.0068172565431676635,0.004834613773595683
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2013,172.08631024738474,190.19685945037588,141.53369281565008
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2014,34620295.51599876,35570170.2310196,33234097.759090915
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.11991284519335829,0.13280312106926595,0.1071219153426682
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,3572.169830315238,3670.1792132221162,3429.1400342873994
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2013,34129071.490458824,35064881.68142909,32756609.176285908
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.11961141506147577,0.13264362638067928,0.10676432623145468
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,3558.3677868047816,3655.9372984465836,3415.2720190596274
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,262952.9254674785,273447.9953476167,248530.23089810117
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0009151491163647094,0.001012092441930849,0.000822535271712677
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,31.36252201199281,32.61427404916094,29.64232028729174
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,210277.9298838896,218457.6297180811,199623.1264920857
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0007318232051187364,0.0008040165766487555,0.0006641595287873563
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,25.079949929803707,26.05554666692026,23.809146399799875
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,38880.85994766763,41144.15396139505,36141.827084482444
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,0.00013533201956604504,0.0001512205366685008,0.00012096876231210485
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,4.637338884083834,4.907283050702037,4.310653115859353
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,126515.12847981145,131012.76393769454,122789.06013375254
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00044879747467281344,0.0004902290644770193,0.00041068108381258587
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,13.33183502822467,13.805784149267211,12.939191641695013
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,790398.2252275348,813059.0960603764,757092.3140431223
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.002804799849483099,0.003093513242538375,0.002521029071642777
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,83.29010824200816,85.67805184345306,79.78041798827576
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,634334.8752043804,662181.0849255073,595783.0777775884
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.002250402284891553,0.0024802957565244347,0.0020145640198901073
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,66.84455851636585,69.77891963684348,62.7820704209792
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,1407143.928879561,1442961.15488776,1364118.9206941365
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.004994592583766971,0.005529946748026701,0.004465941274531262
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,148.28116562979875,152.05549170485122,143.74730222462026
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,151984.38465085486,159955.50141463694,143751.10439891717
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.0005389822956100293,0.0005855940233947556,0.0004938819732736357
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,16.015718968777485,16.855694511326277,15.148117320034842
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,113611.42069959689,116791.67977682396,108695.71171211441
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,0.00040328741059253567,0.0004517065693735834,0.0003565986176627902
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,11.97207587969176,12.307203305747933,11.454071257988867
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,141894.54641963277,147926.4796473785,136238.3034020156
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0005034803249240672,0.0005561885258712217,0.0004542177538237992
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,14.952478071214857,15.588107498776996,14.356437900394866
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,1243681.0921089188,1283193.5112460856,1184729.2689686534
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.0044131634661239046,0.004859708726962437,0.003958750254857797
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,131.0558772452593,135.21959315680616,124.84368752405535
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,543482.2196236623,559474.2373062449,516845.70615326357
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0019291422510805197,0.002159210528638868,0.0017001313166983795
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,57.27074208324611,58.95593929305387,54.46385560586249
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2012,1842992.1984084737,1912310.3090157495,1758254.5702271538
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.006541028932231905,0.007282496863995794,0.005870037540250549
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2012,194.2097221314341,201.51428425130663,185.28029137346223
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,738192.5856521993,760913.953261775,708422.3428493032
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.002619806985024088,0.0028834236811058657,0.0023342315655572867
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,77.78881379031411,80.18313238466985,74.6517030702967
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,267948.874449534,286125.0520006439,248495.89157899906
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,0.0009502044132357443,0.001044196934906814,0.0008539395536692424
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,28.23575514709856,30.151113440346347,26.18585043172503
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,266505.28620178916,277577.8054446381,251835.22203545034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.000926007907585133,0.001023816008597141,0.0008306889209771173
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,31.70177307106371,33.018889505654805,29.956715583584508
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,208338.34543268353,215944.76017112995,198006.69759081546
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0007238943676560714,0.0007956494304950739,0.0006545385730098487
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,24.7826039139312,25.6874146115323,23.553616827029472
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,38445.123592830634,40708.57748994752,35487.24037211854
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,0.0001336003645061857,0.00015005238668644485,0.00011872544498623408
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,4.573187275940539,4.842433349164331,4.221336309041812
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,890.1640973122161,1283.4430381774519,618.8741998639207
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,4.7315970157703456e-06,6.602907302361412e-06,3.284754235013663e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,0.3234278516183272,0.46631989064218476,0.22485871255465215
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,78891.00389214596,90756.19964335821,58003.80849396375
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,9.312051207956633e-05,0.00010975529396231733,6.712855426582482e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,2.683366891565428,3.0869448899424445,1.9729182241132464
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,405563.7944801972,510910.34506043966,339322.66330734885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0004785049454190988,0.0005989793994215641,0.0003969898400467104
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,13.794683865521844,17.377899086792308,11.541584659279392
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,1070520.3213951967,1233949.3105056689,781780.9597650603
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0012637146773010447,0.001509803235304618,0.0009195696113306086
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,36.41224785410332,41.9710557899307,26.591183283176022
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,98558.89551231537,107720.40370237216,84706.23591890873
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,0.00011633368121547707,0.0001312159900820583,9.980560364405646e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,3.352342650482266,3.6639585070584224,2.8811638559533983
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,116110.95892816188,144939.65096718143,68058.67914263274
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.00018454309650654392,0.000228783064485944,0.00011183453150683187
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,9.664630720465153,12.06422043433119,5.664943320665614
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,35585.34800921076,46927.86863680955,16169.400323745282
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,5.65889969222216e-05,7.532341408125794e-05,2.6378466354158226e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,2.9619878325270386,3.9060957299807493,1.3458788433316913
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,324336.3013780275,378544.3295276813,252911.76481152888
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.0005155441230982274,0.0005846914296454898,0.0004058468463751995
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,26.996509295901273,31.508577570827175,21.051404917574196
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,43169.39713799636,49584.090950576196,36200.57848370135
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,6.860629571667967e-05,7.799751818503064e-05,5.862032747675884e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,3.5932549831232783,4.127189483843355,3.0131972566745637
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,271463.6729802113,315605.19017610827,219829.77092871966
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.0004312811336527697,0.0004897675947943381,0.00036024636522368706
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,22.595594572585433,26.269765099446264,18.297786677526297
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,278950.55513026845,329441.95845391357,246661.30238049617
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.0004435798106724952,0.0005191747502699927,0.0003968672404114662
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,23.218773916687724,27.421484601240863,20.53114040692239
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,685109.0123405652,845810.9909105736,500173.33921951463
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.0010890446560183613,0.0012957590942794476,0.0007889489400747548
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,57.02584552445907,70.40206163071105,41.632509664909115
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,92206.04999278861,118684.7949683007,75035.0479651826
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.00014656711249622293,0.00018581426474577185,0.00011973699186133127
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,7.6748778203132435,9.878866957015035,6.245629494150982
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,44127.948877281386,58004.26031687259,32338.868596612876
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,7.015595411671346e-05,9.176375365241532e-05,5.0792947808562176e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,3.673041152078973,4.828052074939313,2.691763342487613
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,332424.3273153559,438856.0765181837,177013.18131849065
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.0005285181178431309,0.0006924609872342964,0.0002848571034073488
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,27.669725542355565,36.5286959829916,14.733898039343645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,1146450.3909822963,1336956.345163601,940326.8182705084
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.0018216744084520702,0.0020865718648080023,0.0015073832796502987
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,95.4261317834093,111.28311646606362,78.26919645678863
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,120482.39501265078,150732.10368949216,79471.07285773469
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.00019157427895942337,0.00023821588803856852,0.00012937311933013275
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,10.028492287579088,12.546361974145038,6.614867185830302
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2015,1294499.894030969,1533775.1011672518,926457.1521589216
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.002057139877391463,0.002378314397468964,0.0015046960875768288
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2015,107.7492043729577,127.66555455111553,77.11473866553425
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,738746.0542586545,868936.4326066081,598810.3230546489
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.0011739810928944445,0.0013442728035424404,0.0009597096024344756
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,61.49038709626005,72.32693466856185,49.842673743709526
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,12829.840924184056,21606.063820726864,8973.662828106673
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,2.038446443956797e-05,3.489428177038722e-05,1.4301863233889309e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,1.0679067323116913,1.7984058531402012,0.7469332631838338
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,3705540.9107916523,4145322.82719744,3308567.8629667554
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.002653885144752697,0.0030427789995649997,0.0023600099546442015
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,83.09151713099197,92.95300497329606,74.18995765614669
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,883851.7441826696,1055934.080702135,693470.2224506952
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.0006332895177369185,0.000787285386410382,0.0004954220209168295
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,19.819126036128846,23.677829193664248,15.550089516157723
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2017,6370745.887250764,7456740.832823916,5149819.496752781
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.004562123899522003,0.005300310475425559,0.0037172591098846197
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2017,142.85497145262997,167.20687304990156,115.47742292893282
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,3568523.5816946523,3960398.7413032996,3046693.920293997
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0025560761459495337,0.002902195828867968,0.0021652355979584507
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,80.01909720040919,88.80634373788595,68.31780465133606
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,417888.9842612043,584506.4426847761,321740.6153339318
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,0.0002986983647462857,0.0004217732942369958,0.00023782609901991467
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,9.370569784688874,13.106730775545893,7.214578517510923
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,37584.915211819054,40697.419727880035,34847.98449091052
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.0001333307289907179,0.0001485850561118245,0.0001195984393862939
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,3.9606005635424224,4.288588190250252,3.6721899260694895
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,314037.80475537287,323744.27109763375,303446.5805747564
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.0011144972664839528,0.0012253159835899688,0.0009983856459648529
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,33.09248669255034,34.115328858044315,31.976411048320543
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,276501.8797006584,285725.602017964,268012.5823216197
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.000981311736373798,0.0010866763129635734,0.0008754304343659483
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,29.137048584284056,30.10902044059917,28.242468516881683
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,54232.73990287925,58030.228366389754,50454.011229450654
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,0.00019244419591921014,0.0002158079658963753,0.00017160933043502678
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,5.714905009397186,6.115074462058235,5.316712414599237
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,246396.26320736515,311705.8011439784,181564.26665324304
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.0003827188627852827,0.00048379765475041486,0.0002818669760345817
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,22.125892637389693,27.990558788462373,16.3041087493082
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,329410.0206182577,503060.6639303124,256771.69188950688
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.00051141409656272,0.0007896818180296772,0.0004025002984526404
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,29.580362360227657,45.17384352882245,23.05758542404027
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,371120.10684271285,501413.36800300796,298310.28708095744
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.0005764046078319664,0.000782922930334803,0.0004722875819706732
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,33.32584485125826,45.02591964249762,26.787668362597408
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,45906.97701823798,64892.12675022695,32662.73047901299
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,7.128387307783835e-05,9.984409707033086e-05,5.1330397958652026e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,4.122354907459842,5.827183459673859,2.9330480033068733
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,139884.0705944863,177116.51514595083,92431.00268123156
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.00010109365476949602,0.00012645257038618876,6.511273457496293e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,3.2789951013040874,4.1517535417397005,2.1666570304419634
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,629611.4599641951,857599.1310038597,502355.2503739911
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0004547938345761767,0.0006179630529067174,0.00036348895329916674
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,14.758598918187941,20.102813261677728,11.775611033409797
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2012,6348952.102387127,6669774.63501377,5974117.681985293
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.013517959217564131,0.01478949268968529,0.01226802906517077
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,430.11771714946184,451.8522417006234,404.7240895693041
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,1309532.9117099133,1346631.5353926977,1259771.7733669938
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.00278961766878057,0.003077584779532589,0.0024910675343028346
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,88.7159483066472,91.2292410627584,85.34481762529155
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,940357.0792667108,992854.7079774495,877251.4255027242
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.0020019571503260467,0.002194055782377145,0.0018080252338715155
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,63.70566885950513,67.26218651039956,59.43049725662206
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,3384844.9555439353,3571297.8120196587,3168280.4952929895
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.007205079588887754,0.007833711211596418,0.006567497717032881
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,229.3105636497142,241.94204608808087,214.6391328755208
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,9121770.045395209,9475808.93016411,8612377.494783241
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.01943041758543296,0.021471551803244476,0.017313829907737034
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,617.9657437977161,641.9505517539272,583.4563070483374
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,1100862.8547430956,1130251.4542514465,1060749.173288327
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.002345079246882324,0.0025879396013421233,0.0021019991406151578
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,74.57933377678337,76.57030128242876,71.86178215321725
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,231778.2148465957,240463.40465013502,224633.8390081327
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.0004937975983950184,0.0005492838490301292,0.0004419639923031177
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,15.702105646270729,16.290494714429474,15.218100951237336
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,653865.22753539,676631.7733794972,632403.8938854558
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.0013929512198045712,0.0015478398890683078,0.0012463438374033906
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,44.29691931132904,45.839267492246066,42.842994366294114
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,1122751.744318021,1175583.9334079525,1042664.751835698
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.002392301618912025,0.0026945400747695383,0.0020856283439737873
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,76.06222403380143,79.64140689687981,70.63663035718324
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,4743517.952682475,4890983.273602206,4468372.45095411
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.010107769071866996,0.011305807019773344,0.008872115037161395
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,321.35556862968957,331.3457916097712,302.7154917825428
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,1103394.7945977175,1154640.3430194878,1053128.7528125786
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.002349263781161246,0.0025564713167792047,0.002149787819711824
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,74.7508632154478,78.22255711796703,71.34552721761682
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,369994.9388155889,402189.62865150906,343818.91648750013
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.0007876606494585044,0.000875557294099851,0.0007027911684080147
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,25.065770834903724,27.246840446588855,23.29244339657297
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,1935430.8358002808,2003661.346045175,1834202.3622375797
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.004123678159330791,0.004607800087266014,0.003638788045669073
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,131.1181875954138,135.74054902344264,124.26033778694804
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,145758.09591625797,156491.7221059679,137000.57537915627
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00031010600161673955,0.0003308534122820841,0.0002900270808222058
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,9.874564882601865,10.601727840992728,9.28127567824774
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,1900976.2971686665,1958374.574512872,1814573.7826131978
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.004049615741897548,0.004471975963561793,0.003609635085668986
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,128.78402169485577,132.67253992927738,122.93057506031616
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,1917060.8291999027,2004921.176878261,1800263.165278063
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.0040827156776554714,0.004509073695888908,0.0036572144305234457
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,129.87368847562902,135.82589784214258,121.96108435383037
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,64051.93563456801,90767.14408211655,45124.0168632567
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.0003407079589706125,0.0004742356964312209,0.00024986813915421624
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,23.27231574137247,32.97888838322083,16.39513868795525
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,83541.15497328641,128246.40102143551,61304.461685605565
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.0004442570869961389,0.0006811293218436025,0.0003438413823452135
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,30.3534329864653,46.59641754299731,22.274062049302277
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,78877.06672062473,111609.88219950773,57626.040560641864
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0004195800894967892,0.000594654975874715,0.00031733962362212955
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,28.658806065573483,40.5517864943731,20.93756258208415
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,4252.256771251332,7699.421450105721,2541.7321160258944
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,2.2601919256171335e-05,4.0514971827705805e-05,1.3798416027319503e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,1.544994092895807,2.7974699786598367,0.9235004648667914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2012,122652729.71383378,129938263.07602867,115784992.71725667
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.08875975564860844,0.09665881121342304,0.0801875907942087
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,2908.425030549305,3081.184557719616,2745.57257524173
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,8397922.916898115,9300293.260502852,7632104.524424937
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.006076713258626967,0.006852573743094255,0.005342633487692705
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,199.13726562072014,220.53488555375134,180.97765851926647
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,15928197.96952399,17910462.31126609,13239062.184758712
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.011525819312056332,0.013170383050777423,0.009659955145766341
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,377.70027437785797,424.70507600061194,313.9336558508582
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2012,7752681.805636913,8336609.659911692,7229019.3226950355
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.0056106116887580625,0.006167016296923431,0.005005758266653806
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,183.83686910194726,197.68336392819475,171.41942779019502
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,2114434.0295051713,2318266.8373942515,1860688.766949539
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.002495861440979123,0.002830500559898515,0.0021652193539002398
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,71.91950905999705,78.8525962450978,63.28871970707885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,285024.19851795805,402585.65058834257,223346.40198018274
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,0.0003357755774261005,0.0004829484793855088,0.00027093565191380195
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,9.694698506355332,13.69338647642224,7.596814729892808
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,730481.7900764828,749500.7851724777,707296.6519528935
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.002528045760242189,0.00277230243293202,0.00228385722672094
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,87.32632921976652,89.59997799478676,84.5546338369503
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,126949.75141107242,133063.5041050457,122006.15591351633
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.0004393884045079422,0.0004875009215258015,0.00039609350004446865
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,15.176361596816937,15.907237558100311,14.58537349305636
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,474752.4418516363,494030.2738268208,457618.07985589607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.0016430920606397637,0.0018235431877666737,0.001478074708929748
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,56.75485494399979,59.059446686843934,54.706506912690166
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,526261.8547090201,546447.7372941123,496947.4168756829
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0018215873899916936,0.0020214863041521968,0.0016126633205223984
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,62.912610012240215,65.32575576366641,59.40818008133336
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,2759884.386512671,2845802.367482042,2619726.9073668076
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.009553492518603927,0.010587235348632724,0.008506719894086105
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,329.93371747140293,340.20488643681045,313.17842208584267
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,673253.143784399,700674.812987228,645806.7501802512
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.0023291238833532736,0.0025204729554568735,0.0021336469984885907
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,80.48486147232163,83.76301808771248,77.2037491484673
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,188113.23331536315,195188.78169325803,177075.34247639115
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.0006511384090335257,0.0007233267671509181,0.0005758674109288258
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,22.488224027285057,23.334079017036053,21.1686860149891
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,761768.7489383561,898636.0495854015,541352.4430895074
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,0.0007046976866686202,0.0008347357000429996,0.0005025084696466517
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,29.690996384110555,35.025589768622424,21.09996432998945
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,653431.8455408417,706257.8916809321,602296.9921223985
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.0006043440533234861,0.0006631109990018972,0.0005517383493602367
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,25.46841490971404,27.52738352337558,23.47536288432585
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,172852.3934266858,218197.1188962094,112526.0959530911
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.0001598711128197823,0.00020128108854696068,0.00010450338114882287
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,6.73716242018206,8.504536156411632,4.385861080173653
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,126202.08679803828,151157.5347429773,94204.02440270243
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,0.0001167586733195439,0.00014626285628671122,8.575688993454734e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,4.918901842599728,5.891575131875081,3.6717328609336852
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,956029.1760800022,1074370.5013312078,838254.1513851949
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0008843515495210991,0.0010129547592437546,0.0007651203688082329
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,37.26256669055426,41.875084419879926,32.672121312970205
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,154874.71206807013,169234.57346183632,141882.39119732566
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,0.00014324208147555557,0.00015878729919613935,0.00012881566707550254
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,6.036457287610984,6.596152855738237,5.5300635132114815
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,460692.05248600215,509110.8038724877,408403.0525398052
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.000425933618889766,0.00046782937541767764,0.000381510412666199
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,17.95611343155437,19.84330160295522,15.91807694017169
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,253902.36670619604,330217.01290834695,185236.4338525562
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.00040658862332125083,0.000527452601124275,0.0002974162518032535
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,20.62404959795721,26.82295616484628,15.046434772089148
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,348562.4264961273,536302.7074355127,266157.99897705927
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0005581788900753757,0.0008683787279666192,0.00043903112159950064
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,28.31312234422353,43.562940279590656,21.619553385840728
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,406724.323272528,560017.6099540322,323352.5318143865
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0006516469450118218,0.0009016706940049894,0.000527240368306447
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,33.037512508005676,45.48926074716877,26.265366251909782
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,56016.23040352522,81800.66652261437,37110.398475091715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,8.96556018821422e-05,0.0001253943509752987,6.164591127297098e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,4.550101399683837,6.644526498095011,3.0144134088986014
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2012,33691526.19678277,34609935.07998543,32345873.939985447
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.11956386726076795,0.1324736418107162,0.10684471140735888
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,3550.325360308932,3647.1048985857938,3408.524027072782
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,764521.4804153001,789342.052124736,738510.5877141203
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0016041419093933192,0.0017645144763635155,0.0014434574278099305
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,51.00048337824326,52.65623954380971,49.26532205859122
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,16796710.675778437,17236108.447549637,15955075.980219577
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.03525650730772226,0.03940226812920711,0.03101460650421002
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,1120.492210583619,1149.8040080016337,1064.3475797249987
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2014,454230.4849639014,581021.9183833052,368134.2576333875
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.0024174304432306977,0.003010099676921564,0.002002666152535436
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,165.0378737302613,211.10565048992393,133.75609330120332
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,44706.378127411,56431.93637815064,35023.6196087976
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.00023793072504201766,0.00029337249366900874,0.00019100973978114199
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,16.243395880651505,20.503702632533592,12.72530995147277
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,196692.4251401167,280263.7730455499,153259.01160491465
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.0010462513278913842,0.0014425172568923454,0.0008506693922018873
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,71.46525981529668,101.829662953454,55.68437663818768
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2014,330315.70315872,390006.0190257166,273515.3484059317
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.0017572192847486639,0.0019955972235779773,0.001526725619343458
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,120.01528544118656,141.70287167565013,99.37772348567476
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,605252.9692564664,740030.8688565695,488708.78279599716
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.0032190101103713926,0.0038428996320794503,0.0027322716070676883
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,219.90964151812224,268.8791816792132,177.56504914540304
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,32808.68353946345,42581.68758681287,24435.050514151942
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.00017454669041966407,0.0002260969353536783,0.00013437347555636932
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,11.9205459573511,15.471421253754794,8.878111255935735
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,131915.93650965128,168797.57381711947,81677.09142289206
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.0007018001810590736,0.0008807859209337041,0.0004394982412510017
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,47.92968854659581,61.33008152418068,29.67615329027844
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,187808.0081282044,227973.93743765287,153338.31990570948
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.0009996302494705012,0.0011810724017848329,0.0008432452021404923
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,68.23723936859439,82.83093087337785,55.71319212672403
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2014,50860.814620490564,60611.47578182748,42133.94627671155
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2014,0.000270543651233517,0.0003069787041839266,0.00023580239502568885
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2014,18.47951861227858,22.02227595420197,15.308741124951469
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2014,22721.14621707126,29444.200310045206,17493.977381659854
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2014,0.0001208374007919806,0.000152772259317929,9.767106861242032e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2014,8.255389685432093,10.698111143385596,6.356175830831505
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2014,11450.567014925884,14024.765241073637,8937.032049961397
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2014,6.090967442954637e-05,7.192153667996812e-05,4.839710072932645e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2014,4.160392786713589,5.0956893285945215,3.2471373362403084
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2014,12534.143739922618,17859.702135980187,8457.338649757134
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2014,6.67373873231784e-05,9.351400224240071e-05,4.5846233947947347e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2014,4.554094232646427,6.4890564670317525,3.0728478919322217
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2014,51953.58770365874,62969.27087474409,40879.91843679735
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2014,0.00027649215786007775,0.00032876690605152404,0.00022415773198668475
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2014,18.876561417827098,22.878945644386956,14.853108807991417
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2014,22374.397837213295,29861.63421123549,15194.106648967776
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2014,0.00011899932902261717,0.00015704673876879832,8.309822506133576e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2014,8.1294038319381,10.849779527071574,5.520552093230267
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2014,6541.239492568106,9954.846542599302,1960.7730534555712
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2014,3.479790698334608e-05,5.223846928368323e-05,1.055282727514314e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2014,2.3766618339137815,3.616945055619059,0.7124176520992782
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2014,51778.65067537996,69178.60340699396,36429.56876737185
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2014,0.0002754388236644548,0.0003665969512147088,0.00020151655224798145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2014,18.813000657069033,25.1350140332977,13.23614061428569
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2014,10287.672535828548,13256.75120443961,7630.34827791346
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2014,5.471151153731038e-05,6.91122742411065e-05,4.1649339713186666e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2014,3.7378724175267104,4.816642880157341,2.7723732714863383
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2014,47057.87622748596,59025.13940976684,35474.03897946948
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2014,0.0002502345259762631,0.0002985910966510666,0.00019602273065676915
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2014,17.097777652381257,21.445904287102895,12.888963113652133
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,62053.68806257394,73677.48734204208,52527.28671792228
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.00033033066602696794,0.00038086319960706504,0.0002876588891821054
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,22.546282281740694,26.76961642872825,19.085006400296145
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,3443246.6783011504,3936775.1196220713,3152393.707908875
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.00248853018887225,0.002846619425685157,0.002223853344698907
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,80.71247099650883,92.28117452771221,73.89464348360534
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,735809.7409129968,894650.2203907801,578985.26888711
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,0.000532010585487692,0.0006673934643727072,0.0004221203648625565
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,17.247972022059873,20.97132059122123,13.571880288726016
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2013,6317177.98265977,7352224.851233307,5147161.649053795
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.004565272264189893,0.0053108203573823945,0.0037477062293075356
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2013,148.079731817755,172.34206274113436,120.65360809948389
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,3307624.223165174,3621888.4154908815,2801239.593109985
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0023909773973153857,0.0027182002159991756,0.0019975412510012916
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,77.53337158849345,84.89997696944884,65.66330865516548
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,357792.81692360766,508096.95681921055,271287.81402576086
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,0.00025804480842085107,0.0003708081416608786,0.00020274312023446688
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,8.386951344698325,11.910201249629475,6.359204514520528
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,757354.9350308798,784521.9222672066,730571.2003361469
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0015777128678010515,0.0017376683172271746,0.0014165155512135567
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,50.05836419919521,51.85400172444022,48.28805825155007
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,16633814.190294998,17103426.738297746,15783781.206409197
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.03466447061516617,0.03875369901267278,0.03043882461824131
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,1099.4336872256317,1130.473342310832,1043.2496462687325
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2012,76770701.63003728,79068481.45394087,73174307.51029006
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.1635403429891674,0.18070507966957472,0.14559210513568482
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,5200.927396610676,5356.5933705275165,4957.285169703049
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,2081869.9282546341,2126047.880409842,2003985.8363989303
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.004436025532190511,0.004928352700202452,0.003926046744240217
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,141.03888744196377,144.03177817777384,135.76253202913293
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,5063012.610660488,5230629.016577774,4792253.154611897
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.010787685687648364,0.012018621696450897,0.009503914713016086
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,343.00013464858864,354.35551813665063,324.6571959629336
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2012,2852431.2867974713,2942458.4173819576,2712548.7443522736
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.0060780738955291515,0.006753798734247475,0.005354001411588753
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,193.24153240055765,199.34053319061823,183.76501425152807
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2013,106934.10088324743,146296.9284368278,70559.52430898591
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2013,0.0005688528909201619,0.0007834365225219813,0.00038320349000824723
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2013,40.04645854372676,54.7877041217805,26.42430283478973
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2013,15774.97419239997,20614.403164253665,12317.502160288934
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2013,8.389743661497092e-05,0.00010905307285336662,6.80641400492606e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2013,5.907674397655818,7.720024154149732,4.61286283374505
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2013,6841.250418369725,10942.423775552012,3688.811309731711
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2013,3.636136483273155e-05,5.8481209465406146e-05,2.0153356366608483e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2013,2.56202510708553,4.0979006367105875,1.381447339722704
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2013,55339.18287089745,78183.59396092582,34666.87800643071
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2013,0.0002943636355334459,0.0004181520945443615,0.0001939012538991353
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2013,20.724336524816636,29.279491093063363,12.982628380077893
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2013,198500.21721860341,239585.09246358747,153447.49929171888
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2013,0.0010554006265865315,0.0012370495934420256,0.0008538604089399939
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2013,74.33765893299716,89.72380553808074,57.465568684526716
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2013,10696.487915920075,16282.98022545674,6124.624350613572
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2013,5.6874222783740706e-05,8.65793999955311e-05,3.2913532384110593e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2013,4.005798490381051,6.097920936175674,2.293651072266793
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2013,292031.8870950245,365880.33970220195,202573.02844460093
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2013,0.0015526176516111679,0.0018985546547470441,0.001091113455942181
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2013,109.36495246512466,137.02094780641067,75.86291294056969
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2013,169071.24911499937,210551.8921239662,129422.14541995602
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2013,0.0008991853435468716,0.001097962407140476,0.0007149156834448736
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2013,63.31661006821665,78.85097036025671,48.46815504493957
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,3499583.615314329,3933732.5571310543,3184731.9656242784
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.0025276311866110454,0.002860671931797035,0.002256961708037529
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,81.1150856163839,91.17800522533948,73.81729784263064
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,767794.5450692413,928119.5027684106,605250.0742881044
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.0005547887746071963,0.0007016565841326438,0.0004353148467757046
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,17.796322964407903,21.512414391199883,14.028786562024369
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2014,6305369.79037039,7343706.364407592,5139124.807843325
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.004554095237026626,0.005248331293165586,0.0037030968187711016
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2014,146.14898988287652,170.2160702444029,119.11718495803159
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,3352022.6903990535,3682015.4939573975,2837270.378741841
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.002421382312820665,0.0027592268141492845,0.002025560785685136
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,77.69484527528823,85.34358222681885,65.7636607627685
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,370207.5178195392,522972.96812571597,281868.4629543801
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,0.00026683518137488,0.00037978412063444176,0.00021034717217017224
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,8.580853554220246,12.121726967441427,6.533287104514426
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,1256106.8724770679,1299360.8919646896,1196766.4877309129
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.004347695853764665,0.0048140864049602715,0.0038809995284375155
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,150.16281551612516,155.33366959786585,143.0688974407303
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,99660.32447479863,106875.98367442223,93704.83199467442
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00034453175949722246,0.0003677734622621944,0.0003224200382189647
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,11.914014043147876,12.77661875056707,11.20205749056809
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,1234965.2746361354,1272389.3996605529,1189506.5408815583
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.0042740599963749775,0.0046927664915791785,0.0038354693331277326
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,147.6354176283614,152.10932992438427,142.2009983126516
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,1290683.7817332186,1344044.4638072723,1218375.9830113018
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.004465815275109132,0.004895527421343203,0.004038499456960884
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,154.29635395900468,160.67542124513406,145.65223069388455
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,1768310.6613054245,1819111.2571524763,1698828.5845347072
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.006120876829339407,0.006753505413345332,0.005498328442637837
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,211.39483703736494,217.4678557186867,203.08851812102677
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,181090.2284760181,192871.88125690958,170199.399132433
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.0006262020648709641,0.0006728305620617278,0.0005752372233790771
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,21.648650418409126,23.057102351741218,20.34669305047169
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,260228.100347307,268468.9514934074,249332.31411803066
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,0.0009007689681184647,0.0009959370480163991,0.0008057048884361877
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,31.109283040148163,32.09444555892921,29.80673309531465
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,181716.3031055674,191418.79362967165,173992.91304116475
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0006287262996724521,0.0006947049923738896,0.0005717049573209829
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,21.723495267327863,22.88339123362003,20.800193259503576
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,1216287.3059862594,1263600.4743538448,1152992.0212663892
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.004208389342012452,0.0045825122775721636,0.0038066033170292366
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,145.40253727236407,151.0586472170971,137.8358258955787
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,667703.5593622092,691921.7181195982,626179.8297382027
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0023109263971674123,0.002555279014046047,0.002050620526134348
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,79.82142968953299,82.71661877360711,74.85742520257806
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2012,1641013.7826366357,1701898.8628263131,1559274.8241358125
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.005679356970526527,0.006269829967095611,0.005133302533595285
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2012,196.17697769262273,203.45555825334958,186.4053950233595
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,1048114.4844975595,1082991.9690391915,1004630.1531870815
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0036276074342136123,0.003997226866958496,0.0032587110615886015
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,125.29811389775584,129.46758497672832,120.09972691055584
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,339608.5847159756,373806.8602025559,308041.983690754
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,0.0011737734746344263,0.001279516610321765,0.0010581868230312651
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,40.59891906636183,44.68719327724493,36.82525156235892
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,738350.9254921165,872692.5391082746,518062.4736601734
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,0.0006782903394932653,0.0007964883877154996,0.00047808572395326203
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,29.304386556678956,34.636266615516824,20.56136515103363
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,624829.0690891118,682003.3042226229,575712.840425029
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.0005739395190120407,0.0006330836566498493,0.0005242932727606014
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,24.798821184158868,27.06800759618666,22.849448736336434
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,167728.23275400838,208947.0280150391,110688.93340896828
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.00015406577753973385,0.00018946497196992357,0.0001030827156303033
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,6.656960531086331,8.292891994062124,4.393129581304406
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,120917.46055986903,143998.32396049908,90133.08101357425
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,0.00011110225174195009,0.00013709204218340164,8.148717630819564e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,4.799089272268026,5.715144930630152,3.577289004961696
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,910703.068333559,1035716.2780902968,796474.3128928571
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.0008365487965647798,0.000975987542540506,0.0007183784420536751
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,36.14486530915192,41.106510641906034,31.611243843056247
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,149624.0035396912,161877.43922520656,135704.3272465422
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,0.00013744754713111037,0.0001523247557502187,0.00012413459757017469
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,5.93842234972838,6.424748571553604,5.385964757064821
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,443950.6162962175,487258.57646740606,398118.9633353574
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.00040765613990895817,0.0004495852689529819,0.00036665086634243404
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,17.619941985376606,19.33879024847303,15.800930958876648
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,1508115.9015372784,1721290.2934665163,1113719.184773495
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0010800699890615216,0.0012620549465450384,0.0008014744151440497
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,33.8173673654934,38.597501781845814,24.97357847304159
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,146449.34833937054,172561.59383203724,116702.67502869996
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.0001048545644716244,0.00012558689239279425,8.345514104664666e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,3.283919629904642,3.8694498253381195,2.616892527927361
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,767312.2709272194,792373.4503139143,740162.8270049596
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0016004208692218488,0.0017619317723021372,0.001439703859306939
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,50.938325981798265,52.60202220230205,49.135999501256684
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,16811088.359935254,17248428.465548143,15951604.005399492
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.035076993412214666,0.03916652978651616,0.030837700425980358
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,1116.0106926902254,1145.04368708989,1058.9534867958205
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,48591.95614667295,51814.44478820882,45275.53928771685
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.00016808489064196788,0.00018425443378480052,0.0001529208500115167
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,5.808984176665841,6.194220479391811,5.4125191115683675
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,260966.9656327296,271145.70421396545,247224.8752513759
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.0009031417550443767,0.0009976773322230264,0.00081346064078983
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,31.197611584460116,32.41444120083409,29.554796766743397
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,213615.35432956138,221519.58541174897,203331.41401820077
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.0007392702505142211,0.0008108378433935208,0.000670759708846512
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,25.53690593249039,26.481826798539604,24.307499848031732
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,39160.25547998087,41329.87507767298,36610.938540477975
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,0.00013553924580106126,0.00015063849822779564,0.00012159806573831957
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,4.681460111438135,4.940829910717975,4.376698934131783
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2017,6432789.269217338,6791216.6992989145,6026522.992057608
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.01339472440433948,0.014661535082588419,0.012071713267776178
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,425.1836136012324,448.87434301236885,398.3309130730666
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,1266190.4522967562,1310480.2787386035,1215036.3030504142
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.0026379677896420694,0.0029281022350551834,0.0023499551073941
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,83.69051269736627,86.61790665731269,80.30941235084369
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,1111321.985456122,1177276.5937678479,1031250.5650054608
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.0023138223140846256,0.0025397450919721907,0.0020808177872005066
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,73.45427898778657,77.81363501858749,68.16185380975219
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,3691347.8903750377,3911018.2524237493,3433131.141410553
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.007684579193688103,0.00838817203942295,0.006954169022676777
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,243.98446294509233,258.50386260643495,226.91728946523736
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,9481880.652926685,9868667.299516793,8900331.72730197
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.019752897147094942,0.02190927150427998,0.017474354719896466
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,626.7172933892004,652.282462277423,588.2790571382072
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,1176251.1286104498,1213557.4145360168,1128891.2984848311
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.0024505930355278403,0.0027244110053433346,0.0021876561783080325
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,77.74585555885427,80.21166328176197,74.61554569331742
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,225251.6130802758,236203.02626028383,215693.62793940457
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.0004693302604498795,0.0005249387916102023,0.00041934762092073457
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,14.888299742271986,15.61214770853412,14.25655222329301
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,747903.9620148985,780560.4543295181,719571.8993123993
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.0015582162254288243,0.0017418883596295796,0.0013953895440928254
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,49.43368978646239,51.592163323954765,47.56104507567252
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,1147321.0622763643,1212730.0248081335,1055049.828204336
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.002390927038190826,0.00271770612131054,0.0020653644434948278
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,75.8336850165187,80.15697587640246,69.73489721354701
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,5289321.653403183,5478941.022101154,4953150.4804377835
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.011023067927203246,0.012402788871545372,0.009649716446497496
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,349.60462716460745,362.1377671475365,327.3849541537136
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,1071224.8605444417,1123156.3629298008,1017556.4854830832
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.002230516815048695,0.0024287198671329464,0.0020378641046048473
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,70.80400711481381,74.23648763296305,67.25672572726867
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,417176.3453368212,452668.08485685906,385107.75649470254
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.0008685661734756593,0.0009690471776277487,0.0007718464146877723
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,27.57381574242777,29.91968864927637,25.45420045326672
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,1912700.4799219256,1983496.293824981,1794532.1429861493
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.003985720965116963,0.0044734127901271525,0.003497943273747442
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,126.42243788112836,131.10177972233905,118.61194722009728
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,148150.47072743214,160202.94862711566,138962.5320914254
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.0003082265081750319,0.00032907714231440396,0.0002871983482685983
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,9.792198976895332,10.58882325475853,9.18491016525996
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,1965674.9615189855,2032573.0199989965,1864052.71749199
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.0040953632608010946,0.0045498180249571585,0.003648880674514972
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,129.92385547331835,134.3455700759635,123.20700044677066
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,2041775.5675765853,2146607.985521472,1899644.8979689602
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.004252663543701783,0.004726660522291317,0.0037911321990294084
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,134.95382448468482,141.88286015163195,125.55951212993152
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2014,502182.9043674857,596118.9793205613,458095.8395881192
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2014,0.0004644828982727666,0.0005542861627476396,0.00041607171080194265
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2014,19.573277085095736,23.23456624359206,17.854922423297786
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2014,1540125.4234813063,2031961.6286592414,1199508.6220520814
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2014,0.0014242688589604076,0.0018532156916039374,0.0011185570245615026
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2014,60.028530237541474,79.1985303325368,46.75251670496113
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2014,323454.0128041407,376952.98478786065,271581.7899177347
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2014,0.000299117157368278,0.0003475736577009548,0.00025078601536699475
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2014,12.607069977572602,14.692266811829736,10.585277951708497
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2014,87473.527905056,106656.53632080721,67194.5668981239
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2014,8.089283711748466e-05,0.00010064572901758397,6.201414487280355e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2014,3.4094023998148857,4.157086830690013,2.6190016925537067
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2014,646563.7049200707,876695.8316009215,400390.73080290883
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2014,0.0005982198028192752,0.0008153521842295748,0.00037560701495967686
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2014,25.200719577474363,34.170439260345915,15.605785557714665
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2014,2053003.7575519762,2382299.7881581318,1830513.7307175165
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2014,0.001898408845333811,0.002187004071237627,0.0016848004596136232
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2014,80.01867656948716,92.85344731540619,71.34681835602142
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2014,339140.6011075157,450271.05968979275,258280.05591841735
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2014,0.00031377307149835454,0.0004146180427692178,0.00023982901049289537
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2014,13.218476572085251,17.549940744814055,10.066824370321038
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2014,2962925.893465287,3568499.1202080203,2373847.3568706755
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2014,0.00273946399822412,0.0032471465116459732,0.0022298711587634464
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2014,115.4841572483364,139.08721593325964,92.52400205115431
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2014,2003099.595250919,2259160.0010965085,1668262.253233703
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2014,0.0018528081008129657,0.0021322498013463757,0.0015302195489488633
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2014,78.07359244192513,88.05390286378329,65.02284137744057
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2014,67508.66334065856,106438.6657270937,46303.922316502925
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2014,6.226157514186799e-05,9.60656851613714e-05,4.3007067427460984e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2014,2.631244038216423,4.148595021306697,1.8047597672987223
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,253520.7317601502,326836.7734364527,183210.94175266667
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.00040279199833939325,0.0005171359780064144,0.0002982641571528886
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,21.10209298986058,27.204638996100133,15.24977583798693
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,344196.861156835,532367.7196132069,263230.3356721544
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0005466915812950291,0.000850664976113966,0.000429056776412325
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,28.649626089835024,44.31224636376565,21.910283165170085
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,398378.63191171025,544357.2633511439,314979.471894244
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0006331195704507784,0.0008735707924793937,0.0005165983124468249
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,33.159508799965344,45.310209982391164,26.21768271045314
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,53869.14104886911,76399.95053464633,36044.20397496532
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,8.554590449442811e-05,0.00011879777997770714,6.0265445499557e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,4.483860612916678,6.359238747102222,3.000181242553425
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2013,857.2675872242286,1231.3794782076316,585.8341492631016
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2013,4.554106278502199e-06,6.417432986976947e-06,3.14975814127628e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2013,0.32104380743929806,0.4611474433163092,0.21939290439799858
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2016,35896446.04801176,36902610.357434034,34333113.08351894
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.11983826420968784,0.1325620587314883,0.10710914325957104
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,3631.942006320268,3733.7440180225785,3473.7666076746104
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,3376260.3079623175,3842217.079808871,3058284.660477775
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.002443167118534898,0.002792415353966949,0.0021701679703498527
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,80.06018302436672,91.10926722782753,72.52012798925358
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,708358.7333660928,866095.1580615778,563038.3972847874
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0005128200134264033,0.0006408151705908988,0.00040382990535687234
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,16.797084545422717,20.537438036813146,13.351149800286453
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2012,6341461.092063572,7311766.640072341,5206345.28847309
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.004588829687955584,0.005316364844706396,0.00374363945562081
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2012,150.3730427642658,173.38158851529644,123.45640402791395
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,3237870.9846938974,3568080.5438815374,2760752.4265155774
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0023434530586780296,0.0026610452476799463,0.0019743458223854585
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,76.77860117377324,84.60875505219667,65.46484109372427
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,346078.96726327145,485411.1928366363,265109.4712440154
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,0.0002499028537738515,0.00035008937819712476,0.00019795109096211347
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,8.206460086812276,11.51040067880069,6.286456272116875
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,65429.46197366619,69724.75532427215,60911.511999763075
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.00013907754614798882,0.00015359368172774055,0.00012577259046235703
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,4.410086306231647,4.699598306106854,4.105566771588842
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,487541.8573069116,504568.4208713037,466029.5622752728
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.001036915984701351,0.0011525597807092113,0.0009299383075004159
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,32.86136862151359,34.00899558576605,31.411393719185536
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,312993.90169609006,323051.0552915932,298952.53316918906
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0006656849584132877,0.0007356221896766992,0.000600201216456611
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,21.096461413048033,21.774335172258297,20.150043007740596
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,68902.2916541673,71812.53017052198,64709.47425736908
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,0.00014656210800721386,0.00016410952026439863,0.0001312321387937993
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,4.644162487753928,4.840318816137136,4.361557587325551
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2017,47712540.937445,49173247.17140189,45447074.46930419
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.16751142956834475,0.18416732785764667,0.14984135996941605
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,5629.810214593119,5802.165295980052,5362.497973145349
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,1186113.2152436036,1215844.4991095993,1141731.8852237267
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.004165184006929346,0.0046167764352667865,0.0036968217613833764
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,139.95465686049297,143.46278034989587,134.71791071002664
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,2921929.6516791973,3019626.4396428354,2777191.2271623155
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.01026065147977483,0.011391532669472581,0.00910084645451993
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,344.77118753564696,356.2988564462535,327.69287133660845
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2017,1276741.9050562298,1325665.2319754292,1218736.8827988775
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.00448365777081321,0.004994357389043047,0.003964224283308058
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,150.64833012998517,156.4210062484653,143.80406528082776
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,599781.406583368,621645.922485671,578731.1404746149
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0021056274336035664,0.002308256448786934,0.0018963274256433359
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,70.77081670693556,73.35070603048476,68.28700425782837
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,10101852.886696812,10376196.282065207,9662592.729013335
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.035474245791247486,0.0395354563550525,0.031554680539010616
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,1191.9615566566865,1224.3325270390035,1140.1313402397386
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2017,4061033.431395742,4270243.169202522,3809270.5400540386
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.01425148156278167,0.015524430068319425,0.012893844461806069
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,479.1789966468351,503.86456349688314,449.4723981408086
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,835180.6589493436,865655.7847012221,804124.2684510447
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.002932285412194617,0.0032383431538789247,0.002627913770724499
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,98.54659828216253,102.14249091076688,94.88211969811603
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,695415.5544066832,736246.0684153162,643595.1206537172
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.0024401130832205162,0.0026711305641017665,0.0022101350088571626
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,82.0551057366375,86.87287566287678,75.94058738286559
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,2327503.810481156,2454768.8806940867,2178990.397298595
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.008166959284296569,0.00890546587053918,0.00742784812143105
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,274.632297280727,289.6488564110617,257.1085537510021
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,5741080.95980506,5972723.474368587,5407296.692673968
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.020155011282906067,0.02234346114028076,0.017887668975932216
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,677.4151113161703,704.74761905944,638.0304539568232
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,2089002.8069143295,2299683.033716513,1822654.9012067704
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.002475489991426508,0.002793645515275286,0.002147166144000176
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,71.73771904613365,78.9726154612492,62.59115822537622
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,274785.8401871531,382346.2730586624,216736.5605063518
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,0.00032499865890177365,0.0004600468112066332,0.00026341508627795984
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,9.43632499485206,13.130020421338523,7.442874865063622
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2015,6403372.690440424,6737396.078002647,6007784.157944431
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.013429764324795791,0.014704795807185395,0.012172718001780065
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,427.16275582747926,449.44513070078966,400.7734300949625
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,1291812.8397872245,1331158.614286659,1241034.9680750289
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.002710760129506399,0.0029949224590960738,0.002422869356922064
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,86.17557642406716,88.80029472141632,82.78823405556543
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,1044623.1871400636,1102310.7355257524,973934.0143018838
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0021906717453019256,0.002402643113473458,0.0019734771417586126
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,69.68579543811363,73.53407560805434,64.97018956344678
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,3527311.449251714,3714959.8869881276,3281716.615376593
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0073961408535181405,0.008058799583379045,0.006697392263286081
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,235.3035114719443,247.82135599938732,218.92011929305286
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,9353333.871090364,9717571.803632759,8780279.285358787
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.01962587071475723,0.021717921552007663,0.01743099155846655
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,623.9517931720872,648.2497509145724,585.7238798653816
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,1145903.4157663444,1176474.810869917,1102034.6122723685
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.002404567619599333,0.0026597656296168774,0.002153985954797905
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,76.44210085126349,78.48148884462971,73.51565569474216
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,227626.50774671885,236807.19549977698,219460.56847695858
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0004777081355931668,0.0005315929380937164,0.00042672126296965367
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,15.184742642519202,15.797177381300292,14.64000078677837
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,707358.103130266,734058.1993233217,683237.8362611828
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0014843897926006572,0.0016534734197998107,0.0013289074979637994
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,47.187170151928264,48.9683075652966,45.5781306402232
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,1128063.0065521863,1185966.244625709,1042670.2798005093
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.002367718197881501,0.00267909107661473,0.002054280649182256
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,75.25198452766026,79.11465314661244,69.55551889146108
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,5054798.788286766,5224280.476152787,4754394.760155558
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.010610254001552204,0.011891469308401908,0.009305972938586019
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,337.2007042134962,348.5066625499868,317.16104406537227
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,1111183.4374074808,1163899.6720574787,1057017.2980568095
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.0023304520671633016,0.0025370020995128407,0.00213178937009746
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,74.12596490931168,77.64261358159001,70.51259450653774
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,402867.5881341213,437099.0871171985,373068.36694137787
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.0008448304594987934,0.0009401172241983618,0.0007531630779982196
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,26.874904444942583,29.158454403474053,24.887027421134768
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,1906093.1468247133,1973665.6179945897,1800455.3687372208
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.004000525463220514,0.004469433537452854,0.0035179972444708257
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,127.15361744866918,131.66131119045139,120.1066241548521
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,147273.9846330426,157909.34582329122,138078.14511492662
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.00030862434429986484,0.00032901637464409077,0.00028816335994701623
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,9.824504082272531,10.533978669317804,9.211058584000977
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,1967946.0933432856,2031854.4784631752,1871361.0319694076
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.004129669707377085,0.0045728782875174515,0.0036813403573950692
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,131.27976727130346,135.54303340120592,124.83667189285951
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,1992316.0993009042,2084077.416284545,1859438.8443188504
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.004179586177460636,0.004616577253331865,0.0037316503974857366
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,132.90546663438002,139.0267747224766,124.04135436590886
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2013,62967.712377033495,89348.67993895267,44335.90385315999
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2013,0.0003347610250390078,0.0004690509982572502,0.00024714348091138316
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2013,23.58119498337908,33.46077797033718,16.60364580605345
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2013,81393.66980303111,125441.56149196034,60130.370280009214
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2013,0.0004325397112434793,0.0006636719645490382,0.00033413857428143165
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2013,30.481653621866418,46.977439848050714,22.51861997948097
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,75978.15362132333,107310.06003274948,55157.679715037244
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.00040389045408925585,0.0005696326079989928,0.0003049542434912291
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,28.453561156765673,40.18725397166147,20.656364207785145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,4044.1724769137427,7289.067272632488,2412.954933883557
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,2.14895545249134e-05,3.8532020272639324e-05,1.3086614552297214e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,1.5145288930537915,2.7297310020366243,0.9036434489045877
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2014,272113.6242699165,335142.36508956074,188726.869634489
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2014,0.00025155724495940635,0.0003154519664274292,0.000177027040672996
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2014,10.606006935208502,13.062639762925814,7.355892207066073
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2014,579367.9992347485,852313.5262687091,466242.95580971893
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2014,0.000535417081078311,0.0007829098888270101,0.0004278458935405195
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2014,22.58167349910587,33.220105001472845,18.17246760825525
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,842080.9651599671,1062195.3941530283,721113.8274123392
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0007786511937691985,0.000986914255611482,0.0006586094735739584
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,32.82127670180416,41.40054268564985,28.106414278704555
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2013,41818800.90893969,44409376.67258707,39184858.83370468
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.038410719900923734,0.04153730265339926,0.03563811061108996
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,1659.745068180929,1762.562347825685,1555.206624365555
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,1867569.6609505948,2131298.018893722,1720120.3866249856
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.0017154877884556392,0.0019405465334322559,0.0015475313418470728
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,74.12191327524312,84.58901974222898,68.26980368459068
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,3199888.22939409,3800120.944618392,2738700.536652563
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.0029391505252692866,0.0034769655453905455,0.0025371280455407062
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,127.00026284904094,150.82288012168047,108.69619908116132
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2013,1729439.4479122313,1983071.1872070157,1543181.9887559244
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.0015882414802905567,0.001837586262155038,0.001411948630406756
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,68.63966761362262,78.7060497020358,61.24730120121052
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,1002007.315601256,1101549.164517769,912964.0595650065
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.0009205697430286249,0.0010365431221155328,0.0008293741214962902
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,39.76863669457531,43.719349991605185,36.23460171871008
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,3091950.0356619605,3322459.5077520343,2871504.9322741954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.0028401016708254887,0.0031068761982336705,0.002585267140083658
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,122.71630728787206,131.86499044365112,113.96706854357656
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2013,4123697.0053269747,4480699.867174689,3837241.0639691087
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.00378732107496258,0.004106611609912641,0.003454312473187013
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,163.66528017308113,177.83435547890988,152.29613936593276
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,3461827.5351995314,3836599.0009566974,3145993.3906646045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0031795285287059,0.0035236938162859595,0.002846528911891988
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,137.396363682252,152.27065654731652,124.86123229729331
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,311451.4443726968,393517.63144978817,262573.28323885676
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.00028604942301823223,0.00035844518069248814,0.00024383352626543875
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,12.361186536673415,15.618308843030555,10.42126274353802
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,1135048.452853256,1351412.965010072,803375.7519047228
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.0010426484516137292,0.0012510000045998985,0.0007426156337866077
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,45.04890218807929,53.63618647591937,31.885154837975442
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,2333393.6248737453,2483016.387974812,2182868.686305971
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.0021433719971293732,0.002327098626821353,0.0019794644349545197
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,92.60998586358596,98.548358981585,86.6358063319894
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,2466345.2633390073,2661730.0108054793,2261161.210880314
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0022659533889504875,0.002510521369779623,0.0020189448594154324
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,97.88669924257056,105.64131831238537,89.74315586648841
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,664562.5743565637,745254.2197236852,595632.2355931087
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.000610466595846142,0.00069910202041423,0.0005384465702997904
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,26.375803019501163,29.57837118335434,23.640028981890527
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,1184940.9099091874,1292952.6357592861,1080722.5450421534
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,0.0010888450222626342,0.00122800059871147,0.0009666298718040536
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,47.029082340024104,51.315956315099925,42.89276294916934
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2013,100522081.1684576,107329515.31349885,94049760.02345483
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.11863500266515237,0.13066537501767195,0.10740931647650245
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,3419.1176581737677,3650.6629865395807,3198.9707286731227
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,7249266.220686652,8113927.778606912,6469434.530756209
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.00855387458269135,0.009741248211511615,0.007463153685464744
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,246.57362696674724,275.9838775969029,220.0487453641035
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,13512779.886620011,15586636.04130725,11256661.587267045
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.015945544770353752,0.018297441418376914,0.013439854422877907
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,459.61826281662076,530.1575723551944,382.87956196024356
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2013,6427042.993689679,7040872.504839107,5898148.383836125
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.007584921240156348,0.0084739484031176,0.0067936746288033
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,218.60685666406383,239.48540689186902,200.61724802441822
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,986559.0832363707,1061269.4206102893,912849.4216827889
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.0011643883063000345,0.0012919913723489582,0.00104637398288099
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,33.55642405246628,36.097591433742494,31.049293256263216
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,21055669.23144862,23079630.787344955,19144588.769600213
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.02484902256858671,0.02785175288580402,0.02197888598558684
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,716.1790686890597,785.0212834023923,651.17634612956
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2013,6370351.530168806,6886163.046950379,5951299.65036812
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.007518486576792463,0.00827818671016243,0.006746029945139268
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,216.67857601429156,234.22318158569595,202.42511383699815
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2014,1431389.8190386905,1621269.8893395632,1057928.6487982392
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2014,0.0010339016696858567,0.0012081745292866347,0.0007703421855579877
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2014,33.177463516989036,37.578598009646896,24.521195192413426
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,132935.1685383824,152885.64392606285,109881.37637738418
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,9.600411770114535e-05,0.00011120069283149544,7.856203985894236e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,3.081237302127098,3.543659320585971,2.546885067553119
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2016,6456912.217950472,6795615.752754876,6058889.996596346
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.013461522716838233,0.014737996742712606,0.012179938132533099
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,428.6446494546077,451.12961642406054,402.2217882186785
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,1282825.9663668354,1323447.7674902887,1230809.8535603932
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.0026758975963479276,0.002964716452574307,0.00239377712326775
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,85.16090479531415,87.8575989913992,81.70779475024901
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,1080280.7990946602,1142284.9744677965,1006018.7296721148
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.002251972891791373,0.002466044924613333,0.002022943572956094
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,71.71486444451874,75.83103593956437,66.78494784647258
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,3616570.189297072,3825866.550642748,3362983.0338935163
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.007538162873945599,0.008213654323693422,0.006813449988595829
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,240.08743013565316,253.9816511522769,223.2529473883174
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,9455924.847171813,9818368.106057802,8887938.676470675
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.019723108233229477,0.02184880913201887,0.017481190515190346
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,627.7352788097281,651.7962166710895,590.0292941506191
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,1168044.5913826686,1201031.6479783608,1122596.3413698573
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.0024364606189679937,0.002699015653251329,0.002175896356084018
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,77.5410982092455,79.73095689614092,74.52399831110714
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,228478.1518614721,237944.39639842493,219479.82138636764
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.00047664564180274435,0.0005312333382453168,0.00042633835681818184
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,15.167611701523779,15.796032056986146,14.570254004534334
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,722870.0204779778,749124.7416171274,697771.6782261194
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.0015079230830581933,0.0016777912182900467,0.0013509934912476762
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,47.988009759157045,49.73093971690581,46.32184646727726
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,1134201.1093589177,1196274.8762604757,1045721.7756790554
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.0023664707783652957,0.002680470205243619,0.002050306434831506
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,75.29438538448932,79.41517674043737,69.42065012388827
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,5197544.284302458,5375431.980285728,4881716.488832777
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.010845092467659974,0.012170483633598971,0.009504300616693022
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,345.0410153596298,356.850159810294,324.07466331588233
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,1083612.5292680978,1135347.1409007367,1028856.9842667072
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.0022590965960469973,0.0024589940238181084,0.0020656555654991193
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,71.93604265851091,75.37046513777165,68.30107433300572
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,414394.92669490667,449944.191076351,383439.5342651938
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.0008638500499552643,0.0009623976619359373,0.0007688583020870019
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,27.50976969999575,29.86972155543389,25.454783835409252
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,1916563.4886918084,1983824.4037486226,1809776.3279423343
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.003998625805401592,0.0044774876009170865,0.003517767987916592
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,127.23181871420365,131.69696093440803,120.1427111747735
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,146595.91899009695,157786.43096777337,137411.10665590124
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.00030537279024146297,0.0003254576930934517,0.00028474532067955993
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,9.731827564930411,10.474714090560019,9.122090196602446
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,1979927.5047050861,2046986.765646962,1881019.6759099872
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.004130120797449363,0.004581026075134708,0.0036846528782697365
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,131.4382637633619,135.89001909607413,124.87222876534413
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,2025227.888708704,2124028.400064527,1891320.726438383
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.004223373768631443,0.004673581318838301,0.003771145504437353
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,134.44554751849915,141.00445820622969,125.5560680438902
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2013,1410729.0236233913,1594121.5661497698,1045691.6877379164
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2013,0.0010196315300900062,0.0011838345820105035,0.000755884442729249
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2013,33.06862273931376,37.36749140966403,24.511854044531837
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2013,128061.05748206853,147111.2857443412,106289.23858249967
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2013,9.25444955910899e-05,0.00010791632488408089,7.638515111827656e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2013,3.00185416657496,3.4484068361194433,2.4915052239486073
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2014,103856.2636029806,131876.31931868737,79668.40490259128
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2014,9.599056833647193e-05,0.00012209490066947403,7.39119361396176e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2014,4.047942307164489,5.140062946265356,3.105186876184274
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2015,35038772.97025366,35990622.56895226,33587345.081200406
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.11954012309983898,0.1322802359611352,0.10687709035130373
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,3579.1492321366873,3676.3789999480155,3430.8884177806294
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2012,40499447.9128629,43014145.752788775,37863024.05941728
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.03704118384677889,0.039918419824337886,0.034346650871909676
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,1637.4432054864035,1739.1155764455675,1530.8492999374903
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,1816691.6720757561,2074301.2811372061,1669871.2001754926
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.0016616240732351705,0.0018753268393836191,0.0015053043954895832
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,73.45111077327512,83.86658865665898,67.51497592381617
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,3119682.533627163,3741948.785748435,2729462.574103074
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.002853294423921962,0.003385013234108336,0.002466553529618179
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,126.13265689332964,151.29165779457014,110.35557709849704
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2012,1676204.746027052,1927060.890610762,1484828.5911994837
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.0015327704187671196,0.0017881819440144116,0.0013644362864408716
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,67.77104908421047,77.91347597326074,60.03347238714673
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,1389624.7759052543,1577869.0272063636,1018491.9406797603
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.0010055793919674261,0.0011650547614482697,0.0007406872718030099
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,32.95172876090067,37.415504606889115,24.15117429996874
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,122550.13205743398,140519.17246537644,100284.01964440149
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,8.866661692656964e-05,0.00010292741897461336,7.323664181530292e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,2.905992165070931,3.3320862847806674,2.378002948473954
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2014,47075547.798380084,48294040.40490119,45069642.50080292
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.16357129367752385,0.17976662976527158,0.14662501862713234
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,5599.8076239668935,5744.751751159375,5361.197893360323
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,1149790.8350503976,1174538.1470634872,1107952.764665715
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.003995985532478253,0.0044156187231255495,0.003562833094251903
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,136.7718016083083,139.7155843780195,131.79501097135963
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,3038685.6849001823,3130539.6027320065,2899012.473312059
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.010560425875228662,0.01169448662940559,0.009413759839344976
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,361.4627138917467,372.38907148972606,344.84807738310826
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2014,1266044.4779406216,1310182.4719242137,1209356.0289009837
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.004400270181328739,0.004863133260133285,0.003903688902778696
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,150.6005952435678,155.8509701574087,143.857298054917
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,611813.5127449015,631641.6608857426,592507.3142986161
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.002125720429595686,0.002320316041180731,0.001922479618419505
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,72.77744250132255,75.13607283747437,70.48089997966443
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,10168038.237260165,10402322.60962734,9745311.717234835
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.035338427430320465,0.03925728448451769,0.03149177806801292
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,1209.5251293869312,1237.3941075701903,1159.2402723773168
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2014,4054300.291351561,4248328.853152333,3820498.5760806673
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.01408141903163687,0.015350315511828964,0.012774144205692135
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,482.2737651104483,505.3541682168081,454.4622007442125
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,873494.3432830632,898697.7645147571,845441.0765615676
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.003035156204865646,0.0033395352598621668,0.0027291406689309134
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,103.90532902469523,106.90336764482464,100.56829091869125
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,636669.2409938509,670696.5335342756,593547.9916471334
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.0022109674000799348,0.0024158920889128218,0.0020106757659931734
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,75.73412177659803,79.7817919812426,70.60469233520485
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,2173744.596552655,2279171.7632063953,2035733.4354565167
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.007548850925593415,0.008218450467666161,0.006884195063774681
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,258.57482564974555,271.1157705608776,242.1578960919918
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,5615679.534613843,5814221.938898679,5320964.935349088
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.019511689469400947,0.02150560677301036,0.017448368346335806
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,668.0055048189487,691.6228459055927,632.9481313620244
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,984875.9664847292,1081852.1629882266,892995.4718718405
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.0009009420574022363,0.0010065501441936131,0.0008156425787475131
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,39.81976403819251,43.740632648555405,36.10492101257152
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,3006335.5486846445,3260417.744819752,2768590.9401698494
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.0027495821741288584,0.0029830991888102924,0.0025160912981467463
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,121.54989688248139,131.82275706051738,111.93758575440954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2012,3895233.658482232,4242266.282724677,3587016.512797297
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.003562610110067335,0.0038811269585297264,0.0032560811010986933
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,157.48915643459708,171.52011838426412,145.0275527084899
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,3341140.1179188103,3743965.870825958,3009514.3913179436
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.0030559082425584846,0.003427849977623124,0.0027428000130995207
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,135.08646331266633,151.37321106073279,121.67842145601143
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,300641.1629171231,373988.2731486991,258076.1659714093
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.00027496779745117225,0.00034674776113571436,0.0002353933250236975
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,12.155297291147086,15.120812464320847,10.43434136132136
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,1098469.8285112206,1300817.0080389637,776908.6241612511
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.0010046032312322883,0.0012145411227670847,0.0007056167538328293
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,44.41250559754511,52.593654510486445,31.411384931807646
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,2247887.4860770553,2406555.7591596805,2099007.00587623
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.002056087846727241,0.0022335884875845156,0.0018883714225481863
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,90.88489548534665,97.30005171770823,84.86547193026735
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,2378221.8377584377,2574862.3121398874,2175523.042555991
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.0021755836175686165,0.002397907216857108,0.001952143866699986
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,96.15447592657459,104.10489563087049,87.95911075323585
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,636145.0397061129,716603.4515782755,568702.1040279863
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.0005818467154759557,0.0006648650456849449,0.0005118329231852298
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,25.720137598216958,28.97317156864928,22.99333556817911
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,1144732.2170222742,1255727.3630625627,1036980.1961296414
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.0010473640642460738,0.0011842496918780011,0.0009264183011598532
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,46.28295168115558,50.770623911075425,41.92640304701891
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,3631253.946083349,4064680.636268827,3280171.8126853914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.002612688876717108,0.002961503100114208,0.0023195875329678874
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,82.31097027027768,92.13561264999383,74.35286227958923
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,843860.7229293686,1027784.786800332,659767.6949159419
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.000607376062615471,0.0007729710978510921,0.0004737274436429294
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,19.12810172701151,23.297176205980517,14.955197275610548
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2016,6342820.910578134,7238935.136908347,5101772.740801972
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.0045630900634944975,0.005291020825171771,0.003668664188076285
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2016,143.77505708831217,164.0876082173227,115.6437612540981
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,3495991.0169295627,3849374.4490278754,2939037.6981536346
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.0025154435622291946,0.002867298187695961,0.0020838759251071808
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,79.24491564959858,87.25518802529585,66.62024969552944
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,399661.2810609778,555246.4764387653,305449.3239008932
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,0.0002869583341755467,0.0004098068594308153,0.00022597069205031571
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,9.059269418233129,12.58597633033144,6.923732295231153
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2013,46736103.17460458,47954461.44448833,44768517.71199921
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2013,0.16265537446418282,0.1788343890910668,0.1457674413642034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2013,5574.237525452388,5719.551702846652,5339.562660087291
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2013,1127137.7190510125,1150685.657826526,1087839.1288348378
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2013,0.003923604771868685,0.004328819143564179,0.003507172102253213
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2013,134.4342583808096,137.2428323750754,129.747096606496
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2013,3081131.636530168,3173167.682009054,2946064.656588314
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2013,0.010725264562129582,0.011869744377380125,0.00956094809223638
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2013,367.48805361542276,378.4652370679229,351.37854989345755
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2013,1242413.6146917192,1285704.6509984978,1188617.7758087856
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.0043251581175315235,0.00477761001041625,0.003839303925103391
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,148.18326995030048,153.34661269189405,141.76701434819915
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,617223.0338999656,636346.7850216877,598134.6902563139
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.002147985166196404,0.0023497075968841787,0.0019459847412347758
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,73.6164883983797,75.89738740127395,71.339812462441
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,10103852.86572894,10337780.67411964,9734261.421323987
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.03517223815494727,0.03899760437836352,0.03141584815704788
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,1205.0913955188228,1232.9920778437195,1161.010046014961
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2013,4067710.6086993096,4259352.802893457,3842660.749667733
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.014151077449029837,0.015405681687012219,0.012838378772499095
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,485.15780258747066,508.01505934989376,458.3159975566811
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,867119.9934074638,892157.5343251717,837272.4376296704
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0030178943666143393,0.0033177818659621446,0.002715927437945631
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,103.42181906488831,106.40805862378195,99.86188671798242
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,636257.0790814235,670819.6297469273,596247.491704117
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.0022131623291296383,0.0024208095116688543,0.0020178150263471615
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,75.8866881305922,80.00898018766055,71.1147253825804
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,2106648.5636521145,2207342.00549695,1977687.3574104537
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.007327728821130061,0.007948768478007184,0.006687582812375489
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,251.26098837506112,263.27074365999545,235.87972322177643
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,5609651.74704094,5813851.557310362,5328530.459435498
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.019522396127791823,0.021502241657474493,0.017497692008061717
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,669.0658644828216,693.420874160063,635.536393171973
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,3443876.2086575893,3700446.7744239983,3183609.9892586367
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.004081767563959943,0.00456289755814363,0.003610460644620333
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,118.26495544602383,127.07575603544274,109.32724370018849
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,790399.8742700614,889858.4446362873,624076.7960249895
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.0009366558535268784,0.0010756549963433372,0.0007441076976698282
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,27.142847260334193,30.558319443543684,21.431204260841376
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,1958001.2198668164,2184854.0724759926,1661025.4339747853
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.0023201144782646166,0.0026259887103848778,0.0019563820346825355
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,67.23903909457655,75.02931402930928,57.04069688971564
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,8841798.988659052,9505438.073397886,8170447.389665178
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.010475485729282747,0.011495536574042831,0.009440292258421093
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,303.6331447767287,326.4229438384879,280.57849294457856
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,1161509.8739618233,1247966.721603556,1080836.7165594983
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.0013762212539569522,0.0015131546322277659,0.0012433486021708935
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,39.88700672483139,42.855991268656986,37.11663787652858
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,1293771.940856054,1407649.8875094238,1181719.4807251126
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.001532782575299456,0.0016956094785551376,0.0013623832222560096
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,44.42897237653592,48.33961534720619,40.58101780381079
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,394948.832027613,420036.6328512194,371652.5530729778
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,0.00046805049631688594,0.0005142902913663945,0.00042049019279336486
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,13.562800516982508,14.424331962039592,12.762791101515722
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,1272450.1755627526,1478929.5861611378,975625.3271355797
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,0.0015080897613741675,0.0017431263493511836,0.001155376553101137
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,43.69676904817474,50.78740669465909,33.5036101343136
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2014,4063117.8503987445,4663779.693127086,3421035.774364074
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.021617343667514076,0.02377531985071589,0.019050370276399956
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,1476.2732862339035,1694.5148103858194,1242.982337922727
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,227922.65027327195,273238.3336460147,173568.43960412312
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.0012124569028606096,0.0014061077569588601,0.0009536108456056698
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,82.81229644693737,99.27707430319589,63.06350447002743
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,385829.5065947325,453686.9532139321,284210.5183096915
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.002053502235630726,0.0023480557940712505,0.0015359230112123978
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,140.18539815937484,164.84038957345265,103.26365399569036
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,3562100.2802861007,3848361.5637235586,3296579.8020083504
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.00422085956140352,0.004658415381893752,0.0037389414062147137
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,122.32484718331857,132.15524638481833,113.20670076023143
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,326235.0827031111,372517.8112971373,253548.75938428182
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.00038672292365216066,0.000453354891641635,0.00029484518555038003
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,11.203125543195,12.792504633341368,8.707029787131969
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,508576.32379172737,564082.7463765955,408436.0448285584
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,0.0006027948320927813,0.0006929612238537317,0.00047959527089534726
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,17.464842703384026,19.370969461792214,14.02596020227693
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,1428549.0878517898,1593423.7436188266,1291138.3295255927
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0016933420187534719,0.0019355756631878414,0.0014718941764542497
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,49.057307519513124,54.71921074630408,44.33853244554298
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,173958.81982064497,182956.8557507601,166105.07960205886
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,0.00020612967524647342,0.00022377618807500722,0.00018831786521889904
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,5.973859345992831,6.282857769252529,5.704156783891219
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,1136744.3722791637,1203080.6966350647,1071825.3965200835
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.0013468881225270866,0.0014742996477191553,0.0012183157315462608
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,39.03654324251013,41.314575892081365,36.80718326829031
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,1250003.2330468628,1421300.0380788315,1145586.1522718603
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.0014807657866481342,0.0016939885581646911,0.0013166067276486784
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,42.925926400036666,48.80837042175395,39.34017573495311
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,3802641.9619061514,4557267.003562711,3136541.023826709
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.004506417944891614,0.0054879247437287825,0.003744795272829866
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,130.58520543550875,156.49952160796914,107.71086472416626
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,408927.8460306738,447734.27495249547,344952.71707029885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.00048427015646851303,0.0005326480094371175,0.0004094483145597031
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,14.04284897635955,15.375487058971537,11.845901316878598
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,171902.27414987015,184192.1294329241,160833.26867637568
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,0.0002037309659716648,0.00022597334796400123,0.00018196915622542364
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,5.903236226173521,6.325277873267161,5.523119357900576
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,281787.6453051618,369914.77208806726,226657.5386757587
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.000333982245475854,0.0004443002041950921,0.00026906101728129463
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,9.676771549882503,12.703114568939219,7.783567726855897
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,2447173.3396945065,2670675.904644535,2180108.7309400267
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.0028996681618726305,0.00326907097902694,0.0025674817917718095
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,84.03752877647162,91.71275264759645,74.86635590557755
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,536726.4186313371,621148.6745811477,440290.66033717716
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0006362617446570053,0.0007650779495436522,0.0005133376167857154
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,18.43153532248527,21.330650660446004,15.119868477611105
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2012,5100155.061791124,5682732.364546079,4170917.8324600807
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.006043819566966381,0.006851486394147231,0.004904990988720362
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2012,175.142651653456,195.14873624528173,143.23203905671002
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,3565013.186389066,3989013.1132365465,3208473.355675877
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.0025704835696204495,0.002920680464888808,0.002302606647448625
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,81.71310265515478,91.43153782968453,73.54090966048373
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,804173.666853735,966780.4027827539,636043.3430756801
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.0005801208639184113,0.0007249585039253935,0.0004520238596244096
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,18.43233726121202,22.159420503461075,14.578648736644181
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2015,6324185.7602570485,7297774.393792938,5106565.418997683
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.004559960235165584,0.005300629940364107,0.003699261990131041
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2015,144.95566025144996,167.27113113378596,117.04677724361208
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,3426465.544114432,3764014.7415464576,2890773.66656078
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.002470979287106401,0.0028107793380956238,0.0020528721554460465
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,78.53747408832639,86.27438578510066,66.25896540028108
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,383916.47887136316,546902.7980657746,294925.9165488208
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,0.00027625253570229475,0.00039499973444771027,0.00021741592325214134
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,8.799688811472901,12.53547242163352,6.7599502258865725
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,141412.1489405512,178817.95745948952,90229.6523791842
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.00010196250757128517,0.00012846564844531328,6.444036381800911e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,3.2412854704667584,4.098658083582667,2.0681395725402956
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,642406.0295472521,865996.1628732255,510287.3992639098
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0004630098234730886,0.0006268635394037286,0.00036588933492396296
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,14.724486865602316,19.84936090166462,11.696216664465704
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2012,46719383.913183846,47942734.83091475,44824761.815066494
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.16168555909959373,0.1776084857453265,0.14519354644660146
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,5585.125263862077,5731.372229144929,5358.630373318784
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,1132646.7575394309,1156024.9180742877,1093130.7661660276
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.003920662307245863,0.004320460097951851,0.003511412533445985
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,135.40362673275308,138.19839721321333,130.679639743621
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,3125727.7616775203,3218420.1498044804,2993950.003288704
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.01081943606449926,0.011969444959764725,0.00965925046118863
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,373.6689062968098,384.74992996051225,357.91537476565446
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2012,1234803.5182069228,1277939.399915486,1182533.0304912187
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.004274590199091748,0.004728113647791287,0.003797806446354927
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,147.6160802603629,152.7728114184012,141.3673415775528
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,625795.2666828195,645835.6872081356,607268.010391093
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.002165593244110514,0.0023686662241116756,0.0019654856987495195
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,74.81145214693682,77.20720846046936,72.59658888210313
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,10064819.051381588,10291731.454251243,9688835.441883057
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.03483977344105435,0.03857555694356281,0.03116915949485434
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,1203.2109683751341,1230.337486060085,1158.2635529702045
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2012,4076078.969260771,4269337.842586928,3855725.208188746
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.014100862921286017,0.01534011586858687,0.01279750655094938
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,487.2797909967938,510.38315678357753,460.93733407918285
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,888170.0022135894,912607.5814232042,857701.3642006004
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.0030738321882977813,0.0033712650562620775,0.0027714801652194603
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,106.1773572867627,109.09877725421934,102.53494709920469
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,607382.0594765057,639552.3907504408,569523.9221111701
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.0021008934429803524,0.002290135988972261,0.0019146081916085022
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,72.61022301797807,76.45606418486376,68.0844261916583
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,2129729.6011789762,2230682.8812289466,2001887.259014994
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.007366430326845879,0.007988941642011766,0.006731101822231156
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,254.60110139386921,266.6696833752703,239.31803395577552
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,5606710.528561968,5799437.883664358,5326684.401439907
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.019402849730506048,0.02132659086854591,0.017436079464712127
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,670.2609922772615,693.3008170750352,636.7849301777027
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2013,444435.010111956,570157.9644548283,360144.56652583607
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2013,0.0023637981644923046,0.0029567467887957983,0.0019525047956157168
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2013,166.43940577254642,213.5222262900512,134.87292018167435
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2013,43273.80996467919,54934.414303317244,33848.4830579685
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2013,0.00023015544066708546,0.00028249206952600124,0.00018437409138277175
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2013,16.20589524263842,20.572752067402963,12.676142244174716
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2013,188626.59546969653,271337.0804171356,146027.29897795213
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2013,0.0010026735943149331,0.0013972733024599023,0.0008116795777908857
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2013,70.64002103472059,101.61481746748372,54.686728802795756
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2013,313327.42345360876,370299.19706925587,259007.5215235426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2013,0.001665660136394274,0.001884979439241496,0.001450045840284068
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2013,117.34005869322654,138.67579492158464,96.99743942795824
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2013,586261.3244695214,716255.2636090501,477178.62539429567
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2013,0.0031160105224503727,0.0037260217339285043,0.0026621123599157937
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2013,219.55288006575597,268.23516992173586,178.70177877746482
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,797908.2995068949,937464.3097336757,561303.9196621198
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.0007416477749043989,0.0008848356136576909,0.0005262965713802136
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,30.55252389068867,35.89623110513665,21.492759789580205
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,689973.8046496012,752622.0857305258,637466.011805186
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.0006411650464595105,0.0007034813295551211,0.0005883705471813708
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,26.419628876568808,28.818479854329585,24.40906501062366
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,178925.68209927855,226619.23810325057,112972.98402609907
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.00016625043055297498,0.0002089511983507634,0.00010673269483819881
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,6.851202300282294,8.677425326341526,4.325822648533506
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,129672.99468667888,156932.6639201956,96609.58195096065
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.00012053476633570528,0.00015024667630265788,8.946289120403894e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,4.965278930661967,6.009072679923617,3.6992553686310723
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,1011540.1057661301,1136142.4531322473,887552.897983846
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.0009400455658449371,0.0010810271160652364,0.0008111873059504536
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,38.732650439792,43.50377037561905,33.98508467283727
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,159801.3593638344,175593.47342396493,146311.9062988754
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.00014850165342343558,0.00016451065561946387,0.00013475668214667975
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,6.118917239920113,6.723609461325495,5.60239568312695
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,478541.711136444,530782.8850284962,421501.71388390433
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.00044451948629691977,0.0004922523415895874,0.0003967805449027877
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,18.32373102425778,20.32408584498206,16.139625557677167
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2013,31540.3661037034,41326.87854386633,23706.221744703198
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2013,0.00016768466398454497,0.00021662483616191781,0.00012983600868290653
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2013,11.811760263500751,15.476776020733816,8.877899739056753
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2013,126862.12949368505,161438.983151628,79000.26186450341
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2013,0.0006745148064687206,0.0008499479592369134,0.0004236205688290099
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2013,47.50943775255192,60.458352319076816,29.585330456507585
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2013,180796.0768248814,217653.14430341416,148029.1386655207
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2013,0.0009616664514826986,0.001148781081227223,0.0008109988581566276
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2013,67.70751832795678,81.51036524611546,55.43641098459977
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2013,48902.61793997613,58331.2613067638,40162.51524955886
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2013,0.0002599533286367917,0.00029519513749013944,0.00022744261525964543
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2013,18.313864761916832,21.844859763444905,15.040725911272183
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2013,21940.78429142848,28596.314768753076,16909.572027625094
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2013,0.00011661334078078256,0.00014754877242003012,9.40543261784925e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2013,8.216749393188136,10.709223011474712,6.332577443520986
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2013,11021.933248683554,13392.446016621787,8572.269794023461
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2013,5.859275339739219e-05,6.92215587902464e-05,4.6860673345177015e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2013,4.127676665061654,5.01542566659168,3.210285999475611
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2013,12124.884484167069,17354.654536462527,8229.938393701184
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2013,6.450957389911568e-05,9.11026836681064e-05,4.4719925942180355e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2013,4.540728166525801,6.4992593353728365,3.0820840496954385
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2013,49503.82480870202,60530.02032953048,38906.59545353688
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2013,0.00026327787947302036,0.0003131741693966775,0.00021395831923373362
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2013,18.539014697678876,22.668287569220432,14.570388202064219
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2013,21541.074867744326,28516.674937085867,14673.984847994314
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2013,0.00011449527780830454,0.00015145914657333393,7.991204109078089e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2013,8.067059568025812,10.679398164293621,5.495357617754474
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2013,6225.921909777966,9442.50480746245,1879.833649419245
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2013,3.310246373154785e-05,4.9534001380462405e-05,1.0049793864301798e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2013,2.3315866650304775,3.5361860641054492,0.7039913338099995
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2013,49077.77146458538,66440.5976079395,34299.57708816331
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2013,0.00026090242133327467,0.0003487258852424146,0.00018896362833127362
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2013,18.379459163554042,24.881778738026636,12.845075430410995
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2013,9780.407720225212,12531.369617696582,7188.982331287052
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2013,5.1979465779288625e-05,6.509014417354947e-05,3.963378219724252e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2013,3.6627295602959875,4.6929554720726365,2.6922495305384224
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2013,45301.3646250376,56240.513158092836,34355.050546327286
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2013,0.00024075991222036758,0.0002889629055039037,0.00019110024245945793
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2013,16.96520759464326,21.06188166413363,12.86585005257822
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2013,60157.61780303362,71488.28676921551,51009.07491677625
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2013,0.00032001902863510503,0.0003695662302999297,0.000277016944266551
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2013,22.528824084553182,26.772121229982133,19.102725764149135
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,79205.47571717206,91044.36061389901,58552.781490566995
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,9.384635941066737e-05,0.00011016798935459774,6.844729659503672e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,2.7199677018657455,3.1265227317248967,2.0107407103700523
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,403413.19916666474,508040.8909626241,334044.26696967543
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.00047787342614838033,0.0005972725058586187,0.00039490714685704427
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,13.853472405844869,17.44645559076973,11.47129802484033
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,1063309.7287695615,1234631.4199868357,777710.9654781057
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.001259978242878473,0.0015056345067798824,0.0009146103838131611
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,36.51474968296666,42.39804831252051,26.70710185544223
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,96283.3746481144,104808.30922793734,83888.28024373557
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,0.00011409371252968157,0.00012796696314679837,9.891164789103035e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,3.3064338910691187,3.59918570535574,2.8807782639016946
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,1482470.826652534,1693873.1508559724,1093919.0214716655
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0010665191291373663,0.0012450428385821569,0.0007909227810480688
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,33.603712092558204,38.39564641633228,24.79626525475143
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,141992.35812441062,164843.23754000658,114284.45731385433
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00010213619784329847,0.00012100031339258432,8.180502697886546e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,3.218593065018514,3.736562362719529,2.590527874940193
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,291412.1722789651,336204.97093565925,245854.83998249646
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.00047886178496869423,0.0005419466976024389,0.00041165901285420607
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,22.564429093884026,26.03279460964584,19.036864729393077
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,233036.67062237614,286613.7378557374,184994.83421401956
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.0003829669326504333,0.0004646685396412309,0.0003116690162587649
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,18.04433695892317,22.192879983708494,14.324394162097912
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,80508.91297128698,98572.10011076205,65145.864267782476
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.00013229016863225009,0.00016131084957597021,0.00010741187713366941
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,6.233911383863692,7.632567803157206,5.044330247203881
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,116002.05025735415,139421.45170062297,83800.46590023262
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.00019075244994516997,0.00023926345824803387,0.00013882474573522814
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,8.982191846370524,10.795587008127766,6.488780671214046
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,425805.76661547524,477024.8076334875,377929.9850233003
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.0007000090931421329,0.0007796046649467642,0.0006268817221552216
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,32.97070247074015,36.93666041364073,29.263617517484445
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,282092.2795778932,323698.40179615055,237416.6340873313
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.00045819296781821235,0.0005164366970182993,0.0003961172110626339
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,22.370776000748787,25.670268074041775,18.82786139332417
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,227479.72123938796,274926.8840867443,183671.29685218702
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.00036955394407009066,0.00044383505668707437,0.0003039340048095324
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,18.039833972676796,21.8025383384876,14.565692637159678
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,78191.57094595014,94579.15983201505,63636.736720362285
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.00012700161292144717,0.00015242925944699938,0.00010264556810667
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,6.200829464017663,7.500415119857236,5.046586828679066
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,112414.61740969482,134530.569899082,81441.7798316929
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.00018269521361783612,0.0002283527611190354,0.00013293206330051624
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,8.914821167899966,10.668683485307584,6.458580917008122
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,408792.1198759565,456865.07365456154,366875.8380123579
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.0006642266315024003,0.0007426630101860854,0.0005999454532382339
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,32.41845880468729,36.23079029523618,29.094370127897086
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,754405.802799032,782711.6874194208,725715.3848161008
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.0015623393821887195,0.001727046320994627,0.0013976683903924622
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,49.671370193936845,51.53507811933931,47.78234393332017
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,16552508.42853478,17038624.012126513,15633899.61688599
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.0342924026714931,0.03835074839101226,0.030071960600915753
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,1089.8455058822449,1121.8521885191453,1029.3627283405983
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,2582575.8916223994,2647054.4692163793,2498807.7618261627
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.005502719297188412,0.006108210297104981,0.004917412422932174
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,174.95984045181436,179.32802250020933,169.28486351439338
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,311029.011450694,332898.31988714216,288696.6093192007
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,0.0006618964255986918,0.0007159552347457127,0.0006076099422542053
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,21.071050185136365,22.552613893387697,19.55811361413122
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,380665.9017466833,392181.30644358695,363758.31850870815
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,0.0008111200168304524,0.0009030465925770385,0.0007160448367453493
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,25.78868859230548,26.56881411544845,24.643263176023304
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,245311.01710818076,255374.24585100258,234769.4189854653
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0005224180315047634,0.0005744009532956207,0.0004734223286552378
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,16.618902295783887,17.300648338943972,15.904748519455245
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,2302892.273297818,2394100.6275324007,2169751.598183469
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.004904650821573874,0.00539147670854849,0.004389148857293029
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,156.01232320835598,162.19134747498873,146.99254131105835
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,1175110.75971839,1219203.9234044834,1101249.3040737251
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,0.0025036675134488154,0.002797023206326965,0.0021941994668385712
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,79.60935115226435,82.59649778697111,74.60551427101356
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2012,2765309.786572928,2863583.7932553957,2622137.9041854637
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.005891249311277657,0.0065449238671876925,0.005258287495289217
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2012,187.33937718078076,193.99707292769023,177.64001857492
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,1544446.4525854995,1595500.9213960506,1468136.701753235
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0032902982333090237,0.003649706100008367,0.002919803744675706
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,104.63046054417296,108.0892095189551,99.46076083705474
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,628981.3033933971,688082.7906999424,573877.2220687873
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,0.0013382908548728815,0.0014692413411978625,0.0011902548444554133
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,42.61112668396771,46.61503101187585,38.8780316341487
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,866550.8192309976,1015239.8493597172,622112.2534938041
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.0008148610249284338,0.000972191635984449,0.000590736803834054
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,32.06245822124708,37.56396570431715,23.01820931203092
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,765778.4751819462,824901.7462347134,711056.5222028254
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.0007198126182571309,0.0007896264727938333,0.0006557435554078569
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,28.33387243120983,30.521438775806963,26.309155251050537
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,192809.4201925617,248838.1845891679,120653.00725358588
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.0001812098366363351,0.00023094000291176887,0.00011624444288074859
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,7.133965882200566,9.207035202299387,4.4641721160322465
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,140087.51932511883,165833.28042626756,105863.57826587782
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.0001317148723265166,0.00016352725066234332,9.939679100486839e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,5.183250809993691,6.135846285481602,3.916961913801642
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,1122951.105535269,1269603.6164969318,992310.3854551828
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.001055635815858091,0.0012031018671231285,0.000922250051595573
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,41.54929186689744,46.97544795768737,36.715573478311114
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,171808.42503779134,189581.69979630108,154992.7587264045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.00016149746074363433,0.00018025107045692882,0.00014440636073342856
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,6.356927173320249,7.0145399373415955,5.7347460079389325
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,510180.1042910632,568936.286896306,446126.57576165954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.0004793213264201566,0.0005366232161451356,0.00042380405974443706
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,18.87670972795333,21.05069376698794,16.506723413451898
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,828752.2927148418,972362.7545523839,579989.6482356847
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.0007754630195880899,0.0009231658473447322,0.0005523451493926962
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,31.187898681740496,36.59229825058532,21.82637507569084
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,726318.4049150804,782561.9230912444,673100.5768477749
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.0006794478588839272,0.0007484537022614253,0.0006204109106590801
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,27.333070475099316,29.44964639507255,25.33035839283363
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,185744.2100969963,235470.48339020275,117077.63893018443
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.0001737403190217306,0.000218425896561742,0.00011256938026582644
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,6.989991649070816,8.86130831017922,4.405907015823331
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,134026.83966497274,159994.9680090468,98987.0627806666
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.00012540482190134437,0.00015411958214777598,9.276053044152953e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,5.04374531793098,6.0209870859101216,3.725116071405869
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,1064011.417476892,1202470.7831948977,938735.5220537509
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0009954006716510059,0.001142365948300636,0.0008576439533564235
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,40.0412530694531,45.25180477170585,35.32682637275903
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,165215.63305058822,181398.56517796882,151303.38234151714
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.00015456985058356817,0.00017147637372320844,0.00013824060699588122
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,6.217452994720489,6.826454806237521,5.693902267484341
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,495790.9958657714,551861.2160787658,438483.123292862
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.0004635835548275537,0.0005150637057330131,0.0004122912783823328
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,18.657781682543522,20.767835992423347,16.501151602383988
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,754907.7035083716,774925.7375866987,728662.3402311353
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.00262260542320148,0.0028934898491464476,0.002359188553654139
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,89.53850463138428,91.91281453536791,86.42558026933322
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,123608.86248185001,129475.36853413089,118648.27536325096
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0004294582256871885,0.000475179653172276,0.000386911366832016
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,14.661067378667365,15.356885128163086,14.072699356154319
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,511718.9738447867,533260.097087328,492366.3228226284
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0017778079274088174,0.0019704753426241406,0.0016039078546252628
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,60.69424314605699,63.24920444033676,58.3988533585055
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,529633.6324006431,550589.4153118569,500069.1396095497
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.0018402760078930966,0.0020433542459984996,0.0016254386901258658
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,62.81907473887099,65.30460966788257,59.312473253156384
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,2929781.8308257386,3021089.2418888845,2780673.1807590546
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.010180533740148807,0.011328154771401582,0.009038051538267727
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,347.49716132076384,358.32700053205,329.81160122841356
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,706323.7507942333,736922.5396773514,674274.6042491009
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.002452805002431237,0.0026597096728598565,0.002251376269263336
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,83.7760326697274,87.40531051043942,79.97473001640046
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,200478.3934251712,208463.2108438526,187643.02266476263
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.000696592454165943,0.0007753564457007807,0.0006143362288488662
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,23.77845063014795,24.725518209536368,22.256065974467123
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,1457148.9084321954,1650034.7405523816,1078462.5167901916
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0010507229514836733,0.00122893580632623,0.0007845931399691301
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,33.39907936193872,37.820184972694165,24.71926855156266
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,137559.5762394301,158703.5085891988,111524.74425941896
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,9.917851566510859e-05,0.00011651375656582266,8.05324942523377e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,3.1529812617151483,3.6376179865459703,2.556241001029843
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,1236521.3601643543,1278497.2486105165,1171167.7374026356
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.004296341171622259,0.004756562078599294,0.003815385715496616
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,146.66199989659236,151.6406989674537,138.91050176359843
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,101059.40419393581,108657.31992821943,94993.88030122517
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.0003506712879327225,0.0003722254366214333,0.0003276095570074911
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,11.986508931370716,12.887686664756341,11.267085965311106
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,1271275.45828044,1312639.878049629,1218724.7470779521
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.004416554408893516,0.004864878520601561,0.003945190145224894
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,150.7841329211525,155.6903065816747,144.55116950520255
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,1325007.5723957762,1379224.6768366406,1246093.8261072794
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.0046020968747734715,0.005048152636811213,0.004150215694177496
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,157.15722081813763,163.5878327121714,147.79737615806255
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,1818442.2728469642,1870812.2046486996,1744116.7514965385
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.006318665819803562,0.006975388639756816,0.005659163484396424
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,215.68279289311468,221.89431432730126,206.86715091895448
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,178001.04402210485,189722.7667049191,167206.62267343717
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.0006178699640941222,0.0006670056711109059,0.0005658064752409303
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,21.1124449127942,22.502741389893696,19.83213429809389
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,264915.2833648216,273331.4912401951,251982.39049494342
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,0.0009205078663777082,0.0010195016728077081,0.000817139404645728
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,31.421216416587374,32.41945059054755,29.887264805357173
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,167629.6477843148,177118.8040832404,160301.26533971349
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.0005821981720182606,0.0006428602372134161,0.0005277258996289971
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,19.882308691166674,21.00780371694351,19.013099909209654
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,1252113.655332744,1300941.0718359533,1182762.181869571
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.0043488623543278095,0.004743599390000651,0.003922600833982698
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,148.51137934610708,154.30272819364563,140.28570195665029
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,711084.616760956,739584.7313542336,667026.6486504294
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.0024705630627998494,0.0027354531579578335,0.00218562133200909
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,84.34071205692865,87.72106919283512,79.115060545651
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2015,1628100.1070594061,1687999.5237244978,1541594.7423999722
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.005656250464438268,0.006261521799050122,0.005079973169349615
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2015,193.106585479001,200.21116816051173,182.84631000664675
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,1045758.8065482088,1083620.4591336553,995152.1561537664
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.003633286584612658,0.0040086545728829515,0.003234685821003105
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,124.03593089362239,128.52664643357363,118.03354970230198
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,370612.4923373543,407126.63103915186,336869.5337015861
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,0.0012859577693864425,0.0014088431752143711,0.0011512447225129744
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,43.957808626639654,48.288697504932415,39.955605385045885
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,562393.7277017172,668016.7622080233,514396.6782078533
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.0005286535958661579,0.0006402203243933197,0.0004698647409374125
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,20.808618488560903,24.716680261631613,19.032723341977547
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,1671684.1106155699,2168174.042852313,1291270.3871195414
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.0015711060807700008,0.0020373631647058045,0.0012399319185669698
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,61.85246239026002,80.2226345213499,47.77712041873617
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,364139.8118706004,427162.35397529684,301168.2857445742
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0003421848652560111,0.00040138165801690477,0.00028594599930304094
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,13.473205778231025,15.805045502324528,11.14325364993504
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,99499.21432170282,120230.08688350272,78673.79477674438
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,9.351708300424113e-05,0.00011355976930401898,7.373768500624705e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,3.681479875661041,4.448524024315318,2.9109374801293844
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,662069.7347261095,888144.4011527263,403549.0540248136
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0006224141779298734,0.0008368316245549786,0.0003887561346447275
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,24.49663971011646,32.86142269378305,14.931351281136187
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,2204740.0343351117,2572134.1720766188,1937583.0595146695
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.002071713308474044,0.002403913816512664,0.0018363757325835406
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,81.57557949378231,95.16919562182619,71.69074740592312
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,406046.1165551487,533757.5331891566,308442.23060127965
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.0003817987635496163,0.0005061007431594249,0.0002905012276343741
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,15.023742819264061,19.749076716978145,11.412390263617713
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2017,3050503.9485009457,3626293.320187783,2412004.481201273
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.002866222279683442,0.003429286336793218,0.0023082975083479236
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2017,112.86892035871274,134.1731788790964,89.24438266252602
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,2153403.0424076384,2429814.703671473,1785879.4464331912
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0020241265703322495,0.0023132591249906058,0.0016745597311984312
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,79.67610617686843,89.9033624952018,66.0777000825664
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,75769.78890450376,118648.53046134011,52994.17232805614
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,7.102552583874596e-05,0.00010750919833822088,4.990501709172229e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,2.8034890017636283,4.390006294501003,1.9607891407288958
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,128670.81013188873,165728.85767413315,71214.59319943716
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.00021136061019305533,0.0002640861746044215,0.00012205012746110231
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,9.963150643186754,12.8326041721364,5.514239937651664
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,39333.56884749499,52872.424223195674,17550.567847946135
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,6.464247817555912e-05,8.652221397480263e-05,2.9623476434861473e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,3.045650146758717,4.093981586548066,1.3589636310156539
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,372129.32667334913,434278.0732924893,289517.9264217315
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.0006114729128843577,0.0006957176703398307,0.0004749420478173206
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,28.81446488596701,33.626724358158484,22.417755137207266
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,49237.032880648214,56931.63553888815,41031.095728014625
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,8.087183680634113e-05,9.157554265419387e-05,7.002649051609796e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,3.8124884370481005,4.408291675909581,3.177091893446567
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,287541.90670474933,348611.6820157615,221757.85424361733
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.00047204267651257837,0.0005500410069231841,0.00037687607329824286
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,22.26474932264823,26.993462622467487,17.17100332137762
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,300929.1214587052,356761.9917773253,262899.10340200656
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0004946727934877135,0.0005776290717985915,0.0004389066349200717
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,23.30133902896654,27.624551863763646,20.35662454031426
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,729181.0011656617,900898.4324960944,528518.5266477948
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.0011980437410044355,0.0014530402451047746,0.0008787870288123783
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,56.4614472646639,69.75775459849162,40.92388703630367
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,101812.74654207587,133060.18114290753,81158.19336132036
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.00016725193686732386,0.00021479829074127718,0.00013489836553053693
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,7.883495333211533,10.303025433489166,6.284186021358694
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,47479.5135572837,63400.764942567985,32697.328721783102
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,7.801743375485022e-05,0.00010544340886637095,5.433621202940208e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,3.67640139633511,4.909204903339067,2.5317973155761315
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,342509.401582472,459994.1783103447,174697.50453077632
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0005627461073085385,0.0007595979642513028,0.0003000510168747321
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,26.52095499496818,35.61795630879503,13.527058334713665
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,1201330.7177008393,1438673.1128137908,970093.8588154097
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.0019726050941514415,0.0023315047549636037,0.0016493629856937854
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,93.02062294060924,111.3983578293633,75.1156477797984
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,137096.00095362542,172807.67188894138,87247.07489196754
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.00022532616600295363,0.0002835176894156901,0.0001484553427764698
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,10.615524287749311,13.38072609912959,6.755656154143074
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2018,1324816.0873750064,1598762.1569065508,929537.527910552
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.0021760849202352092,0.002576705532317254,0.0015480675617772196
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2018,102.5822580856141,123.79426379268985,71.9753175531848
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,770478.531506669,928163.1374039869,599019.3063595814
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0012653049176741572,0.0014569238374751606,0.0010092963854741847
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,59.65916954182444,71.86889668239493,46.38285545354358
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,13703.515588336644,23092.747080276036,9562.561968117923
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,2.2514092989682186e-05,3.9107339719606955e-05,1.6320722333749007e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,1.0610812973658217,1.7881018833251359,0.7404417934845623
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2016,47682214.91887391,49007241.793322265,45506168.827127695
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.16608439932859337,0.18233057868229835,0.148656343215172
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,5639.884249188578,5796.609313484933,5382.500063088412
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,1186344.2469255857,1211951.2232260327,1144061.1141725616
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.004133107161270726,0.004580209855237929,0.003677899271710353
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,140.32159042391064,143.35040069524447,135.32031322179517
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,2985499.964825128,3079282.7846567673,2840965.934536768
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.010401089095500448,0.011510811113891493,0.009245203660986367
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,353.1269312094273,364.21962581920695,336.0313495070679
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2016,1265925.0661400864,1312141.8639153212,1211210.6713754898
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.0044106178565824945,0.004904617640685198,0.0039054190846090726
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,149.73446290873565,155.20101663875772,143.2628077274117
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,606955.1250995952,626892.6015106691,586877.9701933508
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0021140088516243497,0.00231749299730617,0.0019066942818418851
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,71.79105785747628,74.14927589266395,69.41631855652514
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,10182637.2066586,10438318.467794612,9747778.293235874
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.035475930556040404,0.039493896109016866,0.03157649985350594
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,1204.4091344067085,1234.651284859388,1152.9737314875083
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2016,4092406.867818754,4298492.714577198,3849432.9551526913
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.014248301627696915,0.015540297775317395,0.012929737742291607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,484.05261950082365,508.4285911936483,455.3135027181713
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,849065.5139241056,874246.5793315062,818411.3408101401
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.0029574903077268797,0.0032610618272643404,0.002657473034963624
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,100.42803646301067,103.4064697092558,96.80224037926106
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,678329.7900408858,714219.9446060075,631451.2284675317
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.0023614065310642238,0.00257926998348556,0.0021504488200268716
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,80.2333009302527,84.47841239953237,74.6884733358968
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,2277908.0499311225,2396848.8098528828,2135343.8759645326
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.00792989565356996,0.008645856025288775,0.007234860445248058
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,269.43248659409846,283.50087917213983,252.56990081403887
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,5743018.369959322,5956699.926337479,5420692.485216517
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.020002833447058846,0.022122392408550493,0.0177978904767862
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,679.2880511662951,704.5624484695592,641.163130091222
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,931168.7431091821,1089576.4613846568,657295.1843701843
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.000888781285545012,0.0010505788624549563,0.0006401614522845635
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,33.351897723073975,39.02562555980146,23.542501748700772
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,846180.6746821079,911686.4381712019,781106.0836501892
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.0008074001619118636,0.0008798894210139581,0.0007300047383136607
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,30.307859371446185,32.65409526083529,27.97706689099781
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,205212.35581921728,262570.97762036184,124193.91797647046
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.00019578854279734984,0.0002493536483916393,0.0001239603012783098
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,7.350140942167648,9.404568672914568,4.448283816259288
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,150775.1567524933,182971.57760558694,114887.23641193063
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.00014391455912013385,0.00017877518841741816,0.0001082981004290291
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,5.400350521215865,6.553537570596367,4.1149441353703695
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,1229445.113584164,1395684.811236782,1055526.0235738996
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.0011731680408700663,0.001355513712214295,0.0010128224432874894
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,44.035335150402666,49.98958290050651,37.80603273337311
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,182856.4110991869,202610.52924109847,163516.48656905786
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.00017451560543528083,0.0001970325116271922,0.00015409843349312651
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,6.549412623779794,7.25695068576273,5.856709835295838
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,537343.6087171584,610150.4251334255,473767.1729638501
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.0005124496696869065,0.0005735408258715951,0.00045092136471439645
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,19.24616694095885,21.8539064217215,16.969034253104752
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,51142.44288938977,54509.59508706897,47576.726785726285
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.00017757838721965756,0.00019481205964831452,0.00016105853871949065
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,6.065930759787446,6.465303784125817,5.643006359389488
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,124533.10949220191,159995.3526891404,70047.17126680851
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.00020221151349605397,0.00025461140647696246,0.0001177878178189769
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,9.875854459028204,12.688118233952729,5.554953791151755
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,38078.740991292645,50602.009076953895,17032.643318758463
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,6.185834017636225e-05,8.228968850927063e-05,2.8335689799019336e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,3.019760010381702,4.0128932700400775,1.3507404348490233
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,355873.5743367361,420015.4619522383,275112.6184979592
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.0005779678380856213,0.0006653368255081076,0.00045642292013649245
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,28.221857145419136,33.30850397694076,21.817267642370485
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,47191.314626550746,54684.292494867885,39615.59021245873
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,7.661816017765526e-05,8.671379462544495e-05,6.631908926207363e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,3.7424148235149306,4.33663076491366,3.1416368292903156
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,284066.9953112508,339383.87400146713,221281.959385312
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.00046102680842718865,0.00053244180607741,0.000371386950765513
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,22.527376966227862,26.914173740996468,17.54833260173895
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,292405.2949153285,346416.1961344036,256251.83664881918
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.0004750818700911766,0.000554053555808577,0.00042398782445020154
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,23.188629493057288,27.47185828109246,20.32155026018104
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,715425.4369319632,889894.8109383652,523184.24079381436
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.0011618610049315967,0.0014068579415789915,0.0008441966979294349
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,56.73541374046526,70.5713659002632,41.49010201708988
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,98310.77567194728,128428.6853036169,78739.09850578892
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.00015963611637383925,0.00020389759122619873,0.0001302533928645388
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,7.796343608934931,10.18478547267205,6.244250065296494
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,46441.36909932581,61946.36745440738,32682.41287228244
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,7.542774083326472e-05,0.00010024690692660466,5.32471267629298e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,3.6829418615912037,4.912535403153309,2.5918147728957397
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,340539.06876602734,449304.7255518715,176811.99014209665
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0005531818950422547,0.0007293051002514248,0.00029894377623206525
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,27.00578420036062,35.63123168928624,14.021728746473007
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,1187024.863896336,1404719.9913511826,962063.057288722
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.0019268580281411114,0.0022404817407445507,0.0016104040831238634
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,94.13468308058309,111.39856899775192,76.29452739864406
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,131391.6657581344,165294.68708586658,83809.10154457763
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.0002134564800196186,0.00026873822354433606,0.00014141190928212668
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,10.41975883721003,13.108371574170393,6.646316731117951
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2017,1316630.0163836887,1573999.2128750603,926426.9663461347
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.0021377623804357438,0.0025046589390234587,0.0015440611851832867
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2017,104.41276598017855,124.82292627530065,73.46847696857972
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,761810.95255061,907364.7431536296,596498.8731711071
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0012367287855527926,0.0014320418658785616,0.0009848290799577613
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,60.41392625111143,71.95678467500151,47.30417541514182
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,13326.126806481912,22655.75298011004,9273.650134547453
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,2.1638881900635786e-05,3.749825117813192e-05,1.523377805993503e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,1.0568023988159605,1.7966701385969335,0.7354286695818271
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,276500.74388180766,287876.57718973863,261842.15057495655
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0009605638072915457,0.0010608847263881534,0.0008606752195737452
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,32.79535103640376,34.14462207787579,31.056716606531968
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,207214.20664053445,215074.18585317442,197107.68546702177
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0007198564477220298,0.0007945700708265494,0.0006496846289115201
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,24.57737563777072,25.5096363391291,23.378655862232353
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,38099.73438367427,40492.744968119296,35071.352650025394
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,0.00013237590740530783,0.0001486205551249249,0.00011794342209006013
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,4.518954075727348,4.802785580297371,4.159762123355235
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,539110.5525934325,634348.2319613312,491721.0998502858
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.0005043751040739036,0.000602532940449982,0.00044824218795066616
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,20.287998525424747,23.87201647737526,18.504621919738653
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,1627376.4593702478,2120637.717835983,1262149.7322638254
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.0015221752296745246,0.00195322771347147,0.0012028291523768727
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,61.24200509373741,79.80458680589498,47.497664039132225
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,349281.45333809854,406773.2280826977,292115.0559632098
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.0003266570975157218,0.0003796527136433736,0.00027255733825798985
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,13.144282886307375,15.307833637876714,10.992976850715376
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,95528.52469207355,115645.80636290251,74441.80235451553
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,8.935210727382925e-05,0.00010917084315142947,6.968875374667815e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,3.5949631458065507,4.352023787468908,2.8014201709335502
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,654678.4671446842,893763.0315588721,398349.14689145196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0006124761042777023,0.0008437080396729478,0.00038365824652967834
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,24.637091060755697,33.634405743157906,14.990815642283998
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,2156004.015670871,2493635.606416491,1917903.2704896894
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.0020163709146949513,0.0023314474432411855,0.0017881649581014134
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,81.1355038040363,93.8413749509321,72.1752125541239
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,382078.63316189806,503384.61400565587,293549.8302869571
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.0003575396805399049,0.00046778978945710605,0.0002694769041850653
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,14.378517929013247,18.943547399581508,11.046970784287023
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2016,3015405.8826385536,3560827.876103361,2407409.507682236
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.0028197169160645913,0.0033547793685508314,0.002270533101298527
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2016,113.47681807791342,134.00233097302666,90.59648398087357
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,2101296.0284988927,2373922.4041001583,1730777.3240448292
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.001965714940533358,0.002245026360825255,0.0016191816901782964
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,79.07671352858212,89.33628548387568,65.13322291530287
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,72532.82494086205,115041.1136519604,50712.25953175618
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,6.766196336002084e-05,0.00010355544428761185,4.722998445060619e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,2.729580859373128,4.3292677780216575,1.9084216431154346
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,64596.12700398637,68598.85197967588,60341.09665145489
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.0001375317033547396,0.00015136156162990695,0.0001244594589649959
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,4.376145580497444,4.647315200484551,4.087883216548528
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,484256.24941722,501092.8081500506,463294.72010680486
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.0010316088059156576,0.0011444931706424003,0.0009260302727139443
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,32.80654652228072,33.947160294448736,31.386481448618007
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,315357.03777325863,325299.0921619936,302267.36342491605
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.0006718044976518243,0.000742030205139178,0.0006056104391518138
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,21.364257752559116,22.03779468723699,20.47748135888903
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,69467.4710028136,72104.00866985816,65644.80945127284
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,0.00014800453847955207,0.00016490088608816676,0.00013247594022524798
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,4.706160884824196,4.884776433380845,4.44718988717475
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,520012.13862748136,622737.8738091416,473279.1330964726
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.00048323778441464817,0.0005774604337650331,0.0004336031729248953
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,19.911665662185463,23.845113252924694,18.122222854218414
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,1587965.4943107378,2086944.4752249422,1227770.9109172598
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.001475500062839862,0.0019099656953933102,0.0011590018026875464
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,60.804422929929444,79.91071276894245,47.01229466001817
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,336127.8667642562,397334.49562995136,280557.7390869582
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.00031227765873158774,0.0003651792620696479,0.0002592894657395059
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,12.870595137295485,15.214244140374333,10.74277210986426
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,91462.3687278248,110062.72343180058,71584.78878982036
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,8.49871682231268e-05,0.00010429915276773154,6.628676067944219e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,3.5021646063623826,4.214386526875937,2.741036747032847
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,648871.6163675442,887314.6869198072,393814.4786317717
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.000603154050418213,0.0008328874878219361,0.00037340410979858963
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,24.845794401826314,33.975963387559794,15.079459975954714
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,2105138.273154663,2413527.8846055465,1849909.1081271654
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.001955744556844656,0.002251617485177613,0.0017260090442580353
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,80.60736731715762,92.41584327525477,70.83444583367114
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,360423.2661839282,473160.6888166133,272831.58793789
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.00033503039604781433,0.0004353306921843754,0.0002561253745897676
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,13.800884710247793,18.11768753143464,10.446931826324338
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2015,2995693.156860735,3605239.833088048,2390203.71046435
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.0027826933967877,0.0033083552662678834,0.0022492993440256974
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2015,114.70740033751132,138.04741246601506,91.52274266692689
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,2055517.2681695342,2309597.1356388386,1694977.7396235764
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.0019102320756437935,0.002191675572949728,0.0015809134867248579
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,78.70734078375153,88.43625477774843,64.90200429803564
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,69840.97330431367,110292.56189732999,48980.113595813484
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,6.471800603010232e-05,9.967851539488017e-05,4.5030260720605e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,2.674264707796233,4.223187218902107,1.875486308050121
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2015,47469117.81199709,48731978.10198525,45361242.71193439
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.16490917192853446,0.1810382820908541,0.14771604148551126
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,5630.243015542474,5780.029037593115,5380.231016019617
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,1177787.2837118625,1202877.4390493466,1135705.4897155657
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.004092554774869004,0.00452713213904718,0.0036460988572740013
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,139.69563652260516,142.67154335127688,134.70437614849163
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,3017793.573247008,3106954.9798000194,2869963.899096246
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.010485975266201512,0.011614431974663542,0.009330972281550474
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,357.9361060682859,368.51141080618385,340.4022434489371
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2015,1272959.7494355275,1316743.8675568749,1217052.060769098
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.004423526024923506,0.0049023286386602445,0.003927296564474368
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,150.98390424510316,156.17707480750403,144.35277461518334
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,606973.1798907825,626579.8141108968,587091.6613176806
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.002108538583482673,0.0023079928854256512,0.001906263402245923
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,71.99220596928798,74.31772033450741,69.63408797080486
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,10153850.764443818,10388217.228040323,9720822.49604889
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.035282964461855804,0.03917596898570516,0.03137599563149169
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,1204.3334694735358,1232.131334813434,1152.9726164381175
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2015,4078833.43260654,4276803.508935574,3847854.835043931
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.01416394707696964,0.015440196811194292,0.012871448805230296
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,483.7845004081822,507.26544319613186,456.38846493060663
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,858404.6074790814,883093.1754509575,829193.361165595
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.0029821899023157613,0.003284101464910344,0.0026825848741651127
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,101.81412186571353,104.74239700109578,98.34941843087888
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,666574.1163651677,701203.0615481439,622189.5058971595
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0023144173980686644,0.002525221048283709,0.0021071026238704445
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,79.06138634954554,83.1686751667557,73.79699226337762
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,2228964.188063419,2342834.654767189,2084565.462075524
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.007739203233645997,0.0084177659934307,0.007060933109583819
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,264.37420011556804,277.8802105363774,247.24727726719124
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,5707044.920586275,5912569.700263205,5395456.582461238
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.019825576074546016,0.021876097009951617,0.017690719208602344
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,676.9042966161296,701.2812917791721,639.9472570646255
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2018,6461177.5323181655,6818400.648289669,6031254.724659449
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.013374853984265566,0.014657895160312738,0.012038934270052362
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,425.41499535896,448.9351771621997,397.1081413358321
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,1262140.803359103,1307695.890472535,1207371.049539941
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.0026140869011814206,0.0028956493913324033,0.0023317321698211805
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,83.1015122735257,86.10093723530737,79.49537787306292
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,1140570.0540837562,1209231.8145848848,1057179.413845527
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.00236078878274654,0.002590886032500481,0.002126175132337802
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,75.09708591624525,79.61789383071914,69.60650333242332
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,3769122.915149851,3990917.8213567478,3487807.2858428257
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.007800319609817866,0.008521043869560185,0.007037457452199596
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,248.16550844417603,262.76886495662194,229.64320557640238
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,9561946.571174193,9978739.312235586,8951433.070716262
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.019802707215792425,0.022006931808264234,0.01748875786949014
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,629.57493983906,657.0172877883917,589.3776852883542
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,1190630.861234112,1227535.4100057757,1139208.64353298
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.002465982457877274,0.002749481492797812,0.0021990084931062144
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,78.39317520260359,80.82303390341993,75.00744831377358
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,224614.24723539982,236216.37286862993,214458.5020226156
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.0004652540556905963,0.0005202585821888872,0.0004150645818614349
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,14.788986754697744,15.552890578377962,14.12031509524353
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,766989.5349820724,796760.042585948,738970.1749619937
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0015886031788391187,0.0017731917701708925,0.0014170151051109737
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,50.49990467414108,52.46004588536585,48.65506201917902
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,1160098.9193961315,1227142.5776716655,1064457.735321701
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.002403371954506352,0.0027421396331771247,0.0020769219619365125
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,76.38289985722963,80.79716914970336,70.08572048464055
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,5396168.487421501,5608157.343871545,5053174.1465472635
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.011179720151565029,0.012595140445133612,0.009797007689211504
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,355.2929757076273,369.2506851083918,332.7096408276752
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,1070706.0414917672,1124184.843521385,1016060.9468434374
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.0022163441769599405,0.00241248918319744,0.002024015994834664
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,70.49711966490531,74.01825558841696,66.89919303776476
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,418243.3539914972,454922.44405678764,384479.6665659746
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.0008656538882761584,0.0009659130585509598,0.0007676427318816088
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,27.537858789243288,29.952872902668773,25.314799779088368
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,1911430.2476648986,1988249.7891426673,1790479.7023950692
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.003959697768290488,0.004435859221662458,0.003469054815598175
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,125.85184138216864,130.90977156869897,117.88825031888979
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,151571.8892159101,163006.18462281805,141924.11578821065
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.000313482968062332,0.00033471641413119503,0.00029183752523415476
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,9.979752796577399,10.732606390698875,9.344526869501445
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,1969489.9074324062,2039299.5600999258,1868895.0040327464
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.004079220039028153,0.004536691243873857,0.003623368713571244
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,129.6745888251841,134.2709759259899,123.05124808754809
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,2049051.6652557077,2151250.9448268507,1898288.4065858435
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.004242755714189639,0.004717693028568962,0.0037727858912809326
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,134.91307123274095,141.6420468454646,124.98656005632841
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,609000.9646083534,725048.6175758854,554429.4305404939
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.0005812254092183405,0.0007009214436114503,0.0005140527837296891
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,21.812735914063655,25.969242971906443,19.85813398364954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,1737964.405970823,2247485.49776145,1352832.625440183
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.0016580073654327808,0.0021192168998188654,0.0013202222990854372
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,62.249094531178194,80.49873560526373,48.45473572218929
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,384169.86593790096,454496.08441175346,320775.81788630993
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0003664481607063796,0.00043292749807026136,0.00030543384638198666
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,13.759905679679315,16.278796979615787,11.489305616570912
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,106835.79048311814,129403.34668596243,85377.77000342406
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.0001019268716421408,0.00012437918110516993,8.094095107148355e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,3.826563535046532,4.634871193467084,3.0579963879269205
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,659456.2233086491,907526.0544915685,394157.379817659
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0006293026725677309,0.0008573017860760837,0.00038929078881237066
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,23.619904206831606,32.50508178503007,14.117630897466645
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,2270168.4005704094,2661836.038550416,1995435.3048851208
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.0021654589898266077,0.00250466590138221,0.0019116438822118866
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,81.31117466117614,95.33962986869331,71.47099244259755
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,453353.3588696931,605038.1487274858,346624.7760696746
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.0004327170190013542,0.0005841195595068399,0.0003266423305547131
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,16.237867700485246,21.670798772238257,12.415144049142212
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2019,3041639.609665949,3601282.501789526,2351350.591209515
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.0029010134309890457,0.003474818297917199,0.002316706074831012
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2019,108.94314690300412,128.9880127102773,84.2188969608852
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,2215100.1603538035,2506219.3442748813,1830914.0426881993
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0021134497412397773,0.002391463712763953,0.001746349632601131
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,79.3387820856251,89.76586881852032,65.5782943138553
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,81305.42286981086,126950.44698662852,57079.212741525545
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,7.737439719702827e-05,0.00011684960240595068,5.5424594731556e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,2.912136138537952,4.547015087361134,2.0444200683889635
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,254508.78984243225,328478.61539445876,185092.6359097791
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.000413037663772129,0.0005331562492314488,0.0003025208087031579
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,20.183321345434198,26.04935355558527,14.678409148671753
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,346893.4650690694,534663.2510023622,260657.15955887694
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0005630126707657544,0.0008762855105418705,0.00043993052549173124
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,27.509707159642062,42.40042245007013,20.67090576958858
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,415204.27478075883,575444.0679981947,326609.3960369171
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0006742618216218153,0.0009387923213428932,0.000549678118205053
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,32.926962196811544,45.634465308337674,25.901118773667804
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,56735.59700959204,81310.45492823792,36051.0567200184
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,9.20214715658089e-05,0.00012948678420842365,6.123916932587774e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,4.499305453766847,6.448166452624666,2.858958478695717
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2012,99446108.3057608,106531289.66870438,93028547.88764197
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2012,0.11783053591326867,0.12891215874681003,0.1058253814137306
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2012,3415.0442279241097,3658.353977591956,3194.661016990745
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2012,7336385.071403248,8223605.244598797,6568631.799641734
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2012,0.008691041655141733,0.009913789197192309,0.007558912602854749
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2012,251.93624887654775,282.4039683578719,225.5711007187378
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2012,13661536.452846484,15278043.928993814,11194249.43400181
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2012,0.01618501348466192,0.018450118472224806,0.01343753968566101
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2012,469.14607321205347,524.6579943909068,384.4178275734103
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2012,6211418.6819271175,6758824.153540149,5715761.063956797
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.007359638019755278,0.0081448061795426,0.0065538775172556095
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,213.30416924627275,232.1024302140968,196.28296332766894
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,978369.793922177,1055727.1517201085,910970.7900619293
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.0011592852050672602,0.0012791321260301855,0.0010419246153177703
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,33.597856913981225,36.25435904097281,31.283331157044813
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,20711771.82764396,22639110.37869979,18883098.40585474
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.024540426354660045,0.027275377116930788,0.021559975948943173
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,711.2557548516895,777.4418178980354,648.4579167036303
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2012,6248387.191464662,6660334.549354836,5857782.477273451
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.007404029384077906,0.008118150156557096,0.006641577463626848
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,214.57369197835362,228.72023296159665,201.160071301542
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,272110.93909870484,338605.77560204244,186829.9566914391
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.0002527416043766921,0.00031394389620742653,0.00017557386633369347
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,10.419337626728197,12.965476176898914,7.153863067772487
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,585291.7915631587,858051.5216576754,468628.49695009436
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0005434558017213155,0.000789073248247573,0.00043467444233347206
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,22.41127389677298,32.85545423087977,17.94414641102697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,861172.2124717598,1081104.613414663,734719.5832601401
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0008000448791106593,0.0010138033563199106,0.0006777480188502057
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,32.97494788787228,41.39632906450274,28.13297923381017
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2012,101413.91782963276,140734.9262380005,66708.9488642314
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2012,0.0005317276851681483,0.0007462030874787642,0.00035878172827845796
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2012,39.15931337172877,54.3424728759535,25.75856143987536
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2012,15168.00448279795,19827.30409534085,11868.268236791837
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2012,7.950936553369542e-05,0.00010348640491949961,6.443028423202385e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2012,5.856875007664052,7.65598678171908,4.582736226057399
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2012,6535.4544291490065,10491.92599158344,3514.680596487995
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2012,3.423662171303273e-05,5.453158512240079e-05,1.8846253375193496e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2012,2.5235580430649613,4.051284346075734,1.3571360009049203
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2012,53636.58121684694,75042.15261297666,33897.0043398471
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2012,0.0002812020393001375,0.0003996407852955048,0.00018492441735557842
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2012,20.710882066376197,28.97629076116809,13.088769704537205
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2012,190616.57679526132,229931.9143283115,147866.32913449383
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2012,0.0009989409346518297,0.0011849031440948551,0.0008046468769171653
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2012,73.6034503381621,88.78442012732216,57.09614660023433
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2012,10258.055513941203,15656.468261168153,5866.086756190441
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2012,5.375354140503463e-05,8.188006436798498e-05,3.116295433702095e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2012,3.960979114620492,6.045487247258922,2.2650927453301524
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2012,280249.0047896365,353032.8298080416,196180.9094600326
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2012,0.001468595521205319,0.0018189804599067683,0.0010193177777119145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2012,108.21353553373748,136.3178103047491,75.75202571309619
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2012,162657.72910398562,204874.8439638652,126208.65486929921
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2012,0.0008526617999780844,0.0010469411870545696,0.0006793985208739915
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2012,62.80760198040168,79.10904527170146,48.733392536454645
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,272289.4797182012,342134.8084209135,187084.49164320275
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.0002545488264046719,0.0003196326636096616,0.0001766911980988059
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,10.246893770557666,12.875337823288127,7.040429597098895
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,593120.6430419777,860378.7345479904,473473.5508385219
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0005545284387830821,0.000812133402765806,0.00044021882234433405
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,22.320525305149115,32.37807609931973,17.817923717185625
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,880415.7576788302,1102247.1007836873,748402.8184564034
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0008234213961658399,0.0010492721498744826,0.000688007559884815
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,33.13211642328823,41.48015179405637,28.164158917360126
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,273456.6801298755,343211.92565775925,189138.97798460553
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.00025684232875093703,0.00032145358578299213,0.0001792377678071756
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,10.11792175070099,12.698872106775147,6.998159190504705
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,598656.4093581851,868142.0547922386,473730.4299952104
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0005624042369390258,0.0008147758675989549,0.00044591358490811536
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,22.15034097014905,32.12133408007754,17.5280685018958
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,905279.4711889602,1136329.7987419502,769636.8714990516
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0008507166212781013,0.001086230375223421,0.0007195389383263227
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,33.49542182570062,42.044304718393846,28.47663344184275
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2017,36151121.8259667,37177777.24071002,34610294.77825989
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.11946521049070417,0.13221426720373103,0.1067024506210408
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,3624.3234021258445,3727.2505329486726,3469.8480983021836
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,109191.8839799493,136587.28669022257,82681.70422715711
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,0.00010139220704508665,0.00012831469290624362,7.669970562631984e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,4.181041412939809,5.2300325016625635,3.1659461936718993
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,253010.78029209026,325410.3851471298,183136.31369886908
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.0004153319250737327,0.0005351016760896431,0.0003013694751542261
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,19.59095863169349,25.196955585770237,14.18048646580753
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,344904.52751450014,532528.1815591448,258098.16678989647
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.0005663062743632298,0.0008729798791429803,0.00044260302626819386
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,26.70641275687809,41.23435990787434,19.98488168235125
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,424823.29698513023,584695.4625279261,333220.4880536654
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0006979415982302842,0.0009752793871267962,0.0005648949132018111
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,32.89462855063778,45.27374132161278,25.801702161289928
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,57367.36343026174,84260.11454561992,35954.49094592969
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,9.409761094972869e-05,0.00013378135244410046,6.10491657805435e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,4.4420306615951715,6.52437187245259,2.7840036852664016
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,311195.9348748492,363867.40595807415,261212.76876901253
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.0004915581338411768,0.0005618475710038784,0.0004159170377689993
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,22.99387184802296,26.885699858634982,19.300679273196256
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,245305.3387192891,301263.43251227716,196275.98308460112
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.0003876245072612425,0.00047304007254841463,0.00030889187937633146
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,18.125299497937206,22.259971880637437,14.502582765764778
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,85668.21010237721,106300.66086898292,68309.09756496667
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.00013533930343402546,0.00016753124533076187,0.00010732703832151246
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,6.329915091390131,7.854420638124762,5.047272343369822
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,123189.06673771271,149169.40629135957,89730.74376705573
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.00019470983303306605,0.00024334263147475689,0.00013967222431773783
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,9.102283469042336,11.021937716791191,6.630090537131302
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,461452.47823108017,525411.4192148519,402938.0464339772
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.0007289310647074678,0.0008247649963118785,0.0006441550154264325
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,34.09613673991348,38.82198154604041,29.772579793247203
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,271813.4793443924,343198.4123062471,186780.28759632134
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.00025912171368485564,0.0003242916554222875,0.0001767280012592983
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,9.735609608820479,12.292421143497513,6.689955064211625
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,598301.5834634698,874453.4993472033,468368.38928487623
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0005705284334297587,0.0008362976342548941,0.0004502088810036176
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,21.42951357301637,31.320514020295448,16.775664702824404
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,938753.2487618745,1188854.860051873,786233.7843519954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0008954960949852419,0.0011514793925419633,0.000742425025238317
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,33.62355380977207,42.58150415104763,28.160726996243774
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,2230102.63729171,2459906.3649959667,1899666.2883026288
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.002570662504719517,0.0029174616581597377,0.002174272861722882
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,73.70995277071123,81.30548744806804,62.78828160167008
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,318605.9108680136,443632.33996880613,251447.97019017301
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,0.00036667235757020854,0.0005183846516844078,0.00029791702141755195
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,10.530648343194978,14.663055538274508,8.310926007207115
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2015,78086507.16484275,80379841.70164394,74028097.14297627
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.1638581778265083,0.18149050947314593,0.14545320734931994
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,5209.074843210827,5362.060956643961,4938.342263205541
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,2144021.0679808524,2191847.923360131,2056132.7999883676
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.0045002771536387185,0.005010149908294886,0.0039706711137240825
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,143.0255573470119,146.21604028998894,137.162616585088
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,4872946.51958809,5051132.992148114,4588478.223091906
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.010227667664791957,0.011419799857988569,0.008943921041091443
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,325.0695164775743,336.95616252326676,306.0929134667476
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2015,2892067.7166273724,2993167.098997427,2748625.476925954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.006070599180664101,0.006772197217369257,0.005320296519285774
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,192.92702074307405,199.6712620786006,183.35812863338987
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2012,822.002494425008,1180.3768788751688,562.8000665535938
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2012,4.303724804038981e-06,6.115298516774988e-06,2.9622110487274756e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2012,0.3174027190785256,0.4557830826954774,0.21731597243709197
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2018,36502080.99907335,37569991.263820395,34898071.883363426
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.11937718546200796,0.13189240645770914,0.10644522289566652
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,3628.46942291936,3734.6244594542554,3469.0237729416185
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,116934.88935971564,147863.1963530003,85101.23210840236
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.00010979783316916945,0.0001380630805993267,8.106110638032618e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,4.326601419671151,5.4709515591195235,3.1487532392776454
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,3617801.094859765,3932888.0518910424,3296580.870322991
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.004214638636333406,0.0047675682728761,0.003673796572571086
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,120.73877973789106,131.2543425634244,110.0185281483809
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,779789.0041069882,882762.7270551474,644548.050112803
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0009082354573175707,0.0010732366861790315,0.0007421982515778563
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,26.024308783220278,29.46090502713577,21.51084125758809
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,2118478.4669628483,2367266.931314601,1792719.8697166978
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0024675798427812685,0.002805878453747878,0.0020707517613923142
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,70.70109668702148,79.00404502803812,59.82938359684891
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,9526761.237642607,10407101.453126773,8654971.847113803
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.01109320248991088,0.012445273648664944,0.009969787835090574
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,317.9416160610661,347.32167333474274,288.84692996833394
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,1239767.0038218172,1339609.7486571353,1146205.0219085654
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.0014438052945681575,0.001598390261472924,0.0013016587364792398
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,41.375396622392124,44.70750108613,38.25290336478465
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,1317858.3722455571,1459553.4943390475,1189422.735026829
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0015345380681396723,0.001717574677209345,0.0013747617198070195
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,43.98158095489759,48.710446828891286,39.69523084718143
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,425461.02031050134,458290.46811506327,394588.8848835458
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0004956006004397914,0.000549352066049712,0.00044241790475708454
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,14.199134521606194,15.294768959061416,13.168822500127293
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,1337161.150523922,1589038.8414532132,1023726.1114042073
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.0015574295517018467,0.0018399207688662015,0.0011865902226197698
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,44.62578273210198,53.03182945733775,34.16535023232153
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2012,61278.63081016501,86374.00917759712,43454.85163202095
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2012,0.00032110900972489367,0.0004472280190562862,0.00023258846297251356
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2012,23.661733598704927,33.351900458477246,16.77937495166042
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2012,78798.90713898877,120407.58618709134,58452.92869109244
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2012,0.00041269247027806317,0.0006376733503784832,0.00031873104229329554
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2012,30.426899621304052,46.49340544908938,22.570635284548434
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2012,72709.93957644759,102900.0298895506,52456.44245447937
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2012,0.00038092153268778727,0.0005365706599850533,0.00028652655042920693
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2012,28.07574512501094,39.7331510569821,20.25519092844668
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2012,3840.7768717277745,7005.3134852874,2288.2805467652543
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2012,2.011794891786911e-05,3.655500338417568e-05,1.2167460484996775e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2012,1.4830527044970232,2.7049863757202224,0.8835818291109196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,113813.38036969819,144220.8074905087,84162.64183400114
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00010636544693207818,0.0001342513713731377,8.043737128410073e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,4.283065285971869,5.427368311800796,3.1672382319545616
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,3863369.9422174226,4177857.3099230076,3514919.219867374
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.004499589180237052,0.005046455614448449,0.003976070729119867
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,128.9342781067014,139.42983052214603,117.30524878413651
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,346015.51489351457,405104.5163414511,262291.6578709517
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.00040309657445546207,0.0004811522768603256,0.0003071793858533871
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,11.547757862636283,13.519766202423362,8.753597524132166
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,539676.4164604645,601212.3462253596,439814.3378227776
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.0006287001548521883,0.000731094782319509,0.0005080175015824612
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,18.010905041002555,20.064576007161072,14.678155340104203
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,1539964.84017351,1691771.354403203,1368586.1973108905
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.0017941638108963044,0.002075632525517564,0.0015449084681854433
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,51.394056988368824,56.46037567305215,45.67454735535772
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,191408.07205597326,201252.99739544268,181918.7876438881
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.00022293902836317096,0.00024252641674855018,0.00020337758670137675
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,6.38796231358769,6.716522187646853,6.071271431347432
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,1210214.5232692345,1292526.1718222671,1135470.8591242891
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.0014094637779613784,0.001549954269355947,0.0012878765515641501
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,40.389126137478996,43.1361560995816,37.89466650153564
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,1328468.6154144148,1513995.914939411,1193748.7364747785
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.0015468129581730635,0.0017957891388574272,0.0013801472256104153
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,44.33568218361086,50.52738238087738,39.83960476997997
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,3972828.1122029857,4740538.770211899,3242665.1586145456
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.0046276729317187805,0.005617266480209989,0.0037870449221245614
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,132.5872832139135,158.20849499680222,108.21917072941535
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,439924.65001504106,484687.63818187616,372342.93405320786
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.0005120813326487033,0.0005636656515497559,0.0004343903232335652
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,14.681836846946311,16.175735606710717,12.426396676557179
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,175380.28143363923,189203.1195615824,160493.63328380304
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,0.00020430215302409235,0.00022833225346796375,0.0001823965863992094
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,5.853058422828039,6.314375273678011,5.356238480307626
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,277493.08905276435,364411.09149011923,222411.5135053607
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.00032327224254322204,0.00042644681925282967,0.0002588064140756182
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,9.260922886427329,12.161683120717672,7.422656480050518
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,2551428.6059531113,2795363.0205657138,2262049.953999878
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.0029714084891687086,0.0033463534973455908,0.0026150460227428816
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,85.1501695073338,93.29112109205433,75.49258347567729
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,608408.0014635096,701732.6534469521,493396.0198503255
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.0007089210493289345,0.0008509773412475425,0.0005674216767429589
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,20.304720396000814,23.419293116970405,16.466365010752384
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2015,5045263.635551451,5611305.665651499,4118386.4514719755
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.005876680677961646,0.006750822503455545,0.0047247568537570565
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2015,168.37823828345358,187.26905682285368,137.44507826764962
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2017,4392026.094558896,5167253.269828774,3639793.6457903665
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.023760977241888543,0.02639208383488606,0.020638382286712078
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,1467.1306134491845,1726.0907144889272,1215.8517662252573
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,248256.98588199177,303772.62351185235,188051.49092157907
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.0013430332642549226,0.0015822539793604075,0.0010696226299503077
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,82.92879326043067,101.47346711672294,62.817500009302314
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,411432.72198889614,485706.92692272586,304511.45503243693
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.0022275744568584256,0.0025599025310909787,0.0016794494801851503
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,137.43669295417962,162.24755643766812,101.72026946231323
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2015,4173010.9568306915,4828464.7717412785,3487525.9742617365
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.02233810848712368,0.024668239552563344,0.019640728867807676
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,1472.717407769873,1704.0367724190173,1230.7995990131858
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,234044.17084676508,282601.27849603945,177404.9462518696
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.001252690389095803,0.0014683568040778135,0.0009935953231761557
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,82.59765626277539,99.73417913458525,62.60883454953443
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,393489.9818540518,462653.9083470503,290455.6506850957
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.002107366452864507,0.0024025917156166544,0.0015719049813696752
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,138.86844584267024,163.2774204630761,102.50610347640671
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,137658.02931778002,179857.27912758803,75671.94035609424
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.00021740372220958987,0.00027374121197737135,0.00012265726284686442
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,10.171376712415546,13.289425611735707,5.591303433121727
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,42003.265935957665,56755.6235751839,18610.226411658114
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,6.641732028640331e-05,8.941320803429844e-05,2.9731962212901035e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,3.1035679001342156,4.1936008440060215,1.3750859610182649
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,409097.273522514,487108.933079627,314374.777915503
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.0006460247433832146,0.0007461534768781314,0.00048183014776799173
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,30.227677249496566,35.991859558719995,23.228752517435233
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,52380.871267623894,61284.86204554768,43516.38715050056
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,8.268251767866726e-05,9.477478066227018e-05,7.030941510410348e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,3.870355959822902,4.528260514282767,3.2153705022849035
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,297303.2307537396,372745.7549058293,220186.95764092443
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.00046919762114314975,0.0005695704842015522,0.0003563855150252821
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,21.967357609295014,27.54170977087503,16.26933426568571
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,319495.08708015364,382212.1008404043,275669.1905565077
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.0005044967124759606,0.0005934391339381538,0.0004464912517589555
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,23.607085649587408,28.241166032654952,20.368845893355722
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,759258.8181810244,953404.1482299824,543370.0294438686
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0011987831623350598,0.0014402847145885264,0.0008508800647938715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,56.1006684478603,70.44581997059207,40.148920416050615
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,109021.55482815536,141640.81585479394,86587.74888498615
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.0001721250665741561,0.0002206974796651564,0.00013802596091226443
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,8.055464032327308,10.465659744316197,6.397858642565058
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,50610.390798096036,69410.56019660083,34393.986284221115
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,7.994116439171747e-05,0.00010832676752491158,5.531597492076651e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,3.739537409631611,5.128658016377946,2.5413279041710157
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,349548.26207206293,472049.64369499066,178646.51526133326
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.0005524120201774401,0.0007462688368905777,0.0002849223945787474
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,25.827676528025712,34.87914781853651,13.19996380951109
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,1244382.1607905962,1506410.4801910152,996845.6402279197
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.001963859634054745,0.002374076648973316,0.0016168982477947316
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,91.9458152520278,111.3067545241589,73.65565656530595
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,149498.53387610076,190177.20948220856,94726.55469829077
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.00023624366566870383,0.00029977737374820414,0.00015213562384416962
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,11.046256535442303,14.05195214072169,6.999224653153634
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2020,1336289.0814477252,1651302.5598287387,898468.2459537747
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.0021099732853102414,0.0025606104430403167,0.0014483731880307548
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2020,98.73670073189845,122.01264601442918,66.38667601904066
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,790853.6445374399,975001.1804525361,595355.2602487397
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.001248147474267386,0.0014716539971763335,0.0009679136976313421
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,58.43516998494529,72.04159721434925,43.990043005257384
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,14396.84415494161,24267.114100368377,9900.968522056648
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,2.2726568506942527e-05,3.951642697884133e-05,1.634559809206512e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,1.063764504661081,1.7930661978911315,0.7315699720146945
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,319925.2183751098,376759.22974657075,267499.36161958077
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0004863544443539397,0.0005591660064896584,0.00041251699025510256
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,23.127800751887612,27.23640368605361,19.33786891892023
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,251322.61656884765,308556.90433896903,198472.9374147461
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.00038222930963519253,0.00046731749065764784,0.00030792727826404825
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,18.16843145397875,22.305970877868535,14.347860961020244
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,87828.83172580654,109971.858114268,69383.1905758499
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0001335329710722058,0.00016645124700826787,0.00010497854083496897
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,6.349257900775592,7.950005428454606,5.015799052411772
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,126494.48062002455,153756.26674243974,91527.20485387002
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0001924055135489732,0.0002391884106619086,0.0001383725775424024
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,9.144446814327942,11.115235990567646,6.616617995882873
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,477095.2231639847,546880.1878746038,410741.0065391812
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.0007252686795576798,0.0008218440778440742,0.0006357027711148827
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,34.48982020565987,39.5346640210428,29.69298953085289
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,300602.108305834,350450.03395035025,253249.92450512966
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0004981752568325541,0.000566272519699067,0.0004258780892839403
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,22.72785567253454,26.496746270171794,19.147662555236792
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,238688.69433746813,292376.12489891343,191925.79200613353
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.0003956347087633823,0.0004820830786583409,0.00032081540179718153
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,18.046720384437183,22.10590739449071,14.511081526129226
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,82880.28928027695,103152.90125246883,66185.82908481278
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.00013734631550062974,0.00016818722779344186,0.00010945254864242422
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,6.266394016583435,7.799161040760463,5.004163076182485
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,119239.51752670627,144980.06501205344,86903.61675532258
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.0001977647287137874,0.0002487243397876953,0.00014248067924204591
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,9.015434256543552,10.961619702401382,6.570588843065318
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,441910.0395836344,499722.14611938875,390507.8403072244
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.000732651559871014,0.0008237188450286668,0.0006521889655094921
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,33.41183352474159,37.782878095503534,29.525427760692477
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2016,4292893.445629657,4996764.436704768,3564136.513264619
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.023087706279755066,0.02553455376289796,0.02017294007079032
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,1473.2267698802102,1714.779838859743,1223.1333922798526
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,241242.3175838555,294167.39622996235,182817.62514108914
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.0012972918994026668,0.0015308624971628842,0.001033006501364956
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,82.78906634738301,100.9517912430678,62.738994753752536
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,402646.90820317814,474900.2325522328,297559.19368059095
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.002166799596800342,0.0024740170253482246,0.001628447859103904
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,138.17957782723778,162.97533225068617,102.11578165316394
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,121005.3943607047,157948.96043177895,86284.06863771017
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.0001153050632628509,0.00014847877864778434,8.217886764471538e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,4.3340796891259625,5.65729639527738,3.0904575069034275
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,904628.7218436468,1076853.943777481,640333.923885158
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.0008569057116416495,0.0010213253826573281,0.0006190231615125054
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,32.92299760332965,39.190950888523396,23.304270284981513
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,808112.8727194705,868227.1018507723,753929.8910481808
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.0007652058773290036,0.0008346252943184534,0.0006986477302087775
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,29.410406202381598,31.598199463668227,27.438474367109368
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,198986.42098253302,255157.7840794684,123039.76936119104
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.000188395155043609,0.0002403971078424734,0.00012105131113261842
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,7.24189858547888,9.286195442256986,4.47790119192441
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,145612.70542247352,175111.90759772665,109474.7461006508
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.00013791514318622696,0.0001723927845499886,0.0001028339411290348
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,5.299419127294757,6.373011131467117,3.98421663657921
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,1177453.2937208917,1348676.7895978754,1041167.1721627295
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.0011149919530418551,0.001282751855180891,0.0009747853968965184
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,42.85215694699726,49.08365348062817,37.89216889324412
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,177281.45584303397,193928.61783328804,159892.93359547935
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.00016789411266124018,0.00018759705291599712,0.00014830116985980216
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,6.4519695261718475,7.0578252336828635,5.819132802709252
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,524099.24664166,588906.530412541,459162.2157220602
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.0004960117378204639,0.0005562145663359765,0.00043769530362307567
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,19.074033163488835,21.432625143542925,16.71071917432407
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,79670.6751046897,92693.74253311241,57763.0688651268
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,9.278150151509114e-05,0.00010969960235636637,6.635654105582785e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,2.658891365448893,3.0935170478796175,1.9277572939541356
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,412310.5276534459,517612.49091845565,346156.13207004976
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0004801170154879648,0.0006015703419809202,0.00040002910952471416
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,13.760256209965219,17.2745540431672,11.552450753665902
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,1099585.1213236817,1277419.9475927467,808021.508990919
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0012807878766154027,0.0015286394140598737,0.0009406288823801361
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,36.6970328897278,42.63200812900614,26.966527025531356
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,100767.72047718352,111517.42026659411,85891.9021591229
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,0.0001173736404877703,0.00013348270539607606,9.85361155022854e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,3.362974162584698,3.72172955048211,2.8665156497391133
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,3710672.202901258,4091808.1058446774,3367853.490993978
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.004278289119649428,0.004794917991343227,0.003727398153004678
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,122.6461366619448,135.2435431379531,111.31520030006996
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,797250.8676327446,918758.7464488745,656883.957785796
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.0009189541416422851,0.0010866582470142948,0.0007638853845264306
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,26.350950318136082,30.367061441919628,21.71150542336918
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,2207348.9573241146,2454204.7161580315,1874709.771932003
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.0025448417751547142,0.0029166871605141764,0.0021339136068858305
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,72.95789201452634,81.1170350156411,61.96341210363016
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,9876830.666086435,10851457.394684006,9007624.538346205
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.011384284413027513,0.01264639703161995,0.010121089665275196
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,326.4516662810053,358.66529131005035,297.7224313335267
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,1270328.5684358259,1385584.5449964157,1159906.3520647152
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.0014643392328415902,0.0016204168753845515,0.001312251037975917
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,41.98724185017935,45.796713417434425,38.337537026083794
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,1342130.525600722,1507048.0475511607,1206209.3368960842
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.0015469970266525981,0.001750724762059007,0.0013592179611030646
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,44.36045946939015,49.811357805079396,39.867955746725286
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,441613.37321672187,478027.8824022596,411155.3258747959
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.0005091842419319609,0.0005689414974570036,0.0004513978005286944
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,14.596324105625065,15.799906266979875,13.58961652476327
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,1376745.6737693953,1625948.1617556843,1051372.7766636992
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.0015872960975594978,0.0018972778958265555,0.0012162313729380788
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,45.50456866597971,53.74127639084053,34.75025607180419
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,4012094.476691845,4416055.455986502,3626144.62620743
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.004625361333237743,0.005135677803302254,0.004084602935680538
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,132.60882680616444,145.9606538508516,119.8523084399885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,353591.98550377315,413164.3764306825,268783.3467205522
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.0004077381651120335,0.00048389962898481213,0.0003094235744243726
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,11.687017501237944,13.656020204626282,8.883899539433651
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,553123.6816916026,624113.9229823536,452387.6226848443
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.0006378212676650502,0.0007402853467836593,0.0005234235470357832
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,18.281992842877774,20.62838141048082,14.952437499759975
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,1596454.2290646299,1785302.742303274,1413118.9794145483
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0018407923163202024,0.0021149995867276606,0.0015809229607677356
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,52.766434986984656,59.008306889591005,46.70678895682464
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,197806.7536515204,208280.8328838967,187521.40578300768
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.00022805131725470675,0.0002490264288380426,0.000207031342798333
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,6.537962076529341,6.884154163218561,6.198007989690047
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,1251463.1049096761,1343770.8055578335,1169104.9214873258
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.001442677839481536,0.0015841103614789495,0.0013038213270687624
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,41.36369547062856,44.41467444413961,38.64157061913948
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,1374448.1227507724,1574187.675037263,1226235.5055551655
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.001584141036667215,0.0018426554681582165,0.0013842613117870878
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,45.42862939115037,52.030474848523525,40.52986606482249
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,4030623.023858054,4818855.217338182,3327908.096512005
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.0046473596792449366,0.005634030482062548,0.0037877700648760765
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,133.22123733547983,159.27410000745667,109.99491436728911
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,453420.35479944886,499750.4235355434,383034.2274054708
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.0005223684314122318,0.0005771488826467933,0.00044131220332201734
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,14.986571639650847,16.517885544803015,12.660150407207471
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,177824.34043604217,193829.75000391435,163523.17849287367
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,0.000205038430535075,0.0002292535095486898,0.0001816777258934682
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,5.877497975134223,6.406513081253507,5.404812120335454
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,278416.14177706355,362125.6643756346,225566.70258036483
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0003211019507032789,0.00042499965749323674,0.0002579163746321908
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,9.20228527504611,11.96907495280404,7.455491382242113
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,2599341.3304998046,2863614.6336300094,2300701.4299981426
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.0029964325730484423,0.003346721150783642,0.002642581156432033
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,85.91412946750235,94.64896183196404,76.04340307431697
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,637065.1079764145,727831.7563533311,505555.424040616
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.0007346671541569034,0.0008797264873374352,0.000580768785620041
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,21.056447463707986,24.056491162657775,16.70975398435721
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2016,5064056.97760866,5582965.579407997,4061659.7803465948
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.005838065718757971,0.006681935388600608,0.004684066466589766
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2016,167.3785746027523,184.52968141342126,134.2470725668594
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,69314.36183812577,74142.07184352417,64417.36856588639
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.00014450288318930968,0.0001594880176678824,0.00013044078470315503
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,4.60146108997346,4.921950511709677,4.2763722714008345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,529688.2448119023,548508.6890631904,506268.655044297
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0011049247536207964,0.0012265362335476676,0.000989907185459249
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,35.16356183167886,36.412964403119496,33.60884318173383
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,318003.8799732956,328373.53536600457,303999.7059169917
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0006633487138875244,0.000735278929778195,0.0005967152346914963
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,21.110812266799833,21.79920590616446,20.181139680795393
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,67670.01867184267,70846.75871759816,63530.96940502155
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00014117960481674883,0.00015804914676766476,0.0001262507732041637
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,4.492300724104601,4.703189857696313,4.2175283155345165
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,133031.1218333413,172735.86682066816,73434.4665325575
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.00022036003628883734,0.00027681535672147676,0.0001273063847476941
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,10.058186730704499,13.060174037688538,5.552216403763468
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,40507.1508974433,54510.04917291177,18109.47147298025
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,6.71359329553665e-05,8.960586796358944e-05,3.049695995653542e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,3.062655430100991,4.12138337048601,1.3692167904724852
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,389115.5549465447,457080.78236894467,300198.89378933853
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.0006447834062040524,0.0007404850470766353,0.0004955698990783765
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,29.420160166559967,34.5588595865777,22.697369521297503
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,50717.38928864736,59384.21990428932,42563.827036833405
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,8.40046952384091e-05,9.565005697691354e-05,7.252266863491864e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,3.834628806619569,4.489908559914601,3.2181561307602378
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,290708.2601105265,355574.78161501524,224146.94355657726
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.00048125113679061267,0.0005673021496899837,0.00038234509090092684
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,21.979803853815625,26.884217023245036,16.947251006671536
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,309623.38936417573,367022.6865582244,269851.46990224475
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.0005132831278341134,0.0006052615153577269,0.00045512740017793034
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,23.40993463409246,27.749767610260335,20.40286841474719
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,743108.3002845655,924746.7588226991,542850.0761365476
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.0012311977710268746,0.0015002551390264508,0.0008955403139467169
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,56.18476295165181,69.91804211427248,41.04368479579417
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,105133.21951549301,137949.49643617755,83218.82528570728
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0001741698109625737,0.00022438097242472412,0.00014030652744285272
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,7.948888492511744,10.430054076368602,6.2919899697014685
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,48734.51917954535,65978.0275796619,33543.29585459146
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,8.07665509263138e-05,0.00010917515549264844,5.6026260481042154e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,3.6847084154718033,4.988451667356305,2.536133865663525
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,345023.7659291593,466932.1293246923,178630.41950128906
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0005717508668971544,0.0007770664185574622,0.00030361962500436346
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,26.086478234723998,35.30369798126553,13.505848032905503
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,1218349.4647495078,1467531.3744171015,986042.7204621073
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.0020174691903791053,0.0023921067500451343,0.0016888596081311561
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,92.11668856748047,110.95677758432005,74.55249320745084
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,143073.1510888168,180206.6939217996,90626.04890035228
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.00023714637794815244,0.0002999228717917425,0.00015368922321859951
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,10.817442189237786,13.625026629927259,6.852033644034454
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2019,1331855.0527553007,1631932.207521296,920884.6603694285
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.0022060849418488178,0.0026476459309836033,0.001551241616919783
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2019,100.69859318804666,123.38675829302174,69.62603745491145
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,780405.9957338757,950997.6939369924,597013.3293492096
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0012923853315230094,0.0015029874899467658,0.0010225093888680896
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,59.004758605932565,71.90281683161983,45.1388476963813
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,13998.805302610903,23865.009076001665,9844.337115987524
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,2.3194716329493076e-05,4.033626797480301e-05,1.684777011250593e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,1.058418479826332,1.804380165395419,0.7443083963213738
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,80481.03394695521,93890.7802106107,57474.52371017383
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,9.274985052662255e-05,0.00011001652611212679,6.640240874539307e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,2.6600808016497144,3.1033033454164176,1.8996634313391392
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,418398.6417209441,523617.13907325594,349411.5277010123
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0004821833383682931,0.0005993674607786068,0.0004029039425510389
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,13.829024550203442,17.306734652310112,11.548843884450667
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,1112960.9235025456,1293001.9979443406,814240.7261799739
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0012829101369836806,0.0015271723408003981,0.0009413037270825718
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,36.78588408228898,42.736650146585085,26.91250369696093
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,102113.99320202022,113614.10582270627,86753.63939326134
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00011772107338089405,0.00013437972442102497,9.872485224298274e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,3.3750991951161464,3.7552040135912508,2.867404645613248
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2014,18364248.56520778,20528614.175950706,16141030.403773464
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2014,0.028981267517952436,0.03186270588183618,0.026126428708561
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2014,1567.1145677101283,1751.810874036107,1377.396074431715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2014,962514.1726270636,1080243.8711500969,831381.0403787084
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2014,0.001519043807262695,0.0016828617824922185,0.0013375007473594262
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2014,82.13622115794223,92.18269406166381,70.94596520349012
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2012,434232.768212215,560356.008480067,350871.9779020167
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2012,0.0022762543593804778,0.0028451760628446857,0.0018714134684897795
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2012,167.671828587287,216.37223968277007,135.48343294561698
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2012,41952.237449225075,53247.68240289772,32832.26923832384
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2012,0.00021990701201919617,0.0002699487338242531,0.0001772419747361603
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2012,16.19916524356339,20.560715197259526,12.67763978873539
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2012,181158.30720458945,262230.91391791776,140537.9467129399
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2012,0.0009491243220519404,0.0013350882090219333,0.0007688814730085318
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2012,69.95129537973118,101.25614662789481,54.26641247798504
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2012,297969.88111690263,352672.9899759388,248250.78133847605
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2012,0.0015611208402476525,0.001766459620192642,0.0013496273362802683
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2012,115.05615994044692,136.17886408266725,95.85794878313403
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2012,568883.407903958,693108.2072363207,462804.67213016655
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2012,0.002980076537477907,0.0035312028275725537,0.0025551317496996253
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2012,219.66495446425625,267.6323138731312,178.70439850564446
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2014,1074912.0386560971,1214945.1817514673,830407.7789684338
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2014,0.001696480515189118,0.001866315530323963,0.0013269132995764365
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2014,91.72770172455465,103.67744079107703,70.86291186597862
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2014,1418685.407481247,1710639.6130837752,1213093.6459181085
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2014,0.0022389228881770683,0.0026631785745042163,0.0019658858407788555
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2014,121.06362866780783,145.97756332074928,103.5194398379321
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2014,214021.22337951366,240702.99683982064,186281.34265945217
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2014,0.00033777001154836154,0.00037324965957763153,0.00029923813883078027
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2014,18.263517604123876,20.54040880027151,15.89633274335537
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2014,1261481.0117044179,1384434.7019440215,1157630.9999681902
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2014,0.0019913686916554923,0.002184001935734204,0.0018406595423038946
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2014,107.64857942932849,118.14084206909965,98.78653066807178
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2014,1906404.5881396304,2136589.9938837746,1698851.798315318
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2014,0.0030088493431728505,0.0033136297443832298,0.0027292605988486433
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2014,162.68318256610527,182.32607191902648,144.97164923831218
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2014,2001436.0836221064,2314443.591404869,1706264.5741227483
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2014,0.003157503543955656,0.0036794940813849233,0.0027858919883419746
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2014,170.79270256269353,197.5032223809848,145.60421903357198
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2014,134330.24353083532,164164.5732577779,106440.4008442536
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2014,0.00021195597332339448,0.0002577054717808657,0.0001692844828444497
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2014,11.463081692329476,14.008996520640872,9.083099815581686
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2014,862261.4798470524,1056646.2149033018,523670.04710035643
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2014,0.0013610956944563966,0.0016614498704682653,0.0008505631160795099
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2014,73.58114988726837,90.16898624580305,44.68742385894248
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2014,1081628.4231456495,1175524.076365077,992424.140117835
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2014,0.0017074342628549976,0.0018392501906528283,0.0015730319082795214
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2014,92.30084491299205,100.31343772245764,84.68859054066381
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2012,30336.413254156316,39658.95198326591,22922.53715747572
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2012,0.00015896097936497414,0.00020482774909981054,0.00012158691550492278
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2012,11.713906124694216,15.313650847371843,8.851160028474949
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2012,121707.52592377152,154535.36684464954,75928.17710549277
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2012,0.0006378381026062653,0.0008082037015580747,0.0004020121122260105
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2012,46.99535575928776,59.67128562620692,29.318414519918367
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2012,174145.55580309403,209366.24777047615,142744.5717201565
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2012,0.0009129439532591951,0.0010830977870395805,0.0007696792046327746
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2012,67.24343697522185,80.84332684671683,55.11846436593843
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2012,47136.08647284094,56654.834725678695,38734.21663908643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2012,0.00024695053352631255,0.0002816855520659415,0.00021680205255211778
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2012,18.200823129698104,21.876330927016973,14.956579531090865
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2012,21215.809314487862,27699.79559008554,16427.390896017016
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2012,0.00011114079945294598,0.0001398827716493532,8.928374748747965e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2012,8.192135193677693,10.695819657290112,6.343166320205499
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2012,10636.478559742853,12881.581583789706,8310.138253439061
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2012,5.572988940996571e-05,6.572978632488535e-05,4.460818442852922e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2012,4.107100938476312,4.974010478626018,3.2088229603306457
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2012,11751.747549698097,16861.442077448686,8052.81884017849
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2012,6.16185015439573e-05,8.729367217492632e-05,4.286045895730874e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2012,4.537743682648729,6.510768032049487,3.1094633087547368
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2012,47208.85756424038,58429.34790998058,37139.800222199105
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2012,0.0002474515661127994,0.0002948203544072815,0.00020286885022230606
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2012,18.228922487591966,22.56152995446286,14.340921902925786
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2012,20791.97495788011,27552.320895306024,14101.137670552132
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2012,0.000108923953596323,0.00014322681518206227,7.601945085923195e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2012,8.028478540396735,10.638874733843089,5.444921966890942
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2012,5931.125664578815,8994.348530404877,1798.4103660466662
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2012,3.1085480016402804e-05,4.6634344894108784e-05,9.445572735810394e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2012,2.290206448157548,3.4730194850411102,0.6944265304225243
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2012,46674.84173500165,64227.32601300618,32574.918237573154
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2012,0.0002445569839663206,0.0003275188262171891,0.00017667813870831327
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2012,18.022721074115832,24.8003236656004,12.578267940170642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2012,9332.71452168655,12017.766396252919,6765.619220293811
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2012,4.888575667317378e-05,6.139038170552085e-05,3.701955465063733e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2012,3.6036739373145537,4.640462477050559,2.612432384737857
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2012,43108.21668887538,53107.46661231877,32992.46918162826
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2012,0.00022581779004389552,0.0002696448435654874,0.00018146545207548884
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2012,16.64552757987234,20.506573180064514,12.739498357226253
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2012,58282.768847037645,69484.59153318955,49642.05796218602
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2012,0.00030556481496463823,0.00035250108910997593,0.0002654668810415689
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2012,22.504930864492138,26.830330122200298,19.1684627293903
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,141720.45746483302,185280.77006315943,77052.80899730997
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0002153954018930265,0.00027509314806629297,0.0001212001805076989
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,10.245152036967488,13.394182412193498,5.570245518356063
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,43094.40342056031,58500.86006428467,19327.77542837341
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,6.554965704357565e-05,8.832686483579327e-05,2.9381438274576254e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,3.1153492084627894,4.229101545206915,1.3972294567930417
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,427246.89960115205,503427.7882205574,326380.53538249887
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0006493678651776636,0.0007524121853128317,0.00048600225056670484
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,30.886221523967052,36.39343480974671,23.59446382488777
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,53882.26211364047,63728.721508698036,44991.4097459434
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,8.185683192181602e-05,9.410136096559338e-05,6.945725415046213e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,3.895217227808925,4.607030295115911,3.2524862073569807
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,298320.006136829,377545.52654747356,216538.09215705586
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.00045300939422026693,0.0005545972796572125,0.0003430089077791315
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,21.56593249283926,27.293246081396774,15.653813963269295
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,326646.83276835136,394262.8833694288,278640.52094874275
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0004964373322465347,0.0005885958574459895,0.0004369527335859483
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,23.613714801450456,28.50176505855056,20.143277490393878
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,769953.6070542976,969433.1458354593,548624.3176253377
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.0011698267846313565,0.001408251799729161,0.0008468820424709913
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,55.66092508302994,70.08155453650377,39.66074937800619
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,112450.75407513772,147714.81717356294,88134.02963317806
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.00017084618884687612,0.0002178716448927634,0.00013673247772917884
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,8.129207968844629,10.678491920840287,6.371321045492444
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,52192.179060656854,71260.98412665748,35131.70775733559
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,7.93439789380858e-05,0.00010847805547602675,5.490082356258279e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,3.773038975334574,5.15154713540702,2.539715816127164
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,352830.1533267592,472978.63058213005,178640.03784752666
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.0005366992203512718,0.0007276851275576624,0.0002795224389541445
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,25.506540331032944,34.19222649456266,12.914115438074196
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,1255750.693027276,1532296.9292538997,1014663.0834021106
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0019073908467143641,0.002317215217029607,0.0015749642480582379
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,90.77981401368385,110.77169299908678,73.35128422325612
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,154510.71183428133,198446.53255982258,99330.0199981461
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.00023497400855649825,0.00029705879973111976,0.00015085911583526715
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,11.169775785370247,14.34595212048977,7.180693422250288
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,1,Number,2021,1333586.0942640326,1646513.5727243624,879098.8091045574
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.0020262911854604703,0.002474082021494904,0.0013810059960847616
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,487,Leukemia,3,Rate,2021,96.40663411992574,119.02855935726497,63.551170493703445
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,795709.1379636343,980153.1757697267,599271.2540826506
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.001208671268351854,0.001426985710204539,0.0009439838540255537
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,57.52282515503931,70.85651912864577,43.32208080110408
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,14674.940034457177,24600.960184078962,10197.058301616198
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,2.2301841996471917e-05,3.850566965740123e-05,1.617778050345859e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,1.0608700710954326,1.7784346864941136,0.7371583079726022
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,586861.0609152948,699282.5026403697,533910.9719446662
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0005557760941895511,0.0006696235303413046,0.0004942216622570261
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,21.358182462551937,25.449640943921256,19.43112044231971
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,1704147.0187145711,2206447.7932913145,1312540.654635965
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.0016134028398008683,0.002057349164654218,0.0012750528764861589
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,62.02061338326397,80.30131440261438,47.768517385546055
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,374487.71061882697,441143.50493417995,312210.94217883446
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.00035448561776577737,0.0004197078448634242,0.0002972729259806057
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,13.629080860988832,16.05494741099175,11.362584287771073
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,103305.27927249005,122990.9147015571,82224.14427164543
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,9.781197780188089e-05,0.0001194543703834725,7.756556224144065e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,3.759685470706655,4.476123178687375,2.992460044021344
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,659920.1340301259,899954.7388641912,396634.73102644645
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0006249073134976607,0.000855344277963815,0.00038396510829340506
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,24.017089515778103,32.75289297729364,14.43509805035569
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,2236489.275494163,2617094.205980611,1959128.919123331
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.002116949987871789,0.002458919506180681,0.0018706358845334756
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,81.39464211008436,95.24635266453495,71.3004077268942
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,430971.77992686094,572129.9935670928,323377.59605347284
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.0004082222387915695,0.000538568935814917,0.00030976171917982044
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,15.68475832683888,20.822060976147053,11.76898274702259
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2018,3043067.3837759364,3622532.355952353,2377355.31818932
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.0028802463898401397,0.00343018890855999,0.0023276188421252147
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2018,110.74919219748328,131.83820189783523,86.52131150942803
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,2186491.7313390123,2442767.876459143,1807132.372469495
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0020704020874394206,0.002355535490797262,0.0017136026265768484
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,79.57503480971293,88.90193180938493,65.76865550593881
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,78647.10028841041,124453.21045578018,55535.77076359393
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,7.426734531593408e-05,0.00011199836887126877,5.2736883135555196e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,2.8622773429381376,4.529341873218243,2.0211651516243605
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,3766082.903272725,4291124.1454407405,3373447.155900098
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.002695255981930606,0.0031162735239407017,0.0023955351143631113
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,83.58748641830313,95.24067590614753,74.87301144688666
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,923664.4494792216,1131256.8405585876,719719.7436869498
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.0006614306240990193,0.0008276567381517942,0.0005162906495355409
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,20.500554982159645,25.108028215106952,15.974041423288613
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2018,6364412.890961053,7314397.585956044,5021842.857098641
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.0045548173328499525,0.005303266611574549,0.0036384039057686924
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2018,141.25692124870278,162.34164902288015,111.45883731019605
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,3619709.2801066674,3987229.2262475947,3059524.0145097757
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.002591006897159583,0.002944808604035773,0.0021521777871090124
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,80.3387519765418,88.49578656540191,67.90554764130977
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,433795.8099532149,608554.8499590913,333200.65394796
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,0.00030986753080026195,0.00044595699409434575,0.0002460723406603045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,9.628014651847238,13.506757966359203,7.395324492788507
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,2686583.9740694957,2754488.8470668867,2590259.336745023
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.005638905348620503,0.0062701881861639865,0.005024924952013745
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,179.21940040109337,183.74926834505723,172.79367765735358
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,312575.57098060247,333979.07957692107,289913.33541607833
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.0006552379603270181,0.0007077131102006909,0.0005992757026370185
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,20.851611917537575,22.279419130762843,19.339836254158552
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,383640.7586835881,395350.97542133584,364087.3029477157
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,0.0008052549144882067,0.0008996767877090064,0.0007064209926396173
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,25.592301377628434,26.373478531427548,24.287909388926057
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,229364.24577079967,239460.89314141183,218569.40376185245
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.0004811585133163914,0.0005298583510382662,0.0004349854196020849
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,15.300665453693467,15.97420296649322,14.580552056553863
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,2360373.0387379793,2457086.8990078187,2216446.3182081953
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.004951944781647791,0.0054567210687590925,0.004420261743719981
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,157.45818660741568,163.90987403476996,147.85697525351495
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,1242306.6199295435,1289870.1640277312,1163920.207190156
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.002607349849222409,0.0029173624078112194,0.002281162455312299
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,82.87306471229712,86.04598241615578,77.64398346029141
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2016,106322879.33756244,116021976.39940208,97646540.43334106
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.12256230628977458,0.13568688840141716,0.10925363417681724
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,3514.2124328121786,3834.789600155004,3227.4397434486477
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,7307007.305655782,8389034.612012494,6346309.150921791
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.008421711368914606,0.009657212467014314,0.007155732807942881
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,241.51317270725147,277.27663054748376,209.75991865148782
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,13583548.795413725,15747665.979080066,11253393.372618027
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.01565618534968383,0.018363084347889115,0.013014415172256738
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,448.96711183864073,520.4960956310878,371.9501874645815
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2016,7060994.729543834,7950737.221763468,6214648.205304347
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.008139415486085771,0.00931504612904896,0.007088685337084823
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,233.38189880847054,262.78990720365766,205.4082256303116
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,1035081.4784656385,1134842.7991442843,938869.3017442562
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0011932270829500809,0.0013369954385156289,0.0010585316707551048
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,34.21179169771108,37.509129727182646,31.031760929838956
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,22558661.125327762,25498336.92991601,20038656.609003924
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.02600528843855501,0.029347997273367055,0.022320523762345758
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,745.6149409059154,842.777897038083,662.3230731801393
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2016,6912272.296437001,7510086.333693318,6363435.43012766
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.00796777603997916,0.008780294730607645,0.007127559530467677
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,228.4662849093887,248.22539541622373,210.32598104265008
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,253597.18978313546,323801.3855624978,179750.66258908354
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.0003999973882029794,0.0005057217636588096,0.0002786786702596247
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,18.73797382744492,23.925272567685116,13.281547851300829
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,345991.1175015717,536209.3686969428,256261.80209514117
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0005456252296049952,0.0008334952011969301,0.0004248342781490341
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,25.56484363969879,39.61982830040908,18.934858642317472
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,445432.4125286377,615488.3264453633,353373.4525362815
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0007028555225691284,0.0009707621972833469,0.0005760337374120057
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,32.91243445952537,45.477649661234764,26.110314986538675
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,59526.769842684844,90707.55826540713,33639.92125097664
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,9.38865146834612e-05,0.0001407861533793678,5.474728564859275e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,4.398357317359917,6.702266118099017,2.485610997886647
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,122239.69135857129,161366.44074862625,78308.69691624033
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.0006615697880451418,0.0008648717970843526,0.00043694307143897574
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,40.83345351543298,53.90351516784877,26.1585619191701
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,18121.37176657567,23839.63797824607,13914.202230733044
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,9.803773512508302e-05,0.00012725005751699925,7.95157498719744e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,6.053338186987024,7.963491550007125,4.64795782514165
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,8051.6694205103895,13137.414858892951,4371.646093458803
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,4.353300781045808e-05,7.06702891665091e-05,2.391052875951298e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,2.6896130491660535,4.388476549568357,1.4603227933515017
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,60191.4533415341,86007.27539170603,37149.69281978204
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0003256842889455504,0.00045932499162870926,0.000210512457290272
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,20.10660273051765,28.730227004536818,12.409637475437044
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,218714.8760601445,270021.3004129967,167169.51904795665
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.0011828653878245706,0.0013657324196822188,0.000956288178832974
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,73.0604243636236,90.19903515829468,55.841999512406225
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,12591.176571361237,19170.70771451147,7125.681181954415
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,6.811203515663832e-05,0.000103995876750818,4.0523383429427075e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,4.206008846366709,6.403862719370055,2.3802920972340047
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2017,316469.9263377551,393702.4181661124,209209.1517714329
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.0017121157208833406,0.002066100675262897,0.00116509257126573
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2017,105.71492681733703,131.51398872517083,69.88509279529495
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,185707.35388976592,233635.1869147636,142788.81995347005
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0010045681885147005,0.0012007358252357067,0.000797821402005163
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,62.03445475240968,78.0444668865286,47.69776966296893
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,987.0514388923551,1404.14157305948,672.7836280865998
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,5.33587517177311e-06,7.3539827696226114e-06,3.691861855208014e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,0.32971875664447275,0.469045275027937,0.22473943363316756
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2016,45830465.262656145,48784873.71990898,42754620.623392284
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.04287058501221978,0.046408499874633205,0.039533850270440846
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,1724.7082387747432,1835.8895802192926,1608.9569680833686
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,2040275.2110533628,2323305.2488360964,1860437.745350848
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.0019086510039272911,0.002163433730873795,0.0017085258791323288
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,76.78035659696641,87.43144283811705,70.01264963697989
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,3333077.405613902,3918233.640591492,2863661.321581253
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.0031179862385140567,0.003646766381874188,0.002705838995762869
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,125.43154491212105,147.4523508029703,107.76631321733876
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2016,1873229.5871827193,2118402.3664420876,1680927.4086372599
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.0017519303388828062,0.0019929091991721048,0.0015582040206242127
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,70.49403674204407,79.72046527355809,63.25725331052307
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2019,4598013.530221674,5444715.946032799,3757655.7265062276
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.025186708437611154,0.02816151399862532,0.021945272449162917
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,1450.1094683929,1717.1402594092222,1185.0796245275023
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,263047.43887195754,321146.7542984388,199900.91506084276
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.001441055500484504,0.001699531032190981,0.0011363165636126612
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,82.95921254636617,101.28242252679105,63.044227200470495
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,429720.65723987005,504974.6768044634,319424.5290798319
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.0023564374218007743,0.002722059953914207,0.0017979072318777684
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,135.52417576237815,159.2575914185039,100.73927164657032
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,1084075.5422814717,1196677.1850102236,984510.8168065113
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0010142843527406215,0.0011346719462690886,0.0009047595674372857
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,40.79631329316979,45.03377804070952,37.049458415439986
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,3445674.6365812966,3751358.7485984317,3188367.8174125217
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.0032235973061783088,0.0035430869395934508,0.002921382355074501
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,129.66884363470072,141.17245599030312,119.98578263215595
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2016,4801570.716147408,5183532.542984705,4425221.519085808
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.004491451609867913,0.004913722526951696,0.004067627807832451
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,180.69440329131484,195.0685255235091,166.5314975231011
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,3779431.2992956555,4144207.315787129,3409004.6309814183
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.003535117426958127,0.003958036599049603,0.003182027883662811
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,142.22889212276286,155.95627187648583,128.2888650459702
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,354474.16854551784,443409.6123423325,300376.3713575376
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.00033154896406303717,0.0004138769558569722,0.0002821894707429629
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,13.339696977098734,16.686546976468893,11.303869586411075
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,1265304.4694055093,1480230.7281352826,889114.4504232598
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.0011834879136316694,0.001400273181396185,0.0008472011113127675
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,47.61638422030969,55.7045650196069,33.459468697739425
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,2615995.4961619447,2815696.1872322224,2427037.6467600735
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.0024470463811587934,0.0026621473950275134,0.002239616424375597
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,98.44606549313141,105.96127235834672,91.33513703589605
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,2745881.2173590977,2992445.2354402705,2476780.279888488
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.002569366983105226,0.0028544746656075995,0.002254989984005774
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,103.33397077980273,112.6127549015189,93.2070693560951
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,712976.247730848,801706.9901719225,634445.9018623803
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.000667002993453158,0.0007712447561539751,0.0005850691827272545
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,26.830973708531612,30.17012031425935,23.875692025551665
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,1325707.3686538811,1462068.4758259323,1204656.6908968487
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.0012405992369873978,0.001401015584282861,0.0011002317993538703
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,49.889487436314745,55.02107673265367,45.33406562158268
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,2185218.2988649434,2421967.5766477026,1885338.0752611125
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.0025450254111905467,0.002889077724551911,0.002170348459842464
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,72.92844021765939,80.82959844991575,62.920379709054814
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,305197.8061284809,426697.8295965699,241249.60706451914
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,0.0003548384986755187,0.0005087456589209118,0.0002859201019600249
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,10.185526988476571,14.240411208757555,8.051350089589373
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2015,2753795.850275389,2853611.5745941317,2604041.9200166482
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.005779141614157774,0.006436539532278702,0.005130738573586976
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2015,183.70303920401764,190.36164896111688,173.71310036431524
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,1586412.5575143571,1642797.3324277452,1501970.6218780442
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.0033291791922377095,0.0036948226024731646,0.0029487549028599297
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,105.82803667804978,109.58941009844641,100.19499739116551
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,685663.1739547693,747858.9159832582,622493.9602124855
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,0.001437177724993403,0.0015861523955291797,0.0012727931549620336
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,45.739922555685396,49.88893993293209,41.52596582849182
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2015,44414720.17773411,47423963.19554595,41442192.75453211
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.04127044222522062,0.04452607356018144,0.038209918823815116
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,1700.6738746383344,1815.9001095971653,1586.8535081009345
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,1974267.274214097,2249712.6994882594,1806573.7431861972
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.0018346285057580392,0.0020855924749574256,0.0016535400170912314
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,75.59621588008022,86.14323355300154,69.17510130311685
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,3279865.0215468514,3887464.463625972,2837763.608568152
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.003047741039770692,0.003577584173055008,0.0026276259012859697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,125.58856010267417,148.85401113453315,108.66015618647687
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2015,1818600.999190384,2065891.5331357,1624312.8901038733
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.0016896082700210968,0.0019445452434116019,0.0015032952555952507
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,69.6356342072543,79.10457938676261,62.19619273483107
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,1054665.3091128652,1156588.7031448446,961333.0722765992
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0009801945118627282,0.0010954195381388506,0.0008805220510243655
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,40.383947720890916,44.286673050488986,36.81018442318651
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,3312288.010670865,3581351.0308486647,3078573.3833165197
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.0030780918624988413,0.003350118118459593,0.002809871133922042
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,126.83006135091424,137.1326918125393,117.8809481003568
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2015,4565690.825828304,4950227.997734704,4207178.347007465
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.004242196617959869,0.004632306956813255,0.003863903930999839
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,174.82382138376536,189.5480461333873,161.09610219466444
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,3671475.7178289406,4050390.737002299,3301189.3137020655
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.00341148188147843,0.0038133087541524584,0.003067636365075856
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,140.58363555357752,155.09258374096845,126.40508368806228
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,339606.37960150937,418424.1433944046,286265.6175018756
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.00031553648703658884,0.0003936320985300812,0.00026076346802560374
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,13.00379007539795,16.02178301115418,10.961331174539591
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,1220042.8057550061,1450472.554186784,866432.7524054328
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0011338236149214741,0.0013547737334754866,0.0008128723935979215
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,46.7163795558071,55.539712260126706,33.176378017250315
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,2517424.682793116,2704637.9299116377,2327508.5859161434
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.002339280074216652,0.0025432865655016,0.0021562375124548686
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,96.39413177125557,103.56267132495722,89.12209801669258
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,2645860.2271646303,2860633.5969231958,2394809.330822021
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.002459161825879936,0.002709426992934212,0.00219061261637378
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,101.31202777540719,109.53586567092398,91.69909542086634
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,694675.5336164504,783296.6327016177,618622.901094849
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0006455706491924978,0.0007387877184005595,0.0005664287382270461
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,26.599661703243264,29.9930319046711,23.687547775487435
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,1275074.1836176685,1387510.1850161944,1158062.0748900692
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0011852525125706683,0.0013267910018767007,0.0010571512331952466
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,48.823573437517,53.12883460728412,44.34308959042679
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,737240.8243184792,768496.8486692447,703321.6549906855
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.00141409144482201,0.0015564434395796871,0.0012700849713587086
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,48.27401990454617,50.320642787971906,46.05301612767416
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,16227996.364895817,16733857.146751653,15274649.16958005
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.031138766889254425,0.03460985677164345,0.027557881335556686
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,1062.5979919845963,1095.7214065415853,1000.1734761892849
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,251461.34229786368,327271.74670095544,174976.60125874032
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00038167231633222593,0.0004818541143312633,0.00026573990180496683
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,18.17846011328898,23.658890624080957,12.649280949805492
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,344362.4458709907,530988.6316253338,254030.49940178933
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0005228299115702948,0.0007978678554304358,0.0004067822966547596
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,24.894398994201296,38.38584321711482,18.36418774645802
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,456091.84685297875,639893.3944792375,358868.463862137
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0006929865718392984,0.0009539170925037041,0.000563692964873911
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,32.97145943089807,46.258706972617425,25.94305747603804
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,59460.77755968277,90903.71880089215,32821.776080264586
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,9.022104897694644e-05,0.0001342992237070041,5.14770721198456e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,4.2984952012762125,6.571545396485764,2.3727279186143977
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,272322.8834503289,341695.2364644399,188678.58255193144
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00025763600036986006,0.0003224866318581836,0.0001778761044078515
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,9.910900928388374,12.435633735197996,6.8667557984418135
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,597737.3177659601,871423.8856380552,470598.0331121588
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.0005656397706725794,0.0008220568001914195,0.0004477609206874657
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,21.754012231805596,31.714543000442717,17.126913552675244
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,921817.6766897173,1165661.0143326933,774948.4609311048
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0008726401068613862,0.001113316422401328,0.000725444705156966
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,33.54857128404099,42.422989514368965,28.20342280304962
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,1522967.619903843,1731521.3923849834,1135456.4569462987
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0010899612721621454,0.0012772354479563968,0.0008116548348389985
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,33.80197369888048,38.43078460731913,25.201237893912708
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,148881.3625075159,176777.41383471648,118108.03348503381
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.00010652945413451767,0.00012753228205381918,8.41912269232925e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,3.3043932346048748,3.9235407338302233,2.6213851097764436
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,748800.3882219662,778549.440092914,719452.5576930265
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0015461816572120448,0.0017083989600741945,0.0013796762436049798
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,49.14091172448509,51.09322846319391,47.21492561121367
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,16421746.495370321,16918593.030551,15460952.881513666
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.033921939877033784,0.03793294337018828,0.02986482943811328
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,1077.6965498202367,1110.3026917373159,1014.643331757556
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,253207.00717326486,326211.30339822057,181513.47505248454
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.0004191267827457342,0.0005415286543635964,0.00030115363971789874
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,19.144417671393587,24.664109856611535,13.723829439731846
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,343832.169977781,532597.8119547683,256220.28396726045
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0005693108414731439,0.000891785275107609,0.0004410285591970462
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,25.996384319696098,40.26853394288296,19.372244816257297
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,435300.5459438048,606851.9878633929,344684.9774823502
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.000721274925036597,0.0010122518666423783,0.0005856101792164691
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,32.91210443647536,45.88272674627209,26.060863195075708
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,58074.65287108012,85021.08612389567,34878.282749666774
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,9.605212149082231e-05,0.0001373814516062049,6.0690359117590696e-05
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,4.390895114227099,6.428254896269888,2.6370692504716953
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,64106.089719166106,89217.99145233509,45507.91466323609
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.00034655652443159893,0.000471507179527955,0.0002500119398047908
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,21.41426410285348,29.80274791452812,15.201652567451806
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,85968.25871827494,131056.88698347789,61968.21991974089
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0004648883406382443,0.0007076219289281684,0.0003572143400884473
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,28.71719371311432,43.77878611309138,20.700121207803107
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,85153.52968112407,121167.01829479009,62873.49075146601
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0004606390263288035,0.0006494472210995814,0.0003536033132550755
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,28.445038246289855,40.47513335607751,21.002521631227708
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,4547.894921812959,8193.605039875334,2663.8304959461475
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,2.455688928472743e-05,4.3939650076489154e-05,1.4975199458901125e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,1.5191976830028313,2.7370258121656077,0.8898369876453615
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,119586.69349022442,156260.00477251253,76710.52775069844
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.0006434493996882545,0.0008549749421780241,0.00043178151934182216
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,41.03952739628672,53.625002578816485,26.325368762417924
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,17553.753439771932,23097.91926313388,13574.479195995966
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,9.441369141953817e-05,0.0001230299345103162,7.669905462010657e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,6.024062746229119,7.9266987214935405,4.6584632001715125
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,7750.970318411203,12539.573595807153,4226.789674062467
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,4.1664170130140125e-05,6.732636627604954e-05,2.2954088171548504e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,2.6599628223372918,4.303306321994332,1.4505414069434768
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,59404.91619811441,84650.31712736221,36575.65219871967
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.00031956377277962434,0.0004495095681245363,0.00020806174994836057
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,20.386462863327868,29.05013013957713,12.55196072938594
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,215671.17677966823,263919.19727338233,164700.92638266343
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.0011596289101850788,0.0013468792435938862,0.0009369826631925851
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,74.01361229844616,90.57127353213725,56.52174153496143
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,12111.549715877127,18363.673263540302,6897.432117602106
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,6.51353335090317e-05,9.96363237662798e-05,3.860013496874972e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,4.156417924682061,6.302009446035282,2.3670472532757065
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2016,314461.0973580418,387867.120675749,208656.1226266228
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.0016912671944456662,0.0020396718951058725,0.0011491131662409258
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2016,107.91614387387258,133.10747927312207,71.60619974527717
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,183536.5967522549,230475.85963475407,143122.1495776208
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.000987124784372883,0.0011822438317351696,0.0007912825302430201
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,62.985730023977254,79.09425438237756,49.116379148708155
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,115844.31047050266,155280.679980726,75613.52847603649
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.0006203758010142149,0.0008343450409369351,0.00041628255786084944
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,40.88317389671523,54.800853116292515,26.685134738811083
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,16957.51412960457,22272.05672121417,13256.660597982771
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,9.078797700757242e-05,0.0001188272933980945,7.39042922747913e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,5.984558034838986,7.860138873222924,4.678471979468207
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,7435.802131427139,11913.144014676142,4028.0482286903334
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,3.9786196640917255e-05,6.418024669952597e-05,2.1849124017577475e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,2.6242047655685994,4.204325067243012,1.4215579127628775
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,58214.953637896266,82936.28099687787,36012.781136042104
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.00031172094957322406,0.0004380703816122835,0.0002036006608427957
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,20.544919843718546,29.269442621487787,12.709444147143063
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,210218.88397205606,255090.63628974406,160532.5326786171
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.0011250860005701537,0.0013079177709290173,0.0009093928034186319
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,74.18935945059943,90.02526581150344,56.65430976216282
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,11636.620751517083,17562.07624315114,6678.6173943047115
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,6.22953267187821e-05,9.4158751385905e-05,3.6720739686576246e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,4.106735909792783,6.197916963897341,2.3569830508897645
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2015,308491.9364717788,380992.7275479464,208860.8397191012
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.00165126687591927,0.001993847969839385,0.001142586773910318
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2015,108.87137601567048,134.45797959747603,73.71008550846551
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,179205.5721081958,225221.675997397,138744.14802556962
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.0009593697049262988,0.0011685574539407311,0.000766291936803888
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,63.244302098247935,79.48406708722909,48.96486592947774
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,923.0109844544507,1316.6449057359068,640.5211487463032
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,4.936367828185501e-06,6.9542882892323825e-06,3.421216277752271e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,0.32574425479133207,0.46466349899101533,0.22604940546809807
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2020,6317321.926594084,6685507.1304608155,5849367.549157961
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.01211198586747984,0.013227862541309822,0.010942534079984096
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,413.6538758685032,437.762388682416,383.01254648789825
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,1214568.3569894505,1260367.902887531,1157952.6797677318
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.0023298938046491234,0.0025781648869092283,0.002091044970378134
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,79.52909701513245,82.52801964309067,75.82194157967895
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,1144161.8192268917,1216290.822078582,1053186.274303827
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0021934569698256468,0.002419279753893658,0.001985029594506273
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,74.91892555792691,79.6418828393231,68.96190972052689
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,3853819.709070213,4096013.5842945594,3567129.9797849115
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.007387258503340209,0.00804821656397333,0.006698403145252215
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,252.34545240514421,268.20414005194823,233.5732069713112
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,9489037.391609259,9928926.003756974,8825451.20761349
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.018201348788432294,0.020212652842786172,0.016141552329473802
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,621.3356135574586,650.1392160142701,577.8844486220294
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,1172273.562179823,1215677.5663205124,1120207.520198954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.0022487302729219125,0.002496716181994013,0.002010946389323222
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,76.7596630674315,79.60172727591004,73.35041460474801
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,218077.48129653517,231694.40486888378,206341.14691633423
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.0004183653865083451,0.0004666982362045728,0.0003719540106982449
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,14.279562831553811,15.17118958076143,13.511075763573032
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,752593.9810196735,786489.8311687263,721177.2727334618
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.001443707687270942,0.0016029620546037082,0.0012921331380915876
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,49.279333999674066,51.49881085283059,47.22218964315273
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,1146093.1873974346,1221001.1020885925,1049130.1197480955
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.0021991281801295908,0.002517750993506853,0.0019070540738651185
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,75.04539021158196,79.95030872060747,68.6963155221314
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,5434607.195158482,5678335.503951486,5062001.996042927
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.010428292563816744,0.011717706930634918,0.00918232301647513
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,355.85432501651337,371.8134863134363,331.4563939669554
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,1040522.3695528113,1094968.7302756587,985360.1503252436
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.001994898210734852,0.002167325541971781,0.0018301848204709853
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,68.13268598541313,71.69779607504285,64.5207019753954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,422054.7858018341,460198.12058085104,387732.5752918708
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.0008090676740402715,0.0009017466079801494,0.0007182366877557529
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,27.635855826949296,30.133455039594864,25.38846119188189
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,1867142.2949266837,1950732.116618847,1738534.4570849482
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.003582426938117061,0.004012844097369333,0.0031578021407742667
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,122.25918768569676,127.73259146785334,113.83803530364881
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,146077.87537183607,158044.1825832224,136354.97100349245
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.0002798314390094731,0.00029874058120651307,0.0002612827531696935
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,9.565078371551973,10.34862390165793,8.928429309908772
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,1954191.2621589545,2033023.2553291435,1850686.0510888072
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.0037487591891506005,0.004149169386445592,0.003334832594304612
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,127.95909392830808,133.12095838546253,121.18164420685044
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,2064725.124946321,2180438.3268212685,1909031.748299548
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.003959724006494571,0.004391000370116345,0.0035135312363375228
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,135.19677490895165,142.7735954352616,125.00208015612064
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2021,37880349.966394916,39533961.44890882,35821258.90870042
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.10362575020571928,0.11338404071175696,0.09311994955378491
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,3688.905772967345,3849.9395794000234,3488.385109971008
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,68407.17980604083,72977.38249141612,63722.11503316897
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.0001434654793326523,0.00015849961417626187,0.00012961719188181166
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,4.563376341964021,4.868250112108543,4.250840233828706
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,511147.58470183203,529527.4496984915,487480.04925087193
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0010726275113875994,0.00119094258576957,0.0009613868295504996
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,34.09815756027422,35.324260453743335,32.51931932054944
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,316343.94490160473,326348.60949185514,302555.56905324734
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0006638360234582072,0.0007346985743994896,0.000597586724059345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,21.102996471725195,21.77039790283058,20.18318734761123
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,67740.99629101298,70940.24090306785,63397.798462976454
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,0.00014217196298174894,0.00015900624206269652,0.00012707133954653943
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,4.518935888483785,4.732354380756107,4.229205391288497
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2015,103828893.05196297,111902275.14365605,95568704.3261293
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.1209145946229735,0.13426033492462225,0.10885402580412865
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,3465.1362858067623,3734.5735148168696,3189.464660692028
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,7195921.991171852,8147537.844222015,6275240.123224521
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.008377739199210555,0.009582061115289343,0.007209646950805651
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,240.1532913286994,271.91206796231677,209.42689085834053
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,13419029.763859984,15303979.597833926,11171855.193289682
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.015624562983960808,0.018252214740080965,0.013124196310923607
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,447.8403418189286,510.7477645472024,372.84420234233505
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2015,6972575.9579843525,7752117.131948546,6265442.519509185
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.008119001540029471,0.009177590752106711,0.007213448858608118
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,232.69944663152302,258.7154844489722,209.09991027374565
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,1011491.902080331,1100263.3366860012,930132.5516010037
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0011779652093451209,0.0013099603816417132,0.0010555824202187814
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,33.75705152653545,36.71966732791245,31.041803109175405
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,21901281.228847418,24236167.933120348,19678505.591156512
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.025505050960615182,0.028874433969158668,0.022383205539652312
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,730.922983583739,808.8463862552347,656.7411225336032
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2015,6692920.407835588,7198643.029622979,6196463.755581321
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.0077952164833148116,0.00858513385962511,0.0069766022809479595
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,223.3663547929847,240.2441019768234,206.79784568641625
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,956.3602231562337,1367.5506031954203,648.3260883206314
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,5.138836947000205e-06,7.137319799836389e-06,3.514583625498227e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,0.32820182942968923,0.46931333919885226,0.2224912779743085
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,118632.85784105916,152336.12512529088,85629.85705816493
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.0001121900589103508,0.00014357476364221356,8.165847751646557e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,4.317516346836032,5.54411081728545,3.1164073289137524
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2020,37317124.46706868,38756316.592282146,35347566.29909469
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.10737497618866082,0.1177482074388356,0.09671331863224539
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,3654.8955286412397,3795.8521789303077,3461.994027136761
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2019,6441125.998317412,6806790.276467375,5989855.351784641
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.013293823947037833,0.014516681976202522,0.011975774206478036
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,422.70651707484905,446.7036681127011,393.091346791918
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,1250363.4851122557,1299249.7947795936,1197357.324001223
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.00258204953783869,0.002874197001809062,0.002306280250343783
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,82.05658358607471,85.2648055176936,78.57799152738711
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,1155943.4543792764,1227897.8014636075,1069727.8293851302
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.002385486049055682,0.0026269130931273104,0.002145723148160756
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,75.86015731780046,80.58224650723066,70.20215488651331
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,3835345.902704172,4062654.4498192724,3546743.7215638887
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.00791412103448375,0.008660285652792287,0.007137467159753908
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,251.6991142127754,266.6165066496676,232.75925449851428
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,9596022.239923092,10041396.429601552,8966647.073625177
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.019814828064390704,0.02206997534301328,0.01751837998998125
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,629.7503169275514,658.9785252506293,588.4468267383061
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,1196938.7813319871,1238058.719790876,1147900.9008994265
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.002471764561504089,0.0027550480791681035,0.0022011300316621967
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,78.55052416934966,81.24906879847656,75.33235522687045
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,223355.1562718102,237150.83377362404,213118.74151015482
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.00046128364265974166,0.0005173115374732663,0.0004099093403662213
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,14.657946483740385,15.56330414775797,13.986169649633547
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,770416.5933047233,803768.0205681052,738924.0096347886
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.0015910112481694533,0.0017806208692893338,0.0014172300685458697
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,50.55950076703667,52.7482276544882,48.492762690451485
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,1162046.4317389838,1233867.3805172378,1065347.140022587
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.0024003704673186054,0.0027457622970101193,0.0020712092183866803
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,76.26067243024859,80.97400719795807,69.91466696230393
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,5488219.994033679,5729658.239581732,5126656.103446426
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.011337130400737961,0.012818968901711048,0.009928035031942364
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,360.1709327258218,376.0156033456703,336.44287447481236
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,1064452.1616151351,1117879.4480853458,1005719.4855003787
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.0021968715265193116,0.0023950417697579263,0.0020025844361403807
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,69.85593294505759,73.36216185386675,66.0015315615977
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,421928.24161801935,459968.4700573109,388209.74540181056
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.000870702156591828,0.0009744461183769502,0.0007713975920180922
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,27.689540232011954,30.185975246092596,25.47672401008458
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,1900571.8250158252,1978566.6709087482,1776052.7205860266
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.003925587145050171,0.004409103762237644,0.003445207158136763
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,124.72727545042497,129.84577952343935,116.55556184684853
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,151907.62632290798,164361.2873829584,142091.51636660713
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.00031324947207980497,0.0003350625511713807,0.0002922833290182785
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,9.969117768669323,10.786404015344168,9.324923934868282
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,1974025.0211998087,2050810.0331094195,1865888.7599064
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.004076589197067005,0.00454294325240453,0.0036122724131548304
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,129.5477283859918,134.58683567194504,122.45115825325857
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,2067432.9899371294,2178985.192818364,1913418.170470719
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.004268247236508579,0.004762566548552435,0.0037834522323615775
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,135.67773688796896,142.99848223036258,125.57033207527537
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2018,4482388.8904876895,5303444.029592658,3693017.3640771704
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.024405409019205286,0.02724886420962116,0.02119102341892799
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,1456.3972018205232,1723.1706648885056,1199.9182326037353
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,255293.05631035625,312145.12920175935,193765.42806968396
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.001390027570927268,0.001633226624128666,0.001102419427988123
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,82.94864679047508,101.42076108034593,62.95737254059196
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,419984.42013638077,493032.76681379846,310482.8141854161
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.0022887571684989277,0.002630618581806559,0.001731884733231642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,136.45940797169246,160.19394111859918,100.88064932353605
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2017,472452.7985427306,604053.5251270216,380951.657400746
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.0025564541170566154,0.003135454019935869,0.0021335115318558712
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,157.82009241941765,201.78054496845016,127.25467171273068
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,48630.208860915496,60831.078978315316,38192.162383401665
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.00026323406119441644,0.00032414965282412866,0.00021465193864185766
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,16.244636671595718,20.320265931205654,12.75786833232337
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,219190.90739793962,307101.00263617415,169808.75559973583
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.0011855707029767941,0.0016049371341789018,0.0009511268802018481
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,73.21943984613756,102.58529268454168,56.72362103693366
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2017,378870.4825493158,451735.2622789702,311886.99461847165
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.0020498365162673706,0.002346119226953907,0.0017775291905884093
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,126.55946743326245,150.89952067567006,104.18402529718483
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,649574.3113709427,803954.8495140781,516410.2717403407
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.003512432613243826,0.004169273869445576,0.0029358896065153186
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,216.9864972121017,268.5564124981583,172.50382908892
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,36421.020566475985,47639.900585792,26749.24095460232
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.00019703555617936529,0.00025375280192266363,0.00015094778968527736
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,12.166228773626127,15.913829987868207,8.935427396400094
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,148135.4729501224,190334.06755675306,89651.29382015843
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.0008012273327090458,0.0010094663166206471,0.00049491893637477
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,49.48378780630287,63.57998137596732,29.94749003468564
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,207787.38704050297,255981.30195218557,167853.6307481167
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.001124782044805684,0.0013330664496900627,0.0009431555508375639
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,69.41016060751626,85.50905583869228,56.07052302222029
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,56056.845143846964,67336.90580410082,46080.06011189324
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.00030322057671965694,0.0003449199260469951,0.00026220342038496
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,18.725461059032686,22.493499308332815,15.392774406211014
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,24708.131938726943,32826.088980159126,18988.70655555949
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.00013360041187993236,0.00016904466522885218,0.00010742893824304194
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,8.253606874821738,10.965362915821915,6.343066297346861
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,12598.41405045066,15894.027756974583,9499.396449833914
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,6.813462038390269e-05,8.201905865914657e-05,5.332725334229293e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,4.208426483900659,5.309306955656965,3.1732177907839882
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,13795.125703964564,19234.09635496037,9377.468457459034
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,7.473135800731482e-05,0.00010413093809970566,5.081347474012413e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,4.608181008245763,6.4250373237429015,3.1324884584899024
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,59032.67406661293,72374.62825741238,46307.3013300046
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.00031949746252501684,0.00037711994543674406,0.00025616878543282986
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,19.719519295249924,24.17632101161688,15.468683005238166
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,24586.52015476274,33202.8266664245,15940.919568052588
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.0001329352409431757,0.000173821602113079,9.112597592244955e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,8.212983170096686,11.091209935138284,5.324970890722798
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,7423.470771569425,11337.774852714228,2180.0673522498073
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,4.013397890864036e-05,5.9924836606284416e-05,1.1975774985055967e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,2.479766966891977,3.7873173375309683,0.728238740618872
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,59745.07771802467,79006.74906644167,42595.28065328405
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.0003231547085589516,0.00042198250375463913,0.00023473931418797542
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,19.95749356580677,26.391742154736814,14.22870422202467
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,11474.937134438649,14792.365111924579,8372.267701207547
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,6.204929269973687e-05,7.817472914336442e-05,4.7291904597003497e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,3.833135595026682,4.941302996334271,2.7967070285967948
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,51358.81860954655,65269.61577280787,37150.53280171586
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.00027765702339405216,0.0003344077957733194,0.00021227419202611282
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,17.156112789493072,21.802933171773276,12.409918066486213
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,67643.43889163333,80830.6069657942,57422.54613319833
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.00036621909416104776,0.00042169068447442425,0.00031853459534103643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,22.595894892300556,27.000991212258633,19.181665482038603
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2016,468585.9452243265,596611.74045464,377219.418853474
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.0025206625640117972,0.0031001976779126686,0.0021034813003055746
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,160.80840748490635,204.74404929789273,129.453421803271
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,47319.037339029834,59549.756958432234,37447.36201380698
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.00025460276269289906,0.0003135358800791733,0.00020661227934231518
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,16.238854613032476,20.436169031946438,12.851112397466906
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,211857.99132305983,298112.43232790683,164367.39815174416
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.0011390991568512884,0.001548303190116666,0.0009202512694839182
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,72.70501077727116,102.30564100925577,56.40728196951348
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2016,362257.83069802553,433302.4121045268,299262.5578936323
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.0019482364344711072,0.0022079382426517385,0.001689508161076317
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,124.31893326548342,148.6998736518664,102.70033884967748
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,634916.275327817,784022.7225825517,506861.4821899538
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.003413127857520244,0.004050878008976166,0.0028507558144204334
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,217.88932459943155,269.0593833114731,173.9437313412926
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,35170.77396092251,45605.750863122186,25973.672532654095
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.00018914533952905848,0.00024395589788903514,0.00014632561915029857
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,12.069837365608548,15.650892313770065,8.91359409960752
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,142501.9812126418,183483.73969211453,87103.05652667371
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.0007662263457334603,0.0009591189856625656,0.0004758840780819655
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,48.903550983115124,62.96759064153923,29.891856445708537
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,201064.03741462278,246911.1481306176,163172.4196775586
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.001081878262632884,0.0012822250788064409,0.000906740382131144
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,69.00076280276075,84.73448451840855,55.99719159576032
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,54305.425055881016,65327.16072029868,44708.47533287455
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.00029200565361529375,0.0003327344009228641,0.000253582995680847
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,18.63642947473922,22.41884714641333,15.342967053602
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,24064.004741209006,31627.656188953777,18468.711311998777
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.00012935647502752064,0.0001639150834203507,0.00010462372050629124
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,8.258238044870357,10.853917143825113,6.338056197906686
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,12216.699321402815,15145.186562307015,9384.155651100718
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,6.568397082366624e-05,7.813811465243161e-05,5.145063763572283e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,4.192502960489436,5.197495479682953,3.2204361680578493
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,13357.972847253246,18616.82446782341,8996.605724982166
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,7.192144936791204e-05,0.00010029314778889296,4.905175656159629e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,4.584162975193525,6.388885380809989,3.087437542991997
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,56641.14480805534,69450.7466819666,44660.49592113217
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.00030472898794313115,0.00036095872471741865,0.0002446444015558121
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,19.437997207417123,23.83397130534534,15.326501572993825
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,23839.8440944177,32259.293088565064,15854.030131932315
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.00012814919492268022,0.00016815463114191223,8.851912927376336e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,8.181311032870356,11.070681058685102,5.440755028436152
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,7127.44227711827,10886.44043103606,2109.307986293796
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,3.8313750841937145e-05,5.7363284013616945e-05,1.1416953559964317e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,2.4459816896029336,3.735987318305353,0.7238681860351532
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,56964.81876336223,75643.78184412795,39640.86326417542
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0003063100146842438,0.0003980540741585082,0.00022255051146870323
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,19.549075001848898,25.95928499022002,13.603873863069632
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,11084.210546563245,14331.897705211511,8155.496441434578
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,5.958239861112312e-05,7.511861592214217e-05,4.5420280917691e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,3.8038576794422125,4.918392601614047,2.7987873054281995
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,50440.076904766145,63636.08026979848,36976.95958850142
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.00027110933861275444,0.0003246068161313514,0.0002095630321599615
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,17.309926862165263,21.8385054674848,12.689680613903253
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,65738.67013800588,78646.81544068412,55502.426148344275
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.0003537784871617016,0.00040492843343924894,0.00030779041047856244
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,22.560068142904914,26.989860181831204,19.04721396667392
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,1,Number,2019,37031432.151341155,38201336.24534625,35321346.5777021
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.11994665042714457,0.1323738268255215,0.10689073937026874
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,3652.2179530628327,3767.5995218346034,3483.5610885971655
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2018,48120406.876154,49610432.90762201,45852946.10141293
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.16853416114704386,0.18518051147454723,0.15054898893857194
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,5667.650203506504,5843.146357606237,5400.58732196273
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,1208221.9875168386,1238367.542079465,1160000.0007308554
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.004232552010268151,0.004712337736432284,0.003758617447070467
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,142.30510583700507,145.85566722131344,136.62549149117316
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,2902944.9548526215,3012345.466512723,2750900.0588927893
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.010169353171174159,0.011300547750797625,0.009002298780812604
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,341.91058705058003,354.7958445208652,324.0026485797634
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2018,1295633.2633563522,1345910.2300779768,1231038.3003392317
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.004538987626645289,0.0050491852515788735,0.003989554820970929
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,152.6004580059013,158.52210911340075,144.99242476063577
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,596687.4676565098,620274.0565145238,574304.6868451459
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.0020896910948675035,0.00229763777622485,0.001878804801946322
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,70.2782055895095,73.05624808373018,67.64194832453954
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,10096884.459304878,10405731.554601386,9641561.988508724
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.035370798896574705,0.039462005252891966,0.03150344012312117
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,1189.2170697525617,1225.5932647214593,1135.5889177522986
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2018,4084305.3872567667,4298166.29459718,3810318.9958172534
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.014298463658274788,0.01560994504692249,0.012970155314482182
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,481.05192291588094,506.2405880518497,448.78164242559586
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,834529.121436609,864629.2470177544,802637.9341079441
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.0029228910386495553,0.003226394695263027,0.002614031660417613
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,98.29133733460071,101.83654806639301,94.53517428264328
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,715410.4852804095,758064.528037113,663910.2178100066
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0025042043402020236,0.002743480681581454,0.0022783207611279882
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,84.26147336878601,89.28529194813808,78.19574116996051
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,2378804.495544905,2515896.4827103056,2216448.001814248
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.008326627590982193,0.00906736866613152,0.007597382710087627
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,280.17701134522906,296.3237873057238,261.0545667428511
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,5811697.674879335,6058523.583576793,5455938.458536132
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.0203535651227229,0.0226139961134133,0.018062030099783383
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,684.5052161450208,713.5765187892431,642.6036835977953
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,64354.76038511842,89049.38559571633,45781.61125918094
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.000344358877760791,0.0004697434175073819,0.00025021874662883766
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,22.711748632455873,31.426847826353324,16.15700906483014
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,85117.52155618039,130502.56844609429,62254.71435387776
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.00045543413109980224,0.0007007522690585645,0.00035081598088116577
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,30.039234739325458,46.05629036143462,21.970611266817375
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,80968.1748550317,114902.68783204851,59477.951617833285
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.0004333403599701416,0.0006146754037535136,0.0003311312608524998
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,28.57486879807347,40.55086131341568,20.99065054758524
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,4417.794125735747,7925.01389802039,2607.8018246647134
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,2.3617055699636565e-05,4.1850184748307196e-05,1.446934696405707e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,1.559105015591862,2.796854847775646,0.9203319097236634
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,3903743.351479132,4501794.547383439,3473270.527661322
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0025545305895752946,0.002968027908336142,0.0022614926301997053
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,84.44679918892352,97.38399938321656,75.1346982549679
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,1030207.3508688761,1275750.685101821,820376.0148500913
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0006745152906711913,0.0008659685673223626,0.0005285454378942299
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,22.28571538874684,27.597373141629497,17.746588939871096
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2021,6218839.695006739,7243895.466524199,4938624.853120165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.0040695433615034774,0.004790303080063951,0.003238518941967081
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2021,134.5275699831435,156.70184505734446,106.83362703207519
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,3715179.129978104,4164699.6278562825,3160735.2630771883
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0024314953652268658,0.002777393885369131,0.002032293439157122
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,80.36772853452722,90.09187374536435,68.37385350891327
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,458888.74795061426,662825.7642359022,351628.25722420466
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0002997478737428716,0.00042451644005678935,0.00023735761886785656
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,9.926801651435133,14.338420631178405,7.606514607501661
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,3855522.3585898085,4400193.377560432,3436350.1909996634
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.0026430346122079474,0.0030700159683851288,0.0023373453114292177
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,84.03016425895738,95.90113553972976,74.89440966609176
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,994620.4631005963,1260309.463474533,778561.79443083
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.0006821962845437607,0.0008684932770497981,0.0005350277639269927
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,21.677509067858956,27.468135672183948,16.968563371449424
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2020,6243924.762650591,7195043.341255786,5003480.164997794
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.004279877317684524,0.005006755388041107,0.0034589878220030196
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2020,136.08480891237957,156.81420507626873,109.04962311902686
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,3678754.3487888626,4098659.243162412,3093897.649561137
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.0025220890581225458,0.0028620503849060967,0.002121118531613601
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,80.17754883676723,89.32927303017978,67.43074051011727
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,445863.2094925003,630712.703730074,343179.90041212353
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,0.00030509994677408396,0.0004426807178012671,0.00024169512068776934
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,9.717479305290373,13.746228698835527,7.479521766423099
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2017,19780852.44232749,22297518.48157563,17049371.976636857
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.03212461716586965,0.03557916047217161,0.02866648214417813
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,1568.6817794280776,1768.2610529798242,1352.0670683136143
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,1042371.7662760095,1192285.5224746552,888939.0806076522
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.0016930058385037517,0.00189619667174619,0.00148040196571271
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,82.66325235046543,94.55186931073482,70.49557357734854
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,1125466.2063201938,1270098.0220855926,869613.4337916339
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.001828122076409797,0.002005573991375024,0.0014354600550065268
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,89.25289425033478,100.72263726460919,68.96299098899256
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2017,1499320.5216188356,1785325.5512446868,1282497.6059691124
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.0024350187761719403,0.002838125173766865,0.002152522322185148
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,118.9006788581723,141.58174784177302,101.70596199074414
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,228468.03257864254,257770.3854004282,199964.00451424645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.00037105893654037624,0.00041356917937117955,0.00032883645494560424
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,18.118210068692424,20.441975796176905,15.857753923271455
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,1367708.7299085555,1511312.9348936894,1241402.2576236534
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.0022222298961511165,0.00243727502106294,0.0020372889508791644
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,108.46346336325126,119.85171371627456,98.4469758395292
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2017,2163567.4120233194,2467958.5441450756,1889268.6221374157
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.0035144161372261565,0.0039031189817745815,0.003105774018207158
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,171.57747815472817,195.71662100365478,149.82474959726457
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,2131376.006126456,2495391.490216162,1784763.3757026754
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.0034599263064310133,0.004003415473801247,0.0030406405965275798
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,169.02460172881015,197.89213708837423,141.53716561094325
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,149087.4515364456,184533.17388802458,117250.40838068545
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.00024206113173218995,0.00029469877625316876,0.00019457040610813033
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,11.823088486628988,14.634042108253897,9.298314104184321
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,949154.1582257071,1154506.9240431262,578058.1999213775
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.001541780412583058,0.0018911085412323166,0.0009483060125782786
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,75.27081242924791,91.55591151848829,45.8417739230131
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,1188970.4164246947,1310557.3500220152,1073569.338238534
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.0019316778127798579,0.002113952523124347,0.0017643836447991416
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,94.28897131518039,103.93118506237556,85.13731472177608
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,735733.4335079666,772203.563138973,699304.6857516952
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0013570320221649075,0.0014963491421244963,0.0012223857839706409
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,48.12125096312402,50.50660981825113,45.73859872358444
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,16379382.998570465,16948727.756156556,15423756.891760122
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.030222373091723917,0.03355033089310551,0.026818929380075456
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,1071.307030505908,1108.5454931291274,1008.8035182032615
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,948590.7388850619,1106423.8263026727,674674.2990923682
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.0008595200511735646,0.001029063470548739,0.0006138968386591546
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,33.46923369365021,39.03807626276412,23.804609151005213
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,876410.1453538127,948814.1793023716,806796.1376917502
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.000793749284857217,0.0008691031955691728,0.0007203701880443827
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,30.922477696555827,33.4771173670164,28.46627883725466
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,211810.41329180088,275012.3366605512,130832.13231978891
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.00019182673172586767,0.00024236919595053546,0.0001195009857345493
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,7.473330626803531,9.703291195049374,4.616164834580108
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,154987.25605059034,187426.8712942346,116349.91404940603
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.00014041887566090033,0.0001745858949825877,0.00010579100178937887
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,5.468432781023962,6.613003372971501,4.105187099056773
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,1278499.0719319414,1472073.933759354,1114918.9349329895
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.0011578747436441737,0.0013373653649911155,0.000998681465586262
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,45.10942650135849,51.939350115553495,39.33781013570412
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,187304.78070528543,210589.9764200361,165989.91840046062
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.0001696648006195551,0.00019190074820828876,0.00014854012055373178
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,6.608695636994509,7.430269815438816,5.856640953784496
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,548937.098422528,624231.4508402294,472419.1039896242
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.000496947466283225,0.0005648032204347326,0.00042865295093807954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,19.36820936267228,22.024828464648824,16.668416361894735
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,1561901.3736824016,1817927.2073345003,1161150.967131056
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0010222136772934495,0.001193550841340846,0.0007654114642637584
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,33.78745982526878,39.32587775261626,25.118322010638114
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,142519.474689731,173447.30868964773,113515.83420656569
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,9.324884835935362e-05,0.00011437232470388278,7.299138465656114e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,3.0830186249499136,3.752057634942651,2.4556042733631065
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,1552458.3314203583,1778522.6142509873,1163105.3856194257
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0010640809763894313,0.0012382894486783155,0.0007882994428703265
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,33.83544860109537,38.762464204316885,25.349596634118903
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,143215.4233164038,173161.9670193553,113715.82599579572
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,9.81476466210226e-05,0.00012004634991689861,7.712182415946974e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,3.1213450283543986,3.774022604128456,2.4784085393722806
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,3830179.507542228,4411650.242176269,3468080.5341391964
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.0027359637128273762,0.0031703281966386173,0.0024357647663477734
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,84.20039882227326,96.98310722099355,76.24022935407115
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,967000.2100545539,1201296.3029457154,751510.166455742
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.0006911024690305548,0.0008724547632995019,0.000537687918575984
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,21.257960152385316,26.408586754895435,16.520754604311133
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,1,Number,2019,6361764.464742627,7316465.377205713,5050450.152430825
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.0045443864596538385,0.005248246633027743,0.0036300217633192817
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,487,Leukemia,3,Rate,2019,139.85326381959095,160.84084349492667,111.02610627760446
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,3668451.7861399204,4069119.8066823324,3147192.6849966208
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0026210517337609735,0.00296410805503783,0.0022135389939228404
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,80.64507233799849,89.45312090558365,69.18602084456867
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,447470.14349129616,641592.4825036675,344135.8185627827
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,0.0003190592713712892,0.00046118665596563894,0.00025429689942650907
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,9.83691873157242,14.104389311728768,7.565278106406425
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2021,6388843.888343291,6760452.585454382,5901330.36926556
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.011779227476824567,0.012890670628074271,0.010615446054369941
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,417.8675945842542,442.17296737192254,385.98137148902345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,1221565.432474937,1276324.8383547347,1155395.0060769822
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0022534894151054236,0.002505134952599542,0.0020219038494228795
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,79.89749285108027,83.47907687719862,75.56956163304301
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,1169609.2122472462,1245702.620747139,1070935.5982183
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0021562779988062424,0.002363840649893754,0.0019524523499127523
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,76.49925349045876,81.47620552266945,70.04542452487054
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,3893416.7682692893,4137489.4693105686,3602289.201164607
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.007176659938789378,0.0078097088160077825,0.006552125081329699
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,254.65212925911288,270.61590522081485,235.61069104129066
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,9592330.68601439,10065334.259212,8950251.441447234
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.01769316802212709,0.019601445009274916,0.015739253288610658
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,627.3942860827943,658.3314742213977,585.3985644547727
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,1177032.7264751615,1226119.739545667,1122540.7608215376
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0021711887778493315,0.0023990399241256826,0.0019436051397876014
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,76.98479455046822,80.19537105469651,73.42070267253177
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,219094.00288530398,233308.24979268172,207200.26220066176
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.00040418064985990555,0.0004531411322400615,0.0003581002216510107
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,14.33002364333218,15.259718165192352,13.552103741490733
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,753945.2962858337,792795.800026138,716183.9503243429
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0013907825659518647,0.001547448515772991,0.0012509604628309868
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,49.31241284231318,51.8534620258702,46.8426009200057
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,1165667.3758197366,1240997.0721628503,1061974.0050599088
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0021507899341131763,0.002457753271336249,0.0018676253607640882
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,76.24143443352219,81.16843524333868,69.45928414608117
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,5510093.722249093,5777264.833707212,5128361.8723515235
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.01016715229546537,0.011391329937872436,0.00897693799650439
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,360.39221647769773,377.8667629901111,335.4247305474285
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,1048387.7969584238,1106310.8540341184,990520.9742639004
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0019328459328754582,0.002100923030087327,0.0017771379201130836
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,68.57066701939773,72.35917225668308,64.78583983811183
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,426143.42151473544,466242.1071190246,390943.2665262479
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0007855537275129242,0.000874923424204995,0.0006982236250953266
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,27.872261336853953,30.494948882878766,25.569966218817132
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,1893950.19945974,1985137.96729186,1758680.7739300542
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0034943807329239256,0.003912305928144134,0.003091772116100802
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,123.87537212399103,129.83958315582385,115.02796397710921
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,144861.36401828556,156863.66395845517,135020.3359524478
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.0002668552484607732,0.0002846688508567869,0.0002494988362852654
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,9.474776780969693,10.259797090297967,8.83111623800184
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,1977045.9367758587,2062594.5297589782,1873900.403213353
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0036470184831150767,0.0040297037759482205,0.003249887527020061
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,129.3103172375888,134.90569339557376,122.5639986930845
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,2083679.2132065878,2201456.8782275147,1925051.0752190207
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0038426486179363086,0.004234774867014868,0.0034206948757565707
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,136.28475447591998,143.98809962539866,125.90955050902019
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,626491.7207427748,750106.1344567318,565419.2267027114
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.0005674382459168272,0.0006825302442169303,0.0005044131529707001
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,22.10457782175084,26.46607907924657,19.949750147928686
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,1766842.1771728394,2296413.6327943113,1371532.7352032666
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0015997875955796072,0.0020617192612718497,0.0012607482936046516
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,62.33969118979634,81.02462040016806,48.39194370267988
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,395687.71536740166,471708.9227137235,325539.1646383117
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.00035826174794275283,0.00042591441802551416,0.0003000677533501157
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,13.961094149942749,16.643358956088818,11.486034947507024
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,110295.82951451924,133301.83408948028,88539.34612439817
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,9.989388896144471e-05,0.00012197628887222569,7.881755687362283e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,3.891580153729228,4.7033035997978425,3.1239437041136107
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,664086.9458052678,917064.0635764182,400251.7966909135
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.0006015457497977057,0.0008160003849985037,0.0003708853177956954
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,23.43105437460114,32.35687446407453,14.122129144436792
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,2312386.800423005,2704515.0578067796,2017483.7337942459
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.002093542727217426,0.002443636444979554,0.0018568433443387445
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,81.58820346953364,95.42370886323705,71.18310541262757
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,471322.4618912524,637060.6410119274,353329.4642520086
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.0004270085678504518,0.0005805682893574277,0.00032480094758293327
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,16.62972341543838,22.47748222391019,12.466563213343363
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2020,3031396.709655219,3607035.239660742,2359190.8299682625
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.0027443704974325655,0.003275000941151934,0.002184183541106939
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2020,106.95711093791974,127.26742991327573,83.23959530632929
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,2235412.9709552997,2541923.5305427983,1835760.8591380469
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.002024497710026157,0.0023004260254655346,0.0016762383743614973
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,78.87232718997205,89.68697372601464,64.77135679435735
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,80475.66652582597,128800.40158597998,56590.27321686328
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,7.270112105605471e-05,0.00010963425675447134,5.186573017480593e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,2.83943199020784,4.544479050664119,1.99668097256451
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2021,47218244.27205651,49070876.424763486,44674679.07405634
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.1462096153623042,0.160278787926953,0.13172535970436203
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,5564.734655264837,5783.069887812381,5264.972018524578
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,1180879.5564231833,1226806.2642476764,1120268.8134709948
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.003657284753688429,0.004039826311382201,0.00326028256579882
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,139.1682704985855,144.580795817415,132.0252115605176
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,2789176.7663477,2929735.693260861,2632558.439853794
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.008638341836778446,0.009604046967936,0.007724080935308351
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,328.7082959274663,345.2733576691498,310.25061198503334
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2021,1336486.196122032,1402443.4000949846,1260718.0596642536
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.00413934352280946,0.004607593132845939,0.0036744641141928185
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,157.50672576880677,165.27987244910116,148.57734727937944
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,572811.2391691353,606025.7266934917,541928.1446713037
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0017735529467153943,0.0019476970252490385,0.0015990534420514619
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,67.50658781728671,71.42096059063081,63.866972900143246
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,9791451.190305607,10189852.212918155,9296919.021898232
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.030325587015229763,0.033604289920307825,0.027200893934098275
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,1153.9359119346302,1200.8880172363733,1095.6546196480315
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2021,3982719.193144799,4245504.725417799,3700231.2479963265
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.012327430251811199,0.013562420972028227,0.011116961091027083
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,469.3689030152502,500.338537335329,436.0773123960587
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,799221.1785799767,843491.4199559562,752374.4459910456
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0024749683681865313,0.0027561775512264025,0.0022228552951841507
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,94.18930877736128,99.40661726012587,88.66835728197022
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,724997.60758765,778705.3479278255,663447.2363369763
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0022438290382247616,0.002463750682593798,0.002036437145114133
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,85.44195944012765,91.77149008097373,78.188164022204
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,2410221.511774535,2582480.733875404,2224097.643869962
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.007459255932961063,0.008114419273353627,0.006769696586174902
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,284.0479009799573,304.34888585755374,262.1129486354152
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,5749773.29061558,6065524.804804797,5386507.916412162
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.01780322301411712,0.019668308344310617,0.016036066404715135
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,677.6186447309234,714.8303924472805,634.8073236398553
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2020,47156257.68692198,48779883.75840399,44757391.59562546
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.1531588809936496,0.16780241047625272,0.13742079443958316
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,5549.4167159228755,5740.487384026156,5267.114679262463
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,1182971.0389796088,1220390.1441355357,1131985.474936585
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.0038429838070798386,0.004259772749637982,0.0034263136028663413
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,139.21374553830933,143.6172800389863,133.21369050320456
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,2805210.683692704,2911096.515770862,2651804.807327265
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.009112868903779934,0.010154819155088273,0.00812735776630519
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,330.1212569310203,342.58205503792493,312.06823117407407
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2020,1318333.735462446,1377608.7501192184,1246162.5207457943
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.004282937752918407,0.00474930526148473,0.003775924986658792
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,155.1434237490247,162.11899334058927,146.65021065276767
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,578828.9127693264,604223.9338384105,552637.9866712093
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.0018798615227545651,0.0020649376116969043,0.0016994350815924505
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,68.11742495572139,71.10594782277391,65.03523883189118
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,9816617.46516028,10152273.050723204,9329939.82908751
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.0318909146956108,0.03524401554668298,0.028533184645117816
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,1155.233763812624,1194.73419935784,1097.9608345904016
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2020,3947690.846341246,4178300.545000203,3685054.6532427673
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.012816156666216732,0.01399045741585459,0.0116249370190739
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,464.56997748694323,491.7084608901097,433.66256982403115
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,793737.5103078543,829028.0218927246,757235.5861874558
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.002578031323699262,0.002843572818422591,0.002322550048392374
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,93.40818003416356,97.56121855988314,89.11258072639093
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,710285.040085294,759039.741724151,653616.343116805
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0023056649904821093,0.0025307042510548357,0.0021012628733344304
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,83.58737244775996,89.32489636347844,76.91851809730703
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,2419014.7264079573,2578660.1500960216,2246007.0276565105
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.007852573894866655,0.008560357053863191,0.007092068629469871
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,284.67315722797264,303.46046195255497,264.3133606171212
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,5739429.428945953,5996662.282037858,5385155.88119496
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.01864028588030075,0.020654530185539467,0.016696230655696472
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,675.4243694296716,705.6959042132438,633.732945123881
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,1539175.7007314248,1762550.940259683,1149268.949036865
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0010994295194950916,0.001285413104137691,0.0008196989300026109
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,33.8363274107484,38.746876438088655,25.264848206828326
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,151862.763709969,182570.3849138833,121434.48487613902
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.0001084586462858595,0.00013123360455604197,8.53138124372122e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,3.3384610944350284,4.0135192600279,2.6695438261350164
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,269436.05995161296,342070.1417033896,183508.8942597955
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.0002437460997280347,0.00030426786887554236,0.00016488480367375766
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,9.50654279696648,12.06929926993312,6.474764948752722
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,601301.4237278412,877107.6916706691,463581.85980857036
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0005441629029716391,0.0007988143942205064,0.00042642373478131874
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,21.2157857399346,30.94708930168117,16.356610881850536
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,957710.7577260471,1205677.3937623315,797354.5811144694
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0008671205293682867,0.0011077116845114995,0.0007164826224357783
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,33.79101634381421,42.54005104288931,28.1331513349893
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,64700.41049036867,89167.15191025828,45980.217165915245
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.0003477970536730909,0.00047964329029889373,0.0002518314826076307
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,22.203760229289536,30.60020865924384,15.779400926592592
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,86069.11979170775,131178.41833684134,62455.5388289455
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.00046269911640106127,0.0007038652441859417,0.00035436949469406224
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,29.537032060802122,45.017552839826884,21.433369566572065
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,83205.59302906148,118239.7641732821,61158.55980167984
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0004474263264325623,0.0006360105665416581,0.00034397244277082
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,28.55433255138531,40.57729082974067,20.988274842665934
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,4541.8002574896545,8218.911415917682,2691.2276468208192
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,2.4387748513422426e-05,4.338839756369449e-05,1.476556030237925e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,1.5586461223710109,2.8205499322445933,0.9235702361013575
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,1,Number,2019,48014137.629722014,49553665.745212466,45584821.28645483
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.16873843985011044,0.18568233735773487,0.15081221642277476
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,5649.260535473201,5830.398755494204,5363.431368821581
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,1212526.6835336145,1248808.435701542,1161275.3224146245
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.00426224272413158,0.004741828570974644,0.003771967293553179
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,142.66379611605046,146.93264443445096,136.63364945400625
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,2862154.2783448864,2968858.1761469776,2705168.572704427
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.01006087257514149,0.011192269297736089,0.008912820510452078
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,336.7561307834555,349.3107271709453,318.285463698954
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,1,Number,2019,1298734.2491264993,1352856.1991230096,1228999.3883104934
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.0045655195823162565,0.005084077879906567,0.004015725184834456
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,152.80682944341805,159.17472463662227,144.60194611941353
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,590334.7934619373,615367.8124404077,566938.3000571267
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0020745423161042894,0.002281421219467634,0.0018567715132989234
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,69.45777256565401,72.40311435830307,66.70498154648475
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,9990672.032132987,10325848.023663312,9532358.909221169
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.03511930819843309,0.038981855143877475,0.03122180791109561
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,1175.4852220660705,1214.921450536792,1121.5608913174444
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,1,Number,2019,4055171.8262854926,4286110.719626342,3775604.764364009
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.014244598141608384,0.015517412146578261,0.012911173694098005
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,477.12451568881835,504.2963871554574,444.2311378651675
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,822339.8886890465,855584.2814856169,790284.4943033148
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.002890006144665502,0.003206845211466865,0.002592439987909784
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,96.75509150539644,100.66656936426723,92.98350914669871
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,721384.5599288573,767046.7953810752,672289.5779846681
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.0025336291703725406,0.002779024051497583,0.002303999659512621
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,84.87686182627755,90.24940161218468,79.10043101487864
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,2412912.0352689647,2563938.498999525,2236882.254068183
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.008475119960543044,0.009265803491544431,0.007670628612866367
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,283.8990640951389,301.66857706535575,263.18770396045267
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,5817654.095390218,6082449.188597035,5452383.352223349
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.020444197655959263,0.022735876934681137,0.018106399313292047
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,684.4951364861621,715.6504699751519,641.518011497497
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,117961.3140315557,159290.45956610824,80834.7563296538
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,0.00010669452786729792,0.00014173322948415917,7.335233318578319e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,4.1620423058026255,5.620263194487081,2.8521017961300905
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2020,4717456.978447863,5590552.144520896,3828633.911859564
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.02483784504193149,0.02835278467767573,0.021033001198259307
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,1443.6340764276624,1710.8182689843063,1171.6368387837526
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,270943.61999250675,333487.5960192585,204950.65733321925
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.0014267308259068101,0.001681383835098568,0.0011078148990185366
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,82.9140455119833,102.05372510630608,62.71890856964055
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,439180.497368612,520662.06892815576,325467.6840872185
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.0023148906834158205,0.002669694563595504,0.0017379389578169393
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,134.3978195456447,159.3327736621607,99.59947524076705
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,967679.5991612376,1153374.0682647703,682607.0034144712
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0008374673727189402,0.0009976042125347394,0.0005967807404197189
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,33.670323282852905,40.131545377411044,23.75124834710416
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,904549.8137480315,1002239.6469202121,819505.9782866304
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.0007825243899213238,0.0008618478172888655,0.0007051220229675213
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,31.473728164507765,34.87283698855073,28.514635675959823
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,217237.01332994245,287099.40073852823,130603.66654974177
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.00018792626942322287,0.00024160060902363422,0.00011564175459374292
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,7.55874204040324,9.989597430346262,4.544342650674209
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,158242.15715514054,192429.73801296114,118507.2597369367
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.00013694264564637762,0.0001698687975775385,0.00010281302407220052
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,5.506021407300363,6.695575161186715,4.1234492802847935
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,1325933.240510634,1526171.1384793893,1142069.5660958746
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0011471479688668496,0.0013153333595031982,0.0009941301914078472
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,46.135726017341696,53.102985391137274,39.73820625678852
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,188463.48203268187,211302.183518988,167035.2269500382
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.00016304229966574368,0.0001830054004604585,0.0001426663747036542
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,6.557569646557386,7.352240179108697,5.811975467817412
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,556621.3011233624,646539.65198224,476469.9298216912
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.00048132194325910233,0.0005528502080169419,0.00041244781408946774
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,19.367587341089614,22.496288147744675,16.578727696192228
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,640403.5522119175,768508.4766622506,568850.2043892641
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0005540250217359981,0.0006695177857098105,0.00048774039308335023
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,22.282783116594185,26.740182264108384,19.793090913464752
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,1771843.5638447728,2275327.94711121,1344403.6040930557
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.0015326629735884902,0.0019629646922609094,0.0012144383638531967
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,61.651134996548926,79.16982813335039,46.77840063145055
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,404776.5042661248,476972.0056731128,330148.61844443466
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.00035005031629941957,0.00041699748370680183,0.0002888110370342034
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,14.084161501138189,16.59619737959212,11.487491029103705
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,113546.4059846622,137142.26201779256,90823.61868837237
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,9.823060259787325e-05,0.00011961762381757678,7.85437334045943e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,3.9508368270070595,4.771852482870624,3.1601995181119036
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,662511.7757295283,880453.1434374303,403288.3567176057
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.0005734213451302186,0.0007735486875336345,0.00035313737223683977
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,23.05203673493311,30.635286721594746,14.032381543087343
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,2333598.569870033,2712779.8387564817,2015855.6084092143
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.002018325365609956,0.0023593768024194168,0.0017713230448321432
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,81.1973491308824,94.39092675438029,70.14151180362029
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,489190.9728341225,647886.1759838059,374240.2436788217
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0004233647797269301,0.0005666913521568304,0.00032355909404488804
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,17.02135522610491,22.54314032741255,13.021655102620402
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,1,Number,2021,3010944.2460506395,3617236.1790825212,2310477.3318190426
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.002603948164658156,0.0030980487489790463,0.0020506919919995566
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2021,104.76553007735657,125.861402519706,80.39284776436455
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,2248988.6371618193,2565725.4472324466,1837551.2524781101
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0019455717766259527,0.0022152327921650234,0.0016000189317267222
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,78.25335424900697,89.27418263053059,63.93742802202055
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,82206.79978585882,127664.65298211164,57671.1249273416
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,7.094721515541494e-05,0.00010852550646034935,5.0638739002749754e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,2.8603780912998604,4.4420799419836765,2.0066615252326327
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,265101.3906515389,335330.1165724437,178677.64942760402
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00022908282308894463,0.0002838410620223495,0.00015330929410286708
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,9.224178678260973,11.667780783285545,6.217072494720712
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,600571.0249148865,875482.1461538163,462491.0322924475
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0005191786377049377,0.0007646637378806118,0.000402943946929577
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,20.896813966860552,30.462321325070366,16.092333233236225
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,966150.3306638983,1218256.8208829006,806716.2708886256
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0008357187126841068,0.001064194831249198,0.0006891449797869916
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,33.61711252514311,42.389134829567936,28.06961897502164
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,117116.50181277237,159172.90074275527,78120.86006033586
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.00010118764755099452,0.0001351186539652534,6.769332503024846e-05
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,4.075057985319608,5.538406545434505,2.718208191684474
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2021,4809633.322262953,5723472.364197857,3886308.2151732445
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.02461996045404395,0.028130018053604607,0.021009773296049025
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,1429.7070231898085,1701.3539469317318,1155.2402807495484
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,277053.2368784265,342462.1422675536,208439.33523724426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0014185298056245293,0.0016820404584111269,0.0011078861427862062
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,82.35658147348896,101.79997042813653,61.960478383722055
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,446562.0098652264,531222.6768153876,331578.35189680033
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.00228870126018471,0.0026551550162195784,0.0017292469178114911
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,132.74459797980543,157.91074725074986,98.56466526257138
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,1039106.5469330997,1059484.06892375,1000452.3200206598
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.0035460723507119486,0.003948911680498284,0.003144206380325641
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,106.14291210257758,108.22444024991314,102.19445058853002
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,2171575.0166793684,2239217.227398975,2081018.1333579517
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.007410258223903043,0.008261925833809082,0.006564467840143576
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,221.82258094692932,228.7321141877947,212.57235407169873
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2015,894321.056255169,915222.7402897018,857008.9589415891
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.0030519026450060117,0.0034027309351105303,0.002707657541663376
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,91.35332805451783,93.48839843572308,87.54196272609492
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,386837.77399680816,398395.4115608779,372437.45296363696
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0013197180652323429,0.0014594808411657414,0.0011818215037446896
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,39.51480044514001,40.695392860515796,38.04383289692845
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,6306544.536161014,6487666.569370419,5989275.344557119
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.021521557142924978,0.02405552219281926,0.018987822353166428
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,644.202468311294,662.7037664770392,611.7939765963099
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2015,3166242.6082446654,3302346.621487151,3002514.302163927
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.01079735216498534,0.011825433143311864,0.009792537294148404
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,323.426131665001,337.3289180126031,306.7015722323576
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,1326566.5923092505,1371305.1733530008,1284619.9952150923
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.004525898383824492,0.005006780729259081,0.004071600932250614
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,135.50645178906947,140.07641941109682,131.22168043284205
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,477534.11639278126,504241.84143635945,446932.26547559444
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0016282281980461127,0.0017843157511989029,0.0014709278718925034
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,48.77927282034959,51.507420112008234,45.653347397527384
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,1914469.0172500198,2018594.4490231331,1792145.3300301405
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.006527000203130667,0.007088693393981818,0.005890616792730246
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,195.55965383996374,206.19588415239573,183.06450363716277
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,3490041.5755894813,3606989.905585738,3308950.7738952935
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.011906555757514,0.013152924182563667,0.010613927099336548
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,356.50162852451564,368.4476954105081,338.00352060329834
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,457340.2058933221,471401.76445175067,438384.9091174353
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.0015602462724150945,0.0017323191761249787,0.0013994204144102856
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,46.71650026494816,48.15286382025229,44.78024992998548
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,76858.99085354077,79309.89094219383,74548.22841276915
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.000262242856230465,0.0002909633797440654,0.00023343447626704514
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,7.851011173530257,8.101366320892094,7.614970841222961
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,230489.64503842578,237086.6530630088,222793.00052257365
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0007863591450546629,0.0008682707566690196,0.0007012749341178746
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,23.544113167293,24.217985971732542,22.75791442305249
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,477501.40832358145,494329.1813439161,455950.5802268111
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.001629473814809677,0.0018144769962961643,0.0014355375593658353
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,48.77593174842159,50.494859261534934,46.57455243927888
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,1979100.4193583953,2030583.727066842,1885264.5886543028
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.00675401740980295,0.007577151042175299,0.005948837071605739
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,202.16163825946654,207.42056788605402,192.57647265744652
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,457317.1362490528,477386.753505647,436111.26926362904
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.0015593444671248714,0.001691058536299834,0.0014243311576762516
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,46.714143741229805,48.764219959771935,44.548001604856786
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,287126.4146156882,317958.4943423222,263472.8611818839
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.0009786191345456576,0.0010826422402765473,0.0008813889303239109
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,29.329459889201708,32.4789027812928,26.913290873186877
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,863168.3734511114,888722.7580033888,821528.6767899476
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.002945291634941979,0.0032809367482697143,0.002603274641724505
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,88.17113612012004,90.78147170252342,83.917714105093
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,143665.33891491636,148780.02913094038,139271.54989132722
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.00047941655338345335,0.0005201425489149047,0.0004391358060574958
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,14.535817238270118,15.053312987572077,14.091261058520786
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,861222.1398211209,887011.0599840926,823871.4642841857
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.002875077885179791,0.003176073865867502,0.0025781754616031284
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,87.13700688379448,89.74628642952612,83.35792838489256
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,692481.2040902792,723381.3242993806,646346.3461214481
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.0023111258108129058,0.0025461790377719427,0.0020668273703081104
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,70.06408295570057,73.19050512121733,65.39623565994023
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,1487102.2576499714,1523009.349626101,1438889.9530791808
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.004965648512590617,0.005516367042311644,0.0044295406717217625
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,150.4625040046773,154.09552314808974,145.58446415755787
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,174527.98363038045,183795.68173421733,165257.91444387782
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.0005822480751309369,0.0006319775242424901,0.0005330346776322453
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,17.658447696402686,18.59613779531104,16.720517695340078
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,114810.07579462531,117830.00786341602,109607.90996179054
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,0.00038339189351144806,0.00042803954000151774,0.00033642067771125596
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,11.616290272011772,11.921841916935168,11.08994388700066
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,140746.17055575814,146888.91757829857,135058.41672189833
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0004698293990080201,0.0005179662062995973,0.0004227944589845788
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,14.240460695926984,14.861973502947588,13.664983334096378
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,1282730.6304696158,1324482.6900348673,1219400.2801851956
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.004282067071317971,0.004715028746081536,0.003816368893615989
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,129.78452667333946,134.00892980178872,123.37686840083772
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,598512.362755268,615950.899600585,567077.4237213633
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.0019985626401086464,0.0022323210092278323,0.001752560847819416
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,60.55647371568289,62.32087552895874,57.37593948143998
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2016,1875094.8808631785,1941717.3254821408,1792195.1020873762
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.00626076405561457,0.006988222933451879,0.005592970371575566
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2016,189.71894472601383,196.45969156350625,181.33128460924937
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,824369.3724657337,851407.8501244156,789894.2348204027
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.002752281337821908,0.0030351725371109157,0.0024481851997005546
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,83.40830589684569,86.14401356729778,79.92016948299894
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,303384.1377289358,323425.03384785226,281876.42866082466
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,0.0010120540118976062,0.0011032978245059284,0.0009152381720627926
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,30.695896535139234,32.7236006805925,28.519782723768888
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,150460.94191607635,156236.9841950413,145644.8297672911
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.0004970145008670493,0.0005415000659933256,0.00045436915196937983
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,15.084431280377016,15.663507230055684,14.60159293162162
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,868371.8519085189,893397.497239559,830527.6187694632
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.0028695841569329433,0.0031731389444919706,0.0025700832373348635
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,87.05844426544957,89.56738527323431,83.26437833129462
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,699596.4755674009,730847.1564960945,652753.5484182148
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.00231121949334551,0.0025436760942325574,0.002068765406346643
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,70.13790306840325,73.27093376016116,65.44167488748617
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,1492327.264110785,1528492.6625057666,1445699.8711273163
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.004932630443839267,0.005479847879592255,0.004397114579977571
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,149.61296783498986,153.23872253165268,144.9383479882351
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,176406.58296782826,185770.254838441,166670.64658082667
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0005825577903433028,0.000633195086130154,0.0005333581298456382
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,17.685606272946043,18.624359301243864,16.709531940899378
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,116391.34898554622,119580.08346113696,110974.81033998076
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,0.00038473747552604526,0.00042961685804121877,0.00033800168177576626
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,11.668791136387643,11.988477065877904,11.125757150716407
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,140084.87223471308,145904.02424512405,134266.13676658663
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0004628894976958212,0.0005112651636599516,0.0004163629869892463
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,14.044180514459098,14.62757842153903,13.460824367741623
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,1285287.4289098186,1327381.1307023992,1221218.8269099048
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.004247096405801357,0.004687565627056309,0.003791086452328256
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,128.8562310591987,133.07632661317334,122.43304633238385
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,608869.6230834507,627322.6236251306,576839.2898312504
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.002012560006025928,0.002244669301588738,0.0017612867165969154
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,61.04210083460889,62.89210266925774,57.83090625694979
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2017,1867819.3942643462,1935215.7188077238,1783711.8347749398
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.0061732914129821286,0.006895285121498245,0.0055081298974786865
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2017,187.257855348608,194.01466022552842,178.8256689943194
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,838363.1869916857,866685.3671477422,803252.8552300107
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0027706287479346034,0.0030562145974980448,0.0024634419619001605
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,84.04993163759224,86.8893660770814,80.529952432719
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,310911.8310996645,332328.2780763002,288630.66576016456
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,0.0010266356520627054,0.0011200015497332366,0.0009272340611424848
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,31.170402702217643,33.31750425943831,28.936608980536192
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,38962.74738660708,41873.47887444771,36230.929511452574
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.00013002475244584214,0.00014453038903188838,0.00011672715342083423
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,3.9421852159345305,4.236688129834921,3.6657844802984836
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,336332.20764581475,346317.31133009796,325515.16719321196
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0011228815272646697,0.001236180734170865,0.0010067668246781633
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,34.02952680589746,35.03980279421965,32.93507685529986
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,298549.47444398416,307737.3635001974,290198.4430306895
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0009967753177106385,0.001102901355599789,0.000894271740450646
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,30.20673343950729,31.13634859327595,29.361790133825224
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,51940.889249610475,55535.10720158773,48422.51769548739
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00017339594319850602,0.00019399917709573324,0.00015417229001375704
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,5.255291770638617,5.618948694842107,4.899308857339325
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2015,461427.91847901134,588462.9003012867,369659.30026941036
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.0024706615738795496,0.0030596806651565943,0.002043301096019699
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,162.84475047033277,207.67727812501255,130.45824515741353
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,45970.43405168844,57908.55749865431,36307.81554553905
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.00024617591785026124,0.00030244471143533135,0.0001988530402930254
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,16.223647426527787,20.436788105603558,12.813566162458176
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,204142.77003109152,289470.370316894,158398.98099139432
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.0010925140276298857,0.001493814625016061,0.0008879753294779495
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,72.04500879707334,102.15838343330228,55.90134775399782
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2015,344823.3666057724,410280.5112438502,285809.4674967426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.0018457470986687023,0.002087436336448447,0.0015994829269387128
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,121.69327611634567,144.79407248823486,100.86639657605102
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,618081.4003088818,757319.8425175219,496697.0334269175
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.0033072974506259244,0.00393402399544762,0.0027936123080646606
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,218.1300857031513,267.26939537492916,175.2917437990696
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,1747295.5655997694,1910423.1314669107,1584937.9058165345
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0012513886237685617,0.0013992418642896516,0.0011158985221652493
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,39.180633250901636,42.83853833415458,35.53999222331563
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,25714174.3798766,28863510.72834059,22815075.682912026
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.01841754562806309,0.02079696404288274,0.01599615424688051
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,576.6040134039065,647.2234294215656,511.5958230094291
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2017,9449015.633433025,10272745.026782155,8679536.337551538
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.006767994472267838,0.00753957300382962,0.0060901816482692665
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,211.88081936698325,230.35178666879816,194.6263338181996
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,5208288.686266341,5723444.180206858,4743893.50891866
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.0037315412520840204,0.004197177356488292,0.003270227664100971
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,116.78851185739471,128.3401456351305,106.37510642938892
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,961582.5558643562,1136173.1637706845,811873.8296048379
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.0006887781764730867,0.0008291445603698534,0.0005865688319080398
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,21.562129615348535,25.477077213284975,18.205123042725326
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,2106188.338356945,2535437.6250712657,1687806.5590027713
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.0015083209369169178,0.0018231365773796618,0.0012206035364316112
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,47.228296383939714,56.85360489331707,37.846676365858315
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,11970511.47196608,13119846.975133853,10929149.674696505
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.008572245755618619,0.009549081346280495,0.0076707843077727135
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,268.4217994039392,294.19402347319635,245.0707330682823
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,3849701.0358305005,4132669.2150995405,3494048.823313985
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.0027577031797047544,0.0030536350910048728,0.0024357972552245073
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,86.32410416420674,92.66926560792041,78.34910601402356
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,1918698.0287453665,2130246.71706949,1736242.1521742262
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.001374058592257362,0.001530757844995945,0.0012101772780252905
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,43.024091209031134,47.767771519975916,38.9327760788678
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,33875.59019658908,43942.63189118833,25212.401901871643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0001813326966798188,0.00023501625122965524,0.0001398455252898743
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,11.955197792934856,15.508005993477257,8.89783026133643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,137182.77068720706,176000.68386128964,84916.72138083159
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0007342406762018836,0.0009220645440816785,0.00045894192085920235
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,48.41383272824922,62.11324954171208,29.968369381726678
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,194169.16181867674,238301.61193259546,158134.04631968364
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.0010398745794150247,0.001230487343785297,0.0008751477975635926
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,68.52517465701254,84.10017031426479,55.80784838220454
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,52469.7149595048,63060.460061267986,43384.17153016966
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.00028081734400466844,0.00031896870771420553,0.0002441916905436004
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,18.517339973694497,22.254970867543342,15.310917056081733
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,23374.51540200173,30572.58754121873,17948.35329490283
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0001250700977122758,0.0001580202362062962,0.00010106882628061923
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,8.249212879339591,10.78951920766498,6.334239859816308
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,11824.030251791053,14556.325655547053,9200.55796203133
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,6.327929621939713e-05,7.479055048063512e-05,5.008502743178038e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,4.172875499717219,5.137143038409979,3.247013250636186
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,12938.182827168515,18224.392827197844,8745.4537740103
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,6.932317699609633e-05,9.696891364628979e-05,4.7488826511670685e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,4.566076454529997,6.4316583014760615,3.0864002383577387
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,54171.40097524256,66127.60942071547,42478.08521757365
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.0002900697770452057,0.000344683898249537,0.00023347566051897125
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,19.11789018644519,23.3374133295011,14.99114576880105
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,23063.1403051268,30799.88810065251,15522.653535849324
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.00012340715193633696,0.00016227543404298417,8.5601387788972e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,8.139323993291223,10.869736943524508,5.4781744676721145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,6828.010671603257,10408.452313056783,2027.529526507311
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,3.654061609007039e-05,5.494735669621044e-05,1.0947148064929152e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,2.4097061523523227,3.6732970672627077,0.7155452164742238
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,54167.04576281686,72285.84344919675,37995.05771438453
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.0002899134340613445,0.00038095876638676214,0.0002128940461473485
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,19.116353167438938,25.51074537887418,13.409018927592852
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,10671.908602048825,13771.501979635124,7900.0869373697105
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,5.710094008147561e-05,7.209784836533845e-05,4.3243408145831564e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,3.7662746958859747,4.8601671326425855,2.788057753961895
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,48683.52175447053,60977.173597410074,35947.302514017065
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.00026045453946419247,0.0003115084957174537,0.000201584984095281
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,17.181136282902145,21.51974820159927,12.686335771083037
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,63825.06485968403,75927.80662339435,54128.917072538214
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.00034185562587227855,0.0003913864821209385,0.00029773969637736754
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,22.524811231812784,26.796048154396043,19.102896987599067
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,1730592.7006227933,1875928.2324843793,1595165.1593338535
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.001239919861145478,0.0014014542836106008,0.0011060558119272987
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,38.8060951133441,42.06503898311746,35.7693239271871
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,2286111.0150570874,2713896.05605654,1747543.3353727073
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.0016377624947604013,0.0019389990336886203,0.0012447648929675508
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,51.262808087681634,60.85528295661901,39.186189137836415
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,4710170.31355489,5221174.299623413,4255426.1379118115
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.0033736314339935618,0.0037847137854065483,0.002959632752855451
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,105.61891144119718,117.07745352307272,95.42191608469643
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,383726.29198588093,476136.6848553286,264382.4123740814
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.00027483350066442836,0.00033576954758052376,0.00019335501959672025
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,8.604519699485682,10.676692137207594,5.928401892133139
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,578085.7835782452,680921.2322763894,470300.9507450415
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.0004141637136996355,0.000494282904875054,0.0003383213795935525
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,12.962756570703398,15.268696149535243,10.545834048612576
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,2259567.127065708,2540282.532755685,1980707.592195562
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.0016187920420148699,0.0018751161846989294,0.001389485064319539
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,50.66759891934259,56.96224509984822,44.414568018692485
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,238696.12143241108,259530.7686513703,219124.32415301356
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.0001709383921194925,0.00018844035435428263,0.00015308513701596546
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,5.352423125417686,5.819610639464715,4.913553236223036
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,1386991.6751265267,1498942.3206552006,1288413.0781280147
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.0009932944168401963,0.0010933096565515989,0.000901753626363945
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,31.10132779770008,33.611662781097685,28.890842101159436
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,1733776.8951352525,2000570.40372487,1549737.6564822942
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.001241499380345675,0.0014278207057466844,0.0010905950813349585
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,38.87749617441719,44.85996349109184,34.75067638765634
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,4569777.403646159,5679619.688187232,3610400.6094570914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.0032732778282655566,0.00412628209751339,0.00260261318759799
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,102.47079888230512,127.35744334764513,80.958130354674
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,704628.8102578139,784054.9675283004,592214.8846695104
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0005044004464632344,0.0005674112078452754,0.0004242818959772723
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,15.800305075034066,17.581324382706352,13.279581691147028
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,244958.01525811089,268624.8941340991,219159.78148592077
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,0.00017547552812501447,0.0001986671035841241,0.0001529927848395558
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,5.492837243252755,6.023533548840478,4.914348316794432
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,575812.9337765755,846704.0628402592,405819.6187422655
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.00041253356493741936,0.0006110301647888931,0.00029086968729190424
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,12.91179112658115,18.986141790387503,9.099931323012067
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2015,18888677.8139542,21169611.85712377,16624523.56680974
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.03002349984672709,0.03295148614821698,0.02700609687890554
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,1572.2210681478919,1762.0772662920322,1383.7615558432633
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,988937.0674272202,1121677.438852069,844772.8705265572
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.0015720242632012253,0.0017545533704441377,0.0013752858228132062
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,82.31532708619876,93.36412629827211,70.31565247306114
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,1095918.5706669616,1240225.5675687804,841058.5853848739
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.001742197860363564,0.0019148246749805448,0.0013644113522360592
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,91.220056943542,103.23161768087321,70.0064896290346
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2015,1462491.5711630879,1742248.2174437637,1257154.6829818052
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.0023248041749841706,0.0027266979974514428,0.0020584991463854056
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,121.73218701801585,145.0180568692099,104.64073229332116
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,219157.76058458124,244143.77163715026,191664.15316750266
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0003483808861999825,0.000384885068514842,0.00031219351348703273
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,18.24185111488532,20.321590807242398,15.953388722425832
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,1309947.1939283854,1442766.8325895893,1200725.8416635664
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.0020829772869608476,0.0022734863673462397,0.0019208308400972247
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,109.03497834739495,120.09037546008582,99.9438120511766
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2015,1988193.9783242578,2234453.5154683385,1761458.1093622954
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.003160454652671025,0.003476823277676186,0.0028694670263925267
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,165.48963834709954,185.98733735725727,146.6170145669714
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,2042436.204094494,2406293.100651131,1748234.561636843
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.0032451455729775253,0.003764878057792454,0.002862867203117933
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,170.00455310075188,200.2906051045948,145.51633719111734
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,139461.43285139403,170923.2842736715,109368.65356443908
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.00022163441421521263,0.0002702167847109817,0.00017668303239687052
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,11.608234577492256,14.226998375374425,9.103427091225411
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,890130.946625834,1086158.9640493284,547684.3939179617
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0014152636120669064,0.0017330650865751093,0.0008781306687799379
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,74.09108469528132,90.40770473486896,45.587147565061215
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,1123447.9990083766,1231718.9532667077,1024429.5100090734
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.001786304432403196,0.0019326352375815272,0.0016418394533140764
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,93.51150093230369,102.52355974499977,85.26958182741711
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2016,132007544.31542963,142146281.76943588,123057910.21074542
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.09498140554580066,0.10431209628105503,0.08499767763312971
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,2992.26361387348,3222.0821089569704,2789.39896225222
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,8476810.886945399,9538723.98084768,7501205.368016223
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.0060991472435156,0.0069279853473385375,0.005229891335009877
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,192.14699364518464,216.21776875472668,170.03258411711724
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,15806149.709549181,18154630.694778793,13218239.193261612
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.01137221858217173,0.013254865681055494,0.009569721320837167
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,358.2838154939646,411.51769872706905,299.6226949193388
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2016,8610622.120110946,9582466.928780297,7746181.039682012
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.006195908462601513,0.007047160807308106,0.005439888821991765
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,195.18014213836537,217.20930626223145,175.58553786995876
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2016,19403523.60218988,21729902.248025384,16950358.254433766
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.031091033577745016,0.03408872945856392,0.027802498085616113
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,1576.1146236567618,1765.0823327717362,1376.8482502847594
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,1017923.0894011479,1151368.8784796433,873831.2257468391
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.0016311920150597914,0.0018178597887500325,0.0014190938689806023
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,82.68412994750857,93.52370032370025,70.9797973679414
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,1113306.0539171048,1254479.3807528885,854035.0936562517
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.0017841690617419346,0.0019593136850026053,0.001395759998065512
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,90.43192299291036,101.89918788035797,69.37179183660099
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2016,1489189.8669324506,1763034.2002367422,1285651.5359575795
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.0023862909723555564,0.002759713163069895,0.0021092992582575415
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,120.96431425521101,143.20821526903103,104.43124807088269
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,224251.06893529012,254238.07222947426,196514.98028859484
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0003593348550139235,0.00039759340774495153,0.00032045367668704034
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,18.21552602330853,20.651318376315658,15.962571569501867
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,1345154.505339213,1481561.2279833152,1223829.7391138976
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.0021563101087995764,0.002362246104586992,0.0019901736403882667
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,109.26457124022758,120.34465312289119,99.40957056200654
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2016,2081433.0737278953,2321345.830261389,1864828.2010699417
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.0033358614588124952,0.0037206155492270545,0.0030042643424626455
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,169.07120443294812,188.55890222055856,151.47676569332756
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,2094944.1517509564,2421815.494943114,1796424.4789897443
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.0033555423974958166,0.003864317459877543,0.0029753003936105436
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,170.16868590539102,196.71987911245085,145.92044979455008
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,144714.48504091258,180013.52583199364,113406.26729773165
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.0002318378429235986,0.0002804648783709901,0.00018377969437909954
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,11.75490703668884,14.622186997406933,9.211794721764338
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,919767.068521031,1128574.5875775334,545384.4166396739
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.0014738867541720913,0.0017919268410325861,0.0009044654371892517
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,74.71108633538603,91.67215954362014,44.30063179263426
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,1159356.2851079523,1270744.6496131537,1051143.9948224982
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.0018583715555466037,0.0020216852941954207,0.001696768401747692
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,94.17250353336817,103.22038750543427,85.38260657057924
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,38814.48928839891,42054.48922416049,36018.886139310096
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.0001282149590717099,0.00014338329569199836,0.00011484124062623948
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,3.8913387680395988,4.2161643058637805,3.611066140122938
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,342427.5333025019,352697.3623510577,330786.844698737
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0011316435655120746,0.0012477961809214256,0.0010138648241946081
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,34.330003048177794,35.35960268095535,33.16296816813761
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,301072.79750052426,310145.20777209324,291976.26666550944
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0009950199362876286,0.0011001419520856384,0.000891543544671785
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,30.18399238003356,31.093545035666974,29.272021522193626
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,51151.22644229416,55057.688141595645,47537.065088169635
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.0001690276938728676,0.0001899930340204702,0.0001506623787338096
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,5.128155854601542,5.519797381645859,4.765818839504999
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2017,134806444.716713,145826042.725308,124900991.46179953
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.09654879832417487,0.1067730167439008,0.08696713285018506
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,3022.843973446741,3269.9428825536966,2800.7281855940446
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,8597910.920687992,9862811.22379398,7508763.464479493
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.0061562060418665545,0.007116281911352944,0.005337479379835149
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,192.795999222813,221.15960057948374,168.3734070306275
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,15825930.928842202,18269375.019657463,13418923.604917057
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.011333655747823588,0.01314520520774879,0.009585748561084923
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,354.8741310770881,409.6649109978586,300.9003941503457
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2017,8648718.02874164,9919286.843250431,7715169.653116928
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.006193881947277369,0.0071126698767247165,0.005404562449797867
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,193.93527680491204,222.4259865173323,173.0017740550375
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,142306.0832493126,181061.0416983553,90684.93766329689
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.00010190580685719223,0.00012918701822094906,6.487995783908238e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,3.191012766778077,4.060037929744517,2.0334815436602396
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,662111.6146978744,901275.56992537,525601.6971382425
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.00047405193358030726,0.0006355287338880751,0.00037737715641607
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,14.846917062789542,20.20983069977747,11.785875118704455
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,1063674.5318206903,1084143.400345028,1022583.1362769783
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.0035160068614278374,0.003908086906886352,0.003117655683336427
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,106.63847491321624,108.6905771844799,102.51886536936772
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,2237216.170753625,2308929.1922909794,2139404.362983602
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.0073946622037737685,0.00823315516184332,0.006562730128523564
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,224.29165441423754,231.48122887464334,214.4855514221446
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2017,963409.4129610116,987428.0762739889,922151.5190386222
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.0031845279832635647,0.0035412932486332,0.002818843310504248
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,96.58641571434947,98.99440194371395,92.4501139092438
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,138192.95123387157,143690.2300200528,133613.73710588657
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.0004712801913967846,0.0005148354565746882,0.0004312791277634754
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,14.116167701286743,14.677705091968363,13.648409005972809
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,844503.4811193242,869330.5967564574,807818.0902531033
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.002881075869738331,0.003185262348389966,0.0025832659857658495
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,86.26455009001153,88.8005964277143,82.51720172650172
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,672705.4579903259,702896.9053979288,627768.1044921163
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.002294345004545007,0.0025328415470061054,0.002051349500406301
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,68.71568320797851,71.79968663177864,64.12541132819794
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,1471448.637905764,1506822.9400902987,1426506.7555205787
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.00502110575229031,0.005569784035957296,0.004478407047943284
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,150.30589875279142,153.91932170594757,145.7151642551457
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,166501.7079250414,175128.204992457,157575.4536372841
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.0005676496195921536,0.0006168035412769696,0.0005209988532504108
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,17.007857568964532,17.88903912121471,16.096056342163404
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,111053.20471186575,113852.5099148204,106095.5233154021
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,0.0003789788455580343,0.0004247068896252063,0.00033326697211684875
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,11.343890172987281,11.629834291983018,10.837471709692466
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,141529.87105404556,147204.24932725474,135685.30633650956
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.0004827964818959589,0.0005335716645420879,0.0004358736776770276
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,14.457028210934627,15.036656003741523,13.860016171195086
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,392120.64636500867,403506.2778985315,377438.82038238365
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0012957527509202106,0.0014294953994576044,0.0011562993930557587
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,39.31197604099271,40.45344022607615,37.840052548523225
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,6272486.150298083,6457102.86255393,5948516.074778329
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.02073357785289695,0.02320414308956304,0.01830050410923088
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,628.84682952512,647.3555406482095,596.3672751713933
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2017,3294145.02421106,3434809.0192165286,3120880.7044599326
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.010881210159423607,0.011880152466789869,0.009863322228000692
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,330.25384270838697,344.3560830590209,312.8832633982763
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,1380837.555297573,1427385.5262315236,1331564.4049461237
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.004563315709162742,0.005049151518104397,0.004100816739568958
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,138.43558964204846,143.1022470473026,133.4957199258354
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,529627.4992578996,559108.4019810962,495004.2048507717
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.0017492119831941197,0.001917042028357903,0.0015764094938627675
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,53.09769774809646,56.053299684043274,49.626546374633044
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,2015967.5572795053,2124932.327840358,1896170.7637729803
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.006657253022261561,0.007234122379531534,0.005998638509700424
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,202.1104194483517,213.03466046781816,190.1002161607324
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,3662793.8271337375,3788920.079895759,3475910.902284948
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.012103747195825956,0.013359220270197269,0.010831182843842378
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,367.2126538354766,379.8574157797522,348.4767440275364
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,472304.1131174644,486836.8422790645,452614.5073308641
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.0015607342001288692,0.0017247299029871312,0.0014011223171673283
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,47.35075327212589,48.80772909297893,45.37677582892112
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,78649.90066424239,81057.4116350796,75974.40235121993
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.0002599339957302003,0.00028748306688555113,0.00023172550889555401
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,7.885029873334072,8.12639439846513,7.6167983314495045
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,246870.0640572559,254125.1398791368,238414.93316180893
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.0008158289996248098,0.0008996875462142833,0.0007243312022388656
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,24.749908308636368,25.4772644668221,23.902240871926413
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,501889.0342925368,520025.60325290624,477145.05972241325
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.0016589691702680802,0.0018488339217593882,0.0014616529466302006
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,50.31678355691347,52.135061607419885,47.83608139425784
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,2107079.7843975057,2163927.2130416064,2002447.1045024956
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.006965240825149011,0.0078049460193641475,0.0061210378320488605
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,211.24485733808726,216.94408479159065,200.75492919156332
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,441892.18017704575,461240.0382846395,420926.3149441426
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.0014594972852605174,0.0015839254406601745,0.0013324537693173051
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,44.30181109018046,46.241526688991925,42.199882514485516
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,301959.54831937375,334783.90539740026,276932.1089652266
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.000996903161776795,0.0011033818937446803,0.0008986566356548045
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,30.27289340390999,33.56369267952684,27.763772536701772
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,899841.9769895469,926499.9735479511,858547.631114946
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.002974085392514577,0.00331097257662761,0.0026313253707564424
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,90.21347528628687,92.88606733600358,86.07351899808977
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2015,1257014.191391889,1296667.712955174,1197478.1885979613
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2015,0.004288160333580032,0.0047236185593963345,0.003830448400363469
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2015,128.40179596827426,132.45233367903361,122.32029765595395
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2015,583053.53342692,600257.901565338,553897.4513199353
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2015,0.001989639057255441,0.00222848001611514,0.00174701069650064
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2015,59.55789628338786,61.315292327601256,56.57965360993806
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2015,1850005.9972030919,1916252.9014910785,1772938.221281615
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2015,0.006312387259388535,0.007024086821146679,0.005640494268840536
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2015,188.97486935284564,195.74187448784497,181.10253115064873
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2015,792691.8252006157,816315.7327073894,761559.7073473616
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2015,0.002704544089445188,0.0029811733558343352,0.0024082102896673765
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2015,80.97208026937565,83.38522100591686,77.79198900864978
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2015,292958.9399745944,313082.60107642406,271768.4116992041
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2015,0.0009987141158220726,0.001092132303207849,0.0009001860193168146
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2015,29.92524212956354,31.980838832151793,27.760666815530072
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2015,1661625.2663224177,1802423.5382057554,1521784.6790002026
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2015,0.0011981330885442582,0.001332785530619577,0.00108330848846904
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2015,38.085849578281085,41.313064469938965,34.88058562278045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2015,24424622.20524308,26737813.78348217,22127436.14062141
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2015,0.017611936307429434,0.01975370004745438,0.015590422731656669
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2015,559.8328974462829,612.8531952716452,507.17945946375835
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2015,8756751.436636342,9382723.390092496,8085998.000880212
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2015,0.006313810727331553,0.006933264356007803,0.005705567341844069
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2015,200.71211287504292,215.0599168852209,185.33787960109711
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2015,4968126.184268054,5349296.315488398,4553378.1166122295
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2015,0.0035830785768753764,0.004008954075796439,0.0031668955801394684
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2015,113.87363346895421,122.61037368085648,104.36725869374226
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2015,911894.28305958,1052368.8974773737,754558.1538775397
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2015,0.0006575407909396608,0.0007811310960628608,0.0005366359875744165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2015,20.901384445584533,24.12118083573222,17.295107945878566
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2015,1955843.1646326138,2345932.8301142985,1586190.964273757
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2015,0.0014102007637726871,0.001694919343577991,0.0011486197203569811
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2015,44.82957143024876,53.770754874371114,36.35683188753151
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2015,11248655.167569157,12149725.372906107,10279344.60096737
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2015,0.00810988870037052,0.008999410861980129,0.007334120170426355
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2015,257.82864364970715,278.4819311240176,235.61122966205164
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2015,3604349.501126713,3857170.5727278814,3308634.7266269135
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2015,0.0025992270833395566,0.0028715254400102424,0.0023203178430532124
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2015,82.61472409557584,88.40959583854902,75.83669258152617
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2015,1846522.4626265734,1997336.1501461838,1691451.562843626
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2015,0.0013313863904822682,0.00148802171356706,0.001202631138217353
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2015,42.32384893265517,45.78062557997363,38.76949339726205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2015,1602399.815906497,1725568.0757389371,1484795.1881039026
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2015,0.0011557751591401038,0.001295099026524913,0.0010293664475254922
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2015,36.728352408814594,39.551472586313565,34.03275535996094
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2015,2160745.690272211,2588192.05809361,1621602.0215390567
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2015,0.001558324750059298,0.0018313798720828557,0.0012045766757152075
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2015,49.52610977008242,59.32354027236366,37.168483123070935
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2015,4363700.494698749,4716763.727953844,4007755.460896805
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2015,0.003146804269683738,0.0035041809022363034,0.0027936972777237107
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2015,100.0196879610514,108.11219441597314,91.86112821218533
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2015,378641.6569216653,462574.7754930903,271395.82823152735
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2015,0.0002730284859638179,0.0003300100649478178,0.0001969457152523812
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2015,8.678785452935832,10.602603171248665,6.2206207980189205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2015,554725.6790371838,628209.5084704685,437448.1611497997
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2015,0.0004000908431717467,0.0004742787081978822,0.0003150546811846904
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2015,12.714779437471876,14.399090654300167,10.026680023180479
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2015,2083810.1042016724,2326124.3171810014,1854221.5817841913
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2015,0.0015029540926447653,0.001737337473525696,0.0013167432547472172
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2015,47.76268138602527,53.316727086495284,42.500319223559664
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2015,226391.36064062663,245853.14357724355,209210.85331596027
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2015,0.00016322008091464009,0.00017941420539379635,0.00014860797375683963
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2015,5.189080523711914,5.635160968245389,4.795288836195033
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2015,1315167.5509292309,1406084.1155826086,1229756.2730226817
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2015,0.0009482642892772,0.0010448746545010726,0.0008668215065411457
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2015,30.14474715215831,32.228631332149305,28.187048777820763
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2015,1624778.3295176357,1871817.9462817712,1469026.7649906175
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2015,0.0011713428099819356,0.0013549677503228177,0.0010445189193804012
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2015,37.24128677521697,42.90364270747773,33.67132983102178
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2015,4383870.678003539,5442949.614565316,3491994.881237014
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2015,0.0031613274585880406,0.00398993845669112,0.002531783197326597
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2015,100.48200553823483,124.7569861171536,80.03946164665159
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2015,668034.2672779968,738160.6250063959,565622.2685898659
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2015,0.00048143801508241903,0.0005374136612559107,0.0004026833309568812
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2015,15.311907643892408,16.91926278349481,12.964538440919286
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2015,237522.4412158964,257140.4692216533,211420.09076423317
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2015,0.00017130591108109554,0.0001913569181554011,0.00014980555975626955
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2015,5.444214258751782,5.893875971770528,4.845926417870624
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2015,571573.5796307258,847153.3331063397,404002.314251426
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2015,0.000412269834462059,0.0006108053801957432,0.00029393803277741456
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2015,13.10094749877949,19.417467384711134,9.260073063231598
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2016,78700691.34382704,81095714.76016685,74569341.7609728
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2016,0.1641652371819746,0.18193909505100417,0.14564476444171406
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2016,5224.576254750133,5383.570823373589,4950.314992719363
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,2161029.891664319,2209617.9990122365,2071225.437703358
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.004509024604800471,0.005025769119696242,0.00397369047712028
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,143.460816735001,146.68635729352232,137.49911284493677
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,4823198.594612192,5000486.178190628,4540696.587041116
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.010063138599165047,0.011260753288028015,0.008796684968048883
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,320.1899299621793,331.9592357155344,301.4359234156936
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2016,2908405.86140444,3009734.068569283,2766563.884819638
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.006068615610454179,0.006764301040601493,0.005311834152750491
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,193.07566354512844,199.80237631029348,183.65942831087574
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2018,20245968.620717198,22808871.33888661,17530493.707078364
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.03326370866169302,0.036740842477130456,0.029749559796127558
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,1567.672070135248,1766.121010021314,1357.4092637952006
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,1073249.1848013368,1237043.6605709763,910358.0967604261
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.0017634644592469204,0.001983837436111657,0.0015456254210162131
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,83.10310081123089,95.7859232395812,70.49022888697165
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,1146571.4450150097,1294817.0416094116,883276.1469908747
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.0018842866215153175,0.002079357509668584,0.001483994031629388
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,88.78054018741081,100.2593923804233,68.3932377746231
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2018,1522772.4112226136,1803725.7928525298,1307163.2775415424
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.0025020446694414564,0.0029027150703095934,0.002205694031869684
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,117.91027749610474,139.6648686269325,101.21537772272481
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,233903.8944342084,265437.9605773246,201327.13507021184
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.0003842918668964036,0.00043212165157885645,0.00033885453271550645
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,18.111487243201257,20.553211602082982,15.589025772121206
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,1407111.5768786387,1562966.7611857522,1274339.3067760132
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.0023132240432998485,0.0025491934426315676,0.0021102095283237476
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,108.95450644823067,121.02257906067295,98.67377434656423
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2018,2255549.630890061,2552566.113217779,1965188.0451435442
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.00370682008533709,0.004151755021275284,0.0032619813526739913
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,174.65018470550982,197.64856292281684,152.16710391335607
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,2170995.5549689247,2554785.5354107963,1813855.0796109643
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.0035654063750036025,0.004113690030856799,0.0031130869420606653
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,168.1030510157924,197.8204157123283,140.4491926688724
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,153964.89503806335,191368.39043385797,121250.48769114917
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0002529042814294971,0.0003072895177222678,0.00020414769129422177
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,11.921705019610291,14.817907031768833,9.38858528355057
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,980491.0575243882,1199836.3640911214,590654.5131773271
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.0016108622823473966,0.0019555891117693193,0.0009905173498876878
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,75.92071659764846,92.90491316841947,45.73515847791658
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,1228238.1463077199,1357052.0632067206,1102006.339236249
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.002018888421171635,0.0022270734067482197,0.0018361517789904475
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,95.10410064900564,105.07833223803677,85.32980523168754
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2015,38403.78199926492,41466.023228004175,35468.22979582455
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2015,0.00013097034346171995,0.0001460277424319517,0.00011760397673939144
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2015,3.922879005223875,4.235681578298107,3.6230174939842903
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2015,329770.8015007175,339050.503944245,318200.5765330978
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2015,0.0011251146182183279,0.001240388546352214,0.0010089409692081775
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2015,33.68550924926548,34.633414585545495,32.503631052684156
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2015,294334.1360350119,303402.70515157713,285472.5943070829
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2015,0.001004246930841883,0.0011091398098293105,0.0009003097379159399
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2015,30.06571599626708,30.99205443333761,29.160525044004302
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2015,52463.01798656424,56346.69368984798,48443.07952733473
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2015,0.00017897671660484576,0.00020169876910452425,0.00015909675352962879
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2015,5.359005313958776,5.755715978543879,4.948375647737222
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2015,128952636.45944288,137665600.91625085,120367886.86990014
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2015,0.09298039569066714,0.10230592511291761,0.08404193576252207
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2015,2955.702958096528,3155.411436541458,2758.933272318839
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2015,8337497.041748439,9294886.182604412,7391897.976297941
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2015,0.0060107181377997065,0.0068051381707724574,0.0052370557677641205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2015,191.10244928700996,213.04661416313874,169.42852286205962
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2015,15672102.740505915,17677369.0981,13152885.931285068
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2015,0.01129891056949443,0.013029652635194207,0.009524160931889427
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2015,359.2177849289253,405.18017753790787,301.475215412385
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2015,8511004.057805257,9266227.07610521,7754396.694256325
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2015,0.0061367482645305,0.006894464420403293,0.005485690420031624
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2015,195.0793761237944,212.3897233218047,177.7372985675705
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,1704404.2000835072,1855363.6293849184,1562960.912050432
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0012263942584229807,0.0013674781495445886,0.0010919338069852718
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,38.634357586840586,42.05621055601911,35.42821049575704
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,25142594.116982862,28080149.743230283,22632826.717160404
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.01809272315342852,0.020363878852542948,0.015683702271799462
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,569.9164386761771,636.5030937020903,513.0266168957651
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2016,9082260.10329776,9821728.149506724,8438643.318787029
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.0065336788233293095,0.0071971835866392764,0.005871384049771241
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,205.87093396643215,222.63272845149604,191.28183532394948
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,5094617.440146026,5584063.715683499,4663005.543049642
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.003665809507590811,0.004127700938911499,0.0032358287341195746
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,115.48156941945616,126.57602836747763,105.6980636229206
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,931950.0672531992,1114875.1788449115,765425.3160279884
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.0006704225431188816,0.0008044798004196602,0.0005609824709045167
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,21.12485533042933,25.27128619025747,17.350177477852323
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,2036477.9788245389,2422380.9668208067,1638333.2872926993
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.0014651905161187737,0.0017561518003146887,0.0011818032043188083
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,46.161596203399824,54.90900132675475,37.13670387845148
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,11612180.575553853,12621387.482853808,10640987.340535793
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.008354183141035244,0.00921980917294089,0.007457741123739373
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,263.21757286031766,286.0936374310489,241.20317819632305
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,3727556.6952200774,4009531.312130269,3407596.268021145
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.0026823854424440708,0.0029954349039351966,0.002380551814307562
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,84.49390014487086,90.88552261305466,77.24123932800809
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,1882514.2933752583,2061600.516099338,1729929.2079918282
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.0013545078162988215,0.0015173728144872028,0.0012031541216277009
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,42.67164465391182,46.731058006249064,39.212942339734695
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,1665066.2352241613,1812225.4023366442,1541035.9412566684
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.0011984159796315013,0.001351434068316832,0.001067003833735674
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,37.74266945262921,41.078380479465864,34.93122910971856
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,2218918.1513214926,2648404.4588567233,1694302.0156324443
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.001596772222103937,0.001887275574151452,0.0012199005579987914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,50.297034770206274,60.03235904548964,38.405367652134096
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,4532330.639783469,4935899.673384795,4130294.438948269
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.003261427573509143,0.0036282325660503844,0.0028646998719065765
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,102.73600747440635,111.88385535835614,93.62290487517475
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,378455.37156206265,463458.94214173534,270219.50465162273
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.0002723106392723265,0.00033140904926765935,0.00019499361624627875
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,8.578587259332606,10.505394493070003,6.125165010235382
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,566502.7636722525,656215.7751804448,454295.2576928495
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.0004077022709033732,0.00048301457855663037,0.00032402257078456543
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,12.841126737762618,14.87468460310351,10.297677883480636
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,2162971.2771849683,2388303.663807809,1933913.6236182714
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0015564422420940639,0.0017838382671382814,0.001365534843114444
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,49.02886637379506,54.13655855165787,43.83673219842467
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,232605.92837202933,251500.72171830764,215918.68778910296
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.0001673529558716611,0.00018448603151635664,0.0001508533481178882
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,5.272564226903284,5.700859464989302,4.894308400153487
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,1351670.4561421056,1453573.070636554,1254640.3180817424
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.0009724887628121214,0.0010693264663112457,0.0008763996642760909
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,30.63881193181959,32.94867601641856,28.439394064660572
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,1680970.7550327587,1914339.7795246113,1517453.0301155543
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.0012093454644591434,0.0014014189403867608,0.0010633815012316473
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,38.103183059379376,43.39304466701254,34.39666657935174
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,4476052.648770591,5596410.444518279,3646757.864521254
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.0032208685618850597,0.004017334836892572,0.002574550181420986
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,101.46033352983702,126.85589621619994,82.66240329825189
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,686822.3343501283,761911.897648203,572870.422768712
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.0004938674800558119,0.00055317512150373,0.0004162979059390284
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,15.568454749531444,17.270537529751888,12.985464811156051
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,241469.9332542026,264391.6446786554,216204.60363143438
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,0.00017376810439817615,0.00019526993584107995,0.00015244281001375293
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,5.473487889408107,5.993062762335136,4.900789359829503
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,572845.578151807,853188.7548529329,402736.249635336
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0004123333663381499,0.0006205341183092311,0.00028948054752913423
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,12.984901649076548,19.339543661324285,9.128970863151082
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2016,1063497.6400419334,1084641.0265995618,1024004.3239853543
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2016,0.0035514059320637123,0.003947694722927771,0.0031511018390064966
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2016,107.60290161662711,109.74215388945123,103.6070343554803
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2016,2229820.3445150317,2299865.0839326885,2137666.59903119
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2016,0.007445686208023293,0.00828046358242383,0.00660148113778544
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2016,225.60947022331337,232.69647908966417,216.28550932716067
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2016,941285.5045129388,963899.3221609852,902093.9405652514
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2016,0.0031432593255629297,0.003496057715879328,0.0027861243334469875
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2016,95.23768339652298,97.52571141270464,91.2723469059798
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,142247.4867218581,183023.5516052647,89608.28969881492
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.00010231188587023527,0.00013063206232902827,6.406365111675243e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,3.224376158878491,4.1486622358622,2.031184097527805
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,652425.506184769,873348.4284165108,515579.16868415225
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.00046921632030724205,0.0006304166175608299,0.0003712922136421871
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,14.788769180152729,19.79651040504099,11.68682285944473
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2016,396145.3303885545,407862.97727615794,382440.4421584549
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2016,0.0013224491578115107,0.0014589558159723035,0.0011848556496870761
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2016,40.08131791435392,41.26688970854752,38.69468038516097
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2016,6337781.197262459,6518367.94344113,6019441.036885325
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2016,0.02116395157037764,0.02367318927267121,0.018663401023684283
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2016,641.246036624823,659.5174997204658,609.0369148854155
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2016,3259298.116002897,3395981.701030795,3092136.6750702998
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2016,0.010876345878901175,0.011889668484269835,0.00986431644234625
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2016,329.7702987866423,343.59971391518485,312.85718548433704
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2016,1365407.3859917377,1413349.69867437,1320004.8940660479
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2016,0.004558499022067051,0.005047458983814108,0.004103950839396634
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2016,138.1496216725898,143.00034419479417,133.55587394068385
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2016,509507.5286124475,537800.2604571285,475413.0211339715
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2016,0.0016999891589895098,0.0018587935833592525,0.0015350815622509834
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2016,51.55111437017793,54.41372536857071,48.10148947610746
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2016,1983813.9484695282,2094884.7443431728,1862042.903936561
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2016,0.00661815108266456,0.007186999750233644,0.005977977974552301
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2016,200.71895703919236,211.95691326108005,188.39836766381936
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2016,3611802.436727219,3733859.8363652527,3434197.9105282743
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2016,0.012057506681835427,0.013295630177035556,0.010780584442447942
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2016,365.43609278016726,377.7856550832061,347.46636568373555
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,470869.7523093323,485442.87954926887,451646.5766608558
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.0015719193223815934,0.0017382032080948506,0.0014136982252125373
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,47.641809181625284,49.11629367280261,45.69684061735037
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,78805.240057399,81107.49686653703,76157.6863664707
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.00026311734953512176,0.0002903942330431008,0.0002347347665044662
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,7.973381579329715,8.206320049150985,7.705506552057954
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,242915.90602598622,250087.70008895194,235039.03717022654
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.0008109755408515324,0.0008956580308056969,0.0007218420404134615
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,24.577822604474594,25.303452659414432,23.78085426846592
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,490758.2232851885,508591.20179652225,466929.03850511485
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.0016387733872811055,0.0018233343960649385,0.0014443367906286472
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,49.6540912075975,51.4584019648934,47.24309439015877
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,2053884.261299384,2109005.452479889,1954816.9765022476
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.006858883739374963,0.007682045694016742,0.006041181871776664
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,207.8085533803559,213.38562274870264,197.78509221025632
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,449246.4363474838,468873.71961991873,428441.9583416657
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.001498969856331339,0.001624508124024425,0.0013712200179752778
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,45.453998459284435,47.43985395293853,43.349036383433365
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,295145.69125287933,325838.35361366137,270765.4416565894
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.0009843885493044627,0.0010881184977956783,0.0008867038978058086
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,29.862344383954326,32.967776313478325,27.39559175571633
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,892029.2314435495,918076.4546487648,852275.1765324178
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.0029784476593333344,0.0033103577181775607,0.0026391060796341005
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,90.25401657345597,92.88943078634162,86.23176819376414
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,775748.3464055135,800667.3410129857,746880.9137358607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.0027236199393083625,0.003014813532351517,0.002440276956164619
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,91.53392124459245,94.47422179497548,88.12772731487152
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,121568.09012198723,129182.53082568465,115743.0361141629
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.0004268304694087977,0.0004778332281214845,0.0003812723614969101
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,14.34434767233739,15.242808647373128,13.657024215873363
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,537914.1869414533,565901.7442912273,514477.06013738347
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.0018885921820990135,0.0021066519996565383,0.001700132390516805
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,63.47083439106636,66.7732080050781,60.705385867684335
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,539119.1316965038,562966.689453952,506758.1205313585
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.0018931088199599761,0.00211272325973811,0.001663265689907588
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,63.613011063210116,66.42688811981047,59.79459461268073
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,3047118.3574785977,3157114.9570582225,2886575.295658138
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.01070055038286071,0.011945741789841566,0.009484815995966346
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,359.54274739839224,372.5217245753946,340.59957330703827
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,693190.1695644162,724823.8131123271,661971.5464078853
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.0024326507681489743,0.002643125092352314,0.0022243230923719355
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,81.79252290054775,85.5251140824829,78.10890177958085
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,207443.16584693882,216256.60953490302,193138.0599855549
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.0007284405708825628,0.0008130223456922813,0.000638796874247742
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,24.477121341405798,25.517057893208708,22.78919968565404
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,1227888.8269592207,1275739.0928588263,1156956.805281601
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.0043117110993399965,0.004793879008964359,0.0038252610933984686
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,144.88394297555868,150.5300039574248,136.51436524323964
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,99766.9200576242,107361.67532321432,93459.83970954132
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.00034984606025838694,0.00037443877242460686,0.00032621040885186486
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,11.771932799707791,12.66807100428615,11.02773295894788
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,1268565.6144331603,1313335.3170556687,1213606.3458553227
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.004453873000962097,0.00492380323859022,0.003973724442709846
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,149.6835740393885,154.96614596233337,143.1986909133414
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,1348707.5597483567,1413466.9037943091,1266769.0609487158
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.004734053423142928,0.005235231162961129,0.004254188579157018
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,159.1398707171193,166.7811073697273,149.47159088026393
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,1849774.708280286,1910668.5644585048,1765689.4112758585
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.006495744381376656,0.007198427645097143,0.005801848869841534
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,218.26296279265097,225.4480937201266,208.34137289884748
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,171811.03411245986,183847.63493325957,160631.72781105892
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0006027059573806579,0.0006535326496449518,0.0005479152157561004
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,20.272731148280176,21.692982028206327,18.953636177207315
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,258004.67090171715,266954.14120528137,244689.1506749467
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,0.0009060034070253133,0.0010088194582224738,0.000798680525692691
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,30.44309322279843,31.499080146577274,28.871937079939123
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,155157.96150773385,165054.58420253522,147967.27544205892
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0005445911066695467,0.0006014757522026029,0.0004917116370919394
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,18.307762684802928,19.475508238539312,17.459302362483378
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,1254244.9201709114,1308504.2118423088,1184361.0586344101
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.004402264651726192,0.004810616498856352,0.003969049689994505
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,147.9938130404225,154.39610284696863,139.7479122817681
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,734176.3784329443,765155.8479018172,686925.6155621277
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.0025778942720120616,0.0028732000825849218,0.002268932176524222
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,86.62866394044771,90.28406627769071,81.05334092828194
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2017,1626897.980720876,1697872.8923346098,1534037.5944348858
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.005712052377405099,0.006355060597350451,0.0051144826059421914
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2017,191.96476838179035,200.33940688420668,181.007767539405
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,1053282.5237449529,1097831.7741427908,995226.7285536246
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.0036981680587728906,0.004095312045539701,0.0032810028986742755
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,124.28138586888899,129.53794567506318,117.43113010043213
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,390071.4262286092,428931.0543279643,354459.0063040743
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,0.0013679405803606658,0.0015082863226364958,0.001218423077603285
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,46.02622406301745,50.6114405891267,41.82415975207687
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,152854.1548095395,158704.7916527936,147685.80169369344
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.0004997067788121902,0.0005459229538061566,0.0004561056140154464
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,15.19438376422091,15.775963123789241,14.680626445886814
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,879070.176403314,906913.2523774578,839799.8649646982
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.0028749000591755825,0.003176869442775947,0.002571688987367967
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,87.3834907045636,90.15121646285021,83.47984684691185
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,705467.6829822696,738626.8070010999,658927.7488379078
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0023065205949568015,0.0025356061954517105,0.0020614467594620737
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,70.12662967417994,73.42279428452551,65.5003529424016
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,1499162.391994321,1539319.71566167,1449019.6360877254
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.004903981386633842,0.005454321160157509,0.004370956438269351
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,149.02341867796875,153.01523550169875,144.03900541691095
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,181958.63159235043,191963.58675141516,171333.72270541673
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.0005946818636939313,0.0006467945063773899,0.0005415777088417621
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,18.08749838086912,19.082035483377513,17.03133511668365
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,116105.7555818318,119302.1348444861,110356.49764260162
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,0.00037982937415740204,0.00042334113966824305,0.0003334349539811334
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,11.541429212332323,11.859163546955292,10.969927367341539
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,135951.00915853557,141985.32654976688,130164.79966825369
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0004445862386430854,0.0004912201231483811,0.0003999609051710685
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,13.514135803909346,14.113973828016219,12.938960810170586
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,1796262.1879972643,1959128.9445268037,1643635.7262689767
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.001285748214575113,0.0014440964844153932,0.001139461279943472
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,39.86769412655704,43.48249049430978,36.48017913433514
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,26414812.39306122,29866241.69888963,23273943.295983978
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.018906834097277624,0.02170136245097789,0.016161427665562007
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,586.2716856892143,662.875495970173,516.5606995700647
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2018,9774796.74599853,10643680.86325205,8991310.138656974
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.006995261911887288,0.007752730612292992,0.006230268231576935
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,216.94973563588024,236.23445166985135,199.56040092602186
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,5254943.9805503,5769102.7851069365,4769970.438549582
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.003761679750084659,0.0041889202384771,0.003297298066266524
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,116.6324719568671,128.04412783289177,105.86857737557823
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,994655.6960011829,1161201.7893235798,839488.9427545969
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0007118565324039602,0.0008560996608002721,0.0005893382634315325
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,22.076192058368513,25.772650599286397,18.63229578399275
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,2190151.12185655,2665210.135519979,1783248.8591196304
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.0015675939699887832,0.0019139635695042837,0.0012687995425114088
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,48.60998333125614,59.15382686108848,39.578865792515074
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,12355128.070515959,13611231.767142415,11216893.138458902
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.008841320222637207,0.00991933559660025,0.007888827681050928
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,274.2196935954868,302.09867379279075,248.95678798035075
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,3967618.993303446,4248200.395075558,3587912.4392630607
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.00284031975628564,0.0031553478419317415,0.002504340966275024
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,88.06054121314094,94.28799151421485,79.63302720350238
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,1947905.2696530435,2157363.5246780105,1739592.3610704867
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.001394128280507057,0.0015817068023097954,0.0012347757210897628
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,43.233383187017374,47.88226891172798,38.609918206527965
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,1292958.9820715054,1337260.7514686587,1227470.6148634064
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.0042282598700766035,0.004662323774651128,0.0037755413212520903
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,128.5258813505588,132.92967453820978,122.01604598041853
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,619619.1139164789,639248.8504489947,585331.8063628658
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.002026933746252389,0.002265560932182994,0.0017745618902495562
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,61.59289955987461,63.54418279739751,58.18458848150961
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2018,1869435.8958930222,1943063.6284734707,1773474.2343777157
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.006114680308164824,0.0068355084387856195,0.0054535446502566864
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2018,185.83025407586734,193.14917861482235,176.29123753076496
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,855412.1440506236,888055.1085773981,817838.2156835687
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.002797701178288628,0.0030889012067949425,0.0024821739305407524
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,85.03177692144104,88.27663297942443,81.29676109639038
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,317661.6385165191,340109.5802470878,293165.28000528645
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,0.0010380445859173115,0.0011348814369850837,0.000935341568999184
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,31.576981658139243,33.808407043966206,29.14193452115178
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,1802959.349573346,1938717.5897137644,1675662.6801095507
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0012909090920720423,0.0014510301678737746,0.001144070829988313
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,40.016336340937336,43.02946439609737,37.191011221128086
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,2356323.4994914406,2768344.562263222,1798172.342143619
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.001686894496595362,0.0019911616290733316,0.0012854282804424053
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,52.29814732429605,61.44287564627822,39.91008963081598
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,4904464.232679052,5426084.961311106,4381984.022100722
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.0035103999201749696,0.003974028725264549,0.0030806482198742343
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,108.85364129447763,120.43091314161298,97.25729341068656
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,391943.72359243693,474212.32922730764,275690.8314024417
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.00028053777064734436,0.0003394248334876537,0.0001993267450346023
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,8.699115636581492,10.52505153145564,6.118905031399286
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,592416.0971939706,683744.6117985145,473093.27799914125
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.00042410476771533636,0.0004997441599920438,0.00033907407625314694
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,13.148561449657285,15.175580283331206,10.500214404462373
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,2344415.0476972996,2629684.752529476,2085519.58807771
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.001678214818723599,0.0019393245530736195,0.0014448892688501069
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,52.03384152482974,58.365347811505366,46.2877065430673
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,244700.3111784589,267224.2239585016,224642.56463658245
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.00017514386079887852,0.00019565237770590268,0.0001559903832293666
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,5.431076389584937,5.93099030596548,4.985898559008262
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,1426358.9244006914,1532838.367353908,1312016.0362061225
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.0010208307815345455,0.0011271263752912143,0.0009184912920851046
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,31.657762264702463,34.021053041956996,29.11994383120819
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,1788019.500337046,2096975.2824345217,1588197.1053161323
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0012795905744040319,0.0014964564868218573,0.0011242087613486597
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,39.68474925769861,46.54196347820543,35.249729594332074
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,4648673.746500939,5866293.676173834,3704057.4656813685
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.003327095851656145,0.004193039817900116,0.002627827292867327
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,103.17642060165514,130.20126098574337,82.21084374860745
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,723139.3982306015,813530.9387543506,611556.4701176597
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.0005172514461404505,0.0005812681587081077,0.000439285406722413
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,16.04993999882829,18.05616287281033,13.57337834904361
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,249590.08363169574,271874.18580096733,224077.39268178324
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,0.00017868019216490025,0.0002005876764170799,0.00015730732396555575
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,5.539603949657597,6.034195315609575,4.973354676064333
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,571635.9166201351,853887.5165394472,393790.85655656713
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0004093002932713456,0.0006177637415157228,0.00028633508633170424
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,12.687349334550648,18.951869362587697,8.740112397809948
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2016,764011.7731250807,784720.6128549558,737370.8716781316
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2016,0.002661212487658919,0.002940528511194302,0.002387389228090813
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2016,90.36782315532051,92.81727855939958,87.21671952663068
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2016,123378.74857409613,129519.98637409438,118043.95230944184
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2016,0.000429779949682561,0.00047665619585148406,0.00038636032643488784
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2016,14.593320841985692,15.319710553488404,13.962317574271616
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2016,516955.2153669312,538428.7892486434,496979.5289563836
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2016,0.001800712931015774,0.001999683655095062,0.0016216189515078994
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2016,61.145808382525225,63.6857170531964,58.78307084306193
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2016,532483.3590607933,554418.5130884652,501980.74137207534
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2016,0.001855047115745497,0.0020641145142549005,0.0016376306509459618
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2016,62.9824875969273,65.57699227576141,59.37461759016871
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2016,3001006.4011303354,3100115.864071707,2842801.0990647115
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2016,0.010455448823512667,0.011660452566216402,0.00929415080414112
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2016,354.96104285939145,366.68377637627145,336.248413993972
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2016,697766.5852487229,728118.0167204618,665852.162010918
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2016,0.0024294249903709184,0.0026358708947582755,0.0022280958348164766
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2016,82.53229805808921,86.12228565805776,78.7574387473993
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2016,208642.01434145906,216898.95244817802,194672.38603987917
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2016,0.0007268677581660481,0.0008096918305277509,0.0006394140890814807
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2016,24.678316902967506,25.654953060785214,23.02597993080401
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,1070134.0700183983,1091736.634225253,1028931.5378284645
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.003500817727022235,0.003895491193594347,0.003102158300762295
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,106.37609268316993,108.52348377802872,102.28037747718427
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,2280805.89791637,2353818.389531499,2178528.067973921
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.007460707312951082,0.008315423792667913,0.006620085206416229
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,226.72226442141132,233.9800312682762,216.55539260393488
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2018,985952.4743069324,1011187.1769880077,943252.7154980967
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.0032253676241087883,0.003592911418346014,0.002853093737469856
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,98.00806714458858,100.51650898046816,93.76352094439173
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,2749984.2686752756,2825482.582245349,2649759.5074777817
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.005730662301003201,0.006385598733213911,0.005089382881387471
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,181.76380412414096,186.75396382642347,175.1393175515449
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,307136.4125729297,329497.19280036236,284218.86112890486
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0006392210282961148,0.0006904974583653795,0.0005813438792264121
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,20.300582577946894,21.77854756982664,18.785817064876063
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,379678.6858181002,392621.91577291995,359325.76989460626
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,0.0007912383949089151,0.0008869467698479661,0.0006908098473195853
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,25.095358931779238,25.95085863082838,23.75010635509626
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,214022.3938288594,224455.93658428342,203436.02628202198
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0004457582195897982,0.0004910659047629277,0.0004017640843786808
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,14.146089820662208,14.835708464419525,13.446370022593545
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,2386615.5438652635,2489540.98941344,2234872.481044579
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.004971046263270318,0.005479219239399318,0.004428605857335366
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,157.7464733802737,164.54946521448562,147.7168173339057
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,1278779.8361340181,1330685.3330146293,1191895.013626425
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.002664721316306233,0.002994855561837367,0.002328197500672622
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,84.52262447484263,87.95338612516956,78.77985858358949
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2019,20718260.184972893,23456510.291672427,17923361.86741399
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.03432934187035019,0.03803679665999857,0.0304186544009157
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,1566.4614926486308,1773.4944824407448,1355.1454578447087
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,1102942.354028169,1275567.7902424433,928347.6380420604
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.001827772273088236,0.0020701205098686746,0.0015948247475255002
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,83.39101405095253,96.44283867652899,70.19029656934973
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2017,2763295.9883449716,2875186.996471664,2600474.833229578
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.005757598794655793,0.006436527411032792,0.005102261212439134
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2017,182.6436596324648,190.03924204217455,171.88178259819477
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,1632124.4872150687,1697626.4960015975,1535313.8292571285
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.003400525017589554,0.0037949676046631223,0.00301246032992021
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,107.87740096538148,112.20684183907335,101.4785740082102
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,727757.2059836534,796886.8944529113,660828.8722198267
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,0.0015145467697368904,0.0016785699284437275,0.0013395194928676
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,48.10206361728282,52.671280720529,43.67834793018776
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2016,1234679.670575881,1275374.4108884574,1169388.3125838179
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2016,0.004301265140504508,0.004764125984392605,0.003825525103654165
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2016,146.03873663842595,150.85213772107744,138.31603117740502
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2016,99111.19768874232,106493.68572925942,93076.37264498847
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2016,0.00034481307894955736,0.0003672436714319438,0.00032212455860499854
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2016,11.722938703958912,12.596144323504378,11.00913556438613
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2016,1281860.1858050297,1324838.53110951,1226842.1001302726
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2016,0.004465038758931715,0.004925245782470622,0.0039870949145759775
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2016,151.61927951300115,156.7027869203507,145.1117035678505
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2016,1341373.8053588578,1400241.0943688313,1261318.6011746768
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2016,0.004671162549646551,0.005132084433620205,0.004202507030066433
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2016,158.65859020997502,165.62145249824445,149.18960715387922
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,1830639.3419583768,1885388.974267098,1753280.0983303124
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.006377788448293042,0.007049462038356651,0.005702635209688378
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,216.52924488139197,223.005067982986,207.37914184172863
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,175870.5236292844,187769.3496238498,164635.9115574907
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.0006120764624614566,0.0006610267067602865,0.0005598285330132334
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,20.802083078584793,22.209484169846206,19.473245654038617
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,263247.54015998077,271771.0194007719,250598.69313234763
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,0.0009171183961075505,0.0010175935618397492,0.0008109890978626898
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,31.13709499258677,32.145257813886325,29.640980912254758
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,160742.4929943925,170420.45566143864,153532.33122173883
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.0005597434446720063,0.0006180901112007853,0.0005060611430408737
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,19.012729504214715,20.15744539677496,18.15990675080702
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,1236493.0158059145,1287035.4868859241,1165685.5154196445
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.004305822798950412,0.0046915104571850635,0.003881993612825232
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,146.25322032419035,152.23141758378094,137.8780618540485
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,726994.8900980547,757583.0466042039,680590.742787113
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.0025325007186960445,0.0028100315938180756,0.0022352784983895547
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,85.98944149051367,89.60742908576816,80.50072793219248
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2016,1623584.0571656362,1684906.0882929002,1534692.9731102868
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.005655408787128525,0.006267917979356212,0.005074082856653062
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2016,192.03860740994335,199.29181823648176,181.52451057719279
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,1028488.5164516758,1069007.24384784,978634.1390854584
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.003582645177876487,0.003955860566622269,0.0031779522034846653
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,121.65030911999698,126.44289127725611,115.7535000447638
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,382359.19610965165,420277.1432939721,347042.3777458933
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,0.0013302599241165893,0.0014590213179942327,0.0011884583333305614
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,45.225701267028406,49.7106614025896,41.048404386837205
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,38800.68452198054,42189.07087738016,35834.03489820722
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00012683637859722547,0.00014282896058528618,0.00011346722004468751
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,3.8569608505312583,4.193781545327174,3.5620626651743748
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,347359.5902896015,358960.14985981054,334578.62041256385
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.0011360647881404253,0.0012550891767766522,0.0010196676995094815
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,34.52909033201726,35.682237619437046,33.2586050028312
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,307799.67701331724,318164.66164597694,297852.13444552035
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0010067247204912004,0.001115224692527113,0.0008985113272054392
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,30.596658761883425,31.626984397553066,29.607828726649107
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,51036.970577512446,55155.19282338631,47004.892541380934
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.00016689726340225034,0.0001890147123569467,0.00014867684648561786
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,5.073302181967108,5.482671814792121,4.672495667256362
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,52386.010143633976,56488.95045997146,48085.78482626268
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.0001838219620868385,0.00020354450694827026,0.00016515303585925065
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,6.18125317188783,6.6653769441486075,5.67385088433141
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,307658.0226673747,321651.5706292969,289958.902631124
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0010801408534107497,0.0012008811126863789,0.0009683125744478346
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,36.301908147905515,37.95306773208521,34.21351199855699
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,206646.8385500664,215363.07627714175,195027.18800109727
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0007254900863604574,0.0008031665451889776,0.0006561931366656933
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,24.383159220294502,25.411626018008047,23.0121061163243
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,38764.61243242308,41324.165539955924,35367.948025054975
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.00013611804961793957,0.00015422244241123948,0.00012029976082472674
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,4.5740052143298335,4.8760180173887715,4.173218008273945
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,1168208.8583664158,1331630.1447722567,907533.9531451417
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.001936274136860057,0.0021436691197504335,0.0015291371346108135
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,88.32566903128726,100.68158839654,68.61662022683554
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2019,1539863.158031405,1834556.1411038113,1316868.8352647496
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.0025516287835568078,0.002970766548353107,0.0022375658184778757
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,116.42562258939353,138.7067024684607,99.56551867262804
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,239210.8954308627,276065.5199422309,208839.52685627434
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0003963708158268855,0.0004488687950490369,0.0003526101045126276
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,18.086202845653446,20.872698893470986,15.789891334630013
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,1445066.5857276993,1604384.6852733835,1301590.497839139
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.002395845709019028,0.0026524143304526874,0.002174613697418553
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,109.2582649626878,121.30395151127588,98.41035761975789
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2019,2353526.2471135696,2707866.6114907153,2053508.0385652916
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.0039009334391311096,0.00441484283987295,0.003473685060404119
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,177.94487592714225,204.73576141329303,155.26116761435776
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,2216057.862572566,2634991.918902972,1861825.0314204188
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.003670217256572099,0.004253013251797369,0.0031693349357581196
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,167.55119764925863,199.22586827032998,140.76844251066782
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,158692.62016296692,195987.39342890022,124326.40925738555
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.0002628717642703933,0.0003196339977928258,0.00021103712131124934
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,11.998395446018439,14.818170160524573,9.400042806790518
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,1011140.3907650884,1234805.8902591318,617874.5556552156
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.0016755423288956942,0.002066818730630854,0.0010282580798437043
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,76.45007214186953,93.36092223562223,46.716118538915126
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,1266431.0467947288,1405756.3378910292,1140108.8940634602
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.002099564229549325,0.002323393910080962,0.0019015290623112732
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,95.75202986095888,106.28610470633187,86.20109333659116
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,392359.9808644182,404591.89385369804,377667.91038500087
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.0012831407568188594,0.0014132493295973846,0.001145989566117524
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,39.00232957622087,40.21823620539461,37.54187233556937
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,6215788.56149484,6407939.035014979,5887910.515944866
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.020333695588975867,0.022728369179376928,0.017947537004709982
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,617.8770666606234,636.9776795211618,585.2845286419054
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2018,3339567.356798398,3488813.6851537363,3165963.1549328463
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.010917177266536647,0.01192823070618173,0.009873826818855227
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,331.96786890671336,346.8036186529833,314.7108380493366
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,1399056.3325919944,1454533.5920447868,1342618.5784426616
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.004575572406975894,0.0050631004030319265,0.0041126518478996985
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,139.07243052473163,144.58711719689492,133.46226640191628
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,543342.7947627257,573834.0710824502,507971.8135280501
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0017759635619933052,0.0019428820593167726,0.0015978336303431834
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,54.0106937193567,57.041662386450305,50.49466065066853
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,2061973.138327262,2180497.0576662538,1933291.8543894514
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.006738704820097692,0.007319788351298153,0.00607024928627498
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,204.96931348904403,216.75111894876582,192.17782074970665
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,3715565.2451716973,3845796.6143370867,3519555.882784899
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.01215112741910413,0.013406902480131733,0.010868181348666156
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,369.34373361643765,382.28931173110817,349.85953001597784
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,477767.7792779624,493029.83145781426,456963.69328819425
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.001562471307131658,0.0017260927811669747,0.0014003322680166172
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,47.492245124604786,49.009361084842766,45.42422632075705
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,78580.69360407432,81137.3634134925,75724.11035889869
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.0002570164252965146,0.00028581970139978486,0.00022922668920294812
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,7.811270924017093,8.06541528987422,7.5273138269023665
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,248417.82257438084,256277.0413220649,239411.6285904997
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0008124648948040532,0.0008973477045716423,0.0007224311408068687
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,24.69383795795725,25.47507930457335,23.79858216450748
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,516120.5946380242,534786.7298430479,489520.23879461945
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.0016883747900404106,0.001884068113546185,0.0014843593328253536
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,51.30468578573837,53.16018275965681,48.66049194322787
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,2156120.3887558817,2215194.303281421,2048502.8336830658
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.00705369301155371,0.007904106741864501,0.0061949497498272705
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,214.32796949117312,220.20017969621614,203.63030521386875
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,439720.2113810625,459355.3722064224,418084.2795888407
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.0014373127728939258,0.0015615011456094493,0.0013079095544396672
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,43.71014742080945,45.66196985719959,41.559439439353824
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,307370.63105738605,340786.55917289027,281467.73137321975
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.0010042685463774361,0.0011135513648412774,0.0009050509488178877
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,30.55400968299493,33.87570176429453,27.979146089017092
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,902782.5261588313,930685.431366055,859293.7083182763
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.002952960093922138,0.0032808287395325853,0.0026103350012850143
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,89.74060387944395,92.51427692996387,85.4176216972124
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,141911.25310214353,179789.87417133924,90714.05830186736
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00010157122085070999,0.00012743502167923885,6.309900699878603e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,3.149692995598084,3.990401712183703,2.0133810940983956
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,667104.0176455558,910092.595125188,526856.1393888332
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.00047731535894952285,0.0006416293961092846,0.0003738990267512704
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,14.806245493450664,20.19933028248478,11.69347078294379
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,158306.91941459457,164675.7359598741,152161.35940758232
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.0005125741797764643,0.0005602944312401222,0.0004659305527112247
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,15.61298981949078,16.241113140008682,15.006885132599223
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,893691.4820748715,923645.7232914933,852941.2612791508
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.002894694316367926,0.003206217983034965,0.002586360851939611
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,88.14015245194791,91.09438379505735,84.12116967609506
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,714657.2831962695,748976.1409285611,667033.9458150144
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.002314174079580521,0.002543870520071991,0.00206147997981539
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,70.48293863735964,73.86762945423762,65.78609604542955
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,1516440.8697139109,1565608.1691647014,1459571.14121164
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.0049129317068205645,0.0054549232198194235,0.004367571670811487
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,149.5586923695789,154.40780792697674,143.94992621187353
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,185505.85469836835,195787.00735354936,174533.531421524
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0006004659333562666,0.0006539256209848094,0.0005439705029189773
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,18.29547963899388,19.30945636427893,17.213336342598364
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,118623.55645918686,122163.1239199235,112851.95478400003
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.00038435212430901303,0.00042850453430787595,0.0003372100233949144
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,11.699225695237239,12.048314862875905,11.130002577700276
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,135150.6452768957,141111.32832072978,129237.86426995808
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.00043772925274556854,0.000483868092757628,0.0003933378418600412
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,13.329206686661419,13.917077918220567,12.746059784380881
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,1314382.6739660585,1361727.0892808419,1246818.4642532733
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.00425707731705653,0.004699232900050946,0.003800730922701092
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,129.6307412426045,134.30007519877591,122.96723390945378
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,634470.626784896,655384.9632493154,599352.1084572627
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.002055636004512248,0.002299171431103186,0.0018006693157314115
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,62.574544899174434,64.63721735536188,59.110987708165105
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2019,1874649.6202560624,1963162.242983479,1775212.744780638
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.006072865339697493,0.0068004406057323025,0.005409249343269215
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2019,184.88696226547785,193.61650284809988,175.08001933322436
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,873885.9859298517,911140.69833376,835222.5437437159
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.002830670135261017,0.003127633147068987,0.0025082806512909638
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,86.18683916137537,89.86107808688269,82.37366452901634
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,325070.65902027494,349616.3728196096,298539.18121038825
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,0.0010520525435153347,0.0011524625760817144,0.000946344288049068
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,32.06003192195789,34.480848277163986,29.44336996887576
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2016,51608.57073724714,55259.045342563724,47720.73037418525
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2016,0.00017966633252939615,0.00019728872222298733,0.00016269834690536893
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2016,6.104296239580152,6.5360768157051705,5.644439882984757
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2018,137835546.67993727,149369412.05295807,126250156.04947093
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.09864895625507383,0.10956432581541245,0.08779537426779804
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,3059.2334746685024,3315.2254004915135,2802.0979556566085
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,8820789.493332023,10138902.997357627,7584325.994778422
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.006311743948482589,0.0073860641409385,0.005395425923242757
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,195.77572796708256,225.0310039249692,168.33265819231397
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,15945881.192583237,18641979.237530053,13043774.949299563
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.01141093573489582,0.013317200993952673,0.009361471576304554
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,353.91576920801634,413.75514728399264,289.5040787526247
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2018,8739432.117025465,10133597.657588053,7686001.351604704
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.006254824297212988,0.007348055271409033,0.005411306457692878
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,193.9700166320657,224.91325292815804,170.58932320104427
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2016,288911.2239564036,301658.5132919835,273624.53060661326
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2016,0.0010063121828451308,0.001113161135290838,0.0009028421686090814
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2016,34.17261266444537,35.68037056675559,32.36449235811429
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2016,205846.2813241391,213559.5086100562,195403.92338404214
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2016,0.0007169786101451922,0.0007925718659208802,0.0006483242019962741
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2016,24.347635733140386,25.259961411682564,23.112506656797287
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2016,38070.1108840176,40484.92784219772,34982.87253505524
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2016,0.00013262337245178505,0.0001494018563550349,0.0001181120751722306
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2016,4.502958159660595,4.788584323425966,4.1377975443781985
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,1877192.4456455312,2095226.0248384625,1682317.675239865
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.001286972279255417,0.0014370249370258292,0.0011301516797514568
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,40.91294898130568,45.66493736823115,36.66570115232296
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,27988904.889303792,32006432.014856316,24100358.33655414
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.019185905197578717,0.02219004466848774,0.016273764365016603
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,610.011317931189,697.5723363552845,525.2613994595268
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2020,10317300.892922485,11333520.999913972,9347729.18016155
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.007072655062475833,0.00787486672790112,0.00631815740386801
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,224.8630426976606,247.0113107069227,203.73146500038067
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,5287849.554876598,5865396.660432236,4727109.047526287
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.0036257976418628784,0.004096980162786803,0.0031954717340300785
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,115.2473842313436,127.83488175654955,103.02618239229314
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,1048319.5304924732,1274278.0418923318,851632.3379943045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0007186048304313698,0.0008743965677266575,0.0005878094375101861
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,22.847867072252015,27.77257741307975,18.561117948250235
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,2364295.2703030063,2860535.778295379,1923188.4581783768
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.001620751401243793,0.0019548622562476714,0.0013105466321813792
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,51.52923558531869,62.34467575664722,41.915420794179724
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,13025940.240268255,14620266.005849015,11687497.547314242
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.008927329905719605,0.010023279958711894,0.007856824966585943
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,283.8971729935588,318.645112054413,254.7261427466317
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,4181934.2780570127,4581531.685806541,3708810.9064960782
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.0028676110553200605,0.0032096338452178128,0.002470054374867842
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,91.14423199294485,99.85335949569078,80.8326241407838
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,2011131.9443243411,2272602.2703107176,1779008.2323160344
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.0013785336182808477,0.0015707149190392453,0.0011851210092495986
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,43.83212750705525,49.53080913771102,38.77304813094932
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,1910490.3345048325,2090463.6917332762,1732114.9003460496
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.0013102902878556182,0.0014821245755605671,0.0011496270909469456
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,41.63866830286263,45.56114348614067,37.75101946100565
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,2459808.83639848,2883490.017563428,1879773.0482033202
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.00168683759735949,0.0019987990445236564,0.0012523550692304848
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,53.61093033417157,62.84495777208833,40.9691925811735
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,5238606.365381614,5837587.832941685,4608809.171801906
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.003591033490563682,0.004106047665015682,0.003079054292186258
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,114.17414099293255,127.22879518136114,100.44786561330035
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,405686.679033943,497619.36861711566,277145.41188504244
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.0002781435641219378,0.00034435660895571244,0.00019237716991777677
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,8.841841677028123,10.845492100486519,6.0403162835851205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,620798.392378102,720615.3609330608,513704.66786105826
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.00042563701186118606,0.000505371201606173,0.00034969502075120026
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,13.530148714351826,15.70563506442249,11.196067252673513
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,2500513.523315162,2873970.2070913534,2139807.912626045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.001714458037538528,0.002031062665474024,0.001455640896636609
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,54.49807900291104,62.63747583753273,46.63658867908884
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,253951.2557653054,279705.33234055666,229401.90872521861
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.00017411209939187144,0.00019516474812406276,0.0001541828843339509
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,5.534805339199811,6.096109122106074,4.999758341058901
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,1491898.0660067373,1628194.145522363,1359648.634422292
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.0010226371170561595,0.001128144172293585,0.0009109130762088179
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,32.515552468491016,35.48609209563998,29.633208540583038
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,1905907.7657514988,2240117.896415746,1690248.9034088268
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.00130629312280598,0.0015177838945353017,0.001129640286306934
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,41.53879234073454,48.822820175291334,36.83856032517364
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,4749993.184470578,5918713.500359121,3710863.612117148
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0032559273189989484,0.004141428606486334,0.0025858740549604027
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,103.5249365447802,128.9969092070824,80.8773623563798
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,757830.3885698552,858013.6982283909,635968.740795956
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.0005191895367113676,0.0005895896827229805,0.00043848610562354304
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,16.516727464977354,18.700198129557233,13.860782737671082
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,257756.0338523125,284220.87630123936,230281.80877974664
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,0.00017673409009902625,0.00019798180486229415,0.0001540400029094846
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,5.617729544504383,6.194524295315832,5.018935546956496
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,569309.9075320301,843630.9298198805,398767.33606459014
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.0003905264410588213,0.0005815688777400648,0.0002771637963569787
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,12.407969814410807,18.386729219391786,8.691036293943428
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,133000.8146323162,169169.85871702543,86366.9436895995
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,9.116774024498264e-05,0.00011553166819033375,5.884120635645261e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,2.8987201371635702,3.6870155827226654,1.8823463566777612
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,671073.1896413451,907208.0148725458,533720.3448582579
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.00045998299045805504,0.0006153982961498792,0.00036009341888527295
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,14.625875591075548,19.7723761961701,11.632304024088349
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,3758088.525041039,4172290.5074727507,3384213.5290075922
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.004311908355255003,0.004963099548679625,0.003746630326922478
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,123.03606367126285,136.59662275433442,110.79576983290488
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,819443.633791445,939820.6925328007,697755.9557131693
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.0009399694905372171,0.0011128545056085948,0.0007979304878029808
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,26.827765878951553,30.76879051559156,22.843832874636984
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,2256732.87814144,2558445.716466882,1884415.702116426
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.002588172659526155,0.002951369981186079,0.0021471445265426998
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,73.88317976916487,83.76095666007548,61.6938874014929
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,10171432.323827676,11227325.850412283,9230703.04092448
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.011662332330616854,0.013057023467155801,0.010381812260309556
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,333.00253218722116,367.57143132339024,302.20399533065915
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,1291926.6870711918,1412888.9035584047,1174159.9198945186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.0014814436605933316,0.0016467282710168783,0.001318648588489704
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,42.29638899401899,46.256571110637836,38.44082269531145
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,1363290.6041781045,1554137.1263565088,1205393.1847480866
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.0015628949337558066,0.0017856638289909773,0.0013539318543000357
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,44.632772341694775,50.88089680649157,39.46336858202471
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,450583.7008297797,492457.61940776743,414737.4522354452
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.0005167804599884053,0.000575785974679833,0.0004596791431689303
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,14.751660195104304,16.122570453869507,13.578089829467341
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2017,1412860.0926062863,1658245.882029454,1082643.880978674
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2017,0.0016204440793375161,0.0019157444207430043,0.0012131911210925116
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2017,46.25562786884996,54.28931345404049,35.44467901323342
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2017,4168645.3670917363,4639412.777439697,3747809.105413736
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2017,0.004780395931873297,0.005380066425502602,0.004209627460104205
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2017,136.47728450005428,151.88973917960288,122.69952574264823
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2017,355654.40485801944,419180.52157434047,260165.33814462885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2017,0.00040798454561693034,0.00048770935089741715,0.0003052233557212995
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2017,11.64376988713926,13.723551480632192,8.517553244350113
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2017,562117.8495209336,641015.890856202,458825.2219519653
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2017,0.0006448677377029812,0.000764265031325436,0.0005315145909229185
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2017,18.403176791492893,20.986219839197062,15.02147936268929
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2017,1651754.0423442775,1842081.212766407,1429391.0237614405
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2017,0.0018951104633609568,0.002183424130483321,0.0016119715007122857
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2017,54.076777108627965,60.307898515799366,46.79683403911406
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2017,205069.91593680208,216702.65839245176,193727.04844058683
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2017,0.0002352012138508924,0.00025527827674992046,0.00021400946280665832
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2017,6.713784166110207,7.094628532044626,6.342430016738793
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2017,1283770.713285496,1394839.1790672466,1189669.2713596798
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2017,0.001472176028941823,0.001618522219379946,0.0013287455062278818
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2017,42.02937056076197,45.66564116395208,38.94858336716703
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2017,1406134.270349575,1606421.64045494,1243467.073910703
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2017,0.0016120070886018417,0.0018477474343556778,0.0014116184938370254
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2017,46.035431167813215,52.59263956155756,40.70986967427163
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2017,4087903.8159061,4873820.157417954,3334178.253590201
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2017,0.004688990811531853,0.0057247035481353984,0.0037957568458921054
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2017,133.83388678166642,159.5640026078982,109.15766490508226
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2017,462670.0983200449,515695.77688156883,395198.2049943062
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2017,0.0005303054640693038,0.0005870569584237627,0.00044668702869093274
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2017,15.147356773633454,16.883364512737042,12.938394396102561
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2017,178904.731245622,195258.5114739428,163327.34636511208
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2017,0.00020521284259106983,0.00023019138211539448,0.00018141781567409504
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2017,5.8571621604858715,6.392568586393725,5.347174142582744
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2017,276063.0019540144,363062.5604457215,217961.69465548103
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2017,0.0003167144775073684,0.00042077204092659255,0.0002541136164765149
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2017,9.038026874399733,11.886305499725761,7.135848121415742
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2017,2629012.9462780077,2883732.081330788,2328305.845237201
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2017,0.003014913419626387,0.0033930019930892294,0.0026615686564574114
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2017,86.07125726164297,94.41050725796946,76.22640720461739
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2017,665003.664982211,757323.2365272562,531950.8042326563
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2017,0.000762962941041147,0.0009015030885139447,0.0006032886608173728
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2017,21.77155559832935,24.794006135892445,17.415537868106487
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2017,5058651.151388248,5681199.506009623,4062027.2840948366
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2017,0.005801379152557199,0.006705292957782601,0.004699872437849204
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2017,165.61518468916725,185.99679584261924,132.98671498294266
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,70365.09707313473,75685.79299765115,64849.27502885446
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,0.00014651234505691843,0.00016238213974853897,0.00013140194599083063
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,4.650873049444231,5.002551400060319,4.286297582936872
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,552185.9546555615,572843.1228783848,525356.6170639521
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.0011504464099597357,0.0012800116064202933,0.0010286005047387878
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,36.49745231105062,37.86281484107755,34.72413218033916
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,321097.529118901,332636.731873449,305637.795765832
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0006689791296231676,0.000743845339114319,0.0006013219027273626
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,21.223360821488907,21.986059507847834,20.201529541576754
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,68331.87027173792,71794.19118278418,63573.3498537742
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.00014238594899164403,0.0001599500018100907,0.0001270746533957014
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,4.516484266832362,4.745330892269059,4.201963641015063
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,1091254.6760268307,1115906.1837338507,1050325.9554052777
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.0035357156321357244,0.003939253945788665,0.0031248998955007304
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,107.62478488168898,110.05603514092012,103.58819759446166
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,2327658.9751546714,2423911.8143089255,2213802.427291322
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.007540840172427011,0.008436985462017939,0.006674792901114092
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,229.56492373627634,239.0578416919138,218.33584335718493
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2019,1000372.9424111638,1027902.9196684983,956260.1341715322
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.003241184123935351,0.0036137876165665207,0.0028636740922903326
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,98.66159118828514,101.37672995947123,94.31097386529399
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,39190.85107729118,42814.454625207814,35954.285381722446
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.00012687559855081602,0.00014355197743466902,0.00011365996719904467
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,3.865190233943218,4.222567444697515,3.5459845577675173
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,347904.0237521253,360834.7148886558,334368.8544560382
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0011269221233188985,0.001247171759121955,0.0010122926381863609
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,34.31196817604834,35.587255130151085,32.977064678422614
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,308631.93182780035,320608.2170492427,297449.1548413629
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0009997527911876842,0.0011082330924082483,0.0008893683956899993
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,30.438765579017307,31.619924431259193,29.335866325538483
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,50823.888181154194,55430.447710566,46632.21504112778
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.0001645973252942408,0.00018730271246660788,0.00014541982146442945
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,5.0124963058699,5.466817363354604,4.599093339632707
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,397728.0744462441,410663.92137399013,381554.23674547585
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0012882252632017844,0.0014218281126067728,0.001150011802607106
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,39.22585569991458,40.50165114294537,37.63071403271517
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,6202702.352956123,6404957.2797605265,5855279.016278327
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.020096309764686144,0.022479507449718696,0.01774271595666422
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,611.7403398926067,631.6876935826175,577.4757793878439
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2019,3396359.1217338312,3553783.3435878754,3214304.0013391767
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.010996349720516158,0.012041979267456496,0.0099214211394618
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,334.96527244074633,350.4912063812049,317.01012081617483
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,1424945.066419553,1492672.384955835,1358161.249811498
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.004615420220049832,0.005126913334686776,0.004120120066618563
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,140.53493617090143,147.21453008074872,133.94839495928494
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,562014.6656822994,594880.8549340627,523771.7331214646
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.0018193766867091881,0.00199239151223679,0.0016357533075962453
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,55.42858951554649,58.67001117980971,51.65688756500787
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,2116462.586000466,2243946.697705349,1983381.0569554986
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.006850437815285912,0.007471384801259298,0.006180576673526919
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,208.73572002255756,221.30881629374744,195.61057953075317
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,3791093.735880681,3934073.0479522543,3585425.708158301
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.012279240434703775,0.013554197483815835,0.010951201653541987
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,373.89589868794826,387.99720614833086,353.6119285690257
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,485436.27783256624,501983.4347804667,463288.2480507491
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0015723386823242762,0.0017412553189144141,0.0014087709498822715
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,47.87606057801046,49.50802078495817,45.69171535302594
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,78667.96486862023,81616.64870334612,75502.84614661892
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.0002548316366634788,0.0002837318077386289,0.0002270683887086863
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,7.758613073615229,8.049426456016436,7.446453841619401
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,254043.22415374382,261912.63509209495,244654.84219668986
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.0008229128947676082,0.0009109447772702068,0.0007310184205270705
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,25.054964666676188,25.831083823818577,24.12903728170136
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,530416.8545083916,551390.324099601,501609.90629171545
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.0017185104044009167,0.0019121104060235026,0.0015075242030237346
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,52.31226139798393,54.38076584755483,49.47118160879499
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,2210915.8368421113,2275309.8121637213,2099859.1709556514
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.007163652380970678,0.008028724861175012,0.006289271024546296
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,218.05115392312067,224.4019974923764,207.09821137150146
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,442057.5221833728,461699.7812940688,420165.62340181094
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.0014311124977809254,0.0015552209007766045,0.0013008872808714395
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,43.59783905214462,45.53505312125262,41.438754698347665
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,315497.600516582,349526.04359499575,288656.64124052256
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.0010209390043102618,0.0011335115928813324,0.0009190828054942298
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,31.115890847693656,34.47193957456581,28.468706343869368
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,912417.8020942984,942784.7337024014,865243.1906681764
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.0029558823209249884,0.0032845791523247432,0.002609745087263556
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,89.98703220237851,92.98196505685965,85.33444512243189
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2017,80153.31687023191,94069.88721030127,57257.956261407046
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2017,9.190747152385544e-05,0.00010958214155497336,6.534479728140006e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2017,2.624139514595676,3.079754123734691,1.8745682826053014
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2017,423402.0917548486,540226.5110597219,354058.1544547329
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2017,0.00048547205285983156,0.0006076471300155293,0.00040397862988395125
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2017,13.861761470647266,17.686476241514935,11.591510243720695
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2017,1120485.3710068022,1307853.9638198768,827564.3647971936
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2017,0.0012850193066871406,0.0015402437342728658,0.0009438580247193035
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2017,36.68357159000302,42.81783212211557,27.09363049880364
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2017,103407.5080972778,115089.78577700083,87227.72863688957
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2017,0.00011859354748537876,0.00013565594937297768,9.890760131158645e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2017,3.3854585025253994,3.767924602206241,2.8557486879186285
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2019,141028547.4562163,153666384.9898461,128745481.78214473
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.10073424749108958,0.1111078629840109,0.08999715699418046
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,3100.2880981834455,3378.110836905566,2830.264453996425
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,9075603.311220545,10558047.310392015,7774081.192409446
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.006480558353325968,0.007599219938002547,0.0055479099076494315
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,199.51269042423306,232.10186169313258,170.90079866717366
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,16093921.646812255,19113775.06705784,13345531.52168698
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.011492368607391574,0.013541227491087156,0.009372935456077421
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,353.7992458597758,420.1859156930777,293.3802643997551
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2019,8794116.887417167,10305394.867793534,7676883.149045903
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.006280877785558045,0.007394581627749722,0.005433181191263604
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,193.32465952368955,226.54769996564104,168.76405442324491
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,1105791.9607138592,1135781.4092976889,1062511.1670200606
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.0031827126196024326,0.0035263503948501944,0.0028355287462708155
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,108.30293465904835,111.24014654503323,104.06394835968578
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,2342370.1677134708,2472227.838560388,2204029.5443650074
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.006740738650947313,0.007477365633390508,0.006031573300354654
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,229.41527179977462,242.1337282005888,215.86598221954634
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2020,1024355.734877953,1059608.16022904,972906.2880309562
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.00294823493960262,0.003261576511999681,0.002620931467753466
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,100.32694771129357,103.77962349029559,95.28791118536587
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,404124.4998412741,420140.5030344794,386973.65364470775
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.001162794862662341,0.0012758170678191095,0.0010460625337989729
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,39.580563845097174,41.14919538607257,37.900784066471346
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,6259300.213467656,6490404.083130252,5889734.082351873
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.018014935374525205,0.01998963963393275,0.016057902324226405
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,613.0453160402133,635.679978060511,576.8494510200047
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2020,3431589.7994139856,3606684.026124548,3227557.162237942
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.009870263257388075,0.010726933299302528,0.008973193334237
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,336.09508752683024,353.2440805276188,316.11182290070155
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,1428460.6423114815,1514547.9650678567,1341336.6642133994
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.004110161373644122,0.004547071188406789,0.00369612973282949
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,139.9055926463866,148.33711505086973,131.37253865212404
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,569444.4920779712,604449.5652250112,529907.590302049
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0016376787872044488,0.00177646591393167,0.001482314437785637
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,55.772253559938946,59.200703290511825,51.89994968924105
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,2164561.284190796,2300549.040015811,2003548.7722975966
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.006224019364880496,0.00673023784387021,0.00567452345607427
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,212.00040121098635,225.31924739254052,196.23059262637608
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,3827341.9871801576,3985126.5315637877,3612504.096166764
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.011012434655671696,0.012095351820871219,0.009905137706878477
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,374.85565448297336,390.30931105464583,353.8141069773374
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,492144.420420493,510859.0545082964,468854.8392375087
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.001416077375579918,0.0015578918207233864,0.0012766868379573107
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,48.20136779906312,50.03430732547353,45.92035104481841
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,79021.48821665747,82470.79435852559,75397.07760440896
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.00022738943269702945,0.0002524659019727734,0.00020491659260298868
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,7.739483898458177,8.077314151321135,7.384503649313922
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,258571.6817360541,267972.81522276683,248679.65505890854
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.0007440666018704019,0.0008183243895851626,0.0006667422108238544
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,25.324901018146026,26.24566222993412,24.35606098591351
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,535869.9750280781,561768.27274355,503382.6852138125
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.0015422451244572102,0.0017027641462016281,0.0013649570696129495
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,52.48391465402378,55.02043304528479,49.30206042555513
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,2244058.348418833,2318997.378991844,2122014.067756329
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.006458989325069152,0.0071763653231838665,0.005702318327929351
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,219.7864637422399,227.12610557353096,207.8332625762907
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,444762.77283750416,466337.09674107557,420446.36494996777
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.0012791592047559487,0.0013846441192195932,0.0011758642030809626
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,43.56073767646233,45.67375954228707,41.17915196400468
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,320222.08170623606,353398.17228284734,292341.99447470525
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.0009205923945348061,0.0010239657643061836,0.000828204999054224
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,31.363034298988868,34.61235071438568,28.63241644951943
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,923025.5053682603,959822.1966962419,869578.306389779
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.0026563544157929687,0.0029325416729614876,0.00237013352344088
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,90.40251199873008,94.00643551974267,85.1678126119313
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2017,108072683.8343531,118072327.35999972,98933274.21144807
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.1239259283433945,0.13872924526923386,0.11084974007981394
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,3538.191695264162,3865.5700338300308,3238.976555229849
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,7381383.8416924635,8655538.231244251,6335603.020197775
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.008459921292118852,0.009897642486938361,0.00720533919090875
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,241.65913236931738,283.3736740985338,207.4213130943709
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,13564297.587980684,15842557.16354461,11389801.613934547
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.015551921444287365,0.018122449431703817,0.013127750506455232
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,444.081551184994,518.6694935208354,372.89072549449924
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2017,7106059.420082217,8277306.418519817,6229589.540975215
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.008146768451454801,0.009462810416769978,0.00699377097243814
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,232.64528587747074,270.9907424345299,203.9505377007826
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,1042721.4230361814,1158342.973956447,937621.1328777003
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0011956071412673093,0.0013465402279525846,0.0010571297329414315
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,34.137657626005165,37.922991687724895,30.69677913002402
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,23032141.779070027,26090749.80288639,20241132.845782988
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.02641020413116849,0.029983510536541122,0.02273539077730119
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,754.0493108485967,854.1850817481392,662.6744668195527
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2017,7120187.60977976,7772651.121312443,6569214.316362767
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.008167101573092018,0.009163252581303082,0.007289686680015164
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,233.10782869294786,254.46883219598155,215.06951353397292
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2017,78742704.01153086,81305590.79885353,74466216.98291086
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.1640510375845996,0.18187116438378478,0.14545904679657717
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,5204.601928523677,5373.999280104773,4921.941929532497
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,2154767.7867206777,2206665.577475852,2064396.8847134798
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.004490469012379857,0.0050150086268179045,0.003947414165537572
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,142.42219287573485,145.85244517962997,136.4490100040846
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,4735647.6502863,4914417.578997738,4462347.576840105
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.009868414607260786,0.011053518991050733,0.008616702424605622
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,313.0088203458117,324.8248524139681,294.9446948223165
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2017,2883461.8203571616,2987686.7577988342,2742713.338695255
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.006009145941034576,0.006715838985998842,0.005257033367026839
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,190.5861773410481,197.4750607902341,181.28322250491408
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,1843262.1877490832,2022035.3891931474,1691581.5421791757
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0013168286656752028,0.001474808461892841,0.0011716887656342521
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,40.521184721726115,44.45122894829137,37.186727204668045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,27245302.99968965,30714933.263399385,23837626.594880126
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.019461294944506463,0.022307162803021537,0.016445618922310556
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,598.9446118883384,675.2189095798458,524.0322711541229
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2019,10085483.688136462,11047683.289999124,9199020.308373088
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.0072046171030656705,0.008010915230988317,0.006433729928122033
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,221.7133027797808,242.86572920364205,202.22581662660238
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,5264984.307874125,5844937.254706403,4732521.2437060205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.0037618520327547854,0.004275936773996248,0.0032721594344163516
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,115.74229814635493,128.49164039657376,104.03694536254947
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,1025756.8303006022,1241380.3741608919,854388.9159845326
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.000732747852089038,0.0008859555803924417,0.0006115779888174842
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,22.54963090787443,27.2897712466646,18.782380129590884
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,2296732.8692437676,2786883.4963447214,1850571.959099946
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.001640709384889373,0.0019828846060797834,0.0013225014673430933
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,50.49001572843839,61.265196944780456,40.68187840770882
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,12761735.985947907,14154918.51762163,11422667.55217829
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.009113955038911999,0.010137223395347209,0.008014782306176613
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,280.5464489498273,311.17334896016797,251.10916123219002
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,4082200.3799389615,4438855.820307517,3684349.90902114
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0029170282808228727,0.003234967936701719,0.0025498295131032786
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,89.74067648434011,97.58117854489126,80.99456725970848
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,1979713.497907495,2215359.5359941064,1767187.4136907985
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.0014140450485619705,0.0015945418597914551,0.001239838385648649
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,43.52084954488547,48.70115254340293,38.84880192519966
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,1864036.2589303912,2023137.445001857,1713224.4555957261
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.0013321905862490567,0.0014984714380133425,0.0011818509442855076
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,40.977869604297226,44.47545589077149,37.662512200582974
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,2416885.1763085653,2838786.4120912678,1817650.8759915328
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.001727038788176624,0.0020562981643545337,0.0012953375372683328
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,53.13137291661981,62.40619991795503,39.95816080597993
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,5104923.277996484,5695157.839055252,4539275.61672717
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.003646490219090159,0.0041230021457376,0.003178270498143914
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,112.22361122187479,125.19897839251888,99.7887479007233
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,401756.582425256,495907.1048700578,273169.12005288666
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.0002869924212474471,0.0003545687305037935,0.0001998558715792372
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,8.831978867587614,10.901728215775377,6.005188218747971
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,608304.3611692814,704590.6725962101,492965.8180817299
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.0004346094213107756,0.0005174430182331186,0.0003504245547881436
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,13.37260295892723,15.489304227708068,10.8370687082666
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,2427487.8295252896,2755549.1478091422,2147925.3197005703
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.001734510726638537,0.0020223552050640664,0.0014976710416220737
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,53.36445536815097,60.5763611765517,47.2187186535546
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,250808.82793880897,280002.0231743593,228578.91272154576
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.00017918601701405568,0.00020110007361531264,0.00015951211036658832
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,5.513632794235766,6.155398715882383,5.024943498239826
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,1471440.7909016665,1591588.3361283191,1346103.3249492478
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.0010510102363649912,0.001159281607329103,0.000940492621036523
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,32.34728325221071,34.98853575896148,29.59193860066495
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,1856379.5314538404,2172816.542320147,1655671.9477466126
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.0013257527865461092,0.0015733452772890783,0.0011599716117261449
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,40.80954864024606,47.76591255598536,36.39731193919185
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,4730717.6270292625,6036084.443998726,3749642.488849165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.0033793567242583764,0.004319920455768636,0.002688915936055903
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,103.99729572127141,132.6937070465773,82.42992068135074
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,742405.8102083928,838332.8905905704,627120.418129086
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0005300134243813446,0.0005951777836268954,0.0004505200194849778
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,16.320609826360833,18.429413972519132,13.78624401599998
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,254359.59344576707,279157.17417426326,227555.82451380166
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.00018174901513841766,0.00020546864590880582,0.00015972156326034034
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,5.591690721082672,6.136826055616042,5.002452532750406
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,570747.8329455414,843240.1773117895,398670.3835361334
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0004079367744491785,0.0006050147050920679,0.0002852227855346948
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,12.546982475972879,18.537292858677926,8.764133698243116
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,141746.72075909635,177604.09735375905,90944.53806092308
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.00010128592621919865,0.0001288201785199184,6.388670600696187e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,3.1160759949143735,3.904343334355193,1.999270885439749
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,671828.0665286713,907109.1100462312,530307.9251550541
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0004797895140272007,0.000642788177136157,0.00037859782187897497
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,14.76907049142715,19.94134966541589,11.657975483587823
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2016,2723983.568916841,2796935.9971741815,2625927.659835113
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2016,0.005683427527145314,0.0063260095032480704,0.005052286084889189
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2016,180.8327173431968,185.67569289895803,174.32323736940344
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2016,313244.1763453677,335095.22894878633,290070.1509745567
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2016,0.00065273336531499,0.0007042813426542925,0.0005955526539384967
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2016,20.794837475098447,22.245428170348703,19.256420713924573
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2016,384102.7103533786,396683.23798684287,364552.0364682956
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2016,0.0008014360178888627,0.0008958499735132213,0.000700520925320816
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2016,25.498809040066103,26.333972300054185,24.20092988805051
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2016,220302.78344755468,230554.97705239838,209511.5652953703
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2016,0.00045940362763354403,0.0005066386597679729,0.00041492885964256423
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2016,14.624886663663762,15.305482556182177,13.908507415209389
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2016,2361620.3773098947,2461484.872535035,2216185.446790372
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2016,0.004925092303051996,0.005424943852034918,0.004392485256826107
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2016,156.77709477955042,163.40663845365194,147.12233988948267
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2016,1268264.2102640953,1317828.8881538026,1186448.1039304524
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2016,0.002646022962523477,0.002964829145231435,0.0023121818156558544
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2016,84.19421690651963,87.48458748338767,78.76282260606291
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2016,2764635.7700939896,2864933.9689947753,2609628.886491132
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2016,0.00576743941143523,0.006434636903082016,0.005114672393940552
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2016,183.53142965876697,190.1897649214385,173.24123690993483
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2016,1590934.2142453024,1649534.4206250913,1502324.4976895314
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2016,0.003318793439977035,0.0036822081997213083,0.0029430780373039317
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2016,105.61479164525173,109.50498932391957,99.73240086630817
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2016,707917.6146890107,772464.7629517049,643449.047554078
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2016,0.001475042765900582,0.0016288702302984137,0.0013028708924008251
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2016,46.995388437761896,51.28037618522419,42.71561732927911
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,154152.64141092397,161449.28905005357,146429.2154211125
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.00044338785301990255,0.0004816688808183309,0.00040583441873620954
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,15.097942509429327,15.812587198996983,14.341498503652199
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,902973.9926436053,937802.3440519373,858494.0720034876
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.002598167480796977,0.002859491323823898,0.0023423011607247458
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,88.4386365595998,91.84977789618893,84.0822059561286
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,725301.5815193342,759789.1133633382,673008.8250866513
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.0020864468048252135,0.0022841156093579315,0.0018785164920766054
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,71.03713228361903,74.41489323735365,65.91550074325737
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,1509518.1085571293,1568442.2704593267,1447801.8982909315
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0043443506991519745,0.00480653142295524,0.003889590898453475
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,147.84448330784824,153.61560471500064,141.79990446722326
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,188080.8080961338,200310.4744043395,175889.48504170316
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.00054084249023237,0.0005870324606469938,0.0004950139655868039
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,18.420918394728265,19.61871038285641,17.22688180278291
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,120412.67646092264,124634.11649560311,113985.08336053428
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,0.000346576371574566,0.00038633792256600823,0.0003070518188383488
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,11.79339938630914,12.206853598752456,11.163871210758918
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,133505.36232123917,139838.4609239794,126837.11433095546
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.000384115571471009,0.0004211230618830921,0.0003472833709024842
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,13.07571681274976,13.695990054489632,12.422618533833164
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,790562.0134953022,814734.6866480465,758149.2639330651
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.0027688986090331578,0.003075481731329802,0.0024871404028766085
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,93.11286515516824,95.9599370069513,89.2952721924692
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,121412.69265939861,129223.55398531628,115545.79510195374
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.00042525268616450845,0.00047457019543640627,0.00037826305924514443
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,14.300059308108468,15.220027210652027,13.609052616893596
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,552927.8366750422,579136.6336261607,528487.6756797673
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0019366054719709847,0.002152480509127796,0.0017403250313417127
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,65.124170170071,68.21105789643559,62.24559344076157
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,545005.6416839546,569419.2974628203,511467.2540865651
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.0019091534778043124,0.002135193831470415,0.0016785030660323808
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,64.19108932208457,67.06654425120725,60.24091804068132
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,3111423.6910348735,3226615.665621704,2944063.146324805
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.010899943274803725,0.012155336558744323,0.009649281193558672
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,366.4653368595573,380.032716285289,346.7535121502151
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,695767.3482352931,727393.1095872144,663806.2341877182
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.0024357882412275574,0.0026419955148316563,0.0022296114186205985
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,81.94789297953888,85.67279400175133,78.18349391694915
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,204445.08725096966,213727.96913731308,188456.59597834427
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.0007161742133284801,0.0007983790329479179,0.0006262571137813948
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,24.07966423363862,25.173007595170578,22.19653020178645
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,1233837.9179861357,1285728.9157285194,1163195.3902171357
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.004322128863503938,0.004816187408516948,0.0038259915346029027
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,145.32216539576876,151.43391803891885,137.0018463694436
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,103073.04722639224,110752.7072157748,96693.44293580187
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.0003605502878696927,0.0003870091616751146,0.00033544708045472307
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,12.140004937867381,13.044519868792742,11.388611342029492
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,1275598.3429369933,1322992.1065936713,1215834.2520197001
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.004467726373733583,0.0049390917780598,0.003981824602404964
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,150.24073313731765,155.8227988693267,143.20168288735752
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,1354068.6907169386,1416206.1042605108,1267929.7537735328
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.004741361032902652,0.005234074378592472,0.004262393653816955
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,159.48301747021742,166.80159907369318,149.3375221348681
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,1876390.2884279185,1946846.5306003965,1801305.2822394748
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.006573268589318591,0.007272851766894682,0.005871845693571147
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,221.0023665725929,229.30074477032656,212.15880979013562
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,171420.51412666147,183548.20359921624,159740.9888714866
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.0005998731928512608,0.0006508678421794324,0.000547054179640131
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,20.19001032712821,21.61841682178009,18.81438888112266
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,254837.49583042323,264417.99081226974,241167.2711894737
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,0.0008927241853412991,0.0009938192932233301,0.0007842452390565393
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,30.014912151961017,31.143308561270363,28.40482494576472
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,153674.9669965147,163908.36427142753,145568.94793595403
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0005380749089956106,0.0005966505539427764,0.00048568777658447267
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,18.09992920910362,19.305224839645444,17.145197452648333
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,1273073.4563179056,1330187.6700375057,1194850.946245263
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.004457526149591503,0.004874165240239944,0.00401664849637888
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,149.94335048639087,156.6702966205771,140.7302566263784
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,744225.4524877074,778133.9227822237,694811.9789851499
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.0026068648497176022,0.00290144247783274,0.0022924277382619265
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,87.655317381302,91.64907722335664,81.83536901981981
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2018,1638804.757319925,1711417.2934801131,1544071.5690273484
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.005739939509569128,0.006381844429743185,0.005129673557278748
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2018,193.01940110848108,201.5717488973225,181.86166972671884
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,1077228.3408730766,1123755.5767910618,1016752.2980403393
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0037730592398989666,0.004187889280770112,0.0033395139409956092
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,126.87659605799735,132.35660163645872,119.75369168708495
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,396926.9422651838,436978.0380935316,359524.5074453522
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,0.0013886902315549494,0.0015367260420520166,0.0012289100863991137
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,46.7502918438807,51.46753378255348,42.345010777495794
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,129233.07647475145,164315.69165048865,83292.08181423665
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,8.457516940271504e-05,0.0001083630487354191,5.412018317806559e-05
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,2.7956037769478503,3.554520102132295,1.8017961412163852
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,674989.1051722514,919235.6992383022,524547.407865172
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0004415072876285954,0.0005928715766259076,0.0003416029826130404
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,14.601541209822253,19.885147539592666,11.347146989126871
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,789439.3654592845,817004.2857437483,760048.4885207734
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0027744411374021343,0.0030886190709453506,0.0024826008385584004
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,92.8840727460537,96.12731367495238,89.42599290981613
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,120070.89535669978,129057.27324193649,113335.92437847314
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.0004219861561433097,0.00047367142778554977,0.0003739974329474692
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,14.127334241189065,15.184655947879275,13.33490918404712
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,553482.802222976,581401.7108910214,528226.4963881932
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.001945193111118158,0.0021712200293612393,0.001738773512734906
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,65.12183090269272,68.40672149363061,62.150217564042315
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,544896.4360869332,571628.1291173385,509310.5470693449
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.0019153429651710034,0.0021418837958057484,0.0016788440230315691
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,64.11157388777886,67.25677873656007,59.924599626215795
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,3156129.7628616123,3290065.348510924,2971089.8389220196
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.011094583252394421,0.012442935701314203,0.009824413808536303
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,371.3447787330321,387.10340849619115,349.5733007600152
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,688792.35955024,721683.9930548626,655866.7936825111
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.0024195570075449518,0.0026354067113753404,0.0022106605251869756
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,81.04211980127069,84.91209261090192,77.16815456838188
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,204328.62223598507,214630.07674771236,188516.1480492238
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.0007182208536973715,0.0008005291690971748,0.0006275929207955405
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,24.040952911977637,25.253004264016276,22.180484499937233
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,53020.45560367644,57180.62661123146,48652.81043048155
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00018559743928683991,0.00020516129733940487,0.00016688885485955865
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,6.244780863253614,6.73476828414708,5.73035701146841
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,3833719.024581651,4296929.998995367,3407436.4497101726
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.004343324123084201,0.004935689077731986,0.003733889316898253
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,123.41574528981394,138.32751301904355,109.69278297972002
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,874169.7890902351,1029518.9233141367,734066.6207461758
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.0009901591233598191,0.0011788826401897554,0.0008238282580934451
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,28.141424903246207,33.1424510758574,23.63119949867757
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,2427880.744149812,2733749.2689506877,2040110.7865240462
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.00275040942491291,0.0031410208390440755,0.002298455124103243
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,78.1587564432256,88.00532884640666,65.67559896232335
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,10921817.021678023,12221104.425417867,9685238.875550324
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.01236424998378504,0.013910203678025682,0.010905073165810304
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,351.59702080578586,393.42390541836323,311.7888834501534
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,1355663.7292996785,1494424.113218733,1212181.8743883823
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0015351672015476631,0.001715486588278386,0.0013539582994130787
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,43.641761026591155,48.108759282922584,39.02276836022721
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,1405813.5325394594,1642478.3951253388,1213415.7162100952
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.00159129997782285,0.0018198829887916851,0.001374985335850273
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,45.25619215816078,52.874948309215654,39.06248840935446
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,472666.04666436114,520933.56026313093,430992.8754892126
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.0005354066338742175,0.000605493193400372,0.00047296865177071286
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,15.21614704891887,16.769983187113272,13.874597121500221
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,1504508.7519309889,1784114.1272609008,1148924.5620485307
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,0.0017042412425427186,0.002036363020575232,0.0012855437065247023
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,48.433405714930544,57.43451027218094,36.98637803078588
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,1227919.1634937716,1284595.2041487154,1152243.37569178
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.004316042623793657,0.00482706837142927,0.003832283563292199
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,144.47484873252287,151.14325382287376,135.57096619655925
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,101496.44923673276,109822.30018175388,94803.5759819952
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.0003562485459418227,0.0003839811990735577,0.00033039711025274407
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,11.94189698012605,12.921502227452686,11.154425068446672
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,1277324.4475986087,1328986.4807124906,1215570.7488865994
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.004489099791601321,0.004985065889615314,0.0039988820648707655
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,150.28778916039656,156.3662547803204,143.02195558980034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,1364478.6253891238,1437457.9706782536,1276653.1374421027
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.004794216120966705,0.005322522130536685,0.004283425483396538
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,160.54219924457945,169.1288230099793,150.20880396642173
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,1868047.0165876404,1937415.7486896766,1782497.399169831
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.006566502258857053,0.007289390395185891,0.005863158017572326
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,219.7911867250609,227.95299197671355,209.72556644400234
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,166674.16788413154,179185.58524467313,154433.54313538154
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0005852427802870588,0.0006359556124733174,0.0005314792793148685
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,19.610594824633324,21.082666589887488,18.17038405054989
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,251661.35258989077,262804.67293139274,237281.88646949083
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.0008846447065373436,0.0009905549765265255,0.000779842854754483
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,29.61004024385112,30.921144075911073,27.918177086761645
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,150018.04604484251,160381.1113970818,142200.5394528691
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0005270513403719701,0.0005841919094487016,0.000475620001864815
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,17.650864286382827,18.87016466354287,16.731069957961953
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,1276903.9162025345,1341464.1162261413,1192584.577299573
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.004486206351648546,0.004930142908155473,0.004042159288679891
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,150.23831016239635,157.8343518317949,140.31744232727704
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,750423.2657959084,785261.687327298,699449.5268091236
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.002637667148450448,0.0029508394394435564,0.0023087378144315946
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,88.29350582228251,92.39253434994745,82.29602370098965
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2019,1633022.0056915137,1715982.7851439172,1535650.4473425052
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.005739297921820534,0.00639604405648057,0.005118346445273552
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2019,192.13854972168897,201.89957179745426,180.68198028164812
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,1082956.3464183034,1134553.9268329074,1020742.3991569332
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0038060754376707607,0.0042411425810110395,0.0033658844328575493
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,127.41877395865214,133.48965618525872,120.09878833837291
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,398337.9511745799,440474.9861049222,358007.75116003264
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,0.0013984321731925647,0.0015527391795909138,0.0012372395710052817
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,46.867755591194864,51.8255263700765,42.122573888943755
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,319469.88461390696,334385.0502595017,301697.15195592924
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.001118904681221834,0.001243342582549828,0.0010005476455119638
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,37.627353426295976,39.38407052605259,35.534070380599765
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,209170.8467980043,218046.70269212007,198364.2138932047
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0007325798517042884,0.0008094053875841063,0.0006593612463389224
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,24.636267009824714,25.681670607388824,23.36345534512413
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,38921.867506596805,41720.528700753304,35489.34489532733
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.0001363412352880679,0.00015444864746365605,0.00012062870661360817
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,4.584240753873013,4.913868737431629,4.179956194800786
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2017,2253661.6634530905,2546332.5328577156,1942696.877394923
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2017,0.002584477188215956,0.002956440342916294,0.0022139193980261363
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2017,73.78263126866364,83.36438313077502,63.60195485243805
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2017,329067.80258136016,452698.1275080233,260875.62797510476
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2017,0.0003767666547501265,0.0005268221923256993,0.00030499544253570693
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2017,10.77335109079708,14.82088441206437,8.540807423762114
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,2781122.3249137285,2865279.8604182885,2678103.981059958
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.005761533411774323,0.006412125124375638,0.005112901395204196
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,183.11385734689537,188.65493362858186,176.3309531389196
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,309187.49039777153,331629.51436599204,285699.8157243751
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.0006397053970541081,0.0006911508575244303,0.0005814347031035
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,20.357433940593882,21.835055237104037,18.81096521067636
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,373794.38001216593,387305.72727303975,352293.82728044805
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,0.0007744095139540451,0.0008687880346072783,0.0006756941741405319
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,24.61126221074875,25.500872456486057,23.195628992991125
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,211626.9329660353,221654.18910314373,200314.89869586853
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.00043817945636727656,0.0004826282643416557,0.000394927128465954
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,13.933879738679122,14.594091457316205,13.189076027208156
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,2407497.410524946,2518764.9415642843,2247130.7360726846
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.004985105374511991,0.005499993581109825,0.004436087139943711
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,158.51375304304887,165.8397978644362,147.95493652290241
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,1288815.0836949854,1343958.3812812264,1200641.2353458689
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.0026698788650470133,0.003000204116744332,0.0023293071988512697
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,84.85779257824305,88.488521740132,79.05227537977626
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,4525552.24542696,5099168.675671482,3988295.406302173
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.005124334579694404,0.005782560177692329,0.004485040732944461
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,145.68735988112957,164.15331912206153,128.39189488030806
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,370633.5992631218,442429.89384159155,274302.79729298793
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.00041985821785139394,0.0005066048463706727,0.00031196825506278516
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,11.9315008714015,14.242779592568548,8.83040304882257
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,589269.3313758211,672505.6034432859,492636.3206523014
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,0.0006674623440300084,0.0007883941882135757,0.0005500373825427841
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,18.96986013890606,21.64941659217874,15.859033559917766
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,1765048.4548762005,2005226.584307332,1530951.3271362665
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.001999952464017031,0.00230110870976957,0.0016781416584324216
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,56.8207448523048,64.55260069671984,49.28464966510437
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,214645.680310858,229033.4389617982,201982.0099343889
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,0.00024317054464264787,0.00026668819037422003,0.00022070271655805874
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,6.9099108304355825,7.373084043070682,6.502239765447453
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,1372548.8392661393,1500876.2093734932,1248841.2217080132
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.0015543228381259323,0.0017067706118884824,0.001389530660052048
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,44.18532940430727,48.31646627723164,40.2029124037214
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,1500367.6267465167,1806331.8504533921,1317514.6071842606
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.001698234768010063,0.0019957534862995807,0.0014778250272594175
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,48.30009389742306,58.14974705632248,42.41365789544419
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,4215161.527422337,5078547.818936969,3442882.99212347
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.004774193767545887,0.005793771134095113,0.0038693781595241553
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,135.69520825291735,163.489488938867,110.83388419810196
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,490420.4095043214,551493.7413315128,412920.8546554595
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0005550624807317651,0.0006131490173549867,0.000468213258851944
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,15.787698565341918,17.753781816737046,13.292819504051048
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,187557.7480034501,205949.44270543155,167988.4769306804
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.0002124731269330431,0.00023944327477945005,0.00018828778855973545
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,6.037891432915038,6.629960046768512,5.407914077052909
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,272763.1520727571,352419.49836235156,218352.54207437462
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.00030907176239534543,0.000409779653986872,0.0002460453469734692
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,8.780838523848695,11.34514938788407,7.0292427648567966
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,2735117.189241406,3118124.040149449,2411785.82837426
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.00309725571343573,0.0035071072058712634,0.0027363987702366762
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,88.04936517277635,100.37918789917683,77.6406261334454
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,727966.9375076374,847941.2031602608,582192.6198685565
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.0008248765851088394,0.000993782070938757,0.0006567209566611603
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,23.43483744186298,27.29706973279946,18.742045419238313
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2019,5080670.98216208,5738696.524197289,4051824.287861095
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.005754998747067489,0.006685562918758362,0.0046027106796010415
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2019,163.55783817628347,184.74111012951983,130.43702761297575
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,1320593.4641255692,1378370.876468152,1245551.5508857956
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.0037995873609823873,0.004159040984553143,0.0034239618848721435
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,129.34091830802112,134.99972533142176,121.99119999296792
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,645223.4016230823,669856.2481856549,606800.7303045271
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.0018570100185885006,0.0020543033367207263,0.0016426949291036505
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,63.19415440618845,65.60673260038192,59.430979949256105
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2020,1825659.051736699,1918998.1164055108,1722751.3831121775
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.005253729311149939,0.005862821808796225,0.0047146763920825376
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2020,178.8078047359796,187.9495736953388,168.72887225417563
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,872477.863202553,916184.8710645316,827196.9305745241
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.0025104954911215104,0.0027525119257741514,0.0022449201316336563
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,85.4517995852417,89.73252994392736,81.01691665794283
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,330589.2863484616,357365.9852769235,300404.22249598254
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,0.0009505112396637966,0.0010374637535955106,0.0008569843319552066
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,32.37841397876073,35.00096431143095,29.42204323793545
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,36741.95719451226,40338.673849302075,33677.76721095471
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.00010566898542528765,0.00011838008850450379,9.522305372616644e-05
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,3.5985627773183833,3.950830638444218,3.2984513826235773
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,345595.5557669025,359895.0908051797,329071.5363036315
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0009944375076389852,0.00109357459117498,0.0009018088716957497
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,33.84815066888123,35.2486687264601,32.229763247181964
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,303968.31385304144,319011.27171719586,290702.2821363157
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0008746820105651163,0.0009629265215399055,0.0007865081708915149
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,29.77111572812902,31.244445740031612,28.471820546715435
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,47313.34668786013,52031.59340859156,42795.09000209168
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,0.0001361192315670408,0.00015515919785586148,0.00011947646649286791
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,4.633940629780156,5.096052839359577,4.191415746260755
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,3798548.8774079066,4243796.691176046,3387736.205199508
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.0043388178279455064,0.004916172313546929,0.0037364244514307083
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,123.26480207308732,137.71331528402078,109.93372634833854
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,844681.8379034539,982926.7245995739,711420.1326596655
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0009646571288800841,0.0011349268488934105,0.0007935720276678772
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,27.410346141169292,31.896461535804463,23.085937465399713
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,2329245.9362331848,2604025.9462141846,1952758.098704795
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.002660629460123698,0.0030579299395717455,0.0022344591639700496
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,75.5851901806383,84.50193829605594,63.36797242891359
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,10522390.348855767,11697653.4058083,9475469.074051203
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.012013381887650675,0.01352780110307507,0.010604439435032517
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,341.456805097782,379.59467636769773,307.4836885499307
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,1321491.6536950823,1451545.5164161252,1186761.9428481867
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.001509086537745552,0.0016848984957554222,0.0013301613161642465
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,42.883062030023886,47.103374618995915,38.511015841628044
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,1382683.9258648749,1575210.167792962,1202999.3447437878
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.001578509564070947,0.0018042358848368903,0.0013750863605125757
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,44.86878172479307,51.116354119158395,39.03792761647619
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,459266.62015714555,502861.5341525214,419912.2294174582
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0005245453265183704,0.0005991386075101556,0.00046396848849050167
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,14.903430457126923,16.318107118784173,13.62636088614256
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,1455440.6578900625,1705532.0656210312,1119821.2026723635
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,0.0016622768235462742,0.0019592277236078594,0.00128462995468987
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,47.22977389891229,55.34536458078711,36.3387554983494
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2018,2771809.9462543908,2885497.902022076,2612062.7859389186
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.005741452168617553,0.006424756686903574,0.005079495922602906
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2018,182.5007143858286,189.9861241170061,171.98268773754506
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,1662445.8723852017,1730243.5961692045,1563792.767743688
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0034433485226077853,0.0038391367483488906,0.0030446000461799637
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,109.45828365615755,113.9222019132636,102.9627942746485
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,744642.0147701425,817337.1078574812,673254.1241523866
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,0.0015406201057779822,0.001714022630474454,0.001359856380227209
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,49.02850566680997,53.81487510700614,44.328204676172724
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2020,143289705.83246726,156719730.95356175,130452915.68412521
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.09822010243253174,0.10926860990931861,0.08700042304425257
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,3122.963997574609,3415.668101446092,2843.1893044465205
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,9303466.220863957,10780121.777905652,7894800.282643581
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.006375494649510886,0.007342291307341989,0.005363630960653346
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,202.7667646577466,234.95011038148954,172.0652360021195
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,16231326.958884094,19089611.83811116,13225671.398474768
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.011123071747645697,0.012923037847989538,0.009222764301388502
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,353.75779042161776,416.05340838509204,288.25026460365746
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2020,8811059.971932568,10129539.556439932,7667863.312513045
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.006039878754737523,0.007046711863686562,0.005203203758037492
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,192.03489122232043,220.77083041649996,167.1192003932185
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,79324.71840580687,94072.32946557338,56467.8266320206
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,8.9856465104081e-05,0.00010702584641144892,6.392435753987295e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,2.5536350418965816,3.028392685457589,1.8178220323403376
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,435937.13721293013,540063.3453492767,364152.33697630384
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0004936997883629314,0.0006101902855859067,0.0004113461257217349
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,14.033763649257734,17.385812534152674,11.72285495592946
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,1137154.3275458761,1326496.3393581174,857319.1551713201
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0012880090301227607,0.0015375997716497735,0.0009607181955412537
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,36.60746860782948,42.702799369590444,27.598966384410037
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,105711.27032656001,120019.0205302909,89699.05205968069
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.00011974053685617596,0.00013834644731596828,0.00010039468760957994
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,3.40307548081437,3.8636730476917807,2.887607383523197
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,2710939.160702403,2804807.5299750185,2594081.576342972
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.005201588769860978,0.005779768625010163,0.00464270576078938
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,177.51042357799258,183.6568595554933,169.8586696771159
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,302672.19822340383,325343.89632005396,278456.94263421546
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.0005800352224186428,0.0006241721962116629,0.0005278418435166797
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,19.818766459516436,21.303293589710712,18.23316825097074
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,365665.45777476573,381624.60550642665,343568.8115921921
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,0.0007016665547307503,0.0007873211376434916,0.0006146101978271553
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,23.94352158040357,24.988515549599438,22.496648452308232
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,199093.82018234464,209681.18733121647,186726.55424766196
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.00038179840446745446,0.0004200805345722852,0.00034565220958135125
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,13.036525815345774,13.729779302703633,12.226725785012956
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,2386996.63180529,2502108.353990092,2216736.373233433
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.004577893138923803,0.005055134255749669,0.004099554506312277
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,156.29889055909794,163.8363266107881,145.15036644033552
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,1295589.9620841984,1357374.6551603666,1199576.990829391
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.002485863298637358,0.0027916869028552557,0.0021731457434263756
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,84.83433574856522,88.8799547715112,78.54747271472027
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,53090.597501700075,57734.41695147172,48288.28926696005
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.00018647712162555576,0.00020820350040993735,0.0001657725405537071
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,6.246548039329686,6.792931818077769,5.681516743778507
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,71141.55221754106,76669.27859351157,65510.34141311816
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00014725855856686842,0.00016337165926147337,0.0001321610556275914
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,4.684081648441559,5.048036620862104,4.313313084004763
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,566740.3713331975,587602.8384109756,540081.1976569929
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.0011738426430945728,0.0013070948481496533,0.0010486516654899486
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,37.3151567550172,38.68877732041361,35.55987109864749
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,325525.4757190638,337477.2602934557,310766.3014486284
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0006742241450952795,0.0007503706207661762,0.000605621950921822
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,21.433154877662542,22.22008084492072,20.46138556435185
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,68519.71521589182,72103.43506435229,63587.59742302705
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.00014193958165295976,0.000159690117375054,0.00012676919084583942
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,4.511455409600482,4.747413662577574,4.186716326443204
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,4341729.111101257,4848957.146253757,3860680.5815062276
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.004957958227654653,0.005621830717292182,0.004353222011397503
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,140.891271063507,157.35107331348084,125.28100680160709
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,361955.8325606536,418007.24786582845,268697.5596606737
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.00041348098625954536,0.0004923759024256575,0.00031003800780500263
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,11.745646956169827,13.564543286450442,8.719369574545516
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,573298.5699898917,645519.9865957135,470544.97187802405
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,0.0006548646111820517,0.0007633980698572291,0.0005330597640176976
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,18.603823996812938,20.94744491908193,15.269418585081059
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,1705578.9253154686,1936524.615446032,1484145.9790259223
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.0019483059178652413,0.002272074894191573,0.0016660299726932047
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,55.34688520119934,62.84118781578162,48.16127585991135
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,209558.52496464126,221423.83617508633,197976.2318556444
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,0.00023936891896565368,0.0002614895895502873,0.00021687387480747963
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,6.800278457946701,7.185313713538611,6.424427280639434
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,1326453.3798929264,1431588.561944068,1218858.8410756593
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.0015147861328368897,0.0016692003335424645,0.0013631411651525533
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,43.04407251520049,46.45576151136665,39.55257616765161
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,1446231.2794445923,1684606.3495130455,1268259.63047799
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0016511585591724596,0.001916580668727236,0.0014413225535400368
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,46.930924983725575,54.66631467580113,41.15565637655705
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,4148183.1396731203,5058287.748235129,3378238.577984541
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.004737464526367717,0.005725023842813455,0.003828558550934789
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,134.61060793922144,164.14395555715532,109.62552361708507
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,476703.3007080807,529555.0414103292,405199.0647138984
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.0005440515855579745,0.0006001703290835638,0.00046469199698928175
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,15.469259421367958,17.184324717915217,13.14891136697496
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,182889.80013866667,199879.65979507685,165966.44752859836
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,0.0002089115564086281,0.00023401011395463272,0.00018408566063243798
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,5.934865061065881,6.486194464842322,5.385693844051924
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,271813.92415530543,353559.55404248973,217794.36153380782
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.00031055106467457044,0.00041509093042942763,0.00024610915544927205
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,8.820497153791118,11.473183538403246,7.067535454596798
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,2675492.304597129,2983869.671273824,2353256.4719432592
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.003055016896129463,0.003454465550217744,0.00268336476071846
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,86.82105720310807,96.82805626880426,76.36434401740307
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,695806.6357860508,792886.0606784987,557762.6063649327
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,0.0007950769111195272,0.0009446738425404663,0.0006384020408405806
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,22.579271719108633,25.729547385142105,18.099674243038514
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2018,5072561.115925222,5672276.642268079,4002725.0486245155
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.005793611010734532,0.00672020095715716,0.004636237220312491
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2018,164.60713344429553,184.06820082570405,129.8904204724563
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2019,79215593.287058,81943218.74573052,74809301.5597662
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.16358482723827655,0.18151703754783322,0.1448240034166299
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,5198.617065577847,5377.620714601537,4909.448955879984
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,2194921.8952563596,2251776.495701884,2093625.8490393476
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.00453401401578559,0.0050849386672849155,0.003971502820606347
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,144.04434718984055,147.77549763469884,137.39667426727533
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,4641389.580756242,4833133.554231307,4339272.181749279
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.009587068293238027,0.010750964532362926,0.008362492352665174
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,304.5966845830175,317.18010978210714,284.7698727002342
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2019,2892888.032304722,3011476.7698567333,2730043.906809832
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.005975762445897027,0.00668411561093668,0.005205554562873868
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,189.84920101585962,197.6317272741581,179.1623625450665
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,765412.0300915461,802071.0232990489,727877.0707194591
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0023700871968064282,0.0026261274450110252,0.0021435241289037813
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,90.20485439624183,94.52516687447667,85.78130810768528
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,115786.97257346957,125579.37547224504,107712.67320917657
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.000358532289630339,0.00040317134005301355,0.00031849280329244035
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,13.645653048753662,14.7997011208329,12.694085827605363
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,534756.2087404168,568314.9387234901,500710.3756426667
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0016558514450672125,0.0018332710001391244,0.001491867039597486
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,63.021750443543674,66.97669266137616,59.009402457565486
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,537801.8119346838,565204.5181359771,499187.81059713266
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0016656058697884551,0.001859866761452082,0.0014745247373086096
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,63.38067894464753,66.61012534184485,58.82996608494305
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,3124452.209916569,3293235.0145256203,2939090.4432853963
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.00967700132268759,0.010788361676225591,0.008669846511809434
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,368.22096541888754,388.1122497413042,346.3758277515386
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,667530.0074636701,703755.6280964902,631302.8242123427
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0020661294539091237,0.002247119408837233,0.0019064861310662071
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,78.66932418240232,82.93856311010278,74.3999010979741
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,202209.80430284745,213713.664284763,186045.68289611465
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0006262423161146245,0.0006960896700684727,0.0005522252050912574
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,23.830701945525064,25.18644757515586,21.925738134382573
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2020,2710311.4036672283,2829405.443220806,2537996.75404122
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.005199730820968026,0.005818901273674924,0.004628886294785778
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2020,177.4693184809719,185.2675139230606,166.18627425511724
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,1644240.1058057898,1723658.5776854786,1540692.11245966
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.003154224965886266,0.003510503038074289,0.00279632337917198
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,107.66370631861963,112.86397299654386,100.88345524328379
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,757313.62532288,837086.1221363493,679675.2010039142
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,0.001451305841112824,0.0016242303340966945,0.0012734799492417587
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,49.58837304840822,54.81182103444272,44.504662655137466
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,322095.3105703617,338262.84276297665,301757.5310916754
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0011319687922453719,0.0012616416801309702,0.0010116041803237656
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,37.89717813321182,39.799422057201326,35.50427011361688
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,209441.04904087828,218285.20924862166,197359.53150567433
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0007360384566701506,0.0008154222903707135,0.0006610416537031374
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,24.642472223062818,25.683060843362824,23.220981729021208
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,39223.23256524529,42302.84964969649,35214.17547643371
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.00013786732568286939,0.00015771959241279117,0.00011988408790890138
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,4.614937823383126,4.97728025247613,4.143239088086829
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,768945.719541953,798058.868102792,735991.7476170757
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.002497487539336191,0.0027603395023809247,0.0022511410574139416
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,90.49064618303879,93.91672367946134,86.61257502925669
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,115987.68569934319,125140.03123580382,109127.94332968743
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.0003767173645268818,0.0004189979063292181,0.0003341506640987486
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,13.64959887475664,14.726660155724712,12.842334455560591
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,537638.970777753,566168.7375025777,510635.7911119034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.0017462135037140613,0.001951814761522861,0.0015713685719152722
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,63.27013291372955,66.62755719059348,60.09235961340481
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,536961.2502501134,563747.7998807045,499134.8949596745
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.0017443399971960156,0.0019496259508046735,0.0015463458996837888
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,63.19037778027995,66.34265774424162,58.73891749382432
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,3111631.995831342,3248584.3100502556,2926891.7054498633
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.010108677011886023,0.01128316518997903,0.009029413298999502
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,366.1813608304173,382.2981075590607,344.4408558405198
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,667045.1782698215,701440.2061083176,633152.527164314
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.0021655724992896935,0.0023460427667544668,0.001995002665839144
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,78.49884287134417,82.5464995725781,74.5103065917995
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,202867.37651276242,213173.62550660883,187360.46819889534
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.0006590124300050841,0.0007318201146228015,0.0005776018927351906
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,23.87372674502044,25.086581056417074,22.048851311083627
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2017,47403564.446900494,50741075.61813742,44261950.461519964
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2017,0.04455629800943666,0.04811912114687843,0.041044429775375826
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2017,1753.9361464867375,1877.4243598908765,1637.696146571974
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2017,2110708.8769654543,2380563.8893788354,1926422.4280205662
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2017,0.001984076870788562,0.00226196534592067,0.001780401584345241
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2017,78.09641821696798,88.08107793834057,71.27780303721319
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2017,3406911.391062075,4029879.43770767,2915159.860878912
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2017,0.00320240145522772,0.0038242561006323747,0.0027841553232978143
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2017,126.05602777729285,149.1059015128826,107.86117694820494
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2017,1930566.2530129727,2187845.2183969906,1735269.761595172
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2017,0.001814279350185432,0.0020741060673355825,0.0016221874857113177
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2017,71.43112493449456,80.9504697850956,64.20513719335295
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,79899.89288393459,94401.563012498,57229.06169301938
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,9.124717475828316e-05,0.0001088843044427456,6.460469254139346e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,2.592791300008186,3.0633777149304997,1.857111541824452
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,429727.04294847226,544229.1934140553,361541.1133999905
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.0004907043820324355,0.0006085749140856528,0.00040886858208183483
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,13.94485647125408,17.660508255551832,11.73218911294999
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,1131156.309557934,1313713.799355555,836585.5370663637
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.001291868651404328,0.0015427780499623484,0.0009550028027523166
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,36.70658535965176,42.63066678471931,27.147617148489072
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,104604.08012994424,117658.55846256555,88283.75422666271
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,0.00011946950843425,0.000138051333630131,9.993896459302323e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,3.394454474429111,3.81807879512919,2.8648517742503365
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,2324332.810181564,2639236.9503072645,2034233.4293956975
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.002632534482519191,0.0030144318352432146,0.002271043937086442
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,74.82532346027334,84.96277195330744,65.48639406606502
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,349743.32921977324,497472.27335182624,276023.26776795747
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,0.00039546441116820554,0.0005697652374339072,0.0003222276282077308
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,11.258997688415445,16.014713384853103,8.885788731642833
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2017,1120937.0163299278,1242058.9867252847,1020042.4160648553
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2017,0.0010537586844949084,0.0011886285895791565,0.0009337336510974402
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2017,41.474770385217376,45.95629417965865,37.74166110419558
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2017,3590609.7581810197,3914109.6304857917,3307622.896553749
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2017,0.0033753690364899595,0.0037387688775387075,0.003057392454645936
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2017,132.85288387661464,144.82240823706144,122.38234455367218
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2017,5052994.80905635,5512654.081443796,4663889.096055087
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2017,0.004749744676588757,0.005190494635642411,0.004319859439180713
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2017,186.96126223886242,203.96869664416374,172.56431587416697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2017,3885406.707417679,4303020.911258005,3502691.6510867393
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2017,0.003652144574281194,0.004052604714848276,0.0032731572769166845
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2017,143.76039750292378,159.21216059180102,129.59990600960046
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2017,371137.23141436116,466339.78876995534,318345.7040966542
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2017,0.00034881015790857095,0.00043399784743935175,0.000297093681112232
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2017,13.732110930472945,17.25461411208488,11.778819673346339
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2017,1317001.6588003635,1539215.4810909338,937590.9177103789
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2017,0.001237868142004121,0.0014607255529397538,0.0008884344497551648
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2017,48.72917978436925,56.95111118788202,34.690948252045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2017,2726499.265692135,2948111.7634527353,2526651.9805054683
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2017,0.0025627326938884847,0.002803280944780523,0.002347890790974376
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2017,100.88071796423021,109.0804003060703,93.48635044448865
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2017,2858288.836223559,3090251.838126069,2564634.9728938267
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2017,0.002687409744438207,0.002992341418832877,0.002373436171756166
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2017,105.7569439228069,114.33959584848876,94.89172457782618
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2017,733946.1027378051,826938.0799443355,653077.3438954558
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2017,0.0006899376339309261,0.0007960424165824398,0.0006049565154007125
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2017,27.156071788797156,30.596783306145323,24.16392044089599
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2017,1383813.691236255,1520939.5810923576,1260555.2447110452
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2017,0.0013011887631978836,0.0014575974746890426,0.0011558093240159272
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2017,51.20123099142184,56.27490124478827,46.64065738809013
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,1213088.8396797883,1280901.6409139247,1129201.9445264474
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0037569382162788594,0.0041940306579687486,0.0033664118070654697
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,142.9641785744253,150.95600992935573,133.07799327086423
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,95554.9593079353,104263.19469774317,88782.94401992433
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.0002955305989989681,0.00031645721637242537,0.0002757023668622328
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,11.261282619480355,12.287560068100905,10.463191357508574
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,1261934.8884814102,1330161.014987728,1193309.324027442
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0039075667294193915,0.004305106170437946,0.003511741792295714
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,148.72075221941358,156.76129452286543,140.6331356076265
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,1356070.776573726,1437519.403080694,1262756.7234629043
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.004198126967789897,0.004602184819502126,0.0037792933488761176
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,159.81479535564802,169.41362736506406,148.8176065957873
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,1815004.5032383585,1904096.7642949934,1721770.2928301035
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.005621212692258803,0.006241756374394121,0.005036763891482145
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,213.90076260436817,224.4004073976235,202.9129834161846
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,164803.27375470093,177952.6753579696,153045.66931983843
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005099220040324715,0.0005521522395992027,0.0004667797196940942
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,19.422291169487785,20.971966129363587,18.036641409098586
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,249128.47031731604,262167.9200460617,234650.45175319724
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.0007715927231758321,0.0008573548545135348,0.0006878386687128269
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,29.36013089347983,30.896847874591234,27.653876607972713
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,142338.81892654076,153605.1187979214,133052.83094047802
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00044062138964104733,0.000488750097296858,0.00039859316892098043
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,16.7748244493439,18.10257329510055,15.680458067216565
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,1250167.9792934551,1320330.3771420498,1167983.7861015233
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0038700717671673185,0.004232116326047498,0.0035133658540874766
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,147.33400588114884,155.60274041001,137.6484863320713
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,745516.5769564571,787432.9049019583,689248.6105349687
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0023087787441764328,0.0025813550779496745,0.0020414041716635537
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,87.86014803856497,92.80004460472796,81.22889125309752
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2021,1586635.894944322,1674450.8034329317,1476343.4642517925
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.0049131734406331245,0.005459900601655739,0.0044049680981606935
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2021,186.98720983805978,197.33631688447895,173.98909606339492
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,1054801.9357583,1113670.710341911,986993.9510540597
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0032662630068554686,0.00362822131805749,0.0029087147417054563
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,124.30985050048322,131.24761608428867,116.3185867801873
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,399704.73495132226,444136.6700588573,356208.36826192355
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0012365649234099174,0.0013855084108808525,0.0010871768119148778
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,47.10574958360676,52.34211389374058,41.979643290877746
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2018,79161479.1996527,81822573.42469779,74686892.53575379
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.16395485938847315,0.18183769759111917,0.1452430170476221
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,5212.127377383188,5387.338379051974,4917.512927411118
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,2174392.6203055354,2227658.096215768,2082068.3813862412
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.0045047812139875475,0.005035367524744693,0.003957961718288959
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,143.16573439577868,146.67282456220775,137.08694837342986
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,4699035.734445149,4886063.747903142,4402732.781341586
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.00973467520845974,0.010908233232864542,0.008483459504759736
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,309.39256121064204,321.70680595616267,289.88346727398687
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2018,2894315.0117566492,3003914.391137193,2744059.178656432
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.005996320321133328,0.0066987885345070235,0.005231418005176885
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,190.56665772377545,197.7828685827564,180.67355631598107
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,69832.76749160804,75940.93264055137,63643.53528748814
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.0001338831985979079,0.00014955494773406742,0.00011921213518210357
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,4.572601376213482,4.972559810762896,4.167334726890654
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,550921.4270132676,574835.2672433874,520556.0906467943
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0010568478801441716,0.0011746875221672042,0.0009467230856789357
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,36.0739544748687,37.639816213914536,34.08565322538423
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,318025.4678139715,331665.26577912195,299757.16693429434
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.000610067255595034,0.0006774472688446955,0.0005497955444745456
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,20.824087946562518,21.717212495209644,19.627892224353307
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,64797.72317983655,69567.209085119,58752.89071531491
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,0.00012432152965039526,0.00014082253956779702,0.00010869552860552758
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,4.242910152790762,4.555212795199226,3.8470986986682627
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2018,110443190.2758015,121426013.78797269,99599977.52153546
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.12610495836753435,0.14060675739520073,0.11172514579240908
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,3583.9365054996715,3940.334595960798,3232.0688536338753
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,7563050.10950658,8855068.108000752,6325139.554414176
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.008631736330759313,0.010213909928029528,0.00727659613515724
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,245.42474110622334,287.3513683523436,205.25392733436578
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,13684775.659011524,16123078.957553595,11126297.50520248
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.015621054716128452,0.018292275834316155,0.012688604690571936
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,444.07778271731763,523.2019385960334,361.0538929595015
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2018,7186250.430051847,8448493.601177711,6186777.459439993
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.008204323078218929,0.009797092741416378,0.0070673991383442885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,233.1974039287467,274.15782320420163,200.76400847275866
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,1053793.4081428954,1170101.482679807,939160.2524875068
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.001203363171135784,0.0013596658610031348,0.0010597425093077375
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,34.19612069577942,37.97037561522052,30.476217727855186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,23627289.17519167,26947425.063955743,20488496.316604998
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.02697767515689719,0.030998457059200756,0.022936750948233414
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,766.7172959193302,874.4573583464147,664.8619050980537
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2018,7352226.182141659,8020498.386139395,6736422.379361922
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.008396098120153024,0.009333599793297313,0.007464683464975323
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,238.5833997104422,260.2691654107741,218.6002597495588
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,129069.17297762216,170059.38080066338,83858.28167650466
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.0007072008245770713,0.0009184874075525357,0.0004640437105511094
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,40.7054978377733,53.63288225821868,26.447005312834627
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,19394.556543548344,25622.50078148183,14862.983427798761
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.00010623220635156167,0.0001384259136103862,8.57328412637877e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,6.116604462824402,8.080757210242473,4.68744879838982
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,8658.839587061966,14265.552077409207,4674.085111447159
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,4.740174647622473e-05,7.656882895028568e-05,2.6015917475309522e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,2.7308021579241544,4.499032463331128,1.4741007245050517
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,62600.14968198168,90566.27369888687,38644.205198755386
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0003429496575514563,0.0004802861604344766,0.00022069358970294527
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,19.742671303596165,28.56255427362499,12.187508255229426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,224169.3996840262,277656.43270904536,175000.72675386426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.0012272952661609568,0.001431935310425689,0.0009979572042086821
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,70.6979583398673,87.566558772647,55.19127100723918
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,13637.594143625949,20549.93826121397,7727.0886720457875
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,7.469482029011837e-05,0.0001141863613155932,4.43721794749479e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,4.3009887343280795,6.480985723858713,2.4369489939071354
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2019,322867.2945307534,404967.1961102544,211092.7356267058
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.0017684829861392222,0.002119235374896838,0.0011843476496596534
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2019,101.8250420004465,127.71749400217448,66.57387426750076
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,190981.560402974,244792.456881314,146254.59404261367
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0010457618227956086,0.0012483576533020265,0.0008385597454799636
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,60.23126448161002,77.20200412234108,46.12539093744878
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2019,49940726.99784532,53291191.19275769,46340156.3197221
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.04765053596770289,0.05176288827570107,0.043778423123058956
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,1788.73918543118,1908.7435777397359,1659.7766682825734
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,2244415.427986365,2544397.6119386763,2044529.7878879872
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.002141645558543352,0.0024309673854707023,0.001908805199310196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,80.38877416819979,91.13330913241596,73.22942150069879
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,3526434.8955044895,4211617.956915945,2999961.0850351797
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.003364875231741632,0.003968562846153082,0.0029252010677477003
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,126.307177761608,150.84854639633483,107.45033703259045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2019,2049540.213233624,2298228.8537850557,1834032.0430731974
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.001955201809278664,0.002214955843341113,0.00173890423082099
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,73.40888112594226,82.3162227500469,65.68997249325136
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,1198044.0727252977,1257711.6718626523,1115868.3848089885
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.00389178751438854,0.0043395388231914685,0.0034703856437128195
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,140.98756198454512,148.0093314864887,131.31700798950874
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,96220.05051282002,104692.89333178035,89462.9695333591
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.00031213579134975087,0.0003337935501958962,0.0002905142402678299
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,11.323314930287053,12.320411347120945,10.528131852206103
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,1258623.4472227884,1315857.5857580598,1198530.5856894962
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.004087940669590293,0.0045007760873547265,0.0036610656798884795
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,148.11663053168226,154.85202686482177,141.04481553494261
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,1359998.1553286347,1436946.084245638,1266625.5576303408
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.004416222236672526,0.004866513591569595,0.003968005829197883
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,160.04655303463812,169.10189677761872,149.0583304764309
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,1804780.8819655029,1881946.6085823872,1719211.1720047654
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0058630094006378915,0.00650352540657473,0.0052716070431445975
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,212.38922862479495,221.4702031166028,202.31926119893404
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,163653.16665762995,176125.5434135885,151210.9716919148
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.0005311041796855743,0.0005742130473934976,0.00048531237582040106
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,19.25894172292289,20.726709087252978,17.794726195390464
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,247415.56289928983,259366.48493466905,233299.60975470993
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,0.0008037705125595482,0.0008944439362682182,0.0007126865486640761
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,29.11622185221812,30.522623669642627,27.45503603756346
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,142690.52259020988,153542.854279586,134383.37888697247
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.00046331167866961947,0.0005126456064646114,0.00042002762777950114
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,16.79202740223996,18.069145516310854,15.814430697378777
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,1248761.2300396594,1313445.4353390825,1169015.3283004626
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.004054747404441538,0.00443673750659404,0.0036700897901653993
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,146.95603052700235,154.568161509236,137.5714172891167
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,741881.5339533412,781120.9860533262,689016.6836503652
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.0024099132563084754,0.0026909566019630406,0.0021181855904910864
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,87.30569361734915,91.92344918338732,81.0844814528085
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,1,Number,2020,1588951.9765743508,1667205.98226021,1487207.5369157821
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.005160995835405661,0.005747374062609667,0.004605563588010777
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,487,Leukemia,3,Rate,2020,186.99017038508222,196.1992151342266,175.0167373374034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,1055225.7899759605,1111807.807882954,995838.6946616264
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.0034274242385510037,0.003798374384534474,0.0030501970938700876
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,124.18049958170367,130.83915341463484,117.19174017599545
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,399181.8867347126,442808.84050342627,357487.46180987475
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,0.0012952662282298725,0.0014496435910841677,0.0011409143591967277
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,46.97630269234887,52.11038581056958,42.06964236796824
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,1195941.7977020415,1326814.9079001206,1085733.826664152
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0011413344365620403,0.0012746624603189498,0.0010089283388476425
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,42.83533872338203,47.522852794626026,38.88799297587529
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,3872153.8066496165,4273532.172624295,3517607.1865115245
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.003695503267422332,0.004124380470304133,0.0033102344060462296
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,138.68987622606113,153.0661429438889,125.9909935580025
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2019,5453939.094829537,5926406.762565579,5012070.2893699
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.0052039411286447235,0.005706900718931422,0.004698612394894327
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,195.3450652469991,212.2675548047741,179.5185425938662
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,3968782.2896975437,4403112.915270747,3564966.7798864944
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.0037867504725506763,0.004258563131820651,0.0033855068803944075
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,142.15084214399926,157.70736797169005,127.68728365164792
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,401859.18349945825,499781.78670289705,343051.45140010474
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.00038340385864528843,0.0004805641312017351,0.0003262411765258792
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,14.393488276249423,17.900806011070898,12.287157408919628
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,1427084.5563578873,1692103.1998937747,1017952.9860896366
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.0013614344206239945,0.001613438902762802,0.0009543900291904106
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,51.11423522110832,60.60647254041921,36.46027009626381
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,2919851.2556578335,3163344.9990292066,2694663.9340265905
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.00278591744422839,0.0030629816301811163,0.0025444188436316347
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,104.58102375744242,113.30229848366909,96.51543459848841
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,3047515.2999945674,3365455.9062907007,2725478.744656208
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0029088581277416474,0.0032499771880217625,0.002551351079456895
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,109.15359793493853,120.54135408727053,97.61913617790707
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,762412.5573588979,866240.2027534165,670164.6670598149
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.0007275633923736268,0.0008392927653462449,0.0006310439419140418
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,27.307516305709736,31.02633637527421,24.00345114545592
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,1498946.6470409879,1643361.1820245264,1355191.7594549074
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,0.0014307135907959947,0.0016104130220178986,0.0012630236509088063
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,53.688137230132305,58.860667811876255,48.539233399926395
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,3850892.9931422765,4307495.907310354,3447199.52634844
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.004127699702459903,0.004693347625396069,0.003593355051731896
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,123.11153336753685,137.70894882504857,110.20561211863415
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,898875.733950171,1065221.1968294308,732151.7690137174
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0009632542667950556,0.0011378133103257487,0.0007887932061836448
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,28.736703437499838,34.054702415988174,23.40660389721282
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,2510893.1608860684,2837544.648267025,2102012.5585970515
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.0026909304170483718,0.0030991327956963535,0.002238037018236305
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,80.2722661235279,90.71518561255834,67.20051419438177
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,11215122.638111718,12741332.661381243,9987629.169871554
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.012013365578885242,0.013549936256516175,0.010528693732169685
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,358.5430567252064,407.33539048784775,319.30057365886387
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,1387660.7674044955,1554378.6676893125,1223617.3769068178
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.00148668631735976,0.0016809162447845797,0.001289234406040018
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,44.362968582448154,49.692874238209306,39.11856595195612
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,1428373.0550387057,1664464.591564782,1219107.7831138088
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.001529800123444516,0.0017715891256157262,0.001276809695750307
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,45.664524394690545,53.21227789721154,38.97439601326638
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,485950.1456594271,536558.8075132829,435866.76674648625
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.0005207823876738944,0.0005935601544600226,0.00045690084876052377
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,15.535634897892287,17.15357389895068,13.934488985715623
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,1546945.3240632974,1810521.1192423296,1200699.1184725184
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,0.0016579055378965648,0.0019803660937071166,0.0012696928092887417
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,49.45523316807928,57.88164760256099,38.38587824991281
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,4688126.365569961,5273785.220439564,4108363.8285347484
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.005022795485878339,0.005762275301902346,0.004308696357306988
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,149.87755476818361,168.60083785646265,131.34277464041463
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,376573.33844475384,443087.1475805647,280173.3969394587
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.0004036706528236797,0.00048399455041782673,0.0003018838864731856
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,12.03890141944366,14.1653217192047,8.957033230326894
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,601865.1836104979,684505.7874605537,510947.3769922445
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,0.0006450874864782256,0.0007573821402193654,0.000532923877787523
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,19.24139303968577,21.883380619324495,16.334786545265132
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,1819649.490792983,2087414.757906944,1518405.816685939
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.0019504625181467421,0.0022842253818651254,0.001621642415139675
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,58.17347804831755,66.73382825167879,48.54283634972113
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,210907.9477582163,227083.45401679943,196905.43152388994
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,0.0002260645746884217,0.00024820480627799334,0.00020401315967049618
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,6.742644081295849,7.259768650074217,6.2949891483538885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,1397658.4944561862,1537230.0598302633,1273333.6887675275
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.001497578340900733,0.0016516482328880551,0.001331411272184343
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,44.68259198141452,49.14463999425451,40.707976874942126
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,1549199.59944497,1803430.5484662321,1361253.4727003998
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.001659394925812614,0.0019387341488145786,0.0014276114132519267
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,49.527301464800196,57.6549648455353,43.518737764064184
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,4217956.26381818,5034023.564380854,3362482.528396127
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.004519769272680541,0.005560734279296779,0.0036185015462626875
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,134.84640166335524,160.9357520769583,107.49724303676741
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,500879.0138818224,562326.6960292775,428645.48733497737
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.000536358163318924,0.0005969919590250168,0.00045888257391995884
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,16.012904939301897,17.977363153156695,13.703627525059753
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,191559.52108124777,211255.64865670554,171932.16815789044
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,0.00020529831782919644,0.00022998735936978053,0.00017976770021690912
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,6.1240824955304385,6.753759942173439,5.496603747446971
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,268891.5683337042,348664.7486143763,214994.89962709043
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.0002882958710941662,0.0003795796919063245,0.00022922843740563455
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,8.596357610070093,11.146674786747777,6.873302324013165
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,2748863.8616446625,3081932.566410251,2410214.6321874945
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.002945311606167574,0.0033442501095047542,0.0025777195745846004
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,87.88009576696659,98.52817117011394,77.05361318579588
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,754351.236644468,882055.4178257087,610388.3513648671
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,0.0008087422995817729,0.0009641137059609528,0.0006474123250753057
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,24.11631214016627,28.198964551091724,19.513875358269498
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2020,4934470.604381538,5580344.181052187,3937314.691547542
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.005287518732802629,0.006149059591138919,0.00424279337445992
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2020,157.75308312754368,178.4014071726675,125.87440105195363
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2020,115249347.190508,128902069.82933585,103543705.93531719
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.12346555505115,0.13807719782660716,0.10884429014450617
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,3684.4762701789396,4120.948439543554,3310.2515263226046
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,8008070.042265559,9478492.580099102,6594223.780914477
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.008574689418379775,0.010106847744060725,0.007101806373834566
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,256.014847458402,303.0236772683311,210.81473894049202
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,14024631.586700356,16531966.901924536,11321871.073648695
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.015018663384939736,0.01741213190004924,0.012334185925540845
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,448.3619520532555,528.5204752512592,361.95576219558586
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2020,7198165.043918729,8451953.003617156,6098847.35069523
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.007710745645048069,0.009114013320442876,0.006515002988310694
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,230.1225034212989,270.20561103065285,194.97774943519187
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,1097050.6699273095,1240682.2366091455,966073.1975443678
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.0011754333814899792,0.0013355778350469215,0.0010232596776675864
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,35.072278143576256,39.66412280030188,30.8849799012248
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,25139446.654782508,29178529.019436177,21442002.3298802
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.026930632412947787,0.0312966192102539,0.02274042767891258
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,803.6982152433767,932.8260887511099,685.492375405593
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2020,7777089.932438476,8700071.813633898,7012611.737882138
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.008334138706370196,0.009332934834466011,0.007432281974967857
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,248.63050425570762,278.1378717330112,224.1904372568375
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,1059.5350539276458,1509.5594035533786,713.7845988513511
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,5.800865005445454e-06,8.036617734640049e-06,3.963235705430254e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,0.33415339117555554,0.4760808922823583,0.22511151791618794
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,51499.56348524337,56408.38731594905,46669.63365655438
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.00016717987331100648,0.00018738072402387808,0.00014783060416577492
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,6.06054323405313,6.638220733453041,5.492150095097695
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,51391.27413586795,56592.17039063452,46139.69923272928
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00015905644133630502,0.00017881362045514952,0.00014092443083147237
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,6.056531931055309,6.66946466655865,5.437626647541638
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,308714.6817870174,324993.2020420325,287325.13609951804
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0010026684782170597,0.0011121739393075195,0.0008989511316665046
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,36.329990961831776,38.24567080677257,33.81283824008126
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,200839.3024005407,211484.24769168138,188390.39940100472
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0006522821858896544,0.0007216662449697061,0.0005877755247871048
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,23.635060045592898,24.88777262789609,22.170055106923034
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,36578.297033168696,40177.00365651192,32506.883981177478
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,0.00011882172607861254,0.00013624348977121342,0.00010176862242125861
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,4.304586982782441,4.728087991362723,3.825457196908596
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,71658.12239003635,85031.76853496418,51263.62373775712
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,7.677616555167072e-05,9.089306147728223e-05,5.473503263488074e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,2.2908819698148615,2.718432173507595,1.638877874708729
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,433815.24216692685,547844.256966866,364507.3943642013
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0004648939846194118,0.0005740494344585426,0.00038490625499013975
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,13.868902552340142,17.514365276287485,11.653157936067423
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,1135256.9983769348,1338826.3254096508,839097.2173424021
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0012162587860222293,0.0014527731867295217,0.0009022542680885031
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,36.29371942697558,42.80175069199009,26.825607789003538
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,99285.89933011928,112514.09633989896,82632.73302186176
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,0.00010639188147896936,0.00012248894274200233,8.908720676137122e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,3.1741311249295197,3.5970313770170175,2.641735952359104
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2018,124458.71808778975,164345.13728628345,79179.56686152262
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2018,0.0006778673144223027,0.0008851636641952786,0.0004515768845748431
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2018,40.438554796057694,53.39826684482784,25.726661036306503
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2018,18694.628792511467,24704.03691395488,14312.362006342082
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2018,0.000101782285838329,0.0001331620951940974,8.22313808531928e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2018,6.074172885861495,8.026722159584937,4.650306898117247
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2018,8341.530746149547,13712.753999150842,4506.245466257748
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2018,4.538810036324214e-05,7.368620677152153e-05,2.489054342764916e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2018,2.7102918408916343,4.455485019606058,1.4641485707993012
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2018,61071.17859256325,87505.44281143777,37619.42847355023
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2018,0.0003325543410439646,0.00046740111108151263,0.00021397266753678251
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2018,19.842966727595442,28.431866392739103,12.223131839193202
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2018,220774.28229762046,273752.7598212915,169772.77615230097
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2018,0.001201577459122969,0.0013915569956513395,0.0009743489625303378
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2018,71.73296535125185,88.94648883332324,55.16179032529501
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2018,13086.233356010865,19804.02695995185,7403.905801311896
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2018,7.124218524208024e-05,0.00010896155038489803,4.244639929178076e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2018,4.251918811085357,6.434633440766455,2.405643052180642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2018,316813.44948692323,396122.98890909314,207696.80468231696
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2018,0.0017250015548738358,0.0020772488577765463,0.001165087989421693
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2018,102.93757025657412,128.70646138006506,67.48389141520462
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,187206.94281716656,237082.2788340359,143990.50268066302
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0010190522436659428,0.0012178322698709722,0.0008113908923208552
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,60.826419648437216,77.03168465098443,46.78473249786057
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,308263.28251412115,326740.32396236155,285939.81228312984
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0009545083034941996,0.0010604365092304587,0.0008547514025590691
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,36.32924937378899,38.50679397458718,33.69839788120848
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,201359.76701707914,213240.93281392183,188639.62682709045
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.000623482136688853,0.0006908035394792389,0.0005634178510477001
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,23.730523889027904,25.130735524888433,22.231437973693566
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,36791.52111242166,40896.72166865911,32474.454213399607
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.00011393870242145486,0.00013108167358324174,9.688386428907163e-05
2,DALYs (Disability-Adjusted Life Years),44562,Europe,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,4.3359310730526595,4.819734572193481,3.8271588357015642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,1019.4947913839986,1419.9535191659756,703.5987049961758
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,5.547679143122667e-06,7.669507567840697e-06,3.849814463467841e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,0.3312495630607164,0.46136477279273563,0.2286100582070391
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,64540.88006383562,89037.96583044832,44342.17199751151
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.0003531411626018374,0.00047694225127190275,0.00025554968670635594
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,20.354733770099717,28.08056053957539,13.984518105495415
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,86225.78222166478,131072.7133106847,62852.32752799296
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0004720661016244109,0.0007202000770727924,0.0003655148176948469
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,27.19366143604887,41.33736914223658,19.822202492405484
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,89967.24891332022,130503.3206044222,66589.04455097686
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0004927860497733961,0.0006852485647818471,0.0003794081612511866
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,28.373635405152157,41.1577955613504,21.000678523438967
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,4716.606711819006,8736.398410586211,2600.08462519355
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,2.5763832609499318e-05,4.61137831034114e-05,1.4962329814407488e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,1.4875110754979632,2.7552624566185138,0.8200078814109522
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2018,2289333.724536678,2578727.694882555,1973377.553648301
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2018,0.0026143145386790544,0.002992843446071247,0.0022111842718419094
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2018,74.29001904190959,83.68099744631846,64.03708400664867
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2018,339078.5594379076,476445.36574868974,266884.91983422654
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2018,0.00038659207752332196,0.0005538784259204765,0.00031615221549001515
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2018,11.003268054526853,15.46088930353004,8.66054850980532
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2018,473285.0645512658,607638.6911780017,377145.8449919113
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.0025772307445935364,0.0031720828538168338,0.002146564537158441
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,153.77760843970736,197.43117145135597,122.54049497804635
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,49964.79306610103,62654.140736482135,38984.9785937499
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.00027219947614235426,0.00033556393295253455,0.00022144811853730062
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,16.234330975930522,20.357295513721915,12.66682010957621
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,226690.2681750191,315523.02410689247,175559.95019475772
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.001234054925878499,0.0016716048289946595,0.0009869033872513745
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,73.65516029871328,102.51829117157023,57.04213232323471
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2018,395102.5159838674,472615.46507680183,323862.2196164965
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.0021515350364970124,0.0024661902331806237,0.0018662352432084668
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,128.37489400625103,153.5600452552592,105.22782425813385
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,663160.3442578587,830180.4823445459,526601.8298834364
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.003608667945459227,0.0042900364471573135,0.0030078247606575084
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,215.4710118493086,269.73842766263476,171.10104684209168
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,37616.50690175972,49521.347593642204,27630.525139165096
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.00020481896059566419,0.0002625452103798576,0.0001561872472907947
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,12.222182575511587,16.090248710641234,8.977583266572275
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,153817.37573676213,198330.97278302404,92953.85298575784
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.0008372740843911009,0.0010541747634228288,0.0005165809480468283
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,49.97763493698632,64.44078835027454,30.202138791256235
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,214594.00751012185,264067.4757122152,173562.27789810987
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.0011691511740471333,0.0013838685017651623,0.0009777478871715465
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,69.72489886552226,85.7995908242661,56.39305781986743
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,57863.410442255,69282.72953858771,47359.595736096446
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.0003150117695035708,0.00035905278422968055,0.0002715126287380613
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,18.800713439820235,22.511026129084723,15.38786223028892
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,25420.859537994696,33816.12979828377,19348.055425712428
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.0001383268247365468,0.00017441948405821006,0.00011146933429266202
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,8.259628872804024,10.987381509698004,6.286481265040385
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,12992.903157153141,16623.235324707523,9786.017045325249
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,7.071367533408111e-05,8.556755592891921e-05,5.51486454188871e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,4.22159439172269,5.401145238309315,3.179627691837553
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2018,14244.125706561557,19770.580594303086,9761.813830347473
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2018,7.766880562031162e-05,0.00010870991092789943,5.290042870769136e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2018,4.628135873136829,6.423766201325161,3.171763694440207
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2018,61395.511016313176,74729.33570217516,48394.00869850488
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2018,0.000334437440110411,0.0003955635221992628,0.00026598497968206034
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2018,19.948347328420017,24.28071237672401,15.723958936930233
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2018,25359.27407057322,34064.18426342679,16350.697844510853
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2018,0.0001379781676746979,0.0001795160368152734,9.414508228283188e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2018,8.239618805713274,11.067978226707552,5.312593612547441
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2018,7725.362823203328,11798.141700069289,2279.1937203004254
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2018,4.2029750110976995e-05,6.358003845878341e-05,1.2584275804767944e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2018,2.510089390645777,3.833397988989186,0.7405451507558279
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2018,62566.27372929713,83158.52135058706,44622.52503797898
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2018,0.0003405697030452169,0.00044032833177163716,0.0002472507966623111
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2018,20.328746169494295,27.01948464568641,14.498545795835254
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2018,11893.627884997417,15228.36285260695,8735.060846301503
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2018,6.472567305037353e-05,8.189190638959639e-05,4.9441479244293735e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2018,3.864422921439148,4.94792968408222,2.8381558327709953
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2018,51660.26251589616,66909.61622327598,36691.706475985455
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2018,0.0002810506568258594,0.0003409965390458162,0.00021149324476712247
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2018,16.785215118913747,21.73996505507626,11.921700670606292
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2018,69550.62721541796,83295.26843858583,58559.82193587746
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2018,0.0003789882538406571,0.00043850194356038835,0.00032853518728538465
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2018,22.59807021125655,27.06391588116916,19.026988262332797
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2020,78242366.66907696,81035691.14072447,73461250.68436354
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.15009097585885883,0.165498235314273,0.13329460623176081
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,5123.256121164246,5306.16107799273,4810.191949188474
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,2159701.7755306945,2224790.4302436234,2060129.4995570562
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.004144109687919139,0.0046272797517957105,0.003659463278355057
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,141.41578038116668,145.6777405297746,134.8958565330324
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,4555748.9179837,4752438.715205828,4266066.57496543
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.008741201496143386,0.00977769743771293,0.007673348601513996
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,298.30729212555826,311.1864041781219,279.3390924117309
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2020,2948010.7119809706,3076499.2792664114,2770898.5230831928
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.005656703977804713,0.006316282108043681,0.004940586281321861
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,193.03370499123037,201.44704761964192,181.43652120790847
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2020,132369.15199559933,174910.17112902852,84527.34698712328
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2020,0.0006973076223306582,0.0009009220517218442,0.00044555607708358686
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2020,40.507548741134,53.52593240579779,25.86702095178098
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2020,20076.091705863902,26868.692238742035,15327.53767955471
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2020,0.00010567753387277436,0.00013850987981871635,8.466233152414974e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2020,6.143676612310672,8.222345191933822,4.690526231192997
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2020,8993.510166679906,14753.334593747177,4849.242566748728
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2020,4.736733063344777e-05,7.660912765235175e-05,2.5169456915248864e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2020,2.752189962226111,4.5148088594715885,1.483963043267714
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2020,63623.25029114125,92356.00597791158,39109.22114260541
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2020,0.0003351142671979034,0.00046800905901212106,0.00020869770299276457
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2020,19.469958622409678,28.262743677704435,11.968186377099007
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2020,228117.0446085992,281259.4624853834,178898.13327915606
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2020,0.0012003223346380503,0.0014202431264833029,0.0009687301908692834
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2020,69.80827605115651,86.07089502175407,54.74632680085639
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2020,14165.698640232033,21526.48477203639,8041.219207375243
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2020,7.464614233026501e-05,0.00011514325297798714,4.339709166807937e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2020,4.334980767577118,6.587525250275336,2.4607703084154013
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2020,325584.1036946318,407915.2780397807,210414.5508946643
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2020,0.0017150061930287566,0.0020655575097510387,0.0011267728864666922
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2020,99.63510191700253,124.83005109830279,64.39096683563263
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,193612.2410880576,247645.33375345723,147643.13771582016
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.0010190553531369067,0.0012262396659769522,0.0007913501586971096
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,59.249131497158984,75.78431436854778,45.181687025662775
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2020,2326720.274315464,2641946.4174478743,1996285.30113689
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2020,0.002493019666567447,0.0028980411518741986,0.0021184425252963194
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2020,74.38433142609266,84.46198715625076,63.820455385205705
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,352490.4157762003,510382.65423242364,277498.3484931592
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,0.0003771390379678935,0.0005458213406668946,0.0003050713408282959
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,11.268979860216392,16.316732580895593,8.871512984336459
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2018,63442.35691905174,87707.89295939602,44330.57910608631
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2018,0.00034513017708368476,0.0004685756254022763,0.0002500601399380054
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2018,20.613399093926727,28.49764556455979,14.403688065129723
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2018,85686.92410320452,130464.76401830766,61634.580399817394
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2018,0.00046633782692826945,0.0007146177326302742,0.0003605490805413129
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2018,27.841001650112727,42.3900116421548,20.02602465398976
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2018,87039.28151158102,125369.07054660033,64367.08647942571
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2018,0.0004738664808626625,0.0006623649425538582,0.00036361172738559453
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2018,28.28040340519041,40.734342333925234,20.913857973571755
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2018,4573.278256573603,8360.539506642715,2591.4143594913153
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2018,2.4843563731475196e-05,4.440145206963543e-05,1.486489560418655e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2018,1.4859285570145566,2.7164680800062437,0.8419904461948755
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2020,1095.1961825568633,1594.2178937639744,736.9373485054958
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2020,5.764518503192498e-06,8.098704060729005e-06,3.979792040910399e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2020,0.33515144636947575,0.48786184743239275,0.22551723807024845
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2018,48767830.9924134,51956213.71395909,45493329.091185816
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2018,0.04617613805511653,0.05025718291915762,0.04257549630360191
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2018,1774.8532012233798,1890.8909901695595,1655.681196573225
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2018,2183751.668701868,2512236.061816897,1998796.2173300507
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2018,0.00206775735702869,0.0023454210712172373,0.0018435785222010045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2018,79.47531315213408,91.43015233214243,72.74405674251334
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2018,3479346.283714423,4130565.5657537384,2977765.8141018725
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2018,0.003294645033134977,0.0038913802504387755,0.002874921289118773
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2018,126.62709749744442,150.32752878391403,108.37261120910688
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2018,1994514.1926051844,2233816.532285991,1797274.172135666
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2018,0.001888160003916139,0.0021605550985318326,0.001676242483497372
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2018,72.5882170191549,81.29737047133118,65.40987681792377
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2018,1162559.2888787424,1276590.8477656469,1059819.0556166861
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2018,0.0011010319397523473,0.0012314091336707682,0.0009740394287580875
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2018,42.31010552426256,46.460162502650576,38.570984300520486
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2018,3746048.388220223,4083738.1692623347,3447198.066893569
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2018,0.0035477695420468476,0.003973133439665215,0.003182316906689525
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2018,136.3334361703446,148.62329562700668,125.4570974302484
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2018,5261511.7342924345,5711206.06588662,4855525.225749692
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2018,0.004982002905300852,0.005492392200657505,0.004497703927193477
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2018,191.48710850675374,207.85325413513164,176.71166248676
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2018,3939124.2067101663,4365499.513903463,3549615.8232100047
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2018,0.003729844051911951,0.004207355379899719,0.0033378433272760535
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2018,143.36022468138174,158.8776992849243,129.1844824494554
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2018,387274.6090576942,484421.3645956069,332110.9390212925
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2018,0.0003666608535138721,0.00046284255776558446,0.00031075964761217875
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2018,14.094446393269152,17.62999896032412,12.086823450789543
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2018,1372722.7341830956,1649226.6988910867,986723.7952351111
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2018,0.0012995069890509878,0.0015553005541290243,0.0009338158580699
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2018,49.958779990358686,60.02184691226625,35.91076025031253
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2018,2834659.9856508123,3065128.7048278046,2619302.200399119
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2018,0.002683927665006419,0.0029447082759050357,0.002428589037800164
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2018,103.16442719576415,111.55209045019039,95.32671026671296
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2018,2959717.0040378342,3221177.1815743744,2649635.5417731246
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2018,0.0028034225775120537,0.0031327801859735173,0.002460170008971254
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2018,107.71574401471776,117.2313083457488,96.43065987746827
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2018,748928.8906814548,843529.1909198216,663846.38497141
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2018,0.0007092113552713186,0.000820262295246294,0.0006167811859500141
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2018,27.25646829200663,30.69934533406491,24.159981231692807
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2018,1446598.0783829987,1572624.223012925,1315757.9582314175
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2018,0.0013703002618172507,0.001527299749775356,0.0012108334937904449
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2018,52.64739435922559,57.233981494279085,47.885607718855844
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2020,63975.557368839865,87378.5946414497,43895.10420780339
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2020,0.00033622779725372086,0.0004578295056442217,0.00023783973807216832
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2020,19.57777147688956,26.73955848480461,13.432760174015984
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2020,86378.40338973707,131344.90985652886,63011.193859583254
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2020,0.0004540108226490042,0.0006844758265231664,0.0003515943979289696
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2020,26.433480404916704,40.194110619444665,19.28265738673746
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2020,92435.92225938692,134342.6639137842,68030.11444023972
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2020,0.0004860427211559129,0.0006666737076283262,0.00037746611092864574
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2020,28.287199622448878,41.11148197642245,20.81854521999623
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2020,4706.367896511711,8695.62173020039,2551.2365188004323
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2020,2.4727854605294374e-05,4.5249090149987125e-05,1.4111715726517486e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2020,1.4402406005289998,2.6610302760137587,0.7807282593976687
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2019,2780785.2487987843,2870655.0859886147,2679928.892397754
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2019,0.005743926940215558,0.006400624434550766,0.005100944641044484
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2019,182.49232316832664,188.39013759992142,175.87350541033274
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2019,306462.29344044736,330499.2030269867,282718.22043830145
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2019,0.0006321963456972009,0.0006826095819657645,0.0005738259869964236
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2019,20.111950722408174,21.68940136306063,18.553717829195087
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2019,370648.9425167109,386037.3796359686,347890.21491198253
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2019,0.0007656536293325249,0.0008610654470793323,0.000666181200711201
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2019,24.324275536550974,25.334159935584005,22.830707101255193
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2019,206777.87258246832,217535.4692981097,195906.2346805843
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2019,0.0004268688494507862,0.0004702579169483397,0.0003843008443698703
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2019,13.570042621478727,14.276022638164093,12.856578516972048
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2019,2417525.283222638,2531849.615135742,2254582.4758035373
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2019,0.004991131608357486,0.00552383892226151,0.004440630271702977
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2019,158.65295798877037,166.15562757985137,147.95964339990527
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2019,1304203.5190844003,1363168.773019723,1213696.688149098
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2019,0.0026938773347490847,0.003031811440151768,0.0023403151146524984
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2019,85.58989953820817,89.45956411641164,79.65028163814881
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2019,2763259.8448668593,2885876.721461516,2596348.2025298867
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2019,0.005706938864415008,0.006404178496919257,0.0050468794705229615
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2019,181.34219779299173,189.3890754434931,170.38842371530168
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2019,1677997.6175222278,1753392.7927941028,1574983.1738475594
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2019,0.0034653044839863464,0.0038790372824208394,0.0030645993129343714
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2019,110.12057965455173,115.06847726620319,103.3601348650074
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2019,754101.1045892802,830562.0599893926,680198.2780146019
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2019,0.0015556089550438387,0.0017382613363969804,0.001367016226388088
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2019,49.48877750978641,54.50661820376438,44.63881704766696
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2019,71620.53054095565,77658.4678216096,65425.160763523534
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2019,0.00014781269567769643,0.00016526966324172695,0.00013180288659343255
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2019,4.700182083680503,5.096428863962142,4.293603609467578
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2019,566265.467635044,589745.5354782444,536817.7351645154
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2019,0.0011694114542776853,0.0013048028587849298,0.0010432068906121965
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2019,37.16184152061267,38.70274876280502,35.229299224184935
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2019,327423.78644423245,339757.294429614,310790.39697584143
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2019,0.0006761626377816845,0.0007530893550755168,0.000607469748618233
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2019,21.4875735098887,22.296974568830464,20.395987639472608
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2019,68679.48107815525,72796.78333759966,62954.87714232388
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2019,0.00014185146311195609,0.00016092360130945963,0.00012505165120149582
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2019,4.507172231786597,4.777375065621678,4.131488323106603
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2020,50996097.0566488,55230915.21276331,47113018.59174196
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.04618373289809731,0.05029122213734066,0.04241516381170747
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,1799.3010261297259,1948.718591268198,1662.2939320635305
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,2295490.5622048085,2583920.2030982953,2087455.8731116871
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.002079046975052348,0.0023549470985369594,0.0018582766780134408
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,80.99205159677452,91.16874704563162,73.65194027139154
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,3559815.470538056,4112285.9521579104,3048661.4880275927
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.0032242013522755515,0.0037999757408161278,0.002781661900425179
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,125.60136949022662,145.09424760952143,107.56626605437523
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2020,2108220.499894495,2373901.3609539415,1881452.5521340822
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.001909003327507537,0.0021690350713621915,0.0016930835616975905
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,74.38458093281308,83.75862862505645,66.38350193562265
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,1220168.8001283305,1358497.230704531,1102656.1452115
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.0011052942794868997,0.0012397568659888363,0.0009765042865607212
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,43.05135296302336,47.932010531820964,38.905140747209956
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,3968584.4681100673,4401365.985910722,3588480.7051705406
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.00359488969948781,0.004033939497637869,0.003177515806468822
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,140.02401199097147,155.2938909427603,126.61276818670294
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2020,5642742.821837945,6188879.299593354,5128639.411155394
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.005109931538941199,0.005613971522154435,0.004647872490202699
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,199.0935294173738,218.36292416616408,180.9543609757117
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,4024794.001222403,4501670.229708847,3562853.8239935553
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.0036446012878557383,0.004099986990934656,0.0032399786395553697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,142.00725926761984,158.832936854267,125.70857205681024
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,412820.5446766133,511653.190555493,345910.725821365
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0003737985307209902,0.00046313944225028685,0.00031671771574062605
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,14.565593692767102,18.052717049431884,12.204807031178738
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,1471006.485298509,1719958.1947309761,1045689.0519815007
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.0013320968546355486,0.001588575231994326,0.0009585155256098261
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,51.90168721149237,60.685478365960385,36.8951643917547
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,2990915.2193016377,3286040.3600406824,2715593.1844079974
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.0027086501554323115,0.0029954525502764347,0.0024611413479514394
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,105.52879796229061,115.94173148499848,95.81457964966262
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,3134667.293031412,3476754.7664950574,2767573.62325403
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.0028399792581020847,0.003204883672421951,0.002449670957511082
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,110.60081854227609,122.67072933065496,97.64861131782035
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,778539.6187167517,881212.0190997194,685158.6654711438
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.0007052582231365141,0.0008133108278803716,0.000608086641919722
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,27.469300901274785,31.091902747825078,24.17453022874368
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,1540983.2135562834,1717427.39318032,1389847.5285388697
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,0.0013962075497820187,0.0015879294843851818,0.0012222747237788734
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,54.37068398235402,60.596183810301206,49.038146615139986
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2019,113192547.1383693,125239609.16054112,102021141.41855523
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2019,0.12815934832933956,0.14202410750556893,0.11340153822352461
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2019,3643.9140366732245,4031.7351389724968,3284.2822133691684
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2019,7783916.406558881,9235824.557926271,6465180.712737862
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2019,0.008808018453603936,0.010429993327786342,0.007401444002746074
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2019,250.58118198787602,297.32126008030093,208.1282146604223
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2019,13861683.796300901,16634992.450336765,11372976.86827803
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2019,0.01568810768445194,0.01842801706869271,0.012817264229233988
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2019,446.2377200110275,535.5165514177908,366.12083654605203
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2019,7223268.062763025,8596817.578822402,6201095.019504098
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.008175978512925348,0.009700199268308757,0.0070111951241824885
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,232.53269362672998,276.75023699127763,199.62672239094678
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,1075790.947730441,1212887.7193573331,968158.4825383145
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.0012182201003818772,0.00138400610671928,0.001077273988809739
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,34.6320480814778,39.04549104343472,31.16712516357671
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,24372833.040172588,27842337.114327513,20973570.30477061
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.027592760385411804,0.031641502077532926,0.023393284288515854
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,784.6144527520107,896.3053274228802,675.1847993956837
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2019,7598888.9288371,8377523.069447375,6885753.253921518
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.008607432827912225,0.009585458343755885,0.007581782253013293
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,244.62474545308777,269.69067025231027,221.66735857936814
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2021,79047974.35994324,82029659.52570647,74340210.73434016
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.1458152841558575,0.16052376775322547,0.13011472366939505
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,5170.1978448424325,5365.217417992182,4862.282688910821
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,2180512.6726723365,2251400.688427734,2077109.2253757627
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.004023393877089549,0.004462145669439697,0.0035674290996246293
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,142.6182266172649,147.25471565131477,135.85503901263831
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,4577396.598398633,4790145.616519553,4273037.620945135
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.008445644689042827,0.00942023796764703,0.007457563294022782
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,299.38839318344674,313.3034178743078,279.48154367806717
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2021,3017440.3203908373,3154760.1904359055,2828264.2728000525
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.005567506852303595,0.006221701838410747,0.004884500679019392
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,197.3581684761163,206.33968763469989,184.98495333089275
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2020,481245.73992021446,631009.6524330718,375787.41325008974
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.0025343262234343946,0.0032361384148564282,0.0020648261878170944
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,147.27060627335064,193.10129185467994,114.99829627252406
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,52946.06637714519,66285.94931928333,41710.027126363886
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.00027889514003738407,0.0003418810464933936,0.00022363767647966368
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,16.20253157242279,20.28479658910619,12.764083862011747
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,242898.54484742362,336775.4360694374,184615.00882796693
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.0012794696096197278,0.001735463645521261,0.00099537837482646
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,74.33170414874814,103.05986844920598,56.495802501570644
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2020,431773.1184249709,526021.9145934782,353005.17263669916
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.00227302472278046,0.002659322778933641,0.001956960941674078
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,132.13101675148923,160.97299123747783,108.0264851808443
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,698303.0200929403,882882.748931055,552411.243728264
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.003673219111265041,0.004379806416211793,0.003022939924576703
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,213.69437815418115,270.1793842890232,169.0486419465547
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,40406.64889986019,53863.53496519399,29746.086497083274
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0002127555395240967,0.0002750635270559875,0.00015976409589957415
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,12.365224639585167,16.48329489974305,9.1028840970338
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,165335.71732807692,215241.48410455417,99317.05781876665
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.0008709255770897594,0.0011131657239305923,0.0005310440081550049
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,50.59596233222146,65.86810277948389,30.392961651317904
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,229768.40045306145,283878.79856335826,184497.27135229338
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.001210593672435751,0.0014484143341786777,0.0009910592627777502
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,70.313623228728,86.87246307781825,56.459772531879054
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2020,61927.688197702795,74650.34206610985,50036.461009943916
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2020,0.00032600896785848663,0.0003799412568911305,0.00027492898180735126
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2020,18.951083468281166,22.84446431964606,15.312135438183827
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2020,27149.762583988067,36032.58156673092,20705.544868198685
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2020,0.00014291431547292148,0.00018153244622981122,0.00011333290150251652
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2020,8.308358213382503,11.026674508965403,6.336301587761025
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2020,13869.974883081512,18033.441210313704,10142.41771503443
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2020,7.300533384738357e-05,9.15218733907186e-05,5.603592771205404e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2020,4.244483515565678,5.518585620473293,3.1037781367546833
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2020,15226.763420022924,21322.781981841297,10395.592148580065
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2020,8.029145530670324e-05,0.00011259596700717,5.387712456861291e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2020,4.65968733732465,6.525188213449663,3.181254463770813
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2020,66702.27921944589,81513.77747783637,52288.54110644081
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2020,0.00035149296055189314,0.00042450578321872457,0.0002734857626814636
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2020,20.412201679106225,24.94480975724002,16.001315982913905
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2020,27169.771053424305,35930.92066611689,17380.330115723373
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2020,0.00014290834370359908,0.00018519254863517062,9.487556161058282e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2020,8.314481196258077,10.995564285589282,5.318720855166247
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2020,8384.539060667146,12886.090646069208,2474.10645350516
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2020,4.422505038068122e-05,6.759871291687512e-05,1.2838744585747193e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2020,2.565832896498486,3.9433957010291474,0.7571249512835625
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2020,69219.52000976987,92224.57819695686,48619.49947638092
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2020,0.00036438110664870353,0.00046576753716357356,0.0002632856250039709
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2020,21.182526580867393,28.222524206908556,14.878517502888572
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2020,12867.752462380142,16572.0541659126,9368.72084045727
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2020,6.773934657172304e-05,8.660286193160086e-05,5.112074135307485e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2020,3.937783858251497,5.071372610204045,2.867011764942924
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2020,53331.078423953455,70185.08074804411,36763.75695145348
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2020,0.0002806949881374608,0.00035079715045323247,0.00019717850512312757
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2020,16.32035278693451,21.478007046508427,11.250428473453676
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2020,73673.93614077741,87941.71868236878,61280.98229943842
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2020,0.00038808157660681316,0.00045635785490699167,0.000330417082096505
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2020,22.545665014707964,26.911885452160217,18.75317881829146
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,2730870.451363781,2842203.0811813585,2606590.6584480647
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.005038660883169578,0.005577313665331726,0.004507694987340856
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,178.6148302535084,185.89663256918095,170.4862080757347
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,307548.4573727994,331224.5838323629,283118.51456925663
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005667796241908685,0.0006100756825348604,0.0005172859700717093
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,20.11546006546655,21.66401660959838,18.517599542724263
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,370951.01093985746,387807.7602590901,349399.4140201021
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.0006844771439486301,0.0007653858278524306,0.0006028859088654011
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,24.2623562821522,25.36488584988659,22.852756341740633
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,198902.98169652285,211133.0510924081,186475.22700552148
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00036679511877864106,0.00040425156097802077,0.00033108890210221297
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,13.009413278795067,13.809331036901746,12.196565751202947
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,2415883.4474135214,2540848.789367252,2244562.725729949
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.004455432271530748,0.004901196753649105,0.004009255848725512
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,158.01284592483387,166.18630700186517,146.80747307123016
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,1313927.8068833158,1379775.7657369191,1214649.204290965
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0024242330503377175,0.002721593495395112,0.0021229656691756273
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,85.93852999311139,90.24536995591612,79.44513125243407
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,1,Number,2021,2724034.600639595,2843091.1001126524,2551998.95944649
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.00502543183100893,0.005617995577792438,0.004468403447530045
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2021,178.1677258087955,185.95471417850658,166.9155930560631
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,1654616.0746282176,1736666.8989787626,1548517.2678071752
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0030522582275595506,0.003384371736700266,0.0027135711360952138
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,108.2215266406558,113.58812836144196,101.28204682718594
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,770089.6515756493,855370.3276632408,688895.9185502062
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.001419168078454773,0.001584316673163806,0.0012474190102682
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,50.36834769202496,55.946200524876254,45.05780473501799
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,2350646.2439373834,2711852.2613456463,2027260.0316872844
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0023923916702958347,0.002772675465604041,0.002046763878363425
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,74.72305067203017,86.20517632639068,64.44315237303121
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,360724.8707114331,511289.7480361837,281734.2072886317
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.000366596579660817,0.000519903494163111,0.00029521376349113485
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,11.46683081827005,16.253032479529047,8.955851822267409
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,3879030.402788016,4414178.420922095,3430116.5313954074
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.003949827171923718,0.004548298130353148,0.0033765570161353583
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,123.30778656866892,140.31923292271014,109.03757723965488
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,923557.9850367488,1100693.6043808076,772398.3286340428
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0009402691558519122,0.001126792463089909,0.0007611785303299143
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,29.358339347082698,34.98917975712105,24.553230669382835
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,2562904.7951906677,2956464.1276740106,2143473.3912241496
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0026091662941839177,0.003009904037825261,0.0021382338191880054
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,81.47038941846085,93.98097199525233,68.13737764228927
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,11489283.944988657,13034602.503482204,10075884.305762269
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.011689994550883815,0.013217691013449094,0.010205619302451951
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,365.22481790739334,414.3478695994786,320.2952445468194
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,1415444.593563467,1582520.8257856478,1250444.2758323587
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0014405451651375175,0.0016398515909313669,0.0012570520097770362
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,44.99457898485528,50.30564856779607,39.74949919689416
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,1450621.25292018,1692801.5594006341,1230071.6478727404
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0014758967757691832,0.0017149881378462945,0.0012625705932957447
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,46.112785225527794,53.81128573770822,39.1018879643341
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,495580.03086883214,550149.7115039118,444052.5957262114
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0005044788624492597,0.0005741653409884777,0.00044482191565505094
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,15.753647259414839,17.48832470046675,14.115677634214048
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,1580096.7722898554,1913013.3024546206,1215014.6996226758
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0016084807101032566,0.0019302046001945475,0.0012359846542353298
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,50.228592025296344,60.81144294011091,38.623253159136375
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2021,51863836.21145002,56472696.31790431,47821215.034658045
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.044866934226515325,0.04872371096389978,0.04122834151024582
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,1804.59744469356,1964.9623112095726,1663.934810025354
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,2336417.4082153817,2657062.2228017654,2107231.9209963903
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0020213235425402373,0.002285478282885167,0.0018062140780895062
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,81.29543035368809,92.45223739545278,73.32094225546821
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,3578141.8105258276,4133112.9891485027,3091081.7761161216
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.0030954975781337,0.0035787476067619113,0.0026813151357069076
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,124.50111753593264,143.8112890153025,107.55390811770476
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2021,2157541.2896015625,2451902.7606429784,1909729.899706054
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.0018661851819097015,0.0021125724017528255,0.0016624759556995478
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,75.07145214175772,85.31373264510968,66.4488774608538
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,4820837.206156527,5554113.289358836,4134998.896215684
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.004906012267311049,0.005633532599068505,0.004239095855421591
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,153.24622484830067,176.555825798691,131.44459011967928
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,382858.40302057104,450132.7836496965,285513.74965732294
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.0003899181652420476,0.00046673342810937726,0.000290160095335766
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,12.170418208568481,14.308956478903596,9.075997053248544
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,618671.5613167294,718244.80389729,527863.3891661556
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0006298616425325439,0.0007401760220446777,0.0005259582445018493
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,19.66651789687387,22.831782117347455,16.779880374727657
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,1864953.5322040087,2153745.8100969843,1600906.7104859385
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0018988965192440921,0.0022143231587088423,0.0015931305808583062
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,59.28370449074419,68.46392038683827,50.89010460734403
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,213707.9965205508,231403.1505476324,197069.6657056486
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.00021756863550815897,0.00023820937154438914,0.00019615803702072423
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,6.793414149070292,7.355913033972773,6.264509878686566
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,1424464.3016186033,1569124.47149386,1286771.750291253
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0014497653769930308,0.0016072473959827705,0.001285562534170495
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,45.28130018069197,49.8798012234126,40.90428789458948
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,1591791.3977825143,1870010.6620726832,1371788.6642661584
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.001619396480069229,0.001892020845332507,0.0014025112901800405
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,50.600344302157374,59.444462057905405,43.6068311578776
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,4266591.133678641,5142792.4731314,3424453.815865111
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.004343014592901128,0.005355898667627639,0.003556446577655209
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,135.62768379162208,163.48063582797835,108.85756913311698
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,512343.82573656517,575740.2554372121,438442.79350500426
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005212015388748731,0.0005802061382029419,0.00044662842939288433
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,16.286539818892017,18.301804617312865,13.93735155187969
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,194945.12084508414,217697.54812739068,174199.74079597462
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.0001984524941995332,0.00022427477941358042,0.00017353567364163244
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,6.196974206876996,6.92023521695553,5.5375138186462305
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,269468.6121249196,348910.2807323487,210297.20993651458
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.0002744067328301815,0.0003592131015833817,0.0002173349724219483
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,8.565949389562151,11.09126507418869,6.684991038018275
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,2780074.6954377578,3168714.30316583,2439835.6594744977
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0028293526034013383,0.003254476528965671,0.0024733630038858674
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,88.37385160570246,100.72804449045547,77.55823067147796
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,774816.7431863116,917077.5692850921,621697.6712769994
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0007890305952304571,0.0009582024964077669,0.0006319934864442156
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,24.63010795944778,29.15233793966726,19.762712791568735
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,1,Number,2021,4912813.419731712,5638426.993993436,3884256.8156992123
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.005001136308047074,0.005894851331283763,0.003980366244895186
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2021,156.16999242299462,179.2360152317062,123.47392535616345
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,69937.00882003998,76215.43768199145,63554.18091797536
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.00012894061451739115,0.00014457376209101649,0.00011473094151735809
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,4.574287642458919,4.98493345133504,4.156813528410303
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,551988.4731218506,577564.1177054469,520171.9988332286
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0010182380000900147,0.0011270255574007324,0.0009145987608670735
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,36.10326054804819,37.776056638994845,34.02227785204027
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,318522.45900000125,333869.89129044657,300539.66012399364
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0005875708396957516,0.0006527003066503779,0.0005291972163975955
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,20.833223677015983,21.837035121830624,19.657043910920876
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,64568.86994987118,69955.92245228504,58088.606347462366
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.00011912812253323034,0.00013564870755856356,0.0001035193722302195
2,DALYs (Disability-Adjusted Life Years),95467,Advanced Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,4.223180099955897,4.575524704147888,3.7993331237054426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2019,472332.7219759619,617390.6283715898,373335.84935474105
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2019,0.0025874719055190352,0.003261344554007497,0.002118263109426116
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2019,148.96305716962763,194.71103989020258,117.74168268132838
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2019,51464.819152561206,64510.23981666112,40477.66243596756
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2019,0.00028207998074982886,0.0003457587181584039,0.00022914860643251007
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2019,16.23083991635387,20.34507052916977,12.765739198244221
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2019,234775.63879416528,326193.4195633,181308.2418318226
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2019,0.0012859107625947314,0.0017328405749448775,0.0010229251909763181
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2019,74.04292626059242,102.87402660457026,57.1805185978476
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2019,413434.54722011305,498234.27819284867,339031.972893876
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2019,0.002265174985347122,0.0026364641323845224,0.0019562148153373453
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2019,130.38790502552374,157.13182215245004,106.9230159393707
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2019,679225.4617193514,860728.7203685361,535950.8927347214
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2019,0.00371830951314767,0.004399077215179821,0.003099843229137804
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2019,214.21234773210523,271.45437022320885,169.02678929498
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,1237728.14127783,1405968.2005783976,1094768.0984835804
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0010708178355199982,0.001207961773142187,0.000938646327456378
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,43.06663764455905,48.920535143986086,38.0923560108602
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,4059293.226741365,4542471.771966001,3635880.780828013
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.0035122040763123966,0.003909258626851248,0.00312738866757405
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,141.24273712367827,158.05489048017515,126.51013973478723
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2021,5822293.058150437,6467015.437351545,5250995.978272492
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.005037077281577922,0.00562172083718059,0.004502703329072821
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,202.5861552577501,225.0192115650313,182.707925535109
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,4084276.9971488137,4562033.133785654,3607695.1149322405
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.003533398097398126,0.004045660250885425,0.003104518462255474
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,142.11204513344998,158.73552627831685,125.52942206390136
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,423965.1984941929,536461.4908433575,351924.93250854884
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.00036672002449377687,0.0004620093441488347,0.0003098843700540305
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,14.75183036446329,18.666128583421163,12.245195888318673
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,1502944.463240503,1757719.6826247494,1071112.6601863222
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0013001719113011091,0.0015219514814156635,0.000929203775436576
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,52.294815347295305,61.159695839312384,37.269267195557454
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,3053897.0676368563,3383890.2368660425,2786099.235740264
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.0026417735315788873,0.002926796519424891,0.002385425351043539
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,106.26006958193261,117.74215176978745,96.94206847679294
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,3213304.4330542255,3599530.207258248,2768146.2386953877
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.002780365949300047,0.0031401472683272595,0.0023915649076512654
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,111.80663430430866,125.24532484701648,96.31739558411128
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,791115.2294354098,900193.8609876735,689268.4219025311
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0006845165607790829,0.000787475030640937,0.0005899140918462927
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,27.52678216236763,31.32216318600332,23.983031795065408
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,1577241.0050840015,1772685.9647354952,1380468.0609405292
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0013647943840113842,0.0015585397959146778,0.001184585328644935
2,DALYs (Disability-Adjusted Life Years),95469,Limited Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,54.879956735867445,61.68044625861229,48.03326011399773
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2021,21732867.193445947,24841926.962804936,18336292.804045178
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.0330290750906503,0.03691135823774417,0.02896635912068141
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,1571.0965980428566,1795.8544812652285,1325.5539174251644
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,1164045.533679022,1351596.344427146,982181.6468247531
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0017696299687477092,0.0020132957036083873,0.0015313209220643245
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,84.1503314611714,97.70861800034554,71.00315987997477
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,1211710.0968285296,1394076.4740365446,927624.0120698693
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.0018419902930040543,0.002042044718776859,0.001428213176017703
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,87.59606332640702,100.77956057408348,67.05911910534047
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2021,1612770.775220179,1929800.2402956965,1338169.7392984228
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.0024503387813408044,0.002862658958560595,0.0021361254022736953
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,116.58924962903636,139.50771269357404,96.73799164657282
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,250582.67546156314,289285.8493919987,210508.85235834113
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.00038085278701879285,0.00043332361749389136,0.00033423860819431505
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,18.11494017065848,20.912841816783914,15.217952553349024
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,1534827.476283099,1762576.7729993872,1325549.3473357253
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.002333202362457728,0.0026184953255271853,0.002083411589575352
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,110.9546294608693,127.41891565434156,95.82564746749728
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2021,2553635.69417061,2921973.3032335844,2203596.451832132
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.003882227497241296,0.004397810448764413,0.0034039157764917585
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,184.60557072571484,211.23316474628666,159.30078889806316
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,2330278.8392079356,2742397.4816330983,1945844.8539734012
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0035402603425186475,0.004019783158457877,0.0030371351678693437
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,168.45881973064903,198.25140031106483,140.66759821358292
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,170554.37072667902,210527.15927113363,130681.16952638587
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.00025913661865981975,0.00031415303782127266,0.00020603609480686927
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,12.329592282735478,15.219275983348064,9.447107877836002
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,1054807.6317245397,1303626.0905325536,643433.3339294787
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0016039662839818134,0.0019707858445326193,0.0009791827578115335
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,76.25338465657381,94.24078736252822,46.514613695740856
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,1343042.184962602,1522879.462957046,1179375.295445933
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.002042007582442734,0.0022884987321399996,0.001829519646057428
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,97.09022693789456,110.09089238822067,85.25853942776976
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,1,Number,2021,117336278.94565272,132747420.45091635,104409812.7683926
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.11940269265959812,0.1346581895729943,0.10435260419785747
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,3729.9209695787094,4219.814976633862,3319.010570081168
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,8199304.604851204,9875384.135113288,6768418.819976445
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.00833973484797927,0.010012533350492833,0.006944947608400557
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,260.6419639041298,313.9216847439376,215.15653567993633
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,14169656.348053373,17092755.416838266,11526947.310158536
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.014414762559127535,0.017336097128650738,0.011865845304820594
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,450.4293030189567,543.3496564747431,366.42207230129753
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2021,7216222.641796969,8655324.887799157,6160986.01529365
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.007341877824475467,0.008897260606156702,0.006141225644161666
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,229.39145841887418,275.1380739836784,195.84727876336265
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,1111759.4699374852,1264287.3480525487,983107.2389262364
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0011315395830644613,0.0012918811838190311,0.0009991581246988248
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,35.340944823793286,40.18954694530959,31.251308962286203
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,25799024.652230658,30074452.906137392,21541309.16403863
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.026250794664587747,0.030521818756090148,0.02193755218371788
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,820.1071647210125,956.0157655516408,684.7616226209161
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2021,7952577.0775459735,8856453.360453784,7125152.663376709
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.008095363047525282,0.009118086548397667,0.007122320637840152
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,252.79891496702928,281.5316064399216,226.49649852018754
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2019,38958.03077643881,51675.5154097724,28739.76585236158
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2019,0.00021341642468496798,0.0002742991996979891,0.00016232834467303425
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2019,12.286481744244076,16.297288750296783,9.063872106504045
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2019,160072.1517660871,207285.77547421056,96404.4142135296
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2019,0.0008766211080201985,0.0011100802723013007,0.0005446831882228991
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2019,50.48313611439874,65.37324514219635,30.403771743396863
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2019,222057.2822420652,272689.6978253187,179224.36878464918
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2019,0.0012172256507278856,0.0014458748298988707,0.0010123732432229776
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2019,70.0318442710822,86.00016292919196,56.52331217233949
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2019,59867.29237599782,72248.70479669762,48764.49418891226
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2019,0.0003279109173993997,0.00037605570180042683,0.0002820309097745814
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2019,18.88078992175022,22.785607353304954,15.379218499455563
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2019,26258.906489565714,34731.27563979763,20062.597601099398
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2019,0.00014374791446135156,0.0001813940371544761,0.00011604899162942264
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2019,8.281465176186032,10.953458775969732,6.327289502453528
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2019,13437.963190879913,17340.318505702995,9980.21099152343
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2019,7.357568661551402e-05,8.996687095167e-05,5.758635375872434e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2019,4.238029647135632,5.46874424896619,3.1475328117769314
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2019,14747.162395185558,20494.97992426688,10142.133922117773
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2019,8.0911923564337e-05,0.00011384951443149758,5.506370337291055e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2019,4.650921464373176,6.4636531074472385,3.1985996416723768
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2019,63965.19468001309,77776.44492118584,50477.834488564724
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2019,0.00035058158772563165,0.00041790113674793636,0.0002771227686955256
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2019,20.17317562104045,24.528931560737043,15.919567277199455
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2019,26266.73957780157,34968.610495256886,16782.468836486583
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2019,0.00014376380688635028,0.00018797906980440578,9.673303051097951e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2019,8.283935555044833,11.028308821281481,5.29281108088098
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2019,8054.874486373489,12378.08264816906,2381.2098410749422
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2019,4.4088930115788556e-05,6.702889788965513e-05,1.3153272784887895e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2019,2.540325225803207,3.903767296612202,0.7509797250654568
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2019,65796.02773130099,88041.8417347847,46235.80923758889
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2019,0.00036031688401362333,0.00046224117722757274,0.00026128093559141957
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2019,20.75057895516926,27.766405530391136,14.581728460247287
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2019,12386.426010211808,15886.813077926026,9057.950104722253
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2019,6.781559788574855e-05,8.556933137256108e-05,5.213607204621138e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2019,3.9063986042882006,5.010341512800635,2.856672588011053
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2019,52555.84470710533,68811.94067871237,37036.8440477588
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2019,0.0002876137687182324,0.0003524645539946649,0.0002106444187796426
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2019,16.57492469916374,21.701729684096986,11.68058290390827
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2019,71699.72830250651,86180.93771258881,60134.617387955994
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2019,0.0003931008251916563,0.0004560756607146243,0.00033904997367311133
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2019,22.612472583927016,27.179518492190837,18.965098184096718
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,70380.41793248912,83534.9893599716,50051.57879022327
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,7.164484867047959e-05,8.498261316359403e-05,5.103849651573767e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,2.237273919481408,2.6554353973642524,1.5910546590338355
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,437809.3635622025,548845.7322134112,363144.17487946094
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.00044553593729851706,0.0005550174959632354,0.0003696800799421798
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,13.917215890107862,17.44687341410214,11.543736387708599
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,1144379.2540555801,1347746.799297426,860649.0233261005
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.001165069308206546,0.001396318731023736,0.000872671201389636
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,36.37787234440753,42.8425811143238,27.3585703279232
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,98936.27403122354,112779.94044618652,83253.42412136079
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.00010070915001880658,0.00011636279794138367,8.429672093834196e-05
2,DALYs (Disability-Adjusted Life Years),95468,Basic Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,3.145016072411579,3.5850827092693818,2.6464849167691984
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,134091.2260920003,175967.68743565743,85181.27599506642
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.0006867272139453553,0.0008925731797849918,0.00043672489396538716
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,39.85983022956604,52.307987267282556,25.32090502007664
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,20703.585407398034,27654.098746788866,15688.504315658256
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.00010596623652944842,0.00013903174750457567,8.4504764733556e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,6.154328090907369,8.220431070131157,4.663549859324168
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,9286.10135426231,15009.683154130948,4959.026556796303
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,4.753471099902651e-05,7.70181072196699e-05,2.5435114053877758e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,2.760377649328704,4.461764127003763,1.4741155138829987
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,64350.486478935985,92929.00120640028,39989.64350625791
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00032953327787357193,0.0004591924555528238,0.0002082229686228857
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,19.12876435689033,27.62398644150546,11.887283363392303
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,229336.48220836523,285273.9340047149,178449.3991906932
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0011732242064866193,0.0013921302059120284,0.0009467776338507739
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,68.17234440081465,84.80025807614535,53.04569854129666
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,14614.54558059706,22392.432615370184,8281.452034236267
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,7.483962827663607e-05,0.00011620907378133904,4.293397173708734e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,4.34430590801801,6.656353204371985,2.4617365487617513
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,1,Number,2021,324239.73487825494,406582.8820752492,208736.99441064027
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.0016602393894941283,0.002009157490191687,0.0010793044516574435
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,487,Leukemia,3,Rate,2021,96.38319495310971,120.86044050822484,62.04896026627041
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,194258.5726623936,250601.9799780369,145613.60830585
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0009939529175238256,0.0011963139788006096,0.0007746555189514211
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,57.7451183990835,74.49370602565922,43.28496259854832
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,1,Number,2020,21288425.197679278,24440441.389153328,18030849.458083045
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,2,Percent,2020,0.03361506238493712,0.03777326006055022,0.029193259724366406
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,410,Neoplasms,3,Rate,2020,1572.9746631764972,1805.8731308213103,1332.2765347718687
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,1,Number,2020,1137974.7396892898,1321152.3667729981,966474.8442564721
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2020,0.001797240563148951,0.0020477067791329255,0.001543238107848772
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2020,84.0835062361144,97.61826813549983,71.41159707664085
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,1,Number,2020,1193232.8728621064,1370362.226479867,911802.4186763326
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,2,Percent,2020,0.0018846723124602937,0.0020835850603617484,0.00145365789937945
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,414,Stomach cancer,3,Rate,2020,88.16645941880212,101.25432208400014,67.37192108307148
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,1,Number,2020,1576850.282832046,1889108.0134834005,1331756.016957008
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,2,Percent,2020,0.002489547932254544,0.0029112124425739027,0.0021816053481162013
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,417,Liver cancer,3,Rate,2020,116.51146195576212,139.5837885433163,98.40175836184372
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,1,Number,2020,245793.42735225527,284941.8808950096,210397.734762481
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,2,Percent,2020,0.0003881385645391334,0.0004451102470806761,0.00033909483930149946
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,423,Larynx cancer,3,Rate,2020,18.161363746274553,21.053993189433545,15.546021037159166
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2020,1496436.0248654976,1692780.911025567,1324359.2145372157
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2020,0.0023638366784988363,0.0026331758964496348,0.002114885566806231
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2020,110.56975470569716,125.07742863207716,97.85521803831972
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,1,Number,2020,2455832.7267921325,2831504.655013938,2128097.188975739
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,2,Percent,2020,0.003878398135559649,0.004354010441783812,0.003353101141086076
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,429,Breast cancer,3,Rate,2020,181.45835684758794,209.2162778432649,157.24239477332858
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,1,Number,2020,2274898.983401382,2697912.394452772,1882597.230439885
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,2,Percent,2020,0.0035902922299607355,0.004140998600980233,0.0030548266326949356
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,432,Cervical cancer,3,Rate,2020,168.08939266049765,199.34531561341925,139.10271506466344
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,1,Number,2020,165160.15812450537,203826.63792383054,126178.41496870185
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,2,Percent,2020,0.0002607201617511207,0.00031787214219699037,0.00020613579115784085
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,435,Uterine cancer,3,Rate,2020,12.203474032658445,15.060491048891027,9.323162607968502
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,1,Number,2020,1039841.3817339295,1278921.377988331,621104.9061914014
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,2,Percent,2020,0.001642966265718284,0.0020215704876412922,0.0010053106924672308
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,438,Prostate cancer,3,Rate,2020,76.8325572230781,94.49787408369306,45.892651595487344
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2020,1309249.0331409052,1475236.312848533,1164954.503840569
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2020,0.0020682873652446603,0.0023215562242082047,0.0018573978637180014
2,DALYs (Disability-Adjusted Life Years),44559,Africa,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2020,96.7387459521183,109.003334946618,86.07700669631126
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,1907425.000920291,2142692.7699097274,1704741.9704586165
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0012481447926560188,0.001391394247518646,0.0011103462189480662
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,41.26191747713531,46.35129150986965,36.87742504734636
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,28773291.227732763,33146721.008089975,24283688.145103976
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.018828782552612947,0.02188073721472017,0.015773137831210204
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,622.4313761282755,717.0385552320819,525.3111057055096
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,1,Number,2021,10552367.936147386,11700281.916280044,9510902.802808424
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.0069053362485455225,0.007720279953076592,0.0060751195312188375
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,228.2715885340736,253.10356457309595,205.74234184473514
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,5318837.660740115,5916376.883537449,4733229.922252983
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0034815903600543294,0.003992255432319906,0.0030127598115334267
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,115.05849012456623,127.98461518244255,102.39047006203728
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,1076127.4534982282,1303328.4146421095,889738.880375308
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0007042842185605583,0.0008552112027760395,0.0005677309675694263
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,23.279071082585265,28.19394181402769,19.247064624051735
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,2455978.6734332875,2993273.761155705,2016001.8500273037
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0016072768560242976,0.0019451816698666698,0.0012997665541238683
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,53.12837427417334,64.75128241461199,43.61068033052116
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,13371934.255241072,15046629.701933814,11816659.004438344
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.008748606800648939,0.00985117939395439,0.0076925642582743314
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,289.26518604046254,325.49263681175364,255.62106424175937
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,4283251.954632893,4716346.71976724,3765671.0179888746
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0028032992771079607,0.0031488027097095195,0.002417952521516516
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,92.6564287458592,102.02524820147636,81.45998228781231
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,2041239.0416097923,2315547.5148285474,1796551.4463952652
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.001335678204595304,0.0015291997079461377,0.0011646161189930435
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,44.156617872458035,50.090530650035284,38.86347169027559
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,1121.7658712116993,1617.10043269206,765.8606279905704
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,5.740319330966256e-06,8.02401460557708e-06,3.888220453761529e-06
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,0.3334550550916856,0.4806977353390674,0.2276590012702869
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,1955312.6122795898,2157505.005735669,1754497.194266576
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0012798627368220982,0.0014546230865855262,0.0011232845484539376
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,42.29783483542271,46.671713676930985,37.953743087547096
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,2521805.254773928,3061531.9036476547,1936539.0288248446
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0016507983584470643,0.0019510237231926799,0.001240922482222578
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,54.55235213215936,66.22786044063477,41.89171975834963
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,5404922.409605522,6135548.307162622,4693886.832212035
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.003536943128323699,0.004060053018253058,0.0030802207568883873
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,116.92069797127635,132.72578885407046,101.53939002807427
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,414222.9746373871,517702.3968599881,282834.32886627864
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.00027114457994312864,0.00033140077652866107,0.0001866904003025829
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,8.960579938070985,11.199073917268366,6.1183463212187625
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,641113.1543900344,753634.766385294,528878.9262691232
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0004196390016056522,0.0004977737250271121,0.00034559715158815355
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,13.868727765015278,16.30282476295889,11.440847530353025
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,2568854.3858308736,2992340.5009688297,2233137.3239952885
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0016814033924095653,0.001961579893916464,0.001427495836460851
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,55.57013126481521,64.7310938856806,48.30781180562658
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,255727.83193941947,285272.1380942377,230242.6899475947
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.00016732692129245726,0.0001876990752386752,0.00014754761079872758
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,5.531971476204843,6.171081649286976,4.980670206035704
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,1528944.5456901507,1673158.7351894062,1400555.9016482611
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0010004635135359866,0.0011145161814558207,0.0008888241956902855
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,33.07452908551845,36.19420822534269,30.2971922922491
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,1966848.3599490195,2290365.9201512286,1728984.0397700153
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.0012867271765357952,0.0015167835259455747,0.0011227688412887658
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,42.54737915205032,49.54579579492073,37.40183584353458
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,4788685.863268977,6005915.45941864,3756026.1027400484
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.003133840250105514,0.004029765787201747,0.0025099428800339964
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,103.59010751080456,129.9215371202631,81.25134095361621
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,775535.8913647749,868941.1221824642,654201.5470826053
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005072385998013394,0.0005709936280540707,0.0004279322141779129
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,16.776595637894367,18.797162068591625,14.151859305667548
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,263981.82777084335,294053.5943330651,238253.3893478299
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.00017278531015358747,0.00019560188352348387,0.00015127134122789167
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,5.7105240770612475,6.36104441190189,5.153959754734692
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,565666.4548731389,820284.164346426,407332.90461088356
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00037041387247824215,0.0005531744323116625,0.00026395576441049504
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,12.236644989605303,17.74460200570559,8.811532137655194
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,1,Number,2021,489457.5001264056,646435.5393215586,378918.86045497446
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.0025055853498962177,0.0031728311723571998,0.0020434815717845253
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,145.49567058355262,192.15881309069886,112.63705977416663
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,54060.375136988616,67630.53568401556,42153.60715546274
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0002768740172476239,0.0003395626434232827,0.0002229897114023688
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,16.069935654317796,20.103788661384286,12.530541137924672
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,249319.3904117783,345441.6445972729,188282.50043621103
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.0012765749246497757,0.001737297920411177,0.0009934845117041207
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,74.11244467206252,102.685654454545,55.96867685762261
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,1,Number,2021,449111.69391519245,552108.9058972881,364126.23788739176
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.002299057488645111,0.0027199689568321115,0.001958341175083011
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,133.50251463350895,164.11936782648527,108.23981887050495
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,716567.4372624363,904318.6246461282,560521.8796571263
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.0036648596501046068,0.004365278870505166,0.003008265194179964
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,213.00615431556514,268.8168935609415,166.62020039820672
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,62950.08945882374,88111.05603529907,43615.281709904244
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,0.0003216236519876992,0.00043129232830896476,0.0002256306047816696
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,18.712483671699427,26.191808646041856,12.965037124641515
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,85829.74060006572,130463.37059999155,62774.510293053216
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.00043876646498342567,0.000661549363011666,0.000338053875722338
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,25.513666991299292,38.781417359288874,18.66029117601251
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,94755.96483553146,138451.3057634246,70257.94142818108
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0004846746357185481,0.0006669112349327138,0.0003762792079451599
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,28.16706791085379,41.15590336242803,20.88480879192415
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,4626.277515461433,8409.286879304458,2454.5453630920674
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,2.3616308590918348e-05,4.200692437979431e-05,1.3260314518688717e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,1.3752028505924212,2.4997366131234937,0.729635818204032
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,154757.9831781074,164238.51021860068,145458.12648669956
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,0.0004232292348906336,0.00046283448175000075,0.0003849351909321133
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,15.070811596644683,15.994054675483026,14.165162755830435
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,918751.5968518596,964260.064979716,870117.491141468
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0025133707226801636,0.002762447740481185,0.002266090465928373
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,89.47087533659175,93.90263087593291,84.73473553119598
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,737918.4801173224,775836.0819582909,685384.7570119719
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.00201824287534235,0.0022054476577549878,0.0018216253445777354
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,71.8607864948176,75.5533199706782,66.74488987267145
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,1,Number,2021,1525270.8549716873,1601603.5602201885,1455489.176027726
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,2,Percent,2021,0.004173398965759084,0.004611479930594119,0.0037354091597362254
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,477,Brain and central nervous system cancer,3,Rate,2021,148.53559872692412,155.969113921668,141.74004275840494
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,1,Number,2021,191847.01881941836,207213.89109337315,178742.66302633376
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,2,Percent,2021,0.0005244737259619969,0.0005673517824816984,0.0004808051860936955
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,480,Thyroid cancer,3,Rate,2021,18.68265673039872,20.179130334632386,17.40651398675953
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,1,Number,2021,123110.4598784672,127616.05458069808,116282.54735432524
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,2,Percent,2021,0.0003368910887684467,0.0003731200049504876,0.0002976492757332975
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,483,Mesothelioma,3,Rate,2021,11.988877783896655,12.42764654718567,11.323954520252883
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,1,Number,2021,133776.89372455227,141993.552912137,126766.0316166233
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,2,Percent,2021,0.00036593071852848073,0.00040219475168188593,0.0003304815712692967
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,484,Hodgkin lymphoma,3,Rate,2021,13.02760813952177,13.827771853385975,12.3448686789212
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,1,Number,2021,1342152.8728836945,1412561.1508990244,1260025.50697115
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,2,Percent,2021,0.0036713671161593257,0.004012125129189654,0.0033048978876108253
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,485,Non-Hodgkin lymphoma,3,Rate,2021,130.70300262214192,137.55957874844097,122.705185429266
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,1,Number,2021,658080.2331474595,686088.8184989633,618067.5870889842
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,2,Percent,2021,0.0018007011951399953,0.0019944715903555716,0.0015962158453053199
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,486,Multiple myeloma,3,Rate,2021,64.08589079263962,66.8134535603404,60.189335423754464
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,1,Number,2021,1826107.107331057,1938807.4647269351,1715329.544115975
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,2,Percent,2021,0.00499599802733161,0.005565320318450003,0.004468252159786832
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,487,Leukemia,3,Rate,2021,177.83196449521424,188.807074265371,167.04410237614997
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,1,Number,2021,880159.9490551539,929465.6979421638,829239.8591150299
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,2,Percent,2021,0.0024077723195969386,0.00264115034834401,0.0021520072912066066
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,489,Other malignant neoplasms,3,Rate,2021,85.71270117843635,90.51424767605651,80.75394515039599
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,1,Number,2021,339506.9544014204,369445.33597598464,309208.0267893733
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,2,Percent,2021,0.0009280795617486574,0.0010132426410843138,0.000832666909289876
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,490,Other neoplasms,3,Rate,2021,33.062238473641834,35.977730772991904,30.111635084761993
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,41730.22469229171,55167.05251417938,30554.779245756145
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.00021362942936767034,0.0002761405595407342,0.00016090215944381762
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,12.404686869931073,16.398905518039218,9.082684594159055
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,168325.30800750887,219408.90030509923,100906.80614706432
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.0008617906817283898,0.0010957312498625655,0.0005249827493978279
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,50.036220833087064,65.22128085410057,29.995461144267033
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,236182.95811462894,293028.84071402263,187682.91141567932
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.0012098703317062918,0.0014522712067463828,0.000986915563386739
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,70.20752131169807,87.10547426282596,55.790443596115196
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,63680.456078303796,76862.75753959137,51287.64636225389
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0003259326259436869,0.00038201570201271194,0.00027484074436627114
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,18.92959175778586,22.84815014222017,15.245716938040772
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,27913.98250236993,37276.41858225851,21373.26172811791
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0001428281650619622,0.00017992703988150877,0.00011407261210683659
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,8.297683867937453,11.080752705144445,6.353395436554128
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,14233.115431910466,18596.16497372889,10387.596163858623
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,7.283003683058668e-05,9.254550827859315e-05,5.568893800074204e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,4.230922345094548,5.527878298802867,3.0878069479401864
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,15645.546373320261,21999.928482699725,10619.864965970959
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,8.021705789902993e-05,0.00011232695267669084,5.374580407053297e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,4.650780222275513,6.53967779951057,3.1568509509644422
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,69007.86996637922,84982.69463142403,53745.216941702194
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.0003535110332125848,0.0004314991665770421,0.00027504184598097566
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,20.51321373910495,25.261874912945615,15.976252029179221
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,27998.616465282634,37422.59808644948,17905.053256668645
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.00014318359192893102,0.00018748197670983684,9.615339710285301e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,8.32284207919164,11.124205885415137,5.322439087643856
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,8647.499412147605,13331.719393109408,2578.0460481133923
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,4.430357611463233e-05,6.743522967475927e-05,1.2967411647863376e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,2.570547443887085,3.962974216619962,0.7663475142758364
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,72424.76652252654,97772.93503395861,50566.942088776865
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.00037064919290588194,0.00047586844265488405,0.0002697279659831674
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,21.52891715691529,29.06388960024946,15.031481071729822
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,1,Number,2021,13329.552628499192,17424.866369664483,9727.051101237848
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,2,Percent,2021,6.821373694352314e-05,8.750086045778609e-05,5.144744669552585e-05
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,468,Testicular cancer,3,Rate,2021,3.9623301262344324,5.179699190692524,2.891453951384112
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,1,Number,2021,53145.6281822698,70909.33027817094,35605.04461038309
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,2,Percent,2021,0.0002718492146991062,0.0003376097440468886,0.00019066021859840836
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,471,Kidney cancer,3,Rate,2021,15.798018845285938,21.07844002142916,10.583921669209541
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,1,Number,2021,75071.58134575833,90074.20812512407,62424.18381026955
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,2,Percent,2021,0.000384530321608917,0.0004496831949167625,0.0003277071843299714
2,DALYs (Disability-Adjusted Life Years),95470,Minimal Health System,3,Both,22,All ages,474,Bladder cancer,3,Rate,2021,22.315706811823304,26.775373367581164,18.556153459208446
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,1,Number,2021,36220.69555712359,39846.18105741519,32964.4527177348
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,2,Percent,2021,9.903434361426042e-05,0.00011064027817597459,8.870115232343162e-05
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1008,Eye cancer,3,Rate,2021,3.5272834876156236,3.8803444916374894,3.2101804772405558
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,1,Number,2021,347561.93639989616,366382.81759869296,329878.88589582115
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,2,Percent,2021,0.0009508217492034569,0.0010436162479172894,0.0008625311756414132
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1011,Soft tissue and other extraosseous sarcomas,3,Rate,2021,33.84665756221113,35.67949325058696,32.12462735008206
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,1,Number,2021,303733.46537996404,321770.51062605216,287815.19599013845
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,2,Percent,2021,0.0008309257475481017,0.000916580658948849,0.0007429553763341937
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1012,Malignant neoplasm of bone and articular cartilage,3,Rate,2021,29.578505343206054,31.335008659426567,28.02833498047519
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,1,Number,2021,46368.09159600942,51928.45893111455,41283.236948014994
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,2,Percent,2021,0.00012682110257831476,0.00014536362693366692,0.00011064412107766847
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,1013,Neuroblastoma and other peripheral nervous cell tumors,3,Rate,2021,4.515468334419838,5.056954122710729,4.0202894439838435
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,1,Number,2021,146071333.78301898,160699558.86615604,132547253.95848113
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,2,Percent,2021,0.09558349938866631,0.1064855445289459,0.08501336654203387
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,410,Neoplasms,3,Rate,2021,3159.8533716513366,3476.2949701027237,2867.2969327847786
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,9523437.296404772,11106297.506238066,8090101.870196788
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.006230184478309989,0.007381688410494323,0.005226808580066234
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,206.01349129498402,240.25433815631308,175.00720373730073
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,16409104.89130994,19619475.490308564,13701718.864091352
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.01073548555405145,0.012860408112525906,0.008890533837372863
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,354.96605715675184,424.4136352596867,296.3991731220221
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,1,Number,2021,8871215.519672196,10317635.762160959,7734220.962156664
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.005804865740641047,0.006925287476594305,0.004967940603339176
2,DALYs (Disability-Adjusted Life Years),44561,Asia,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,191.90445890034408,223.19380063280232,167.30869467290518
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,1,Number,2021,1120907.8488800689,1159642.4869082305,1073936.2277594937
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,2,Percent,2021,0.0030674132549483382,0.0033721825649098034,0.002726711388942999
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,411,Esophageal cancer,3,Rate,2021,109.15747711851495,112.92957610816653,104.58323521021573
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,1,Number,2021,2354510.5828454834,2528167.899229599,2193809.0929573644
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,2,Percent,2021,0.006441388041014984,0.007151990929768317,0.005740603621842687
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,414,Stomach cancer,3,Rate,2021,229.28953109664255,246.20081828104506,213.63992241302037
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,1,Number,2021,1055038.9093298106,1100695.3439205613,998904.1031420209
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,2,Percent,2021,0.0028869576406160917,0.003192057370453781,0.0025784595262601196
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,417,Liver cancer,3,Rate,2021,102.74295582761486,107.18912079927807,97.27637458445732
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,1,Number,2021,406999.39997506444,425648.01840318355,389145.320555169
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,2,Percent,2021,0.0011134156817585075,0.0012197473608157982,0.0010025800285232468
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,423,Larynx cancer,3,Rate,2021,39.6348618081457,41.4509220145161,37.89617627061773
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",1,Number,2021,6369658.3088190835,6618153.9000923615,5990135.859188529
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",2,Percent,2021,0.017429804911043706,0.019280351789009054,0.015549299593533817
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,426,"Tracheal, bronchus, and lung cancer",3,Rate,2021,620.2970492109291,644.4963193343093,583.3379779073418
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,1,Number,2021,3507440.7411562,3725850.163912201,3297689.956612656
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,2,Percent,2021,0.009591384528089235,0.010461239976303712,0.008744779345451977
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,429,Breast cancer,3,Rate,2021,341.56543986183624,362.8348257357742,321.139258987754
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,1,Number,2021,1449519.755892548,1557646.3536624545,1345187.4730232386
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,2,Percent,2021,0.003964892368946039,0.004411579141000549,0.0035235614709164358
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,432,Cervical cancer,3,Rate,2021,141.15872214184623,151.68842503737326,130.99852138010849
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,1,Number,2021,584073.8148510546,625271.8070996669,543539.9081932048
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,2,Percent,2021,0.0015970181900524904,0.0017336700782742721,0.0014465351080437138
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,435,Uterine cancer,3,Rate,2021,56.87891662443816,60.890904675641266,52.93159928434724
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,1,Number,2021,2192819.8954538633,2342983.121656772,2037850.9297741363
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,2,Percent,2021,0.005994816507387583,0.006476051167069717,0.005463286713113425
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,438,Prostate cancer,3,Rate,2021,213.54359129716454,228.16695123229542,198.45223357122313
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,1,Number,2021,3883766.215063414,4062536.271567868,3654220.1061026715
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,2,Percent,2021,0.01062433754281183,0.011643834869549015,0.009577437621442442
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,441,Colon and rectum cancer,3,Rate,2021,378.21317977032527,395.6223614188057,355.85926890997996
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,1,Number,2021,498566.0872112028,519113.6484725996,472130.86185617803
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,2,Percent,2021,0.0013639140047716387,0.0014902412191082903,0.0012292082495334545
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,444,Lip and oral cavity cancer,3,Rate,2021,48.55190933955818,50.552894478946115,45.97756524008838
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,1,Number,2021,79709.18192335736,83639.84378368536,75654.09958761014
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,2,Percent,2021,0.0002180685085639294,0.00024164837926654616,0.00019724133256862608
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,447,Nasopharynx cancer,3,Rate,2021,7.762326948310425,8.145106971224939,7.367430474242303
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,1,Number,2021,262076.49478786188,272669.8120823915,251737.50278647433
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,2,Percent,2021,0.0007170460405598199,0.0007886279277909574,0.0006464115871189554
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,450,Other pharynx cancer,3,Rate,2021,25.521820559726933,26.553430599162482,24.514977504833915
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,1,Number,2021,541955.5891314482,575895.3540375482,505362.3922368502
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,2,Percent,2021,0.0014828278274891626,0.001641118731520883,0.0013148831465514732
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,453,Gallbladder and biliary tract cancer,3,Rate,2021,52.77731338840583,56.08247278651964,49.213754567128746
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,1,Number,2021,2287795.687545624,2374993.058862145,2155838.2760746544
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,2,Percent,2021,0.006260528627009608,0.0069322178559113636,0.005546246273629166
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,456,Pancreatic cancer,3,Rate,2021,222.79262801541714,231.28417803336717,209.9422066916193
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,1,Number,2021,452090.8794803337,476628.6615070873,428664.5568428228
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,2,Percent,2021,0.00123623622412023,0.001331779935334075,0.0011403484886889283
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,459,Malignant skin melanoma,3,Rate,2021,44.026009704249944,46.41557489714301,41.744681868219544
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,1,Number,2021,323859.3514436154,357735.6100116304,295336.4000392803
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,2,Percent,2021,0.0008852279617635144,0.000986337122570641,0.0007986571138737001
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,462,Non-melanoma skin cancer,3,Rate,2021,31.53842644615648,34.83740140042558,28.760773119540918
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,1,Number,2021,944236.6293117206,990123.3275477707,889096.8510095605
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,2,Percent,2021,0.0025834138499207754,0.0028488018022689012,0.002318819254526244
2,DALYs (Disability-Adjusted Life Years),44560,America,3,Both,22,All ages,465,Ovarian cancer,3,Rate,2021,91.95268670974032,96.42127546817417,86.58300436310336
